Gene	"Gene synonym"	Ensembl	"Gene description"	Uniprot	Chromosome	Position	"Protein class"	"Biological process"	"Molecular function"	"Disease involvement"	Evidence	"HPA evidence"	"UniProt evidence"	"NeXtProt evidence"	"MS evidence"	"RNA tissue specificity"	"RNA tissue distribution"	"RNA tissue specificity score"	"RNA tissue specific NX"	"RNA single cell type specificity"	"RNA single cell type distribution"	"RNA single cell type specificity score"	"RNA single cell type specific NX"	"RNA cancer specificity"	"RNA cancer distribution"	"RNA cancer specificity score"	"RNA cancer specific FPKM"	"RNA brain regional specificity"	"RNA brain regional distribution"	"RNA brain regional specificity score"	"RNA brain regional specific NX"	"RNA blood cell specificity"	"RNA blood cell distribution"	"RNA blood cell specificity score"	"RNA blood cell specific NX"	"RNA blood lineage specificity"	"RNA blood lineage distribution"	"RNA blood lineage specificity score"	"RNA blood lineage specific NX"	"RNA cell line specificity"	"RNA cell line distribution"	"RNA cell line specificity score"	"RNA cell line specific NX"	"RNA mouse brain regional specificity"	"RNA mouse brain regional distribution"	"RNA mouse brain regional specificity score"	"RNA mouse brain regional specific pTPM"	"RNA pig brain regional specificity"	"RNA pig brain regional distribution"	"RNA pig brain regional specificity score"	"RNA pig brain regional specific pTPM"	Antibody	"Reliability (IH)"	"Reliability (Mouse Brain)"	"Reliability (IF)"	"Subcellular location"	"Secretome location"	"CCD Protein"	"CCD Transcript"	"Blood concentration - Conc. blood IM [pg/L]"	"Blood concentration - Conc. blood MS [pg/L]"	"Subcellular main location"	"Subcellular additional location"	"Antibody RRID"	"Pathology prognostics - Breast cancer"	"Pathology prognostics - Cervical cancer"	"Pathology prognostics - Colorectal cancer"	"Pathology prognostics - Endometrial cancer"	"Pathology prognostics - Glioma"	"Pathology prognostics - Head and neck cancer"	"Pathology prognostics - Liver cancer"	"Pathology prognostics - Lung cancer"	"Pathology prognostics - Melanoma"	"Pathology prognostics - Ovarian cancer"	"Pathology prognostics - Pancreatic cancer"	"Pathology prognostics - Prostate cancer"	"Pathology prognostics - Renal cancer"	"Pathology prognostics - Stomach cancer"	"Pathology prognostics - Testis cancer"	"Pathology prognostics - Thyroid cancer"	"Pathology prognostics - Urothelial cancer"	"Tissue RNA - adipose tissue [NX]"	"Tissue RNA - adrenal gland [NX]"	"Tissue RNA - amygdala [NX]"	"Tissue RNA - appendix [NX]"	"Tissue RNA - basal ganglia [NX]"	"Tissue RNA - bone marrow [NX]"	"Tissue RNA - breast [NX]"	"Tissue RNA - cerebellum [NX]"	"Tissue RNA - cerebral cortex [NX]"	"Tissue RNA - cervix, uterine [NX]"	"Tissue RNA - colon [NX]"	"Tissue RNA - corpus callosum [NX]"	"Tissue RNA - ductus deferens [NX]"	"Tissue RNA - duodenum [NX]"	"Tissue RNA - endometrium 1 [NX]"	"Tissue RNA - epididymis [NX]"	"Tissue RNA - esophagus [NX]"	"Tissue RNA - fallopian tube [NX]"	"Tissue RNA - gallbladder [NX]"	"Tissue RNA - heart muscle [NX]"	"Tissue RNA - hippocampal formation [NX]"	"Tissue RNA - hypothalamus [NX]"	"Tissue RNA - kidney [NX]"	"Tissue RNA - liver [NX]"	"Tissue RNA - lung [NX]"	"Tissue RNA - lymph node [NX]"	"Tissue RNA - midbrain [NX]"	"Tissue RNA - olfactory region [NX]"	"Tissue RNA - ovary [NX]"	"Tissue RNA - pancreas [NX]"	"Tissue RNA - parathyroid gland [NX]"	"Tissue RNA - pituitary gland [NX]"	"Tissue RNA - placenta [NX]"	"Tissue RNA - pons and medulla [NX]"	"Tissue RNA - prostate [NX]"	"Tissue RNA - rectum [NX]"	"Tissue RNA - retina [NX]"	"Tissue RNA - salivary gland [NX]"	"Tissue RNA - seminal vesicle [NX]"	"Tissue RNA - skeletal muscle [NX]"	"Tissue RNA - skin 1 [NX]"	"Tissue RNA - small intestine [NX]"	"Tissue RNA - smooth muscle [NX]"	"Tissue RNA - spinal cord [NX]"	"Tissue RNA - spleen [NX]"	"Tissue RNA - stomach 1 [NX]"	"Tissue RNA - testis [NX]"	"Tissue RNA - thalamus [NX]"	"Tissue RNA - thymus [NX]"	"Tissue RNA - thyroid gland [NX]"	"Tissue RNA - tongue [NX]"	"Tissue RNA - tonsil [NX]"	"Tissue RNA - urinary bladder [NX]"	"Tissue RNA - vagina [NX]"	"Tissue RNA - B-cells [NX]"	"Tissue RNA - dendritic cells [NX]"	"Tissue RNA - granulocytes [NX]"	"Tissue RNA - monocytes [NX]"	"Tissue RNA - NK-cells [NX]"	"Tissue RNA - T-cells [NX]"	"Tissue RNA - total PBMC [NX]"	"Cell RNA - A-431 [NX]"	"Cell RNA - A549 [NX]"	"Cell RNA - AF22 [NX]"	"Cell RNA - AN3-CA [NX]"	"Cell RNA - ASC diff [NX]"	"Cell RNA - ASC TERT1 [NX]"	"Cell RNA - BEWO [NX]"	"Cell RNA - BJ [NX]"	"Cell RNA - BJ hTERT+ [NX]"	"Cell RNA - BJ hTERT+ SV40 Large T+ [NX]"	"Cell RNA - BJ hTERT+ SV40 Large T+ RasG12V [NX]"	"Cell RNA - CACO-2 [NX]"	"Cell RNA - CAPAN-2 [NX]"	"Cell RNA - Daudi [NX]"	"Cell RNA - EFO-21 [NX]"	"Cell RNA - fHDF/TERT166 [NX]"	"Cell RNA - GAMG [NX]"	"Cell RNA - HaCaT [NX]"	"Cell RNA - HAP1 [NX]"	"Cell RNA - HBEC3-KT [NX]"	"Cell RNA - HBF TERT88 [NX]"	"Cell RNA - HDLM-2 [NX]"	"Cell RNA - HEK 293 [NX]"	"Cell RNA - HEL [NX]"	"Cell RNA - HeLa [NX]"	"Cell RNA - Hep G2 [NX]"	"Cell RNA - HHSteC [NX]"	"Cell RNA - HL-60 [NX]"	"Cell RNA - HMC-1 [NX]"	"Cell RNA - HSkMC [NX]"	"Cell RNA - hTCEpi [NX]"	"Cell RNA - hTEC/SVTERT24-B [NX]"	"Cell RNA - hTERT-HME1 [NX]"	"Cell RNA - hTERT-RPE1 [NX]"	"Cell RNA - HUVEC TERT2 [NX]"	"Cell RNA - JURKAT [NX]"	"Cell RNA - K-562 [NX]"	"Cell RNA - Karpas-707 [NX]"	"Cell RNA - LHCN-M2 [NX]"	"Cell RNA - MCF7 [NX]"	"Cell RNA - MOLT-4 [NX]"	"Cell RNA - NB-4 [NX]"	"Cell RNA - NTERA-2 [NX]"	"Cell RNA - OE19 [NX]"	"Cell RNA - PC-3 [NX]"	"Cell RNA - REH [NX]"	"Cell RNA - RH-30 [NX]"	"Cell RNA - RPMI-8226 [NX]"	"Cell RNA - RPTEC TERT1 [NX]"	"Cell RNA - RT4 [NX]"	"Cell RNA - SCLC-21H [NX]"	"Cell RNA - SH-SY5Y [NX]"	"Cell RNA - SiHa [NX]"	"Cell RNA - SK-BR-3 [NX]"	"Cell RNA - SK-MEL-30 [NX]"	"Cell RNA - SuSa [NX]"	"Cell RNA - T-47d [NX]"	"Cell RNA - THP-1 [NX]"	"Cell RNA - TIME [NX]"	"Cell RNA - U-138 MG [NX]"	"Cell RNA - U-2 OS [NX]"	"Cell RNA - U-2197 [NX]"	"Cell RNA - U-251 MG [NX]"	"Cell RNA - U-266/70 [NX]"	"Cell RNA - U-266/84 [NX]"	"Cell RNA - U-698 [NX]"	"Cell RNA - U-87 MG [NX]"	"Cell RNA - U-937 [NX]"	"Cell RNA - WM-115 [NX]"	"Blood RNA - basophil [NX]"	"Blood RNA - classical monocyte [NX]"	"Blood RNA - eosinophil [NX]"	"Blood RNA - gdT-cell [NX]"	"Blood RNA - intermediate monocyte [NX]"	"Blood RNA - MAIT T-cell [NX]"	"Blood RNA - memory B-cell [NX]"	"Blood RNA - memory CD4 T-cell [NX]"	"Blood RNA - memory CD8 T-cell [NX]"	"Blood RNA - myeloid DC [NX]"	"Blood RNA - naive B-cell [NX]"	"Blood RNA - naive CD4 T-cell [NX]"	"Blood RNA - naive CD8 T-cell [NX]"	"Blood RNA - neutrophil [NX]"	"Blood RNA - NK-cell [NX]"	"Blood RNA - non-classical monocyte [NX]"	"Blood RNA - plasmacytoid DC [NX]"	"Blood RNA - T-reg [NX]"	"Blood RNA - total PBMC [NX]"	"Brain RNA - amygdala [NX]"	"Brain RNA - basal ganglia [NX]"	"Brain RNA - cerebellum [NX]"	"Brain RNA - cerebral cortex [NX]"	"Brain RNA - hippocampal formation [NX]"	"Brain RNA - hypothalamus [NX]"	"Brain RNA - midbrain [NX]"	"Brain RNA - olfactory region [NX]"	"Brain RNA - pons and medulla [NX]"	"Brain RNA - thalamus [NX]"	"Single Cell Type RNA - Alveolar cells type 1 [NX]"	"Single Cell Type RNA - Alveolar cells type 2 [NX]"	"Single Cell Type RNA - B-cells [NX]"	"Single Cell Type RNA - Basal glandular cells [NX]"	"Single Cell Type RNA - Basal keratinocytes [NX]"	"Single Cell Type RNA - Bipolar cells [NX]"	"Single Cell Type RNA - Cardiomyocytes [NX]"	"Single Cell Type RNA - Cholangiocytes [NX]"	"Single Cell Type RNA - Ciliated cells [NX]"	"Single Cell Type RNA - Club cells [NX]"	"Single Cell Type RNA - Collecting duct cells [NX]"	"Single Cell Type RNA - Cone photoreceptor cells [NX]"	"Single Cell Type RNA - Cytotrophoblasts [NX]"	"Single Cell Type RNA - Distal tubular cells [NX]"	"Single Cell Type RNA - Ductal cells [NX]"	"Single Cell Type RNA - Early spermatids [NX]"	"Single Cell Type RNA - Endothelial cells [NX]"	"Single Cell Type RNA - Enterocytes [NX]"	"Single Cell Type RNA - Erythroid cells [NX]"	"Single Cell Type RNA - Exocrine glandular cells [NX]"	"Single Cell Type RNA - Extravillous trophoblasts [NX]"	"Single Cell Type RNA - Fibroblasts [NX]"	"Single Cell Type RNA - Glandular cells [NX]"	"Single Cell Type RNA - granulocytes [NX]"	"Single Cell Type RNA - Hepatocytes [NX]"	"Single Cell Type RNA - Hofbauer cells [NX]"	"Single Cell Type RNA - Horizontal cells [NX]"	"Single Cell Type RNA - Intestinal endocrine cells [NX]"	"Single Cell Type RNA - Ito cells [NX]"	"Single Cell Type RNA - Kupffer cells [NX]"	"Single Cell Type RNA - Late spermatids [NX]"	"Single Cell Type RNA - Leydig cells [NX]"	"Single Cell Type RNA - Macrophages [NX]"	"Single Cell Type RNA - Melanocytes [NX]"	"Single Cell Type RNA - monocytes [NX]"	"Single Cell Type RNA - Mucus-secreting cells [NX]"	"Single Cell Type RNA - Muller glia cells [NX]"	"Single Cell Type RNA - Pancreatic endocrine cells [NX]"	"Single Cell Type RNA - Paneth cells [NX]"	"Single Cell Type RNA - Peritubular cells [NX]"	"Single Cell Type RNA - Proximal tubular cells [NX]"	"Single Cell Type RNA - Rod photoreceptor cells [NX]"	"Single Cell Type RNA - Sertoli cells [NX]"	"Single Cell Type RNA - Smooth muscle cells [NX]"	"Single Cell Type RNA - Spermatocytes [NX]"	"Single Cell Type RNA - Spermatogonia [NX]"	"Single Cell Type RNA - Suprabasal keratinocytes [NX]"	"Single Cell Type RNA - Syncytiotrophoblasts [NX]"	"Single Cell Type RNA - T-cells [NX]"	"Single Cell Type RNA - Undifferentiated cells [NX]"	"Single Cell Type RNA - Urothelial cells [NX]"
ACE	"ACE1, CD143, DCP1"	ENSG00000159640	"Angiotensin I converting enzyme"	P12821	17	63477061-63498380	"Candidate cardiovascular disease genes, CD markers, Disease related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins"		"Carboxypeptidase, Hydrolase, Metalloprotease, Protease"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	5	"intestine: 205.6"	"Group enriched"	"Detected in many"	25	"Early spermatids: 470.5;Late spermatids: 1015.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in some"			"Cell type enhanced"	"Detected in some"		"memory B-cell: 3.7"	"Group enriched"	"Detected in many"	23	"B-cells: 3.7;monocytes: 2.0;T-cells: 1.9"	"Group enriched"	"Detected in some"	4	"ASC TERT1: 36.7;HUVEC TERT2: 18.7"									"CAB002426, CAB002921, HPA029298, HPA069790"	Enhanced		Approved	Vesicles	"Secreted to blood"	NA	NA	104000000	92000000	Vesicles		"CAB002426: AB_442052, CAB002921: , HPA029298: AB_10960255, HPA069790: AB_2686197"	"unprognostic (4.72e-2)"	"unprognostic (4.16e-1)"	"unprognostic (1.93e-3)"	"unprognostic (6.06e-2)"	"unprognostic (2.78e-1)"	"unprognostic (1.35e-2)"	"unprognostic (4.37e-1)"	"unprognostic (1.54e-1)"	"unprognostic (1.56e-1)"	"unprognostic (1.25e-2)"	"unprognostic (3.13e-2)"	"unprognostic (2.38e-1)"	"unprognostic (7.66e-2)"	"unprognostic (9.07e-2)"	"unprognostic (1.66e-1)"	"unprognostic (1.08e-1)"	"unprognostic (2.76e-2)"	6.8	2.0	0.5	2.4	4.2	0.0	2.9	0.5	1.1	5.3	83.2	0.7	37.7	46.4	4.5	5.1	1.7	1.5	4.4	4.7	0.6	0.7	2.6	1.4	16.3	2.2	0.4	0.7	1.4	3.0	3.6	3.6	3.6	0.8	3.4	1.4	1.7	2.5	20.1	3.6	1.3	205.6	2.4	0.6	1.4	1.9	32.6	1.3	0.5	6.9	3.1	2.2	1.7	1.6	3.7	0.1	0.0	2.0	0.0	1.9	0.4	0.0	0.0	0.0	0.0	1.5	36.7	0.4	1.3	2.7	0.0	0.0	0.5	3.2	0.7	1.1	6.2	0.0	0.0	1.7	0.0	0.0	0.0	0.7	3.5	0.0	0.0	0.8	0.0	0.0	2.4	0.0	0.0	0.0	0.6	18.7	0.0	3.1	0.0	0.0	0.6	0.0	0.8	0.3	6.3	0.4	0.1	0.2	0.5	0.0	0.0	4.6	3.2	0.0	0.0	0.0	0.7	1.6	0.2	0.0	0.1	0.1	0.3	0.0	0.0	0.0	0.0	0.5	0.0	0.2	0.0	0.0	0.0	0.4	0.6	0.9	3.7	1.9	1.4	0.1	0.0	0.0	0.0	0.0	0.0	2.0	0.0	0.0	0.4	0.5	4.2	0.5	1.1	0.6	0.7	0.4	0.7	0.8	1.3	0.0	3.5	0.0	1.5	1.3	3.1	1.4	0.0	0.0	1.2	0.0	0.0	0.1	0.0	3.4	470.5	13.5	29.6	0.0	0.4	0.1	1.0	6.0	6.9	0.0	4.4	0.0	17.3	2.5	18.5	1015.1	4.0	5.1	3.3	0.0	8.7	1.9	0.7	10.2	2.5	10.7	1.0	0.0	0.9	8.1	3.4	0.1	0.1	0.9	8.6	2.1
ACE2		ENSG00000130234	"Angiotensin I converting enzyme 2"	Q9BYF1	X	15561033-15602148	"Enzymes, FDA approved drug targets, Predicted membrane proteins, Predicted secreted proteins"	"Host-virus interaction"	"Carboxypeptidase, Host cell receptor for virus entry, Hydrolase, Metalloprotease, Protease, Receptor"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	5	"intestine: 122.0"	"Cell type enhanced"	"Detected in many"	13	"Cholangiocytes: 61.1;Enterocytes: 38.8;Proximal tubular cells: 45.6;Sertoli cells: 19.4"	"Cancer enhanced"	"Detected in many"		"renal cancer: 26.9"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"BEWO: 2.4;HaCaT: 4.1;Hep G2: 2.5;NB-4: 2.2;RPMI-8226: 2.1;RT4: 2.5;SH-SY5Y: 2.8;SuSa: 1.9"	"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"HPA000288, CAB026174, CAB026213, CAB080024, CAB080025, CAB080027, CAB080028"	Enhanced				"Secreted to blood"	NA	NA		85000			"CAB026174: , CAB026213: , CAB080024: AB_10864415, CAB080025: AB_2809589, CAB080027: AB_2665870, CAB080028: AB_2665871, HPA000288: AB_1078160"	"unprognostic (1.40e-1)"	"unprognostic (7.26e-2)"	"unprognostic (2.76e-2)"	"unprognostic (5.71e-2)"	"unprognostic (2.51e-1)"	"unprognostic (5.26e-2)"	"prognostic favorable (4.21e-4)"	"unprognostic (2.34e-2)"	"unprognostic (6.74e-3)"	"unprognostic (2.54e-3)"	"unprognostic (1.00e-1)"	"unprognostic (1.74e-1)"	"prognostic favorable (2.12e-5)"	"unprognostic (1.94e-1)"	"unprognostic (9.62e-2)"	"unprognostic (2.11e-1)"	"unprognostic (7.10e-2)"	4.5	0.4	0.2	0.8	0.2	0.0	2.3	0.2	0.2	0.4	49.1	0.2	2.3	46.0	0.4	2.7	1.2	0.6	16.4	10.5	0.2	0.1	23.2	1.2	0.8	0.6	0.2	0.2	1.3	1.6	0.0	0.2	1.0	0.2	0.5	1.3	0.2	1.1	1.2	0.7	0.2	122.0	0.3	0.2	0.2	0.5	17.9	0.2	0.2	4.5	0.5	0.2	0.4	0.9	0.0	0.0	0.2	0.0	0.0	0.3	0.0	0.2	0.0	0.4	0.0	0.7	0.0	2.4	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.7	0.0	0.4	4.1	0.2	0.1	0.0	0.1	0.1	0.0	0.0	2.5	0.0	0.0	0.0	0.0	0.3	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	2.2	0.1	0.2	0.2	0.0	0.0	2.1	0.4	2.5	0.6	2.8	0.1	0.3	0.2	1.9	0.2	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.2	0.2	0.2	0.2	0.2	0.1	0.2	0.2	0.2	0.2	0.0	0.3	2.2	0.5	0.1	0.0	9.8	61.1	0.0	0.0	0.0	0.0	2.9	3.3	0.5	0.4	0.0	38.8	0.0	0.7	0.2	0.0	0.4	0.0	0.8	0.7	0.0	6.9	0.0	0.0	1.1	7.8	0.0	0.0	0.0	1.2	0.0	0.9	4.2	5.6	45.6	0.0	19.4	0.0	1.1	0.7	0.1	10.6	0.0	3.3	1.6
ACY1		ENSG00000243989	"Aminoacylase 1"	Q03154	3	51983278-51989202	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"		Hydrolase	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in all"	6	"intestine: 53.3;kidney: 91.6;liver: 77.8"	"Cell type enhanced"	"Detected in many"	12	"Enterocytes: 70.2;Erythroid cells: 23.3;Proximal tubular cells: 35.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"											"CAB003695, HPA036174, HPA036175"	Enhanced					NA	NA		28000000			"CAB003695: AB_425286, HPA036174: AB_2674988, HPA036175: AB_2674989"	"unprognostic (4.28e-2)"	"unprognostic (1.89e-1)"	"unprognostic (2.10e-1)"	"unprognostic (2.48e-3)"	"unprognostic (3.15e-1)"	"unprognostic (6.51e-2)"	"unprognostic (2.82e-2)"	"unprognostic (1.47e-1)"	"unprognostic (1.05e-2)"	"unprognostic (6.08e-2)"	"unprognostic (2.36e-2)"	"unprognostic (2.70e-2)"	"prognostic favorable (2.93e-4)"	"unprognostic (3.57e-1)"	"unprognostic (3.75e-1)"	"unprognostic (7.88e-2)"	"prognostic favorable (6.77e-4)"	4.4	8.5	2.5	3.9	3.0	1.5	4.4	1.5	3.3	3.2	24.9	4.1	9.8	34.5	1.9	7.9	3.8	3.0	8.4	4.1	2.3	1.8	91.6	77.8	3.5	6.3	2.8	2.9	2.1	9.0	6.2	1.9	4.3	2.9	3.7	6.2	6.6	9.4	9.2	7.6	2.6	53.3	2.1	3.5	3.4	4.9	1.5	1.7	0.6	5.9	6.7	4.1	3.3	2.5	5.0	12.1	3.8	10.0	12.1	6.4	4.5	3.9	8.0	3.9	10.8	9.0	12.1	12.8	4.2	7.9	9.3	5.1	12.4	20.8	2.5	3.5	7.3	3.4	4.9	4.0	25.6	3.7	6.9	5.1	8.9	4.6	38.3	16.6	6.0	5.8	14.0	21.2	8.2	22.1	7.6	3.5	4.4	13.4	7.9	9.1	11.1	0.0	11.0	5.7	25.3	13.6	3.1	3.3	22.5	24.3	15.0	5.5	5.0	5.3	17.5	9.2	1.6	14.1	7.9	1.7	6.7	6.4	8.3	4.9	20.9	4.9	3.8	7.8	12.5	8.0	3.8	10.0	0.2	6.4	9.0	3.6	5.0	2.0	2.8	12.1	4.0	3.3	4.0	0.0	12.1	3.4	1.9	2.7	4.5	2.5	3.0	1.5	3.3	2.3	1.8	2.8	2.9	2.9	1.7	3.0	2.7	0.8	0.8	0.6	0.0	0.1	2.5	2.7	3.4	5.2	0.0	3.3	8.3	12.2	0.2	0.5	70.2	23.3	7.4	3.7	0.8	0.5	6.9	10.9	1.7	0.0	2.4	1.8	2.1	0.4	0.6	2.4	0.0	16.2	9.3	0.8	12.6	21.0	0.0	35.6	0.9	0.0	0.5	0.0	0.2	0.4	3.4	1.5	12.1	0.3
AEBP1	ACLP	ENSG00000106624	"AE binding protein 1"	Q8IUX7	7	44104361-44114562	"Enzymes, Predicted intracellular proteins, Predicted secreted proteins"	"Transcription, Transcription regulation"	"Calmodulin-binding, DNA-binding, Repressor"	"Disease mutation, Ehlers-Danlos syndrome"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"vagina: 177.1"	"Cell type enhanced"	"Detected in many"	19	"Fibroblasts: 159.0;Leydig cells: 140.4;Peritubular cells: 478.4;Smooth muscle cells: 174.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in some"	5	"plasmacytoid DC: 10.5"	"Lineage enriched"	"Detected in many"	5	"dendritic cells: 10.5"	"Cell line enhanced"	"Detected in many"		"ASC diff: 34.9;BJ: 45.9;BJ hTERT+: 30.3;fHDF/TERT166: 49.3;JURKAT: 34.8;WM-115: 28.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"CAB009966, HPA047724, HPA063595, HPA064970"	Supported		Supported	Nucleoplasm,Vesicles,Cytosol	"Secreted - unknown location"	NA	NA		2300000	Vesicles	"Nucleoplasm, Cytosol"	"CAB009966: AB_2225690, HPA047724: AB_2680132, HPA063595: AB_2685052, HPA064970: AB_2685394"	"unprognostic (1.70e-2)"	"unprognostic (5.42e-2)"	"unprognostic (1.66e-2)"	"unprognostic (1.45e-1)"	"prognostic unfavorable (1.60e-4)"	"unprognostic (1.13e-1)"	"unprognostic (7.00e-2)"	"unprognostic (8.79e-2)"	"unprognostic (2.52e-1)"	"unprognostic (3.27e-2)"	"unprognostic (1.26e-1)"	"unprognostic (1.94e-1)"	"prognostic unfavorable (9.31e-9)"	"unprognostic (2.88e-3)"	"unprognostic (9.58e-2)"	"unprognostic (1.17e-2)"	"unprognostic (6.28e-3)"	46.5	19.0	8.9	23.9	9.5	3.1	90.9	1.7	5.4	78.1	20.5	17.9	15.8	5.8	73.7	39.4	20.7	43.7	47.9	35.4	12.7	6.4	19.6	6.3	35.5	13.0	12.5	10.8	84.8	8.8	2.7	10.9	26.7	17.2	46.1	7.9	33.3	11.9	70.2	11.4	19.7	16.9	42.6	43.7	16.6	17.6	30.6	9.6	48.0	19.6	12.3	7.5	58.2	177.1	2.3	10.5	0.0	0.0	0.2	1.4	0.4	0.1	0.0	10.8	0.0	34.9	12.4	0.2	45.9	30.3	5.2	1.1	0.0	0.0	1.2	5.1	49.3	0.0	0.0	0.5	0.8	2.2	0.1	0.0	3.1	0.0	0.0	9.8	0.0	0.0	18.8	0.0	17.7	0.0	0.2	2.3	34.8	1.9	0.0	0.0	0.0	19.9	3.7	4.6	0.0	0.0	16.5	0.4	0.3	1.2	0.0	1.1	6.1	0.0	0.0	20.1	10.6	0.1	3.3	8.0	0.0	21.3	0.1	0.0	0.2	0.2	24.2	0.1	0.0	28.2	0.0	0.0	0.0	0.4	0.0	0.3	2.1	0.4	0.0	0.0	2.3	1.4	0.8	0.0	0.2	0.0	10.5	0.0	0.4	8.9	9.5	1.7	5.4	12.7	6.4	12.5	10.8	17.2	9.6	0.0	4.5	6.7	5.4	30.7	0.2	15.5	0.0	4.0	2.3	7.0	0.0	1.7	0.0	0.8	2.0	14.4	0.0	0.0	0.0	2.6	159.0	2.4	2.3	0.0	3.1	0.0	0.0	38.6	1.9	9.5	140.4	3.8	81.0	1.0	0.0	0.1	0.7	0.0	478.4	0.6	0.6	38.8	174.1	2.4	4.5	24.0	2.9	0.7	0.0	2.0
AFG3L2	"SCA28, SPAX5"	ENSG00000141385	"AFG3 like matrix AAA peptidase subunit 2"	Q9Y4W6	18	12328944-12377314	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted membrane proteins"		"Hydrolase, Metalloprotease, Protease"	"Disease mutation, Neurodegeneration, Spinocerebellar ataxia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA004479, HPA004480"	Enhanced		Supported	Mitochondria		NA	NA			Mitochondria		"HPA004479: AB_1078109, HPA004480: AB_1078108"	"unprognostic (1.11e-1)"	"unprognostic (7.49e-2)"	"unprognostic (1.67e-1)"	"prognostic unfavorable (8.68e-4)"	"unprognostic (1.31e-1)"	"unprognostic (5.06e-3)"	"unprognostic (1.61e-1)"	"unprognostic (2.33e-1)"	"unprognostic (5.35e-2)"	"unprognostic (1.54e-2)"	"unprognostic (4.05e-2)"	"unprognostic (3.00e-2)"	"prognostic favorable (6.05e-14)"	"unprognostic (5.90e-2)"	"unprognostic (9.41e-2)"	"unprognostic (5.74e-3)"	"unprognostic (2.22e-1)"	11.5	15.8	11.8	14.3	14.0	11.7	19.9	17.2	30.3	11.2	25.7	9.5	12.7	33.1	11.4	10.1	18.3	10.4	11.2	77.4	13.2	13.1	27.2	22.9	16.3	23.7	12.0	13.2	12.0	23.1	34.3	12.6	9.9	16.9	10.8	23.5	12.2	14.9	14.8	61.0	17.5	35.0	15.1	14.0	9.9	16.0	8.9	7.1	10.7	16.9	22.4	13.2	14.0	11.6	10.1	15.8	8.5	12.3	19.9	15.2	8.4	15.0	15.4	11.0	12.4	12.7	14.0	14.7	16.9	16.8	24.2	17.8	23.8	9.3	43.4	18.6	15.3	21.5	15.2	27.8	19.4	19.8	10.1	11.9	13.0	16.9	22.3	17.4	48.9	19.5	15.4	21.3	22.9	30.3	13.4	17.6	15.6	29.2	25.7	11.8	23.9	17.5	15.0	15.3	74.6	11.4	19.7	34.8	36.2	20.8	33.5	20.6	14.4	26.5	28.8	23.7	14.8	13.2	22.1	13.3	28.9	24.8	27.4	22.0	18.1	20.8	27.8	15.8	19.3	13.2	2.6	11.5	8.5	8.7	12.3	10.7	10.1	10.4	13.7	15.8	7.7	13.3	15.2	0.8	19.9	10.8	8.1	6.4	8.4	11.8	14.0	17.2	30.3	13.2	13.1	12.0	13.2	16.9	7.1	38.7	35.6	27.6	31.2	19.7	46.8	69.2	40.8	28.1	33.0	33.2	47.1	50.2	61.3	33.0	4.2	23.3	78.3	46.7	32.4	29.6	23.8	24.6	13.9	71.5	32.6	28.6	37.6	18.4	22.3	2.7	30.5	25.6	21.9	20.8	71.9	29.1	36.4	31.7	28.3	54.2	55.2	25.8	20.6	47.7	72.0	27.4	77.6	17.5	75.2	29.8
AGBL1	"CCP4, FLJ32310"	ENSG00000273540	"ATP/GTP binding protein like 1"	Q96MI9	15	86079973-87029052	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"		"Carboxypeptidase, Hydrolase, Metalloprotease, Protease"	"Corneal dystrophy"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	4	"skeletal muscle: 16.7;tongue: 35.5"	"Cell type enhanced"	"Detected in some"	28	"Alveolar cells type 1: 3.0;Alveolar cells type 2: 11.8;Early spermatids: 2.1;Late spermatids: 1.7"	"Not detected"	"Not detected"							"Cell type enhanced"	"Detected in single"		"neutrophil: 1.3"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in some"		"AF22: 2.5;RH-30: 1.8;SCLC-21H: 2.8"	"Low region specificity"	"Detected in single"													NA	NA										"unprognostic (3.70e-2)"	"unprognostic (4.46e-2)"		"unprognostic (1.06e-1)"										0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.8	0.0	0.0	0.4	0.0	0.0	0.0	5.8	1.3	0.0	0.0	0.0	0.1		0.0	0.0	2.9	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.6	0.6	0.0	0.0	1.3	0.0	16.7	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.5	35.5	1.0	0.0	0.0	0.5	0.3	1.3	0.3	0.3	0.2	0.0	0.0	0.1	2.5	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.8	0.3	0.0	0.1	0.1	0.1	0.0	0.0	0.1	0.0	0.0	0.1	0.1	0.2	0.0	0.1	0.1	0.2	0.0	0.0	0.2	0.1	1.8	0.1	0.0	0.2	2.8	0.2	0.3	0.0	0.0	0.1	0.1	0.0	0.0	0.2	0.4	0.2	0.0	0.2	0.0	0.2	0.1	0.1	0.0	0.7	0.3	0.2	0.1	0.1	0.1	0.2	0.2	0.2	0.0	0.5	0.1	0.1	1.3	0.3	0.0	0.3	0.1	0.0											3.0	11.8	0.0	0.0	0.0	1.6	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0
AGBL2	"CCP2, FLJ23598"	ENSG00000165923	"ATP/GTP binding protein like 2"	Q5U5Z8	11	47659591-47715389	"Enzymes, Predicted intracellular proteins"		"Carboxypeptidase, Hydrolase, Metalloprotease, Protease"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"testis: 34.0"	"Cell type enriched"	"Detected in some"	5	"Ciliated cells: 107.1"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"CAPAN-2: 6.1;T-47d: 3.5"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA007718	Uncertain					NA	NA					"HPA007718: AB_1078110"	"unprognostic (3.44e-5)"	"unprognostic (1.16e-1)"	"unprognostic (5.84e-2)"	"unprognostic (5.33e-4)"	"unprognostic (1.13e-1)"	"unprognostic (3.00e-1)"	"unprognostic (2.05e-1)"	"unprognostic (1.38e-2)"	"unprognostic (9.83e-3)"	"unprognostic (4.11e-2)"	"unprognostic (5.56e-2)"	"unprognostic (1.79e-1)"	"unprognostic (8.24e-6)"	"unprognostic (1.01e-2)"	"unprognostic (1.28e-1)"	"unprognostic (9.62e-2)"	"unprognostic (1.17e-3)"	0.4	1.7	0.8	6.6	2.7	0.7	1.1	3.6	1.1	1.9	2.0	2.8	1.5	1.1	1.6	11.2	0.5	12.2	2.4	0.4	1.3	1.4	1.8	3.0	6.4	1.4	0.3	0.3	2.1	4.7	1.2	3.8	0.7	3.4	1.6	0.8	0.7	1.1	1.7	0.4	0.6	3.3	0.6	0.7	1.7	0.8	34.0	0.7	4.4	1.9	0.5	2.6	2.1	1.4	2.6	1.5	0.4	0.2	1.4	2.2	0.6	1.2	0.0	0.0	0.0	0.3	1.7	0.1	0.4	0.8	0.5	1.7	0.6	6.1	0.1	0.4	0.4	0.8	1.6	0.0	0.1	0.8	1.8	0.4	0.3	2.9	2.2	0.9	0.0	1.0	1.8	0.7	0.9	0.5	0.6	0.1	2.1	0.4	1.3	0.9	2.4	1.2	0.6	0.0	0.3	0.1	1.7	0.1	0.5	0.9	2.7	2.2	0.5	0.7	0.0	0.7	0.0	3.5	0.0	0.2	0.2	0.5	0.3	0.0	0.0	0.1	0.1	0.3	0.3	0.3	0.0	0.1	0.0	1.5	0.0	1.3	1.0	1.6	1.2	0.1	2.6	1.9	1.7	0.4	1.4	0.2	1.5	2.2	0.6	0.8	2.7	3.6	1.1	1.3	1.4	0.3	0.3	3.4	0.7	0.0	2.4	0.0	1.2	0.1	0.0	0.4	0.0	107.1	10.3	7.0	0.0	0.4	0.0	0.2	23.4	0.0	1.0	0.0	0.0	0.2	0.6	0.3	0.0	0.6	0.1	0.0	1.2	0.6	0.3	6.6	0.3	0.3	0.0	1.8	0.6	0.5	0.2	0.0	1.4	0.0	0.4	0.0	0.1	19.6	1.0	0.0	0.3	0.7	0.8	0.3
AGBL3	"CCP3, MGC32955"	ENSG00000146856	"ATP/GTP binding protein like 3"	Q8NEM8	7	134986508-135147963	"Enzymes, Predicted intracellular proteins"		"Carboxypeptidase, Hydrolase, Metalloprotease, Protease"		"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"	11	"Early spermatids: 40.4;Spermatocytes: 19.5"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"HEK 293: 8.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA020397, HPA024150"	Uncertain		Approved	Cytosol		NA	No			Cytosol		"HPA020397: AB_2242453, HPA024150: AB_1844639"	"unprognostic (8.84e-2)"	"unprognostic (1.49e-2)"	"unprognostic (4.72e-2)"	"unprognostic (2.18e-1)"	"unprognostic (1.47e-1)"	"unprognostic (3.39e-3)"	"unprognostic (3.32e-3)"	"unprognostic (4.18e-2)"	"unprognostic (7.15e-4)"	"unprognostic (5.00e-3)"	"unprognostic (6.10e-4)"	"unprognostic (3.16e-2)"	"prognostic unfavorable (4.02e-4)"	"unprognostic (2.18e-2)"	"unprognostic (2.14e-1)"	"unprognostic (8.13e-2)"	"unprognostic (1.11e-3)"	3.2	2.7	4.2	4.1	8.4	3.8	4.6	8.7	4.5	4.3	2.4	4.4	4.5	1.6	5.5	15.4	2.2	3.6	3.1	2.4	5.0	3.4	5.3	2.6	3.6	4.0	2.7	4.5	6.8	4.5	0.6	9.2	1.9	3.3	3.8	3.0	3.1	4.9	4.3	4.2	4.7	3.7	3.3	2.9	6.5	4.4	18.7	3.7	2.7	5.4	0.8	2.8	3.3	2.5	2.2	1.7	0.5	0.2	2.2	5.0	1.7	2.6	1.4	3.6	0.8	1.0	1.4	2.2	0.7	0.0	0.5	0.8	4.7	3.0	4.3	1.3	0.0	1.4	2.8	1.3	0.5	0.0	3.4	8.8	3.6	5.3	4.6	0.0	1.6	0.0	0.2	0.0	2.1	0.0	0.0	1.6	4.7	2.6	2.5	0.6	2.5	0.9	1.5	3.1	0.4	0.3	2.5	0.2	1.2	2.6	0.5	2.1	2.4	0.5	0.0	0.3	0.1	1.9	3.5	0.0	0.4	0.9	0.5	1.6	5.3	1.6	1.9	1.8	4.3	4.4	0.0	0.2	0.4	2.4	0.0	1.8	2.1	1.2	2.5	0.5	2.2	2.0	5.0	0.5	2.2	0.1	1.7	1.7	1.7	4.2	8.4	8.7	4.5	5.0	3.4	2.7	4.5	3.3	3.7	3.0	1.1	1.3	1.0	1.1	4.9	1.6	5.1	5.3	2.3	8.7	2.0	0.2	6.6	3.1	40.4	3.8	0.3	0.0	2.5	0.3	1.4	1.5	1.1	1.6	0.4	3.2	2.9	5.5	1.6	8.5	3.1	0.3	5.0	11.8	0.3	2.7	1.6	0.0	2.1	5.1	2.9	0.0	2.3	19.5	3.6	0.3	0.1	1.0	0.0	0.8
AGBL4	"CCP6, FLJ14442"	ENSG00000186094	"ATP/GTP binding protein like 4"	Q5VU57	1	48532855-50023913	"Enzymes, Predicted intracellular proteins"		"Carboxypeptidase, Hydrolase, Metalloprotease, Protease"		"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in many"		"brain: 20.4;pituitary gland: 31.5"	"Cell type enhanced"	"Detected in some"	23	"Cone photoreceptor cells: 80.5;Rod photoreceptor cells: 22.3"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"NTERA-2: 3.7;SCLC-21H: 5.3;SH-SY5Y: 2.0;SuSa: 1.8;U-937: 2.2"	"Low region specificity"	"Detected in many"							HPA037994	Approved					NA	NA					"HPA037994: AB_10673036"	"unprognostic (3.06e-2)"	"unprognostic (2.76e-1)"	"unprognostic (2.58e-2)"	"unprognostic (3.31e-4)"	"unprognostic (3.42e-4)"	"unprognostic (1.72e-1)"	"unprognostic (3.86e-3)"	"unprognostic (2.31e-2)"	"unprognostic (1.50e-1)"	"unprognostic (1.14e-1)"	"unprognostic (5.85e-3)"	"unprognostic (3.91e-2)"	"unprognostic (1.51e-4)"	"unprognostic (5.95e-2)"	"unprognostic (1.11e-1)"	"unprognostic (1.18e-2)"	"unprognostic (2.85e-1)"	1.4	4.5	7.8	0.8	13.6	1.1	1.5	1.3	20.4	1.0	0.8	3.0	0.1	0.7	1.0	4.5	0.9	7.8	1.0	3.7	7.1	7.2	10.2	4.6	1.6	0.8	3.2	11.6	1.3	2.7	3.6	31.5	2.7	6.7	1.0	0.7	4.6	0.8	1.5	0.9	1.5	0.8	0.7	1.5	1.3	1.1	10.7	1.9	0.0	3.4	0.0	0.8	0.7	0.7	0.8	0.5	2.2	0.3	0.6	1.8	0.2	0.0	0.5	0.8	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.5	0.1	0.0	0.0	0.0	0.9	0.1	0.2	0.2	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.3	0.2	0.0	0.3	0.1	0.4	3.7	0.0	0.4	0.1	0.1	0.1	0.1	0.3	5.3	2.0	0.0	0.2	0.0	1.8	0.0	0.3	0.0	0.0	1.4	0.2	0.0	0.2	0.0	0.1	0.1	2.2	0.5	2.2	0.3	0.4	0.3	0.3	1.8	0.5	0.2	0.1	0.2	0.8	0.4	0.2	1.0	0.6	0.2	0.5	0.3	0.2	7.8	13.6	1.3	20.4	7.1	7.2	3.2	11.6	6.7	1.9	0.0	0.0	0.0	0.6	0.2	2.3	1.0	0.0	9.4	1.2	3.5	80.5	0.1	1.7	0.1	9.7	0.1	0.0	0.0	0.2	0.0	0.2	0.3	0.0	0.0	0.1	4.8	5.8	0.6	0.0	6.5	0.3	0.0	0.0	0.0	0.0	2.8	0.0	0.0	0.7	3.8	22.3	0.0	0.0	13.6	3.6	0.0	0.1	0.0	0.0	0.1
AGBL5	"CCP5, FLJ21839"	ENSG00000084693	"ATP/GTP binding protein like 5"	Q8NDL9	2	27042364-27070622	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"		"Carboxypeptidase, Hydrolase, Metalloprotease, Protease"	"Disease mutation, Retinitis pigmentosa"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	8	"testis: 91.6"	"Group enriched"	"Detected in many"	7	"Early spermatids: 249.1;Late spermatids: 264.5;Spermatocytes: 150.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA030981	Uncertain		Supported	"Microtubules,Cytokinetic bridge,Cytosol"		Yes	No			"Cytokinetic bridge"	"Microtubules, Cytosol"	"HPA030981: AB_10611673"	"unprognostic (1.29e-2)"	"unprognostic (8.70e-2)"	"unprognostic (2.26e-1)"	"unprognostic (3.13e-3)"	"unprognostic (1.95e-1)"	"unprognostic (1.07e-1)"	"prognostic unfavorable (6.87e-5)"	"unprognostic (1.86e-1)"	"unprognostic (4.34e-1)"	"unprognostic (6.20e-2)"	"unprognostic (1.28e-1)"	"unprognostic (1.20e-1)"	"unprognostic (3.41e-2)"	"unprognostic (5.56e-2)"	"unprognostic (2.05e-1)"	"unprognostic (1.69e-2)"	"unprognostic (4.50e-2)"	3.8	8.1	3.9	3.5	4.8	3.8	4.2	3.1	6.6	5.0	6.8	6.6	11.7	2.8	5.4	9.3	6.3	7.2	6.6	4.1	3.4	3.9	8.2	3.0	3.6	3.2	3.5	3.4	5.9	5.9	11.2	6.2	6.3	5.4	6.8	3.8	7.7	8.2	5.9	2.6	6.8	3.9	8.6	3.4	4.6	5.4	91.6	3.5	8.4	9.9	4.9	4.4	7.8	3.5	5.7	5.4	7.1	2.3	11.2	6.3	4.6	23.0	15.0	24.5	16.3	5.2	10.5	27.4	4.7	10.3	13.7	14.2	12.9	17.7	12.8	14.9	8.1	19.3	10.6	19.6	21.4	15.2	10.7	29.0	18.7	18.7	27.8	10.6	9.0	6.3	11.0	16.2	12.0	9.9	21.0	14.3	18.7	16.0	10.4	13.2	9.1	26.2	13.6	17.3	16.8	10.3	27.1	27.7	20.0	14.1	5.9	16.4	23.5	9.3	7.3	15.2	25.1	11.0	7.0	6.8	12.8	17.6	6.1	10.1	20.8	10.9	26.2	14.2	10.4	11.4	7.1	2.3	5.7	4.5	1.3	3.4	5.7	5.7	6.3	5.4	3.0	5.1	2.8	1.4	11.2	0.9	3.0	3.6	4.6	3.9	4.8	3.1	6.6	3.4	3.9	3.5	3.4	5.4	3.5	0.0	8.5	1.9	5.9	3.0	4.9	5.0	12.7	1.4	5.7	8.7	0.0	12.8	16.6	7.0	249.1	3.6	4.6	0.0	5.2	6.0	4.1	6.6	1.1	3.4	4.4	0.0	2.4	6.2	2.7	264.5	9.8	5.3	6.8	6.4	8.7	4.4	4.8	7.0	10.6	18.1	8.7	0.0	5.8	150.8	30.0	2.4	7.0	4.1	8.4	6.8
AGTPBP1	"CCP1, KIAA1035, Nna1"	ENSG00000135049	"ATP/GTP binding protein 1"	Q9UPW5	9	85546539-85742029	"Enzymes, Predicted intracellular proteins"		"Carboxypeptidase, Hydrolase, Metalloprotease, Protease"	"Disease mutation, Neurodegeneration"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 48.2"	"Cell type enhanced"	"Detected in many"	6	"Cone photoreceptor cells: 96.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA057208, HPA071094"	Approved		Approved	Nucleoli,Vesicles		NA	NA			"Nucleoli, Vesicles"		"HPA057208: AB_2683370, HPA071094: "	"unprognostic (2.15e-1)"	"unprognostic (3.78e-2)"	"unprognostic (4.93e-3)"	"unprognostic (6.12e-2)"	"unprognostic (1.42e-1)"	"unprognostic (8.95e-3)"	"unprognostic (1.86e-2)"	"unprognostic (1.65e-1)"	"unprognostic (1.71e-1)"	"unprognostic (8.26e-3)"	"unprognostic (5.69e-3)"	"unprognostic (6.31e-2)"	"unprognostic (3.07e-2)"	"unprognostic (1.11e-1)"	"unprognostic (1.39e-1)"	"unprognostic (9.60e-3)"	"unprognostic (1.25e-1)"	7.9	5.7	13.1	8.6	14.6	48.2	6.0	14.2	21.4	5.1	5.0	21.6	1.8	3.8	5.0	4.2	5.4	4.2	5.3	11.2	17.3	13.5	6.8	4.5	11.9	16.0	18.8	14.5	3.5	6.4	8.0	4.8	6.0	23.5	4.9	5.9	7.4	3.9	3.4	13.6	6.0	4.3	6.4	24.1	12.8	5.3	12.5	14.4	8.8	5.8	4.3	7.8	5.7	3.8	1.6	10.7	20.3	9.5	4.5	6.6	5.7	2.9	5.7	16.9	6.7	3.5	3.8	6.4	4.4	3.8	4.5	5.2	3.0	5.1	18.4	3.8	4.6	8.0	1.7	7.8	5.6	4.3	19.5	6.9	3.1	6.9	5.4	7.3	14.1	3.7	3.6	6.6	4.2	14.5	2.9	7.2	9.5	3.9	14.8	2.0	4.6	11.0	8.4	11.7	10.6	4.0	10.1	6.2	5.6	7.9	3.2	20.4	14.5	5.0	5.5	9.1	16.8	2.1	4.6	7.1	2.9	5.2	18.5	5.2	10.1	8.4	8.4	6.2	13.9	5.9	20.3	9.5	8.3	6.6	5.7	6.4	1.6	3.3	5.1	10.7	1.2	2.7	5.2	14.0	4.5	4.3	1.7	3.4	5.7	13.1	14.6	14.2	21.4	17.3	13.5	18.8	14.5	23.5	14.4	59.6	13.8	5.4	2.3	7.0	29.1	39.1	0.0	18.7	21.6	3.5	96.2	3.7	6.6	4.8	44.2	7.5	2.7	0.0	3.5	3.5	4.5	3.7	25.5	3.6	7.2	33.4	7.5	10.4	38.6	49.1	1.7	22.6	3.3	9.0	4.9	16.0	4.6	0.0	2.5	6.1	56.8	12.9	7.2	25.0	27.2	9.4	2.4	20.8	3.8	1.6
AMZ1	KIAA1950	ENSG00000174945	"Archaelysin family metallopeptidase 1"	Q400G9	7	2679522-2775500	"Enzymes, Predicted intracellular proteins"		"Hydrolase, Metalloprotease, Protease"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in many"		"brain: 10.0"	"Cell type enhanced"	"Detected in some"	20	"Cone photoreceptor cells: 3.9;Early spermatids: 18.8;Extravillous trophoblasts: 7.0;Late spermatids: 6.0"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	6	"memory B-cell: 4.2;naive B-cell: 2.4;T-reg: 1.0"	"Group enriched"	"Detected in many"	6	"B-cells: 4.2;T-cells: 1.0"	"Cell line enhanced"	"Detected in some"		"BEWO: 6.2;MCF7: 6.4;SK-BR-3: 4.6;T-47d: 24.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA020233	Uncertain					NA	NA					"HPA020233: AB_1844818"	"unprognostic (9.08e-3)"	"unprognostic (1.66e-1)"	"unprognostic (3.23e-3)"	"unprognostic (1.81e-1)"	"unprognostic (5.72e-2)"	"unprognostic (7.79e-2)"	"unprognostic (2.02e-2)"	"unprognostic (3.42e-1)"	"unprognostic (1.98e-1)"	"unprognostic (7.16e-3)"	"unprognostic (1.08e-1)"	"unprognostic (1.21e-1)"	"unprognostic (3.64e-9)"	"unprognostic (1.60e-3)"	"unprognostic (1.60e-1)"	"unprognostic (1.44e-1)"	"unprognostic (1.13e-1)"	0.7	0.7	8.4	1.2	7.1	2.0	0.9	1.4	10.0	3.2	0.6	6.5	0.0	0.8	4.0	0.6	0.7	1.4	1.0	0.9	5.9	4.9	0.5	1.2	2.8	1.2	6.0	4.8	1.4	0.8	0.7	1.1	3.6	4.2	0.8	0.7	0.2	0.6	0.6	0.6	0.8	0.6	3.3	3.8	2.0	0.7	1.4	4.4	0.0	0.7	0.0	1.8	0.7	0.7	4.2	0.1	0.4	0.1	0.1	1.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	6.2	2.0	3.0	1.4	2.0	0.0	0.8	0.5	0.2	1.9	0.2	0.0	0.0	0.0	1.4	0.3	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.0	1.4	0.0	6.4	0.0	0.6	0.3	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.1	0.1	4.6	0.0	0.1	24.4	0.0	0.0	0.1	0.1	0.1	0.0	0.9	0.2	0.0	0.5	0.0	0.1	0.4	0.0	0.2	0.1	0.0	0.0	4.2	0.1	0.0	0.0	2.4	0.1	0.0	0.1	0.1	0.1	0.1	1.0	0.1	8.4	7.1	1.4	8.7	5.9	4.9	6.0	4.8	4.2	4.4	0.0	0.3	0.0	0.1	0.0	0.6	3.2	0.0	0.0	0.0	0.0	3.9	0.3	0.0	0.0	18.8	0.3	0.0	0.0	0.0	7.0	0.4	0.1	0.0	0.0	1.8	0.0	0.0	0.0	0.0	6.0	0.0	1.5	1.7	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.7	0.0	0.5	0.0	0.2	0.1	0.1	0.0	0.0	0.0
AMZ2		ENSG00000196704	"Archaelysin family metallopeptidase 2"	Q86W34	17	68247574-68257164	"Enzymes, Predicted intracellular proteins"		"Hydrolase, Metalloprotease, Protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in many"	5	"Early spermatids: 585.3;Late spermatids: 1307.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA023299, HPA052406"	Enhanced		Supported	"Nucleoplasm,Nuclear bodies,Cytosol"		NA	NA			Nucleoplasm	"Nuclear bodies, Cytosol"	"HPA023299: AB_2226909, HPA052406: AB_2681818"	"unprognostic (3.04e-1)"	"unprognostic (3.68e-2)"	"unprognostic (3.93e-2)"	"unprognostic (3.27e-3)"	"unprognostic (3.32e-1)"	"unprognostic (1.79e-2)"	"prognostic unfavorable (1.32e-5)"	"unprognostic (2.43e-1)"	"unprognostic (3.92e-2)"	"unprognostic (2.83e-3)"	"unprognostic (3.59e-3)"	"unprognostic (3.37e-1)"	"prognostic unfavorable (3.14e-4)"	"unprognostic (2.37e-1)"	"unprognostic (2.95e-1)"	"unprognostic (3.28e-1)"	"unprognostic (7.62e-2)"	22.3	21.3	29.3	13.7	43.3	14.2	20.8	29.2	35.8	19.8	19.8	20.3	19.6	11.9	19.0	25.3	22.3	24.6	17.7	33.6	26.8	23.7	26.8	16.6	14.1	22.4	26.0	27.0	23.4	20.4	29.4	25.4	18.9	28.3	21.1	15.0	19.0	17.9	25.1	39.9	15.5	13.5	19.3	27.8	16.6	15.7	77.2	20.5	15.5	28.4	20.6	22.4	20.2	14.9	20.9	17.2	31.4	21.1	34.8	31.2	19.7	23.4	26.1	22.1	18.7	17.0	29.6	34.8	17.0	23.0	29.6	24.9	10.7	15.1	35.1	19.2	26.3	27.9	11.6	18.0	50.1	38.9	12.4	17.0	12.9	11.6	20.8	32.2	11.7	22.3	25.2	56.3	27.5	51.3	29.3	29.9	30.2	13.2	22.5	37.4	17.4	26.4	10.9	10.4	12.5	24.4	10.1	60.2	26.3	17.8	12.4	22.3	17.5	15.8	32.6	31.7	47.6	25.7	8.1	15.5	39.9	19.0	14.3	18.4	31.6	29.0	60.6	28.1	16.7	20.1	31.4	14.4	19.6	22.1	16.6	28.6	17.4	27.3	29.0	17.2	20.9	24.4	26.3	25.2	34.8	21.1	15.7	31.2	19.7	29.3	43.3	29.2	35.8	26.8	23.7	26.0	27.0	28.3	20.5	11.9	14.1	28.3	32.0	16.6	13.3	73.2	22.9	57.6	21.6	22.7	7.9	54.0	92.9	25.1	585.3	25.4	8.9	0.0	22.9	56.9	31.5	18.0	32.4	13.7	37.1	17.5	20.3	22.7	19.9	1307.8	33.4	36.7	54.0	56.9	16.8	56.2	24.4	12.9	30.8	48.5	11.6	19.4	27.2	187.0	54.0	19.7	28.6	51.1	15.8	15.9
ANPEP	"CD13, gp150, LAP1, p150, PEPN"	ENSG00000166825	"Alanyl aminopeptidase, membrane"	P15144	15	89784889-89815401	"CD markers, Enzymes, Plasma proteins, Predicted membrane proteins"	"Angiogenesis, Differentiation, Host-virus interaction"	"Aminopeptidase, Developmental protein, Host cell receptor for virus entry, Hydrolase, Metalloprotease, Protease, Receptor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 195.3;kidney: 78.7;pancreas: 93.9"	"Cell type enhanced"	"Detected in many"	16	"Cholangiocytes: 372.0;Enterocytes: 993.7;Exocrine glandular cells: 328.5;Proximal tubular cells: 388.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in some"			"Cell type enriched"	"Detected in many"	5	"neutrophil: 59.4"	"Lineage enriched"	"Detected in many"	5	"granulocytes: 59.4"	"Cell line enhanced"	"Detected in many"		"ASC TERT1: 78.5;BJ: 78.2;BJ hTERT+: 111.8;fHDF/TERT166: 67.0;HMC-1: 71.1;HSkMC: 68.7;HUVEC TERT2: 87.5;TIME: 87.4;U-2197: 95.3"	"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"CAB002417, HPA004625"	Enhanced		Supported	"Plasma membrane"		NA	NA		1500000000	"Plasma membrane"		"CAB002417: AB_563491, HPA004625: AB_2667199"	"unprognostic (6.31e-2)"	"unprognostic (7.94e-3)"	"unprognostic (6.91e-2)"	"unprognostic (2.16e-1)"	"unprognostic (2.50e-1)"	"unprognostic (1.13e-1)"	"unprognostic (2.23e-2)"	"unprognostic (1.89e-1)"	"unprognostic (2.50e-1)"	"unprognostic (7.73e-2)"	"unprognostic (5.28e-3)"	"unprognostic (3.96e-1)"	"unprognostic (4.04e-3)"	"unprognostic (3.20e-2)"	"unprognostic (2.01e-2)"	"unprognostic (4.61e-3)"	"unprognostic (1.99e-2)"	21.3	1.1	0.6	2.9	0.8	9.5	17.0	1.0	1.3	8.2	21.2	0.8	0.5	195.3	1.4	8.4	3.6	1.4	27.7	3.7	0.4	0.3	78.7	37.7	9.7	9.3	0.9	0.9	1.8	93.9	0.0	0.7	14.7	1.3	8.6	4.7	4.0	6.6	1.8	1.6	4.9	155.8	4.3	1.2	7.2	0.8	4.7	0.2	5.6	1.5	4.2	3.8	4.7	3.0	0.0	6.9	59.4	12.8	0.0	0.0	5.5	0.0	5.0	0.0	0.0	61.3	78.5	0.5	78.2	111.8	9.6	8.5	0.5	0.0	0.0	0.9	67.0	0.0	0.0	0.6	0.0	3.8	0.0	0.0	14.7	0.4	11.7	36.1	1.0	71.1	68.7	0.1	30.2	0.0	0.4	87.5	0.0	0.4	0.1	3.7	0.0	0.0	34.7	0.2	0.0	5.3	0.0	0.0	0.8	43.7	0.0	0.1	0.7	0.0	0.1	0.0	0.1	0.0	6.8	87.4	42.2	0.0	95.3	0.0	0.0	0.0	0.0	0.1	0.0	2.2	5.7	12.8	10.4	0.0	7.0	0.0	0.0	0.0	0.0	6.9	0.0	0.0	0.0	59.4	0.0	12.0	0.1	0.0	5.5	0.6	0.8	1.0	1.3	0.4	0.3	0.9	0.9	1.3	0.2	0.0	4.8	8.2	3.1	8.9	0.0	0.8	372.0	2.7	20.5	19.2	0.0	9.7	36.5	10.6	0.1	1.8	993.7	0.0	328.5	12.0	36.3	18.0	24.2	144.7	39.4	0.0	2.9	101.9	51.7	0.0	2.6	46.4	3.3	39.7	10.5	0.0	120.5	201.5	1.4	388.5	0.0	25.8	5.0	0.4	0.1	5.1	5.4	1.0	18.3	1.3
ASTL	"ovastacin, SAS1B"	ENSG00000188886	"Astacin like metalloendopeptidase"	Q6HA08	2	96123850-96138436	"Enzymes, Predicted secreted proteins"	Fertilization	"Hydrolase, Metalloprotease, Protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"bone marrow: 8.5"	"Not detected"	"Not detected"			"Low cancer specificity"	"Detected in single"							"Low cell type specificity"	"Detected in some"			"Group enriched"	"Detected in many"	5	"NK-cells: 1.9;T-cells: 1.8"	"Cell line enhanced"	"Detected in some"		"BEWO: 3.0;fHDF/TERT166: 2.1;JURKAT: 2.3;RT4: 3.8"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA015620	Uncertain				"Secreted in female reproductive system"	NA	NA					"HPA015620: AB_1845121"	"unprognostic (3.21e-2)"	"unprognostic (1.45e-2)"	"unprognostic (3.87e-2)"	"unprognostic (3.45e-4)"	"unprognostic (1.00e-2)"	"unprognostic (3.03e-2)"		"unprognostic (3.53e-2)"	"unprognostic (5.12e-2)"	"unprognostic (3.62e-1)"	"unprognostic (3.40e-1)"	"unprognostic (1.95e-1)"	"unprognostic (2.61e-5)"	"unprognostic (3.41e-3)"	"unprognostic (1.08e-1)"	"unprognostic (1.67e-1)"	"unprognostic (9.93e-3)"	0.2	0.1	0.2	0.6	0.4	8.5	0.1	1.3	0.8	0.0	0.5			0.1	0.3	0.4	0.5	0.0	0.4	0.0	0.8	0.0	0.1	0.0	0.5	1.1	0.0		0.2	0.0	0.0	0.8	0.0		0.9	0.2		0.6	2.7	0.0	2.3	1.1	0.0	0.0	2.3	0.2	0.7			0.0		0.7	3.2	0.0	0.3	0.0	0.0	0.0	1.9	1.8	0.3	0.0	0.0	0.0	0.1	0.0	0.4	3.0	0.0	0.0	0.0	0.1	1.2	0.1	0.1	1.2	2.1	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.3	0.0	0.8	0.0	0.5	1.1	0.9	0.7	0.1	0.0	0.0	0.0	0.4	0.0	3.8	0.8	0.0	0.0	0.3	0.3	0.0	1.4	0.5	0.0	0.0	0.4	0.0	0.0	0.2	0.0	0.5	0.0	0.2	0.2	0.0	0.0	0.0	0.5	0.0	1.2	0.3	1.8	1.8	0.0	0.0	0.3	0.6	0.0	1.9	0.0	0.0	0.0	0.3											0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
ATP23	"KUB3, XRCC6BP1"	ENSG00000166896	"ATP23 metallopeptidase and ATP synthase assembly factor homolog"	Q9Y6H3	12	57941541-57957269	"Enzymes, Predicted intracellular proteins"		"Hydrolase, Metalloprotease, Protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"testis: 39.5"	"Cell type enhanced"	"Detected in many"	8	"Cytotrophoblasts: 11.7;Distal tubular cells: 14.9;Extravillous trophoblasts: 11.6;granulocytes: 10.5;Hofbauer cells: 9.7;Proximal tubular cells: 18.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"NB-4: 15.2;RH-30: 49.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA035804, HPA043204"	Uncertain		Enhanced	"Vesicles,Plasma membrane,Cell Junctions,Cytosol"		NA	NA			"Vesicles, Plasma membrane"	"Cell Junctions, Cytosol"	"HPA035804: AB_10601026, HPA043204: AB_2678361"	"unprognostic (2.56e-1)"	"unprognostic (1.31e-2)"	"unprognostic (8.82e-2)"	"unprognostic (2.92e-2)"	"unprognostic (2.30e-2)"	"unprognostic (6.16e-2)"	"unprognostic (1.20e-1)"	"unprognostic (5.28e-2)"	"unprognostic (5.41e-3)"	"unprognostic (1.03e-2)"	"unprognostic (1.24e-1)"	"unprognostic (1.06e-1)"	"prognostic unfavorable (1.44e-5)"	"unprognostic (4.36e-2)"	"unprognostic (1.12e-1)"	"unprognostic (1.80e-1)"	"unprognostic (2.27e-1)"	6.7	4.9	4.3	5.2	5.3	11.3	4.8	6.1	4.8	5.6	8.2	1.3	2.5	3.9	3.2	4.2	7.3	3.1	2.4	6.4	4.2	3.6	5.4	6.2	2.7	6.8	2.7	3.8	4.2	5.8	3.2	3.0	3.5	2.9	5.1	8.2	2.3	3.4	3.3	11.7	5.6	4.3	6.5	3.4	3.7	3.8	39.5	2.0	20.8	4.7	5.9	4.7	6.3	6.2	3.0	4.5	12.0	4.5	2.6	5.6	3.0	2.0	1.5	1.9	2.2	2.8	2.7	1.0	1.9	2.0	2.2	2.1	1.2	2.5	6.9	2.5	1.5	2.2	1.9	1.8	2.0	3.8	3.5	1.8	4.5	1.3	2.0	1.2	9.1	3.1	1.4	1.5	1.3	0.6	2.2	1.5	5.0	4.7	5.0	1.8	3.1	4.9	15.2	1.7	3.4	3.7	3.2	49.9	2.9	1.8	2.6	1.2	1.8	3.1	2.9	1.6	0.9	5.0	8.6	0.8	1.7	2.9	2.2	1.9	4.1	2.1	3.6	1.8	9.8	2.7	7.6	4.5	12.0	3.5	2.4	2.6	3.0	4.0	3.3	4.5	3.0	4.3	4.0	1.9	2.6	4.2	2.1	5.6	3.0	4.3	5.3	6.1	4.8	4.2	3.6	2.7	3.8	2.9	2.0	0.0	8.6	0.0	0.0	0.0	0.0	0.0	0.0	1.4	3.4	3.5	0.0	11.7	14.9	5.1	0.0	0.0	0.0	0.0	9.4	11.6	0.0	0.0	10.5	0.0	9.7	0.0	0.0	0.0	0.0	0.0	0.0	3.4	0.0	1.8	0.0	0.0	4.0	0.0	0.0	18.5	0.0	0.0	0.0	0.0	0.0	0.0	2.9	0.0	0.0	0.0
BMP1	PCOLC	ENSG00000168487	"Bone morphogenetic protein 1"	P13497	8	22164736-22212326	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted secreted proteins"	"Chondrogenesis, Differentiation, Osteogenesis"	"Cytokine, Developmental protein, Growth factor, Hydrolase, Metalloprotease, Protease"	"Disease mutation, Osteogenesis imperfecta"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in all"	8	"lung: 72.2;placenta: 106.2"	"Cell type enhanced"	"Detected in many"	8	"Alveolar cells type 2: 61.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA014572	Enhanced				"Secreted to extracellular matrix"	NA	NA		2100000			"HPA014572: AB_1845390"	"unprognostic (1.24e-1)"	"unprognostic (8.01e-2)"	"unprognostic (3.75e-2)"	"unprognostic (5.89e-2)"	"unprognostic (1.34e-2)"	"unprognostic (6.76e-2)"	"unprognostic (9.53e-2)"	"unprognostic (2.64e-3)"	"unprognostic (1.66e-1)"	"unprognostic (9.75e-3)"	"unprognostic (7.05e-3)"	"unprognostic (3.14e-2)"	"prognostic unfavorable (3.37e-9)"	"unprognostic (2.11e-2)"	"unprognostic (6.57e-2)"	"unprognostic (1.50e-3)"	"unprognostic (3.34e-2)"	6.9	11.7	2.7	3.6	4.6	1.1	5.9	7.8	4.2	8.1	5.8	3.1	3.7	4.4	9.4	5.2	4.8	7.7	5.4	3.4	2.6	1.3	4.9	9.2	72.2	3.2	3.4	1.5	5.2	3.7	2.8	2.2	106.2	3.5	6.5	4.7	4.6	2.4	4.6	2.4	6.8	5.7	11.0	3.6	3.2	2.9	2.2	3.6	1.0	7.1	2.4	2.9	9.9	9.5	0.0	0.9	0.1	1.4	0.8	2.2	0.4	4.6	4.8	1.3	6.2	15.2	11.3	6.8	20.2	16.8	10.3	9.6	2.5	3.0	1.1	12.7	18.5	6.4	10.1	1.5	5.3	2.0	1.0	2.1	1.7	7.3	2.8	12.4	0.7	3.4	12.8	8.5	8.0	2.6	18.3	10.0	0.6	2.1	2.0	5.6	1.7	0.4	1.0	0.8	6.9	2.6	1.1	3.3	4.9	8.9	0.7	0.8	3.3	14.6	0.8	3.3	5.6	0.9	2.0	12.6	2.7	5.9	6.5	5.9	1.0	0.6	0.2	5.3	2.7	7.4	0.0	1.4	0.0	2.2	0.7	1.4	0.0	0.4	1.0	0.0	0.0	0.3	1.7	0.1	0.8	0.5	0.9	0.0	0.4	2.7	4.6	7.8	4.2	2.6	1.3	3.4	1.5	3.5	3.6	6.0	61.3	0.5	5.3	5.6	1.5	3.0	2.5	1.4	2.3	5.2	0.0	2.4	0.0	21.2	0.5	10.5	18.6	0.0	7.1	8.6	24.4	2.5	15.0	15.8	4.1	1.6	2.9	14.1	4.0	0.5	9.5	3.5	10.1	0.0	5.5	3.2	11.4	11.0	10.3	3.1	1.0	25.8	18.4	0.9	3.6	4.5	20.4	1.9	9.7	6.4
BRCC3	"BRCC36, C6.1A, CXorf53"	ENSG00000185515	"BRCA1/BRCA2-containing complex subunit 3"	P46736	X	155071420-155123074	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Cell cycle, Cell division, DNA damage, DNA repair, Mitosis, Ubl conjugation pathway"	"Chromatin regulator, Hydrolase, Metalloprotease, Protease"	Proto-oncogene	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"							"Low region specificity"	"Detected in all"			HPA048737			Supported	Nucleoplasm		NA	NA			Nucleoplasm		"HPA048737: AB_2680504"	"unprognostic (1.16e-2)"	"unprognostic (2.40e-2)"	"unprognostic (5.99e-2)"	"unprognostic (1.53e-1)"	"unprognostic (1.43e-1)"	"unprognostic (2.88e-2)"	"unprognostic (4.48e-2)"	"unprognostic (6.47e-3)"	"unprognostic (1.33e-1)"	"unprognostic (9.68e-2)"	"unprognostic (1.35e-3)"	"unprognostic (3.72e-2)"	"unprognostic (3.71e-3)"	"unprognostic (7.14e-3)"	"unprognostic (1.57e-1)"	"unprognostic (1.17e-1)"	"unprognostic (1.90e-1)"	12.9	14.8	11.3	11.2	16.5	14.0	12.9	20.0	18.6	11.8	19.5	9.1	15.2	16.7	9.4	11.8	20.4	12.1	8.3	10.3	10.3	12.1	18.3	12.3	9.4	12.5	10.4	10.5	10.7	12.2	14.3	11.8	14.2	15.3	12.2	19.5	8.7	15.5	12.6	21.3	10.0	19.2	13.1	8.9	11.1	13.7	3.9	12.9	10.2	13.9	13.7	12.7	11.4	11.6	13.4	16.2	25.0	17.8	21.0	19.0	12.3	31.2	19.3	8.2	6.4	6.1	5.1	13.5	12.8	8.1	7.9	17.3	17.5	13.7	30.0	23.4	8.1	12.1	12.2	21.0	11.4	11.4	17.4	16.7	6.0	30.5	14.4	5.4	21.3	9.4	6.2	5.2	12.8	10.9	7.8	10.8	12.0	9.8	8.9	6.3	13.2	8.1	7.6	7.2	32.2	13.8	12.8	14.0	12.5	9.4	14.8	13.4	5.7	8.4	13.5	7.6	10.2	9.4	7.2	12.0	7.0	10.8	10.3	19.2	11.4	18.6	39.0	10.2	19.9	8.2	22.6	14.7	25.0	16.2	17.8	19.0	13.4	16.0	14.8	16.2	11.8	12.5	14.0	8.0	21.0	16.9	10.4	18.6	12.3	11.3	16.5	20.0	18.6	10.3	12.1	10.4	10.5	15.3	12.9	29.8	15.1	9.3	5.8	4.8	12.7	24.6	10.2	38.8	42.1	7.0	13.7	22.3	16.6	19.5	0.4	7.8	14.7	0.0	17.5	21.1	9.1	7.6	25.5	7.6	15.5	7.9	9.2	6.2	8.3	0.8	5.5	10.9	5.0	19.8	21.3	12.9	11.9	17.3	11.3	13.5	13.5	19.4	7.1	0.6	1.3	5.6	11.3	11.8	26.0	7.5
C9orf3	"AOPEP, AP-O, APO, C90RF3, FLJ14675"	ENSG00000148120	"Chromosome 9 open reading frame 3"	Q8N6M6	9	94726701-95087218	"Enzymes, Plasma proteins, Predicted intracellular proteins"		"Aminopeptidase, Hydrolase, Metalloprotease, Protease"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Melanocytes: 187.3;Smooth muscle cells: 202.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"A549: 20.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA004633, HPA072729"	Approved		Approved	"Cell Junctions"		NA	NA			"Cell Junctions"		"HPA004633: AB_1078362, HPA072729: AB_2686553"	"unprognostic (4.25e-2)"	"unprognostic (1.07e-3)"	"unprognostic (6.29e-2)"	"unprognostic (1.71e-1)"	"unprognostic (1.12e-1)"	"unprognostic (2.75e-2)"	"unprognostic (9.59e-2)"	"unprognostic (4.24e-2)"	"unprognostic (2.99e-2)"	"unprognostic (1.34e-1)"	"unprognostic (2.60e-2)"	"unprognostic (2.80e-1)"	"prognostic favorable (6.33e-5)"	"unprognostic (2.31e-1)"	"unprognostic (2.56e-1)"	"unprognostic (3.29e-2)"	"unprognostic (3.37e-2)"	6.2	8.5	6.8	9.1	12.7	2.4	11.3	10.5	10.3	14.0	17.8	24.6	24.1	5.1	28.8	15.0	20.2	16.0	17.9	29.9	8.9	5.9	12.7	28.1	10.9	3.1	11.3	6.1	11.7	24.7	25.0	11.1	24.4	11.3	22.1	6.8	11.4	13.1	17.6	29.8	39.1	8.1	32.2	11.6	6.8	10.8	6.4	11.4	3.3	11.6	23.7	7.8	12.9	25.1	5.4	5.8	2.1	3.6	3.4	3.6	1.8	4.6	20.6	2.2	3.9	2.3	3.0	8.8	4.4	2.0	4.7	2.8	4.4	6.0	1.4	3.8	7.4	6.6	18.2	4.1	4.2	2.3	9.6	3.2	1.3	18.7	3.9	4.8	1.2	1.0	3.1	17.6	4.1	2.7	12.6	2.6	2.2	2.1	1.9	8.5	6.7	1.7	1.5	2.9	5.5	8.6	2.7	7.2	1.7	8.1	4.1	4.6	6.9	7.5	7.0	1.6	6.3	7.7	0.9	2.0	2.0	2.0	8.3	2.3	1.7	2.2	0.7	7.0	1.1	3.6	0.3	3.6	2.1	3.6	2.5	2.3	2.4	3.0	3.3	5.8	5.4	2.3	2.7	1.3	3.4	1.7	5.2	1.9	1.8	6.8	12.7	10.5	10.3	8.9	5.9	11.3	6.1	11.3	11.4	20.8	26.6	2.0	151.6	128.8	21.9	142.0	61.1	30.8	31.8	12.2	17.7	55.1	38.1	34.9	33.0	58.5	10.1	0.0	83.2	34.0	56.4	54.9	3.5	70.1	8.0	11.1	10.9	21.5	6.2	19.5	17.5	5.9	187.3	1.8	8.5	71.9	51.7	14.4	100.0	32.7	12.4	12.9	202.8	14.3	20.0	131.6	73.8	3.5	9.5	61.6
CNDP1	"CN1, CPGL2, HsT2308, MGC10825"	ENSG00000150656	"Carnosine dipeptidase 1"	Q96KN2	18	74534440-74587212	"Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"		"Carboxypeptidase, Hydrolase, Metalloprotease, Protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	9	"brain: 60.3;liver: 41.4"	"Cell type enhanced"	"Detected in some"	24	"Early spermatids: 6.1;Hepatocytes: 26.1;Proximal tubular cells: 14.6"	"Group enriched"	"Detected in some"	10	"glioma: 4.4;liver cancer: 1.0;melanoma: 1.3"	"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Cell line enriched"	"Detected in single"	69	"U-266/84: 42.2"	"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in many"			"HPA008933, HPA073283"	Enhanced				"Secreted in brain"	NA	NA		1900000000			"HPA008933: AB_1847033, HPA073283: "	"unprognostic (7.43e-3)"	"unprognostic (6.00e-2)"	"unprognostic (8.55e-3)"	"unprognostic (3.93e-1)"	"unprognostic (1.32e-1)"	"unprognostic (2.17e-2)"	"unprognostic (8.04e-3)"	"unprognostic (1.12e-2)"	"unprognostic (2.81e-1)"	"unprognostic (1.16e-1)"	"unprognostic (1.16e-1)"	"unprognostic (1.66e-1)"	"unprognostic (6.90e-3)"	"unprognostic (1.14e-1)"	"unprognostic (3.30e-2)"	"unprognostic (1.33e-1)"	"unprognostic (1.28e-1)"	1.1	1.2	14.9	1.2	28.2	1.3	1.1	4.5	60.3	1.1	1.1	54.9	0.0	5.7	1.1	2.1	1.1	1.1	1.3	1.1	28.9	15.1	1.9	41.4	1.1	1.2	44.1	12.9	1.1	1.2	1.1	0.1	1.1	50.0	1.2	1.1	0.5	1.1	1.3	2.2	1.1	1.9	1.1	51.1	1.1	1.2	1.4	28.8	0.0	1.3	0.0	1.1	1.1	0.0	0.7	0.7	1.9	0.5	1.0	0.4	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	42.2	0.0	0.0	0.0	0.0	1.3	0.5	0.4	0.4	0.2	0.2	0.3	0.3	0.2	0.1	0.7	0.4	0.4	1.9	1.0	0.2	0.7	0.2	0.2	14.9	28.2	4.5	22.5	28.9	15.1	44.1	12.9	50.0	28.8	0.0	0.0	0.0	0.2	0.1	0.6	0.6	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	6.1	0.0	0.0	0.0	0.2	0.0	0.4	0.4	0.0	26.1	0.1	0.0	0.0	0.6	0.6	1.7	0.0	0.0	0.0	0.0	0.0	0.8	0.2	0.0	0.0	14.6	0.6	0.0	0.0	0.9	0.5	0.3	0.0	0.5	0.0	0.2
CNDP2	"CN2, CPGL, FLJ10830, HsT2298, PEPA"	ENSG00000133313	"Carnosine dipeptidase 2"	Q96KP4	18	74495816-74523454	"Enzymes, Plasma proteins, Predicted intracellular proteins"		"Carboxypeptidase, Hydrolase, Metalloprotease, Protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	6	"Proximal tubular cells: 371.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"Karpas-707: 76.6;RPMI-8226: 98.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB026196, HPA036898, HPA036899"	Enhanced		Enhanced	Nucleoplasm,Cytosol		NA	NA		2400000	"Nucleoplasm, Cytosol"		"CAB026196: , HPA036898: AB_2675370, HPA036899: AB_2675371"	"unprognostic (2.81e-2)"	"unprognostic (9.96e-2)"	"unprognostic (3.28e-1)"	"unprognostic (1.19e-3)"	"unprognostic (2.57e-2)"	"unprognostic (5.06e-2)"	"unprognostic (2.84e-2)"	"unprognostic (5.35e-2)"	"unprognostic (1.49e-1)"	"unprognostic (9.31e-2)"	"unprognostic (1.56e-3)"	"unprognostic (1.15e-1)"	"prognostic favorable (3.50e-6)"	"unprognostic (2.37e-3)"	"unprognostic (4.65e-3)"	"unprognostic (1.51e-1)"	"unprognostic (1.34e-1)"	19.0	11.5	31.0	19.1	36.0	6.1	16.9	10.4	33.0	39.4	37.6	45.2	27.0	51.3	12.5	35.3	20.4	38.9	25.9	11.6	31.1	26.4	89.0	66.4	22.1	23.0	36.1	24.1	11.4	27.6	15.7	13.7	28.8	27.2	34.7	22.2	14.1	16.9	32.7	7.5	11.8	71.1	10.4	39.4	39.2	27.2	6.5	32.5	10.9	43.9	11.6	21.4	28.4	12.0	29.6	49.0	12.5	44.4	31.4	23.9	30.3	10.2	13.9	10.1	9.5	12.3	7.3	42.4	10.8	10.2	14.8	14.8	8.0	11.1	13.0	13.7	11.7	11.6	15.6	15.3	20.5	10.6	19.4	6.0	12.9	7.0	12.8	18.0	25.2	20.1	11.0	15.8	12.8	23.1	8.4	12.9	15.6	13.6	76.6	9.8	11.5	13.4	12.1	15.2	6.8	8.3	14.6	11.6	98.6	58.2	43.1	11.0	5.8	8.4	60.2	14.4	25.2	25.2	10.4	13.5	15.9	13.5	3.5	7.2	14.3	58.7	17.3	10.8	18.4	13.2	7.8	30.0	12.5	21.8	44.4	23.8	28.9	17.6	20.3	49.0	29.6	19.1	20.7	4.4	31.4	43.1	43.0	23.9	30.3	31.0	36.0	10.4	33.0	31.1	26.4	36.1	24.1	27.2	32.5	68.5	54.2	53.8	35.3	8.1	33.7	22.9	91.7	60.2	38.7	113.4	15.7	128.9	159.2	142.6	2.2	45.9	105.2	0.0	136.1	106.3	20.6	56.1	11.5	102.8	184.6	41.3	62.7	36.8	86.2	3.2	17.3	82.3	16.9	112.8	71.7	80.3	99.7	74.1	15.6	371.2	24.6	12.9	15.9	4.8	7.3	8.4	91.2	36.3	82.5	47.4
COPS5	"CSN5, JAB1, MOV-34, SGN5"	ENSG00000121022	"COP9 signalosome subunit 5"	Q92905	8	67043079-67083783	"Enzymes, Predicted intracellular proteins"		"Hydrolase, Metalloprotease, Protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	6	"Early spermatids: 275.9;Late spermatids: 320.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB004242, HPA004845, HPA051531"	Supported		Enhanced	Nucleoplasm		NA	NA		27000	Nucleoplasm		"CAB004242: AB_627835, HPA004845: AB_1078557, HPA051531: AB_2681522"	"unprognostic (1.90e-3)"	"unprognostic (1.35e-1)"	"unprognostic (1.61e-1)"	"unprognostic (2.85e-3)"	"unprognostic (2.53e-1)"	"unprognostic (4.16e-2)"	"unprognostic (2.04e-3)"	"unprognostic (1.39e-1)"	"unprognostic (2.15e-2)"	"unprognostic (4.48e-2)"	"unprognostic (4.74e-3)"	"unprognostic (1.96e-2)"	"unprognostic (1.90e-3)"	"unprognostic (2.88e-2)"	"unprognostic (1.76e-1)"	"unprognostic (2.58e-1)"	"unprognostic (1.18e-2)"	20.2	26.3	29.4	19.6	28.6	16.2	28.1	28.5	40.3	18.0	21.7	15.6	20.2	22.0	17.6	21.7	24.0	17.7	15.5	46.8	27.6	27.5	27.4	33.7	16.8	17.5	31.8	29.9	17.0	20.7	23.3	21.7	24.3	33.7	18.3	25.5	9.9	19.6	18.9	64.0	16.8	22.5	23.3	39.2	16.1	20.7	27.4	31.3	19.6	18.5	29.2	22.4	18.3	16.5	20.7	35.1	33.7	30.0	26.5	28.1	22.3	28.8	27.4	23.3	21.3	24.5	26.2	18.5	25.4	20.9	35.3	31.9	17.7	35.6	26.8	11.7	26.2	25.5	24.2	31.2	28.0	39.0	25.7	26.9	38.1	27.5	23.8	23.8	24.0	23.1	23.8	36.0	28.8	37.2	27.3	34.4	28.3	45.0	18.6	31.6	26.8	42.3	42.2	30.9	60.8	31.5	27.2	16.6	21.1	37.4	25.7	14.1	19.5	14.6	28.3	24.6	21.5	46.6	24.8	25.4	18.0	22.2	21.7	19.9	23.4	29.8	35.7	26.2	27.4	24.5	26.0	28.6	33.7	20.8	30.0	21.7	20.7	20.1	23.1	35.1	17.5	21.6	19.1	21.2	26.5	28.3	18.4	28.1	22.3	29.4	28.6	28.5	40.3	27.6	27.5	31.8	29.9	33.7	31.3	20.8	21.3	38.7	36.8	43.8	32.5	99.1	43.3	26.8	29.6	29.6	31.4	115.4	74.6	65.8	275.9	33.7	37.6	0.0	52.3	84.4	39.7	44.8	34.7	33.9	69.9	23.8	32.8	31.9	28.8	320.8	40.0	37.7	27.0	55.9	34.2	45.4	48.3	45.6	48.1	56.1	44.9	32.3	31.6	126.7	59.2	41.5	106.9	39.5	48.7	48.1
COPS6	"CSN6, MOV34-34KD"	ENSG00000168090	"COP9 signalosome subunit 6"	Q7L5N1	7	100088954-100092200	"Enzymes, Predicted intracellular proteins"	"Host-virus interaction"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA044315	Approved		Supported	Nucleoplasm	"Intracellular and membrane"	NA	NA		58000	Nucleoplasm		"HPA044315: AB_10959750"	"unprognostic (1.48e-2)"	"unprognostic (2.43e-2)"	"unprognostic (6.56e-3)"	"unprognostic (1.38e-1)"	"unprognostic (5.84e-2)"	"unprognostic (2.09e-2)"	"unprognostic (3.62e-3)"	"unprognostic (2.93e-2)"	"unprognostic (2.00e-1)"	"unprognostic (2.45e-2)"	"unprognostic (4.96e-2)"	"unprognostic (1.25e-1)"	"prognostic unfavorable (6.72e-4)"	"unprognostic (1.20e-1)"	"unprognostic (3.58e-2)"	"unprognostic (8.57e-2)"	"unprognostic (8.77e-2)"	25.4	30.0	37.7	20.2	50.6	19.7	25.6	31.5	43.3	32.5	30.4	26.5	15.1	19.3	31.0	39.8	33.4	33.7	32.4	47.2	31.5	32.1	31.7	41.2	20.1	30.4	33.3	32.6	30.8	42.8	38.1	28.2	29.1	34.1	27.4	26.6	25.0	28.3	35.7	53.1	23.4	19.2	45.2	30.1	22.7	26.9	25.5	30.8	29.4	27.6	21.6	25.8	26.7	24.8	53.4	67.6	58.9	64.0	48.2	69.4	45.3	32.3	46.2	27.7	32.9	24.4	29.2	17.6	29.4	45.3	49.3	36.3	37.7	30.7	22.4	38.1	48.2	55.1	24.8	31.3	49.8	50.0	22.3	49.1	19.1	45.8	29.0	51.1	21.6	19.9	28.8	33.1	53.1	56.8	33.0	67.4	34.8	27.4	32.4	58.0	80.6	47.8	32.2	25.0	47.7	55.5	22.9	46.1	53.4	39.2	30.5	43.5	32.3	30.4	60.2	22.3	38.0	24.8	21.4	35.3	47.6	43.4	56.9	51.7	24.0	26.6	45.9	36.0	29.5	70.2	58.9	61.9	51.7	61.1	64.0	61.2	53.4	61.3	57.8	67.6	49.8	48.3	53.9	24.1	48.2	57.4	50.2	69.4	45.3	37.7	50.6	31.5	43.3	31.5	32.1	33.3	32.6	34.1	30.8	47.6	36.9	81.5	102.7	98.2	102.2	140.2	79.0	83.0	60.3	82.0	49.1	166.8	179.1	109.3	59.3	92.0	58.6	46.7	99.3	110.5	106.3	89.3	89.9	52.9	111.6	90.6	72.3	79.8	61.4	119.0	118.2	67.5	148.5	112.8	58.6	129.0	94.7	59.6	117.8	164.9	114.4	97.0	134.0	70.6	115.8	87.7	115.3	82.8	79.4	85.2
CPA1	CPA	ENSG00000091704	"Carboxypeptidase A1"	P15085	7	130380339-130388114	"Enzymes, Predicted intracellular proteins, Predicted secreted proteins"		"Carboxypeptidase, Hydrolase, Metalloprotease, Protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	3231	"pancreas: 3541.6"	"Cell type enriched"	"Detected in some"	10	"Exocrine glandular cells: 8426.3"	"Cancer enriched"	"Detected in some"	639	"pancreatic cancer: 1377.7"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	5	"AN3-CA: 16.2"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA021836, CAB025197, HPA052215"	Enhanced				"Secreted to digestive system"	NA	NA		17000000			"CAB025197: , HPA021836: AB_1846005, HPA052215: AB_2681764"	"unprognostic (8.41e-2)"			"unprognostic (9.24e-4)"	"unprognostic (5.22e-2)"	"unprognostic (1.76e-1)"	"unprognostic (3.97e-1)"	"unprognostic (1.76e-1)"		"unprognostic (2.27e-1)"	"unprognostic (1.15e-2)"	"unprognostic (1.35e-1)"	"unprognostic (1.34e-6)"	"unprognostic (4.99e-1)"	"unprognostic (1.67e-1)"	"unprognostic (2.16e-1)"	"unprognostic (4.37e-2)"	0.3	0.0	0.1	0.1	0.1	0.0	0.1	0.1	0.2	0.1	0.1	0.1	0.1	0.2	0.1	0.1	0.1	0.0	0.1	0.3	0.1	0.0	0.1	0.1	0.1	0.1	0.1	0.1	1.0	3541.6	0.0	0.1	0.1	0.1	0.1	0.0	0.1	0.3	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.1	0.4	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	16.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	2.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.6	1.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	3.0	0.6	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.2	2.3	0.0	0.3	0.0	1.9	0.3	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.1	0.1	0.1	0.2	0.1	0.0	0.1	0.1	0.1	0.1	3.0	0.0	0.0	0.5	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.3	5.0	13.2	1.2	0.0	0.0	0.0	8426.3	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	5.9	0.9	0.0	0.0	77.5	0.0	2.3	847.8	0.0	0.7	0.0	0.0	0.0	0.0	0.5	2.4	0.0	1.4	0.0	0.0	0.0
CPA2		ENSG00000158516	"Carboxypeptidase A2"	P48052	7	130266827-130289798	"Enzymes, Predicted secreted proteins"		"Carboxypeptidase, Hydrolase, Metalloprotease, Protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	529	"pancreas: 1357.9"	"Cell type enriched"	"Detected in some"	6	"Exocrine glandular cells: 4303.0"	"Cancer enriched"	"Detected in many"	60	"pancreatic cancer: 411.4"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"AN3-CA: 4.5;CACO-2: 7.5;RH-30: 6.2;SCLC-21H: 3.4"	"Low region specificity"	"Detected in some"			"Not detected"	"Not detected"			"HPA020342, HPA021317"	Enhanced		Approved	"Golgi apparatus"	"Secreted to digestive system"	NA	NA		1500000	"Golgi apparatus"		"HPA020342: AB_1846007, HPA021317: AB_1846008"	"unprognostic (1.12e-1)"	"unprognostic (3.97e-1)"	"unprognostic (4.21e-2)"	"unprognostic (1.82e-2)"	"unprognostic (1.38e-1)"	"unprognostic (6.76e-2)"		"unprognostic (4.65e-2)"	"unprognostic (1.08e-1)"	"unprognostic (1.40e-1)"	"unprognostic (1.84e-1)"	"unprognostic (2.66e-1)"	"unprognostic (3.84e-5)"	"unprognostic (7.52e-2)"	"unprognostic (1.42e-1)"	"unprognostic (7.12e-2)"	"unprognostic (8.48e-2)"	0.1	0.0	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.4	0.1	0.1	0.3	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.4	1357.9	0.0	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.0	1.0	0.1	0.2	0.1	2.5	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.9	4.5	0.0	0.1	0.0	0.0	0.0	0.7	0.0	7.5	0.0	0.0	1.0	0.0	0.6	0.0	1.4	0.0	0.1	1.0	0.0	0.0	0.8	0.0	0.1	0.0	0.0	0.1	0.1	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.9	0.0	0.4	0.0	6.2	0.1	0.1	0.7	3.4	0.0	0.2	0.0	2.1	0.3	0.0	0.2	0.0	0.0	1.1	0.8	0.6	0.0	0.7	0.2	0.8	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.3	1.7	6.6	3.8	0.0	0.8	0.0	4303.0	0.0	0.4	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	6.8	0.3	0.0	0.0	24.4	0.0	2.8	764.8	8.6	0.0	0.0	0.3	0.0	0.0	0.3	1.5	0.1	0.2	0.0	0.2	0.1
CPA3		ENSG00000163751	"Carboxypeptidase A3"	P15088	3	148865256-148897196	"Enzymes, Plasma proteins, Predicted secreted proteins"		"Carboxypeptidase, Hydrolase, Metalloprotease, Protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 111.7"	"Cell type enriched"	"Detected in some"	15	"granulocytes: 4120.5"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Cell type enriched"	"Detected in single"	1118	"basophil: 111.7"	"Lineage enriched"	"Detected in single"	1118	"granulocytes: 111.7"	"Cell line enriched"	"Detected in some"	43	"HEL: 81.5"	"Low region specificity"	"Detected in single"							"HPA006479, HPA008689, CAB020712"	Enhanced		Approved	"Nucleoplasm,Golgi apparatus"	"Secreted to blood"	NA	NA			"Golgi apparatus"	Nucleoplasm	"CAB020712: , HPA006479: AB_1078396, HPA008689: AB_1846009"	"unprognostic (1.07e-1)"	"unprognostic (3.03e-2)"	"unprognostic (2.66e-3)"	"unprognostic (9.13e-3)"	"unprognostic (3.50e-1)"	"unprognostic (1.18e-3)"	"unprognostic (2.47e-1)"	"unprognostic (1.57e-2)"	"unprognostic (2.14e-1)"	"unprognostic (9.51e-2)"	"unprognostic (1.89e-1)"	"unprognostic (5.30e-3)"	"unprognostic (3.50e-3)"	"unprognostic (5.18e-3)"	"unprognostic (3.24e-2)"	"unprognostic (1.74e-1)"	"unprognostic (1.69e-3)"	12.4	0.6	0.4	12.0	0.4	5.6	6.2	0.4	0.5	25.4	14.1	0.8	4.4	7.1	14.1	21.2	16.5	3.7	50.9	4.5	0.4	0.2	5.8	2.8	37.3	15.2	0.4	0.4	2.0	7.2	0.7	0.8	1.3	0.5	37.3	16.4	8.5	8.8	5.8	1.4	12.7	20.2	24.3	0.4	1.0	13.7	7.1	0.4	3.6	1.4	9.9	7.1	14.0	8.9	0.0	0.0	111.7	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	81.5	0.0	0.0	0.0	0.0	1.8	0.0	0.0	0.0	0.1	0.1	1.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	111.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.4	0.4	0.4	0.5	0.4	0.2	0.4	0.4	0.5	0.4	29.8	269.3	0.0	0.2	1.4	0.0	0.2	0.0	16.0	31.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.6	0.1	4120.5	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	1.1	0.0	0.0	0.0	0.3
CPA4	CPA3	ENSG00000128510	"Carboxypeptidase A4"	Q9UI42	7	130293134-130324180	"Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"		"Carboxypeptidase, Hydrolase, Metalloprotease, Protease"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 18.0;skin 1: 41.0"	"Cell type enhanced"	"Detected in some"	18	"Basal keratinocytes: 15.8;Exocrine glandular cells: 45.1;Pancreatic endocrine cells: 12.8;Suprabasal keratinocytes: 27.0"	"Cancer enhanced"	"Detected in many"		"cervical cancer: 10.0;head and neck cancer: 9.8"	"Low region specificity"	"Detected in single"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"BJ hTERT+: 29.6;hTERT-RPE1: 55.9;LHCN-M2: 60.1;U-2 OS: 32.8;U-87 MG: 59.0"	"Low region specificity"	"Detected in single"							HPA021030			Approved	Nucleoplasm,Centrosome,Cytosol	"Secreted in other tissues"	NA	Yes		480000	Nucleoplasm	"Centrosome, Cytosol"	"HPA021030: AB_1846010"	"unprognostic (7.60e-3)"	"unprognostic (4.00e-2)"	"unprognostic (1.59e-3)"	"unprognostic (3.63e-3)"	"unprognostic (2.24e-2)"	"unprognostic (2.91e-2)"	"unprognostic (2.78e-2)"	"unprognostic (4.36e-3)"	"unprognostic (3.23e-1)"	"unprognostic (5.79e-2)"	"unprognostic (2.37e-3)"	"unprognostic (6.49e-2)"	"unprognostic (6.21e-10)"	"unprognostic (2.39e-1)"	"unprognostic (1.67e-1)"	"unprognostic (7.56e-2)"	"prognostic unfavorable (1.31e-4)"	2.7	2.3	0.1	0.4	0.4	0.2	2.8	0.1	0.4	8.1	1.1	0.3	0.1	0.1	1.1	1.2	18.0	0.2	0.2	4.4	0.1	1.2	1.2	0.2	0.8	0.3	0.1	0.1	1.8	6.9	0.1	1.1	8.8	0.9	0.3	0.1	0.6	4.4	0.1	0.3	41.0	0.5	0.7	0.7	1.7	0.2	2.2	0.1	0.8	0.1	12.3	2.3	1.7	6.7	0.4	0.4	1.6	0.4	1.5	0.4	0.1	19.4	1.0	0.0	0.0	0.1	0.3	0.0	15.6	29.6	15.9	3.9	0.1	1.7	0.0	3.0	6.6	16.1	1.1	0.0	8.6	16.5	0.0	0.0	0.0	6.3	0.4	0.4	0.0	0.0	0.2	13.9	1.4	2.0	55.9	0.0	0.0	0.0	0.0	60.1	0.0	0.0	0.0	0.1	0.1	2.3	0.0	16.1	0.0	7.5	0.8	0.0	0.0	10.3	4.9	0.1	6.3	0.1	0.0	11.9	3.9	32.8	1.3	1.5	0.0	0.0	0.0	59.0	0.0	0.1	1.0	0.4	0.4	0.4	0.1	0.2	0.3	0.2	0.3	0.0	0.4	0.3	0.3	1.6	1.5	0.2	0.4	0.3	0.1	0.1	0.4	0.1	0.3	0.1	1.2	0.1	0.1	0.9	0.1	3.0	0.3	0.0	0.5	15.8	0.0	0.3	0.0	2.7	2.3	0.0	0.0	3.7	0.0	0.5	0.3	0.1	0.0	0.0	45.1	1.0	1.9	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.3	1.0	0.0	0.0	12.8	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.7	27.0	7.9	0.0	0.0	0.9
CPA5		ENSG00000158525	"Carboxypeptidase A5"	Q8WXQ8	7	130344816-130368730	"Enzymes, Predicted intracellular proteins, Predicted secreted proteins"		"Carboxypeptidase, Hydrolase, Metalloprotease, Protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	17	"blood: 25.2;testis: 30.4"	"Group enriched"	"Detected in some"	20	"Early spermatids: 46.3;Late spermatids: 106.9"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	4	"memory CD4 T-cell: 8.0;naive CD8 T-cell: 20.3;T-reg: 25.2"	"Lineage enriched"	"Detected in single"	114	"T-cells: 25.2"	"Cell line enhanced"	"Detected in some"		"RH-30: 11.2;RT4: 5.1;U-266/84: 8.4"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			HPA020322			Approved	Nucleoplasm	"Secreted in male reproductive system"	NA	NA			Nucleoplasm		"HPA020322: AB_10960562"	"unprognostic (2.44e-1)"	"unprognostic (3.76e-1)"	"unprognostic (1.50e-1)"	"unprognostic (5.94e-2)"	"unprognostic (4.96e-2)"	"unprognostic (7.10e-3)"	"unprognostic (1.64e-2)"	"unprognostic (1.41e-2)"	"unprognostic (3.26e-1)"	"unprognostic (5.02e-2)"	"unprognostic (5.83e-4)"	"unprognostic (1.43e-1)"	"unprognostic (8.88e-13)"	"unprognostic (5.16e-2)"	"unprognostic (1.32e-1)"	"unprognostic (8.81e-2)"	"unprognostic (3.08e-2)"	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.4	0.1	0.0	0.1	0.1	0.1	0.4	0.1	0.1	0.1	1.6	0.1	0.1	0.1	0.4	0.0	1.0	0.5	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.8	0.4	0.1	0.1	1.6	0.0	30.4	0.1	0.1	0.1	0.1	0.7	0.8	0.1	0.0	0.0	0.2	0.0	0.0	25.2	3.1	0.8	0.0	0.1	0.6	0.0	0.0	0.0	0.4	3.3	0.2	0.4	2.4	0.0	0.0	0.0	0.0	1.1	0.1	0.4	0.7	0.0	0.0	1.9	0.7	0.7	1.2	0.5	0.0	0.0	0.0	1.1	0.0	1.2	1.4	0.0	0.9	0.0	1.6	0.1	0.0	0.4	0.0	0.8	0.0	0.0	0.0	11.2	0.4	1.5	5.1	1.4	0.2	0.0	3.2	0.0	0.1	0.0	0.0	0.0	0.0	2.3	0.0	0.1	0.0	8.4	0.0	0.4	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.3	0.0	8.0	4.1	0.0	0.0	2.1	20.3	0.0	0.0	0.0	0.0	25.2	3.1	0.1	0.1	0.1	0.1	0.1	0.4	0.1	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	1.8	0.0	2.8	0.0	0.0	46.3	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	106.9	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	2.6	1.9	0.0	3.9	0.0	0.0	0.0
CPA6	CPAH	ENSG00000165078	"Carboxypeptidase A6"	Q8N4T0	8	67422038-67746385	"Disease related genes, Enzymes, Potential drug targets, Predicted secreted proteins"		"Carboxypeptidase, Hydrolase, Metalloprotease, Protease"	"Disease mutation, Epilepsy"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 16.2;prostate: 10.6;retina: 13.0"	"Cell type enhanced"	"Detected in some"	11	"Basal glandular cells: 26.9;Early spermatids: 15.2;Muller glia cells: 22.3;Pancreatic endocrine cells: 12.5;Urothelial cells: 26.0"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"ASC TERT1: 2.0;CACO-2: 6.2;EFO-21: 3.5;Hep G2: 9.5;OE19: 4.2"	"Region enriched"	"Detected in single"	10	"olfactory region: 15.5"	"Low region specificity"	"Detected in all"								"Secreted to extracellular matrix"	NA	NA						"unprognostic (2.85e-2)"	"unprognostic (1.95e-1)"	"unprognostic (1.72e-2)"	"unprognostic (1.14e-1)"	"unprognostic (2.58e-1)"	"unprognostic (2.24e-1)"	"unprognostic (2.08e-1)"	"unprognostic (2.88e-1)"	"unprognostic (9.35e-2)"	"unprognostic (1.65e-1)"	"unprognostic (5.23e-2)"	"unprognostic (6.99e-2)"	"unprognostic (3.57e-4)"	"unprognostic (9.61e-5)"	"unprognostic (1.75e-1)"	"unprognostic (9.09e-2)"	"unprognostic (1.41e-2)"	0.2	0.1	0.1	9.8	0.1	0.2	0.2	0.1	0.1	9.4	16.2	0.7	0.8	0.2	8.3	1.7	3.7	0.2	0.3	0.1	0.2	0.1	0.3	0.1	0.7	0.1	0.2	0.0	0.1	0.1	0.1	0.2	0.3	0.3	10.6	7.2	13.0	0.1	0.7	0.1	0.2	1.3	3.4	0.7	0.3	0.5	1.3	0.0	0.0	0.2	1.5	0.6	4.1	5.5	0.0	0.6	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	2.0	0.0	0.0	0.2	0.0	0.0	6.2	0.0	0.0	3.5	0.0	0.2	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	9.5	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.8	0.0	4.2	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	1.7	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.1	0.1	0.1	0.1	0.2	0.1	0.2	0.0	0.3	0.0	0.0	0.0	0.0	26.9	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	15.2	0.0	0.0	0.0	0.3	0.0	0.0	5.6	0.0	0.0	0.1	1.6	2.4	0.0	0.0	0.5	1.7	0.0	0.0	0.0	0.7	22.3	12.5	2.9	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.6	26.0
CPB1		ENSG00000153002	"Carboxypeptidase B1"	P15086	3	148791102-148860187	"Enzymes, Plasma proteins, Predicted secreted proteins"		"Carboxypeptidase, Hydrolase, Metalloprotease, Protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	590	"pancreas: 3628.4"	"Cell type enriched"	"Detected in some"	7	"Exocrine glandular cells: 6332.0"	"Group enriched"	"Detected in some"	312	"breast cancer: 293.8;pancreatic cancer: 641.4"	"Not detected"	"Not detected"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in some"		"ASC diff: 2.8;EFO-21: 2.9;HDLM-2: 3.1;U-2 OS: 5.2;U-251 MG: 1.5;U-266/84: 2.4"	"Low region specificity"	"Detected in some"			"Not detected"	"Not detected"			"CAB026158, HPA038069, HPA046340"	Enhanced				"Secreted to digestive system"	NA	NA		6600000			"CAB026158: , HPA038069: AB_2675816, HPA046340: AB_2679628"	"unprognostic (6.90e-2)"	"unprognostic (3.79e-2)"	"unprognostic (3.34e-2)"	"unprognostic (2.64e-2)"	"unprognostic (5.58e-2)"	"unprognostic (3.27e-2)"	"unprognostic (6.26e-4)"	"unprognostic (1.90e-1)"	"unprognostic (1.82e-1)"	"unprognostic (1.07e-1)"	"unprognostic (7.59e-2)"	"unprognostic (4.51e-2)"	"unprognostic (5.50e-8)"	"unprognostic (3.08e-1)"	"unprognostic (1.60e-1)"		"unprognostic (4.93e-2)"	0.2	1.7	0.1	0.1	0.2	0.0	0.7	0.1	0.2	0.1	0.1	0.1	0.1	0.2	0.1	0.1	0.1	0.0	0.1	0.2	0.1	0.0	0.1	0.1	0.1	0.1	0.1	0.1	1.2	3628.4	0.0	0.1	0.1	0.1	0.1	0.0	0.1	0.2	0.1	0.1	0.0	0.1	0.1	0.1	0.7	0.2	0.4	0.2	0.1	0.1	0.1	0.1	0.1	0.1	1.8	1.1	6.1	1.0	3.1	3.5	0.9	0.0	0.0	0.0	0.0	2.8	0.7	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.8	2.9	0.0	0.0	0.0	0.0	0.0	0.1	3.1	0.5	0.6	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.4	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.2	5.2	0.0	1.5	0.0	2.4	0.6	0.0	0.0	0.0	6.1	0.7	1.1	3.0	0.9	2.2	0.9	1.3	2.6	0.3	1.8	0.9	3.5	4.5	3.1	1.0	1.1	0.6	0.9	0.1	0.2	0.1	0.2	0.1	0.0	0.1	0.1	0.1	0.2	0.0	0.0	0.0	0.2	0.6	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	10.2	9.9	0.1	0.0	0.0	6332.0	0.0	1.4	6.8	0.0	0.0	0.8	0.0	158.6	0.0	0.0	1.9	0.6	0.0	0.0	31.5	0.0	0.0	954.7	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.3	0.2	0.0	0.0	0.1
CPB2	"CPU, PCPB, TAFI"	ENSG00000080618	"Carboxypeptidase B2"	Q96IY4	13	46053195-46105033	"Enzymes, FDA approved drug targets, Plasma proteins, Predicted secreted proteins"	"Blood coagulation, Fibrinolysis, Hemostasis"	"Carboxypeptidase, Hydrolase, Metalloprotease, Protease"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	82	"liver: 246.8"	"Cell type enriched"	"Detected in some"	8	"Hepatocytes: 1070.7"	"Cancer enriched"	"Detected in some"	112	"liver cancer: 268.4"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	76	"Hep G2: 62.5"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA004146	Approved				"Secreted to blood"	NA	NA		14000000000			"HPA004146: AB_1078397"	"unprognostic (3.44e-2)"	"unprognostic (1.25e-1)"	"unprognostic (2.94e-2)"	"unprognostic (1.89e-2)"	"unprognostic (7.69e-2)"	"unprognostic (1.17e-2)"	"prognostic favorable (2.06e-4)"	"unprognostic (1.89e-1)"	"unprognostic (2.74e-1)"	"unprognostic (2.48e-1)"	"unprognostic (3.17e-2)"	"unprognostic (4.83e-2)"	"unprognostic (3.20e-3)"	"unprognostic (1.34e-1)"	"unprognostic (7.10e-2)"	"unprognostic (3.34e-2)"	"unprognostic (9.61e-2)"	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.7	0.0	0.0	0.0	0.0	246.8	3.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.2	0.5	0.5	0.4	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	62.5	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.1	0.0	0.0	0.3	0.0	0.6	0.0	0.0	0.4	0.2	0.1	0.0	0.0	0.4	0.2	0.5	0.4	0.5	0.2	0.6	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	3.0	24.8	0.0	0.0	0.0	0.0	0.0	127.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	1070.7	0.1	0.0	0.0	16.0	15.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.9	0.0	0.0
CPD	GP180	ENSG00000108582	"Carboxypeptidase D"	O75976	17	30378905-30469989	"Enzymes, Predicted intracellular proteins, Predicted membrane proteins"		"Carboxypeptidase, Hydrolase, Metalloprotease, Protease"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	6	"Cholangiocytes: 178.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"neutrophil: 19.3"	"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA052796, HPA055465"	Approved		Approved	"Nucleoplasm,Nuclear membrane,Nuclear speckles"		NA	NA		930000	"Nucleoplasm, Nuclear speckles"	"Nuclear membrane"	"HPA052796: AB_2681953, HPA055465: AB_2682823"	"unprognostic (1.05e-1)"	"unprognostic (1.31e-1)"	"unprognostic (3.05e-2)"	"unprognostic (3.62e-2)"	"unprognostic (6.13e-2)"	"unprognostic (1.65e-1)"	"unprognostic (7.97e-3)"	"unprognostic (4.45e-2)"	"unprognostic (2.07e-2)"	"unprognostic (2.96e-1)"	"unprognostic (1.62e-1)"	"unprognostic (3.16e-1)"	"unprognostic (1.58e-1)"	"unprognostic (3.74e-2)"	"unprognostic (7.25e-2)"	"unprognostic (3.36e-1)"	"unprognostic (1.08e-1)"	16.4	8.0	9.8	12.3	12.4	18.1	17.9	9.1	13.3	28.6	16.2	18.5	10.1	12.9	12.6	10.1	10.0	15.2	33.6	10.5	12.8	10.4	13.4	26.8	20.0	14.2	22.1	11.4	7.8	14.7	21.2	14.9	22.3	13.9	11.4	13.3	7.5	59.7	7.9	10.0	7.8	22.0	15.1	25.9	7.9	24.6	25.0	13.5	5.8	37.2	7.7	10.0	11.5	11.6	0.4	3.4	19.3	5.5	2.1	3.8	2.5	12.2	18.7	16.2	16.7	16.9	32.2	5.8	16.9	24.8	11.7	14.5	21.9	7.9	1.5	21.6	19.4	14.9	8.8	10.5	21.4	19.9	5.8	15.0	3.5	11.5	13.5	20.6	22.7	9.2	57.4	9.6	15.0	14.6	19.6	23.8	5.3	6.7	18.1	9.4	2.4	7.3	6.2	4.5	28.2	4.3	7.0	18.8	4.7	22.0	14.0	4.1	10.3	20.2	17.5	8.8	19.8	16.5	15.8	28.3	11.7	7.7	18.2	16.1	7.3	15.2	5.2	15.0	14.9	9.9	2.8	5.5	6.4	3.4	2.8	3.8	0.2	1.7	2.8	3.4	0.4	1.4	1.7	19.3	2.1	2.3	0.4	1.1	2.5	9.8	12.4	9.1	13.3	12.8	10.4	22.1	11.4	13.9	13.5	29.8	19.2	7.5	28.1	19.6	23.1	10.4	178.3	18.7	27.3	27.9	43.2	20.5	1.7	21.2	75.9	48.4	31.6	0.0	21.4	9.1	26.2	58.6	24.2	67.2	14.9	44.5	31.0	51.0	34.9	41.5	15.5	20.5	28.7	10.0	69.1	11.1	30.2	20.1	15.2	17.7	35.0	0.0	22.6	15.6	24.2	16.3	20.1	20.8	31.5	38.6
CPE		ENSG00000109472	"Carboxypeptidase E"	P16870	4	165361194-165498320	"Enzymes, Plasma proteins, Predicted intracellular proteins"		"Carboxypeptidase, Hydrolase, Metalloprotease, Protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 203.7"	"Group enriched"	"Detected in many"	4	"Bipolar cells: 533.2;Cone photoreceptor cells: 585.1;Glandular cells: 402.2;Intestinal endocrine cells: 564.2;Leydig cells: 463.7;Muller glia cells: 511.1;Peritubular cells: 583.8;Rod photoreceptor cells: 443.0;Sertoli cells: 840.8;Smooth muscle cells: 614.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in single"		"T-reg: 1.5"	"Lineage enriched"	"Detected in single"	16	"T-cells: 1.5"	"Cell line enhanced"	"Detected in many"		"Hep G2: 49.0;SCLC-21H: 69.0;SiHa: 101.3;SuSa: 59.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA003819, CAB024907"	Supported		Approved	Nucleoplasm,Vesicles,Centrosome	"Intracellular and membrane"	NA	NA		470000	Centrosome	"Nucleoplasm, Vesicles"	"CAB024907: , HPA003819: AB_2667054"	"unprognostic (1.84e-1)"	"unprognostic (5.64e-3)"	"unprognostic (1.61e-1)"	"unprognostic (1.70e-2)"	"unprognostic (2.51e-1)"	"unprognostic (1.44e-2)"	"unprognostic (1.65e-1)"	"unprognostic (9.52e-2)"	"unprognostic (2.91e-3)"	"unprognostic (9.01e-2)"	"unprognostic (4.84e-3)"	"unprognostic (5.56e-3)"	"prognostic unfavorable (2.60e-4)"	"unprognostic (4.35e-3)"	"unprognostic (1.46e-1)"	"unprognostic (2.26e-1)"	"prognostic unfavorable (2.12e-4)"	27.7	33.8	123.1	4.4	135.5	0.9	21.5	82.9	203.7	10.7	9.6	31.6	5.3	5.0	13.3	94.3	16.4	15.7	14.0	19.6	116.9	56.3	12.0	6.3	11.0	7.6	56.9	70.7	23.4	35.5	33.9	40.0	2.2	53.0	66.5	8.8	13.2	12.0	20.1	11.0	5.5	6.2	18.5	40.5	2.8	19.2	30.4	53.3	0.9	40.7	4.3	7.7	6.3	9.4	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	1.3	8.9	1.7	7.1	0.7	0.4	0.0	3.6	1.3	2.9	0.0	0.0	0.0	2.6	0.0	0.3	0.2	3.4	0.7	0.7	0.0	13.0	0.0	3.6	49.0	0.5	0.0	0.0	17.3	3.6	0.0	0.0	17.2	0.0	0.0	0.0	0.3	1.8	2.4	0.0	0.4	5.6	0.0	2.0	0.0	0.0	0.1	0.1	0.5	69.0	22.8	101.3	12.7	0.0	59.1	7.6	0.3	0.0	2.7	7.0	0.2	0.2	3.9	0.0	0.3	2.6	0.1	0.8	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	123.1	135.5	82.9	82.2	116.9	56.3	56.9	70.7	53.0	53.3	0.0	9.3	0.0	67.8	23.2	533.2	32.3	40.8	0.0	3.4	21.0	585.1	0.4	0.0	15.1	5.5	57.1	1.6	0.0	1.5	0.1	129.4	402.2	0.0	7.9	0.8	66.7	564.2	115.4	9.2	11.5	463.7	12.5	82.7	1.8	12.7	511.1	19.3	2.9	583.8	9.6	443.0	840.8	614.9	17.7	9.6	18.2	0.7	1.9	3.7	11.3
CPM		ENSG00000135678	"Carboxypeptidase M"	P14384	12	68842197-68971570	"Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"		"Carboxypeptidase, Hydrolase, Metalloprotease, Protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adipose tissue: 56.1"	"Cell type enhanced"	"Detected in many"	11	"Alveolar cells type 1: 333.5;Sertoli cells: 750.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"classical monocyte: 15.5;myeloid DC: 11.9"	"Group enriched"	"Detected in many"	5	"dendritic cells: 11.9;monocytes: 15.5"	"Cell line enhanced"	"Detected in many"		"ASC diff: 29.5;ASC TERT1: 21.0;HSkMC: 37.8;SiHa: 27.7"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA002657, HPA077243"	Enhanced		Uncertain	Vesicles		NA	NA		5000000	Vesicles		"HPA002657: AB_1078398, HPA077243: "	"unprognostic (1.74e-1)"	"unprognostic (3.11e-1)"	"unprognostic (2.88e-3)"	"prognostic favorable (1.00e-4)"	"unprognostic (4.58e-2)"	"unprognostic (8.61e-2)"	"unprognostic (1.57e-2)"	"unprognostic (2.01e-1)"	"unprognostic (8.42e-2)"	"unprognostic (1.40e-1)"	"unprognostic (1.35e-1)"	"unprognostic (1.42e-1)"	"unprognostic (1.47e-3)"	"unprognostic (8.58e-2)"	"unprognostic (6.85e-2)"	"unprognostic (2.59e-2)"	"unprognostic (1.06e-1)"	56.1	6.6	3.8	5.4	7.0	1.1	37.2	1.2	4.9	6.5	12.9	13.2	0.9	1.6	10.7	6.1	4.1	6.4	6.5	2.9	5.3	3.0	22.1	11.6	24.1	13.0	10.9	4.3	7.5	7.8	3.2	1.0	27.9	5.5	6.2	10.8	2.7	3.2	1.7	8.2	13.0	3.7	2.5	6.7	11.4	5.9	5.8	9.3	1.1	5.1	3.5	4.5	4.4	4.4	2.8	11.9	1.3	15.5	0.3	1.3	4.7	0.0	1.5	0.0	0.0	29.5	21.0	0.3	3.9	0.4	0.7	0.9	1.2	1.6	0.2	3.9	0.5	1.7	0.0	0.5	1.0	1.7	0.0	1.0	0.0	6.4	0.1	0.1	0.4	0.7	37.8	0.2	0.4	0.8	3.5	0.0	0.1	0.0	0.0	3.0	0.6	0.0	0.2	0.6	0.0	2.1	1.2	0.2	0.0	2.9	2.3	0.1	0.0	27.7	4.3	3.3	2.3	0.4	10.3	0.1	0.5	3.2	0.2	0.0	0.1	0.1	5.1	1.7	5.2	2.3	0.3	15.5	0.1	0.1	10.2	0.0	1.4	1.2	0.0	11.9	2.8	0.7	0.1	1.3	0.3	4.7	0.8	1.3	4.7	3.8	7.0	1.2	4.9	5.3	3.0	10.9	4.3	5.5	9.3	333.5	253.0	5.4	2.5	11.0	2.5	1.6	147.7	26.8	114.9	48.8	0.0	22.1	24.9	48.5	13.5	7.1	69.0	0.0	179.6	47.4	3.8	40.7	105.6	33.4	132.7	0.0	10.4	90.2	236.7	12.1	97.2	57.6	10.1	10.8	28.4	65.4	68.6	50.7	74.3	67.7	4.3	750.3	107.2	0.5	1.9	8.7	144.2	7.9	29.3	2.4
CPN1		ENSG00000120054	"Carboxypeptidase N subunit 1"	P15169	10	100042193-100081877	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted secreted proteins"		"Carboxypeptidase, Hydrolase, Metalloprotease, Protease"	"Disease mutation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	127	"liver: 76.8"	"Cell type enriched"	"Detected in some"	12	"Hepatocytes: 24.6"	"Group enriched"	"Detected in some"	12	"liver cancer: 26.6;melanoma: 7.9"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	17	"SK-MEL-30: 56.6"	"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in all"								"Secreted to blood"	NA	NA		22000000000						"unprognostic (2.97e-2)"	"unprognostic (2.23e-2)"			"unprognostic (3.93e-2)"		"unprognostic (1.64e-1)"		"unprognostic (6.75e-2)"		"unprognostic (2.93e-2)"	"unprognostic (5.26e-2)"	"unprognostic (2.63e-1)"			0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	76.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	56.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.1	0.0	0.2	0.1	0.1	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	24.6	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	1.6	2.1	0.0	0.1	0.0	0.1	0.0
CPO		ENSG00000144410	"Carboxypeptidase O"	Q8IVL8	2	206939554-206969474	"Enzymes, Predicted intracellular proteins"		"Carboxypeptidase, Hydrolase, Metalloprotease, Protease"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	7	"intestine: 71.1"	"Cell type enriched"	"Detected in single"	6	"Early spermatids: 1.8"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell type enriched"	"Detected in single"	17	"basophil: 10.3"	"Lineage enriched"	"Detected in single"	42	"granulocytes: 10.3"	"Cell line enhanced"	"Detected in some"		"ASC diff: 2.8;hTCEpi: 2.1;hTERT-RPE1: 2.4;NB-4: 3.9;SuSa: 2.5"					"Low region specificity"	"Detected in single"								"Intracellular and membrane"	NA	NA						"unprognostic (9.39e-2)"	"unprognostic (2.64e-1)"	"unprognostic (2.95e-2)"	"unprognostic (5.21e-2)"	"unprognostic (2.28e-1)"	"unprognostic (1.27e-2)"	"unprognostic (1.16e-1)"	"unprognostic (9.06e-2)"	"unprognostic (4.03e-1)"	"unprognostic (1.33e-1)"	"unprognostic (3.75e-3)"	"unprognostic (1.22e-1)"	"unprognostic (3.60e-2)"	"unprognostic (2.52e-1)"	"unprognostic (6.56e-2)"	"unprognostic (4.03e-2)"	"unprognostic (4.89e-2)"	0.2	0.4	0.2	0.1	0.9	0.0	0.3	0.1	0.4	0.2	0.6	0.1	1.1	0.1	0.1	9.4	0.1	0.1	0.1	0.1	0.2	0.5	0.5	0.2	0.1	0.1	0.2	0.1	0.1	0.1	0.6	0.5	0.1	0.1	0.3	0.1	0.1	0.3	0.3	0.2	0.1	71.1	0.2	0.1	0.1	0.1	0.3	0.1	0.1	0.4	0.1	0.1	0.1	0.1	0.0	0.0	10.3	0.0	0.0	0.2	0.0	0.0	0.3	0.3	0.0	2.8	1.0	1.6	0.4	0.0	0.0	0.1	0.3	0.2	0.1	0.7	0.0	0.0	0.0	0.3	0.2	0.1	0.2	0.5	0.0	0.0	0.2	0.0	0.7	0.2	0.8	2.1	0.0	0.0	2.4	0.0	0.7	0.0	0.0	0.2	0.0	0.1	3.9	0.2	0.3	0.6	0.1	0.0	0.2	1.4	0.1	0.3	0.0	0.0	0.3	0.0	2.5	0.2	0.5	0.0	0.0	1.0	0.6	0.3	0.1	0.9	0.0	0.0	0.2	0.5	10.3	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.9	0.1	0.4	0.2	0.5	0.2	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0
CPQ	"LDP, PGCP"	ENSG00000104324	"Carboxypeptidase Q"	Q9Y646	8	96645227-97149654	"Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"		"Carboxypeptidase, Hydrolase, Metalloprotease, Protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"thyroid gland: 94.4"	"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"neutrophil: 62.6"	"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"ASC diff: 37.0;ASC TERT1: 42.5;hTERT-RPE1: 34.7;Karpas-707: 30.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA023235, HPA024490"	Enhanced		Supported	"Golgi apparatus,Vesicles"	"Secreted to blood"	NA	NA		51000000	"Golgi apparatus, Vesicles"		"HPA023235: AB_1855257, HPA024490: AB_1855258"	"unprognostic (4.04e-2)"	"unprognostic (5.46e-2)"	"unprognostic (4.45e-2)"	"unprognostic (1.68e-1)"	"unprognostic (1.51e-3)"	"unprognostic (3.98e-3)"	"unprognostic (5.24e-2)"	"unprognostic (2.92e-2)"	"unprognostic (2.67e-2)"	"unprognostic (9.19e-2)"	"unprognostic (2.38e-3)"	"unprognostic (6.16e-3)"	"prognostic favorable (5.40e-5)"	"unprognostic (6.74e-3)"	"unprognostic (8.71e-2)"	"unprognostic (3.21e-2)"	"unprognostic (1.75e-1)"	17.4	12.6	12.5	10.1	18.3	9.5	15.4	8.3	11.3	26.3	16.5	19.4	21.1	9.4	24.5	19.5	9.1	16.8	20.0	24.1	14.0	9.2	26.4	22.1	13.9	12.3	27.6	8.8	35.3	18.8	20.7	14.2	12.4	16.6	18.1	10.9	19.8	10.9	18.6	5.0	9.1	14.1	30.8	15.3	12.9	14.5	7.3	24.5	1.3	94.4	8.1	7.2	16.9	19.3	1.8	12.8	62.6	17.5	6.3	7.3	8.4	0.6	1.9	1.6	0.4	37.0	42.5	0.5	11.3	17.1	4.0	8.4	1.3	0.7	1.0	9.2	17.8	5.8	0.6	0.7	0.8	3.9	10.2	1.5	9.6	1.8	5.6	8.2	2.3	12.5	22.2	2.0	4.6	1.1	34.7	1.8	0.6	9.3	30.9	9.1	0.6	0.3	4.7	1.2	0.8	1.9	2.1	0.3	0.5	8.3	4.3	1.2	0.8	4.0	0.4	8.7	10.1	4.3	9.3	8.1	17.7	2.1	0.8	4.2	3.1	0.7	0.4	11.2	7.7	11.7	5.4	17.5	10.8	7.3	12.0	7.3	1.5	5.5	6.3	12.8	1.8	5.0	6.7	62.6	6.3	11.0	3.7	5.7	8.4	12.5	18.3	8.3	11.3	14.0	9.2	27.6	8.8	16.6	24.5	11.9	12.2	10.4	23.2	17.2	13.3	24.2	48.4	5.3	9.1	45.4	27.5	10.3	14.9	15.7	4.0	23.3	10.7	0.0	9.4	1.2	64.4	11.1	36.9	37.7	48.7	9.5	13.3	50.3	56.8	5.7	67.0	38.8	74.2	14.4	6.1	41.4	11.7	8.6	68.6	42.8	14.9	51.8	32.1	4.7	3.6	11.4	5.0	17.9	10.9	12.0
CPXM1	"CPX-1, CPX1, CPXM"	ENSG00000088882	"Carboxypeptidase X, M14 family member 1"	Q96SM3	20	2794069-2800637	"Enzymes, Predicted secreted proteins"		"Carboxypeptidase, Hydrolase, Metalloprotease, Protease"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"placenta: 60.3"	"Cell type enhanced"	"Detected in many"	16	"Fibroblasts: 29.4;Leydig cells: 16.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in some"	22	"memory B-cell: 2.3;myeloid DC: 1.4;NK-cell: 3.9;plasmacytoid DC: 1.1"	"Group enriched"	"Detected in many"	26	"B-cells: 2.3;dendritic cells: 1.4;NK-cells: 3.9"	"Cell line enhanced"	"Detected in some"		"AF22: 45.9;HSkMC: 25.0;NB-4: 40.3;REH: 41.1;SH-SY5Y: 30.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"								"Secreted in other tissues"	NA	NA						"unprognostic (7.48e-2)"	"unprognostic (3.61e-1)"	"unprognostic (6.70e-2)"	"unprognostic (1.47e-2)"	"unprognostic (3.41e-1)"	"unprognostic (5.24e-2)"	"unprognostic (1.82e-2)"	"unprognostic (1.84e-2)"	"unprognostic (2.98e-2)"	"unprognostic (9.32e-2)"	"unprognostic (7.02e-2)"	"unprognostic (3.23e-2)"	"prognostic unfavorable (4.62e-10)"	"unprognostic (1.30e-1)"	"unprognostic (1.49e-1)"	"unprognostic (5.55e-3)"	"unprognostic (1.27e-2)"	24.0	2.4	0.5	4.6	1.1	5.6	14.9	0.9	3.7	32.2	7.4	1.3	7.6	0.2	43.6	41.4	1.4	13.6	31.1	14.4	0.5	0.2	4.3	0.6	2.7	1.9	2.1	0.6	20.7	1.7	0.6	2.7	60.3	2.4	8.5	0.2	16.2	2.7	5.3	2.2	5.8	1.4	14.5	1.4	0.5	1.0	10.1	0.3	15.2	8.8	0.7	1.5	23.0	15.2	2.3	1.4	0.0	0.0	3.9	0.0	0.7	0.0	0.0	45.9	0.0	0.0	1.4	0.0	0.1	0.2	0.5	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	3.4	0.0	0.1	0.2	2.3	6.0	0.0	0.0	0.6	0.0	0.9	25.0	0.0	2.1	0.0	0.0	0.0	8.7	2.5	0.0	0.0	0.0	0.1	40.3	9.7	0.0	0.0	41.1	0.0	1.1	0.0	0.0	0.0	30.9	0.0	0.0	0.0	7.7	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.3	0.0	0.0	1.4	0.0	0.0	0.0	0.0	3.9	0.0	1.1	0.0	0.7	0.5	1.1	0.9	1.1	0.5	0.2	2.1	0.6	2.4	0.3	0.0	0.3	0.5	2.6	2.4	0.0	0.5	0.0	5.3	1.2	3.5	0.0	2.4	0.0	1.9	2.1	0.5	0.0	0.0	0.0	2.1	29.4	0.8	2.3	0.0	6.0	0.0	0.0	1.3	0.0	1.8	16.1	0.3	1.7	1.0	0.0	0.0	0.5	0.0	0.7	0.0	0.0	0.0	1.9	0.0	1.7	1.8	2.7	0.0	0.0	0.9
CPXM2	"CPX2, UNQ676"	ENSG00000121898	"Carboxypeptidase X, M14 family member 2"	Q8N436	10	123706207-123940267	"Enzymes, Predicted intracellular proteins, Predicted secreted proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Group enriched"	"Detected in many"	8	"Early spermatids: 85.6;Late spermatids: 150.5;Peritubular cells: 74.3"	"Low cancer specificity"	"Detected in all"			"Region enhanced"	"Detected in many"		"pons and medulla: 16.9"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	17	"BJ: 9.8;fHDF/TERT166: 38.3;SuSa: 16.1"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA048375	Uncertain				"Secreted - unknown location"	NA	NA					"HPA048375: AB_2680377"	"unprognostic (1.50e-1)"	"unprognostic (3.66e-1)"	"unprognostic (2.58e-2)"	"unprognostic (4.02e-3)"	"unprognostic (2.69e-2)"	"unprognostic (6.48e-2)"	"unprognostic (1.32e-2)"	"unprognostic (1.32e-2)"	"unprognostic (1.26e-1)"	"unprognostic (8.57e-2)"	"unprognostic (4.42e-2)"	"unprognostic (2.14e-1)"	"prognostic favorable (9.02e-4)"	"unprognostic (3.48e-2)"	"unprognostic (2.54e-2)"	"unprognostic (1.27e-1)"	"unprognostic (1.16e-3)"	17.0	4.1	0.8	5.0	2.1	0.1	12.3	1.3	1.6	6.4	40.9	6.7	5.7	3.8	12.2	37.8	20.0	9.1	9.4	14.3	1.7	4.0	6.6	1.5	4.6	3.7	6.1	0.7	12.8	3.2	1.9	7.1	11.6	16.9	14.7	4.5	26.5	5.6	8.3	5.0	4.5	9.1	45.5	21.6	13.8	14.4	7.7	3.4	2.6	9.5	11.9	4.0	32.5	20.0	0.0	0.0	0.0	0.2	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	9.8	0.4	0.6	0.0	0.0	0.0	0.0	0.0	38.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	16.1	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.8	2.1	1.3	1.6	1.7	4.0	6.1	0.7	16.9	3.4	0.0	1.1	0.0	0.0	1.9	0.0	1.4	0.0	0.0	0.0	1.8	0.0	6.6	1.7	0.1	85.6	13.5	0.0	0.0	0.2	0.2	2.3	0.0	0.0	0.0	0.3	1.6	0.0	13.5	0.0	150.5	10.0	0.0	3.3	0.0	0.5	0.0	0.2	0.0	74.3	0.0	0.0	0.0	2.8	1.1	1.9	1.8	4.2	0.0	1.1	0.0
CPZ		ENSG00000109625	"Carboxypeptidase Z"	Q66K79	4	8592660-8619759	"Enzymes, Predicted intracellular proteins, Predicted secreted proteins"	"Wnt signaling pathway"	"Carboxypeptidase, Hydrolase, Metalloprotease, Protease"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"ovary: 63.2"	"Not detected"	"Not detected"			"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"BEWO: 29.5;BJ: 17.0;BJ hTERT+: 22.9;hTERT-RPE1: 13.7;RH-30: 25.1;U-2197: 18.3"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			HPA078608			Approved	"Plasma membrane"	"Secreted to extracellular matrix"	NA	NA			"Plasma membrane"		"HPA078608: "	"unprognostic (2.58e-1)"	"unprognostic (7.16e-2)"	"unprognostic (4.83e-2)"	"unprognostic (1.42e-1)"	"unprognostic (7.77e-2)"	"unprognostic (2.20e-2)"	"unprognostic (2.98e-1)"	"unprognostic (7.77e-2)"	"unprognostic (2.30e-1)"	"unprognostic (1.95e-2)"	"unprognostic (1.41e-1)"	"unprognostic (1.59e-1)"	"unprognostic (7.23e-8)"	"unprognostic (4.30e-3)"	"unprognostic (3.58e-2)"	"unprognostic (6.13e-4)"	"unprognostic (5.51e-2)"	4.3	0.9	0.3	2.8	1.1	0.0	5.4	1.1	1.6	15.7	1.8	1.5	27.1	0.1	7.9	24.1	3.0	7.4	12.9	2.4	0.4	0.3	1.5	0.8	2.9	0.7	1.5	0.4	63.2	1.1	0.3	2.3	18.9	2.3	4.1	0.5	4.4	0.8	20.6	0.3	5.5	1.2	10.3	1.3	0.7	1.7	4.4	0.1	1.6	3.5	0.1	2.2	9.8	11.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	10.4	0.1	0.0	0.7	2.2	0.2	29.5	17.0	22.9	6.4	2.6	0.7	0.3	0.0	1.6	9.3	0.1	0.0	0.0	0.0	2.4	0.0	1.2	0.0	0.1	0.3	2.0	0.0	0.0	4.2	0.0	0.0	0.0	13.7	0.0	0.0	0.4	0.0	0.4	2.5	0.0	0.0	3.9	0.1	9.3	0.0	25.1	0.0	0.0	0.5	0.0	0.0	0.6	0.2	0.0	3.8	0.1	0.0	0.0	0.9	1.2	18.3	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	1.1	1.1	1.6	0.4	0.3	1.5	0.4	2.3	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.8	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0
DNPEP	"ASPEP, DAP"	ENSG00000123992	"Aspartyl aminopeptidase"	Q9ULA0	2	219373527-219400022	"Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"		"Aminopeptidase, Hydrolase, Metalloprotease, Protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	7	"Early spermatids: 334.9;Late spermatids: 344.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA036398, HPA044860"	Enhanced		Supported	Cytosol		NA	NA		6200000	Cytosol		"HPA036398: AB_10970915, HPA044860: AB_10961275"	"unprognostic (3.71e-1)"	"unprognostic (6.45e-2)"	"unprognostic (1.26e-1)"	"unprognostic (1.05e-2)"	"unprognostic (1.55e-2)"	"unprognostic (2.75e-1)"	"unprognostic (2.54e-3)"	"unprognostic (3.34e-2)"	"unprognostic (2.44e-1)"	"unprognostic (3.49e-2)"	"unprognostic (1.61e-1)"	"unprognostic (6.13e-2)"	"unprognostic (1.67e-1)"	"unprognostic (5.63e-3)"	"unprognostic (3.49e-1)"	"unprognostic (2.50e-1)"	"unprognostic (1.85e-3)"	20.1	12.3	8.8	15.5	10.4	7.2	20.0	7.2	9.3	16.5	30.4	8.6	13.8	27.9	15.1	13.3	16.9	15.3	16.6	22.9	10.4	6.8	21.2	33.5	15.5	11.7	10.5	7.2	19.4	19.0	9.7	11.0	28.5	9.4	21.0	15.8	15.9	18.7	14.7	36.6	14.6	50.3	12.9	6.8	17.5	15.2	33.7	9.3	11.3	15.0	20.0	17.4	20.7	13.1	11.6	16.1	5.8	15.0	15.7	15.7	10.9	16.2	8.9	5.5	16.2	14.5	12.0	43.5	8.1	16.4	21.1	22.4	24.6	21.4	10.0	17.5	16.8	27.1	15.9	6.5	18.5	7.6	19.4	4.7	16.0	9.1	26.7	38.6	13.3	11.5	19.5	19.7	21.7	18.2	13.6	14.4	13.4	18.0	15.9	10.8	35.3	20.2	14.8	9.0	23.2	5.6	26.3	12.5	13.1	11.8	25.3	6.9	9.3	9.4	31.1	11.4	10.0	9.1	14.7	8.0	20.3	16.8	10.6	11.6	17.9	10.5	7.0	28.9	12.7	8.6	5.8	13.2	5.4	13.6	15.0	15.4	10.2	11.0	15.0	16.1	11.6	12.0	15.7	1.0	15.7	12.2	5.8	12.6	10.9	8.8	10.4	7.2	9.3	10.4	6.8	10.5	7.2	9.4	9.3	11.9	15.6	23.5	61.6	34.3	15.9	28.8	33.1	8.1	11.4	24.4	31.4	76.5	41.4	49.0	334.9	40.7	74.6	0.0	57.6	79.5	42.3	44.7	24.2	41.8	45.2	9.5	46.1	28.8	28.6	344.5	48.6	32.0	30.4	58.7	90.9	28.2	48.4	66.2	38.5	58.6	36.0	25.8	49.1	17.0	16.6	39.1	55.5	30.8	58.7	65.4
DPP3		ENSG00000254986	"Dipeptidyl peptidase 3"	Q9NY33	11	66480013-66509657	"Enzymes, Plasma proteins, Predicted intracellular proteins"		"Aminopeptidase, Hydrolase, Metalloprotease, Protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA035780, HPA035781"	Approved		Supported	Cytosol		NA	NA		2600000	Cytosol		"HPA035780: AB_2674778, HPA035781: AB_10669529"	"unprognostic (5.74e-2)"	"unprognostic (1.16e-3)"	"unprognostic (2.62e-3)"	"unprognostic (4.77e-2)"	"unprognostic (1.99e-1)"	"unprognostic (5.44e-3)"	"unprognostic (1.67e-3)"	"unprognostic (1.25e-3)"	"unprognostic (1.73e-2)"	"unprognostic (9.87e-2)"	"unprognostic (1.02e-2)"	"unprognostic (3.87e-1)"	"unprognostic (5.85e-2)"	"prognostic favorable (1.34e-4)"	"unprognostic (1.81e-2)"	"unprognostic (3.43e-1)"	"unprognostic (5.66e-2)"	10.4	13.0	5.2	16.8	12.1	10.9	16.9	13.7	11.5	7.3	18.5	9.1	10.3	15.3	10.5	6.8	15.6	7.1	15.7	8.4	9.3	5.9	18.4	31.1	9.8	20.0	9.5	10.6	5.1	11.6	11.2	6.9	10.9	7.4	10.3	16.9	5.7	17.6	8.5	15.8	9.4	15.5	10.0	10.6	12.5	11.8	15.5	6.7	16.1	10.5	10.8	14.0	11.4	8.6	7.5	19.7	12.2	24.4	18.2	17.9	9.9	28.7	25.1	11.6	12.9	9.7	10.5	18.1	16.3	22.0	22.1	14.8	31.5	24.2	16.8	55.7	18.4	18.9	26.0	18.5	20.0	14.3	31.8	8.4	21.8	11.7	18.5	15.0	26.4	36.4	14.8	19.6	16.6	8.2	9.6	16.9	17.7	15.2	10.0	20.1	32.7	30.7	26.9	19.7	28.3	15.3	21.7	11.7	27.5	19.0	24.8	22.0	18.9	13.9	16.3	21.8	11.4	25.2	15.4	17.5	13.3	14.4	14.5	15.9	8.4	15.2	19.1	17.6	12.6	16.2	9.6	11.3	12.2	13.7	24.4	8.4	7.5	10.3	11.4	19.7	7.2	6.3	9.2	2.0	18.2	16.0	13.7	17.9	9.9	5.2	12.1	13.7	11.5	9.3	5.9	9.5	10.6	7.4	6.7	14.9	10.4	20.5	13.8	5.4	10.0	2.8	15.3	9.4	4.5	22.7	9.8	41.2	11.6	43.1	21.0	5.5	31.6	0.0	53.9	28.6	7.1	11.6	1.1	12.4	33.3	6.4	17.9	4.3	7.9	5.3	2.0	12.8	15.1	46.9	17.1	16.1	36.9	21.5	4.9	22.4	61.1	12.9	4.6	7.5	22.2	5.3	30.1	14.9	23.0	17.3
ECE1	ECE	ENSG00000117298	"Endothelin converting enzyme 1"	P42892	1	21217247-21345504	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"		"Hydrolase, Metalloprotease, Protease"	"Disease mutation, Hirschsprung disease"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"parathyroid gland: 114.4"	"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"neutrophil: 21.5"	"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"HUVEC TERT2: 103.3;TIME: 91.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA001490, HPA013616"	Enhanced					NA	NA		2100000			"HPA001490: AB_1078718, HPA013616: AB_1847963"	"unprognostic (7.90e-2)"	"unprognostic (1.01e-1)"	"unprognostic (1.48e-1)"	"unprognostic (1.99e-2)"	"unprognostic (1.49e-2)"	"unprognostic (1.46e-1)"	"unprognostic (5.24e-2)"	"unprognostic (1.23e-1)"	"unprognostic (6.20e-2)"	"unprognostic (1.92e-3)"	"unprognostic (1.04e-1)"	"unprognostic (2.56e-1)"	"unprognostic (7.70e-2)"	"unprognostic (3.55e-2)"	"unprognostic (9.10e-2)"	"unprognostic (1.97e-2)"	"unprognostic (1.97e-2)"	44.0	49.9	10.3	18.7	14.5	17.3	33.7	3.6	15.6	29.5	27.5	19.2	11.2	12.4	24.0	10.5	15.6	19.1	23.0	30.9	12.4	8.0	14.9	41.8	30.1	14.4	13.9	13.4	34.2	42.1	114.4	21.6	27.0	14.6	27.9	14.6	26.5	14.7	11.4	15.2	14.8	23.2	24.1	13.2	23.5	18.9	19.1	14.7	9.5	23.2	10.7	19.1	34.2	37.0	4.6	2.0	21.5	7.5	1.0	6.1	4.2	13.8	9.3	12.0	6.0	17.4	18.6	6.9	20.7	36.1	11.3	10.4	6.7	42.8	5.0	52.1	20.8	24.4	5.9	4.9	9.9	9.9	12.6	4.1	7.2	14.4	5.4	23.2	1.0	1.8	9.7	11.6	17.4	8.7	30.9	103.3	4.1	1.4	2.7	9.5	2.9	2.1	1.6	3.6	3.9	7.3	2.5	6.9	7.2	17.6	2.5	4.1	10.0	20.5	12.1	8.9	6.8	8.7	3.0	91.7	25.5	12.4	11.2	11.9	4.1	7.0	5.8	52.9	2.4	30.7	0.1	5.8	2.2	2.2	7.5	3.3	4.6	4.6	3.5	0.5	3.1	3.1	1.9	21.5	1.0	5.2	2.0	6.1	4.2	10.3	14.5	3.6	15.6	12.4	8.0	13.9	13.4	14.6	14.7	17.9	9.8	18.9	17.1	18.0	1.9	16.1	7.6	10.7	28.4	22.7	0.0	3.6	5.0	21.9	1.1	83.9	51.8	23.3	49.4	26.8	34.3	33.0	18.4	32.5	3.1	0.0	24.2	95.8	8.2	1.7	40.3	5.1	6.8	27.9	10.9	57.2	80.7	84.2	51.9	7.4	4.7	38.8	42.9	1.1	4.7	14.1	8.8	10.7	20.9	38.3
ECEL1	"DINE, XCE"	ENSG00000171551	"Endothelin converting enzyme like 1"	O95672	2	232479827-232487828	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"		"Hydrolase, Metalloprotease, Protease"	"Disease mutation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 28.6;ovary: 57.1"	"Group enriched"	"Detected in some"	19	"Muller glia cells: 76.3;Peritubular cells: 19.8"	"Cancer enhanced"	"Detected in many"		"endometrial cancer: 12.9"	"Region enriched"	"Detected in many"	5	"hypothalamus: 28.6"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	6	"AN3-CA: 30.1;HeLa: 15.3"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"HPA067560, HPA069756, HPA077424"	Approved	Supported	Approved	"Nucleoplasm,Nuclear membrane,Nucleoli"		NA	NA			Nucleoplasm	"Nuclear membrane, Nucleoli"	"HPA067560: , HPA069756: , HPA077424: "	"unprognostic (1.21e-2)"	"unprognostic (1.06e-2)"	"unprognostic (4.39e-1)"	"unprognostic (4.62e-3)"	"unprognostic (2.80e-1)"	"unprognostic (9.96e-4)"	"unprognostic (7.56e-3)"	"unprognostic (1.22e-1)"	"unprognostic (9.89e-3)"	"unprognostic (8.49e-2)"	"unprognostic (1.54e-1)"	"unprognostic (2.89e-1)"	"unprognostic (1.24e-5)"	"unprognostic (3.09e-2)"	"unprognostic (3.68e-1)"	"unprognostic (7.84e-2)"	"unprognostic (5.45e-2)"	0.9	2.6	0.5	0.9	4.0	0.2	0.4	0.7	1.2	0.3	0.4	0.5	0.1	0.3	0.6	4.9	0.3	1.7	1.0	1.1	0.1	28.6	1.0	0.7	0.2	1.2	0.3	0.1	57.1	0.6	0.3	8.9	0.4	5.5	0.3	0.2	11.5	0.3	1.2	1.8	0.3	0.3	1.1	4.5	2.0	0.3	0.8	1.6	0.1	0.5	0.3	0.5	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.1	30.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.4	0.3	0.0	0.1	0.0	0.4	0.0	0.0	0.0	2.7	0.0	15.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	2.1	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	3.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	4.0	0.7	1.2	0.1	28.6	0.3	0.1	5.5	1.6	0.0	0.0	0.0	0.0	0.0	2.6	1.0	0.0	0.0	0.0	0.0	2.0	0.0	0.0	0.1	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	1.4	0.0	0.0	0.0	0.0	76.3	0.2	0.0	19.8	0.0	1.7	0.0	2.1	0.2	1.7	0.0	0.0	0.0	0.0	0.0
ENPEP	"CD249, gp160"	ENSG00000138792	"Glutamyl aminopeptidase"	Q07075	4	110365733-110565285	"CD markers, Enzymes, Plasma proteins, Predicted membrane proteins"		"Aminopeptidase, Hydrolase, Metalloprotease, Protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 165.1;kidney: 63.8"	"Cell type enhanced"	"Detected in many"	14	"Proximal tubular cells: 153.4;Sertoli cells: 155.2;Smooth muscle cells: 60.8;Syncytiotrophoblasts: 49.0"	"Cancer enriched"	"Detected in many"	8	"renal cancer: 41.0"	"Low region specificity"	"Detected in single"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"BEWO: 4.2;HEK 293: 11.4;MOLT-4: 2.7;SuSa: 8.6"	"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			HPA005128	Enhanced					NA	NA		37000000			"HPA005128: AB_1844795"	"unprognostic (2.73e-3)"	"unprognostic (2.84e-3)"	"unprognostic (5.16e-3)"	"unprognostic (3.48e-1)"	"unprognostic (2.90e-1)"	"unprognostic (8.74e-2)"	"unprognostic (3.34e-2)"	"unprognostic (1.03e-1)"	"unprognostic (1.35e-2)"	"unprognostic (1.22e-1)"	"unprognostic (1.93e-1)"	"unprognostic (9.47e-2)"	"unprognostic (4.49e-3)"	"unprognostic (3.43e-3)"	"unprognostic (1.52e-2)"	"unprognostic (8.46e-2)"	"unprognostic (2.49e-3)"	5.8	1.0	0.4	0.4	0.6	0.0	2.8	0.3	1.0	1.1	54.4	0.4	0.7	11.1	5.3	2.4	0.8	1.4	1.1	2.3	0.5	0.3	63.8	14.5	2.7	0.5	0.4	0.3	1.0	1.0	33.3	0.8	4.4	0.5	1.4	0.0	0.8	0.6	0.5	2.3	0.4	165.1	3.1	0.5	4.7	0.7	0.4	0.4	1.4	2.4	2.0	0.4	1.0	1.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.3	0.1	0.0	0.1	0.2	4.2	0.6	0.0	0.2	0.3	0.1	0.0	0.0	0.2	0.1	0.0	0.0	0.2	0.0	0.1	0.0	11.4	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.2	1.5	2.7	0.5	0.5	0.1	0.0	0.2	0.0	0.4	0.0	0.4	0.1	0.2	0.0	2.0	0.0	8.6	0.0	0.0	0.0	0.0	0.0	0.3	0.0	1.1	2.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.6	0.3	1.0	0.5	0.3	0.4	0.3	0.5	0.4	0.0	1.3	0.0	0.1	1.4	0.0	3.3	0.0	0.0	0.0	10.4	0.0	33.0	14.9	0.0	0.4	1.4	2.6	0.0	0.0	2.7	19.7	0.1	0.0	24.1	2.4	0.0	1.7	1.8	0.3	0.0	0.6	0.6	0.0	0.0	0.8	0.0	0.0	0.8	0.4	153.4	0.0	155.2	60.8	0.0	0.2	0.9	49.0	1.3	1.1	0.1
ERAP1	"A-LAP, ARTS-1, ERAAP1, KIAA0525, PILS-AP"	ENSG00000164307	"Endoplasmic reticulum aminopeptidase 1"	Q9NZ08	5	96760810-96808100	"Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"	"Adaptive immunity, Immunity"	"Aminopeptidase, Hydrolase, Metalloprotease, Protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB025095, HPA042317"	Approved		Approved	"Nucleoplasm,Plasma membrane,Cytosol"	"Secreted to blood"	NA	NA		27000000	"Nucleoplasm, Cytosol"	"Plasma membrane"	"CAB025095: , HPA042317: AB_2677946"	"unprognostic (2.33e-3)"	"unprognostic (3.45e-1)"	"unprognostic (1.84e-3)"	"unprognostic (1.34e-1)"	"unprognostic (1.86e-1)"	"unprognostic (4.38e-1)"	"unprognostic (1.88e-3)"	"unprognostic (5.37e-2)"	"unprognostic (1.45e-1)"	"unprognostic (7.94e-2)"	"unprognostic (4.52e-2)"	"unprognostic (3.23e-1)"	"unprognostic (7.09e-2)"	"unprognostic (1.36e-1)"	"unprognostic (3.93e-2)"	"unprognostic (1.19e-1)"	"unprognostic (5.14e-2)"	23.8	13.6	9.3	22.7	11.9	11.6	23.3	14.2	14.6	14.5	23.8	10.1	11.2	30.8	14.7	13.4	12.3	14.3	19.9	16.1	9.7	6.8	13.3	23.7	17.8	16.4	13.5	7.6	15.5	16.5	11.1	39.4	28.2	11.4	13.4	21.9	8.5	13.9	15.2	23.1	17.7	39.7	10.6	17.1	19.5	16.5	5.4	13.8	55.5	13.5	9.8	17.8	15.9	14.1	14.9	15.2	19.8	17.5	19.8	21.8	10.7	7.4	4.7	6.4	6.0	35.4	34.7	18.6	5.5	17.7	13.3	23.3	5.9	27.0	22.3	11.5	10.6	18.7	7.6	5.3	11.2	8.3	40.2	2.2	7.2	3.2	4.0	40.6	3.4	13.4	14.4	4.9	15.2	4.7	19.6	18.2	14.5	3.7	21.6	7.9	3.5	32.0	3.6	3.2	0.9	3.1	23.8	8.7	11.1	9.9	11.5	2.4	1.6	8.7	5.9	8.5	4.6	5.1	16.6	14.5	11.4	3.9	1.9	9.0	8.1	15.1	17.3	12.2	11.8	6.7	19.8	13.2	15.6	21.2	11.4	19.7	13.0	18.5	18.2	9.5	14.9	21.8	17.4	14.4	19.8	17.5	15.2	12.3	10.7	9.3	11.9	14.2	14.6	9.7	6.8	13.5	7.6	11.4	13.8	8.9	12.3	13.7	12.1	22.1	11.6	8.5	10.2	22.7	14.8	8.7	2.0	8.0	0.0	10.8	20.0	11.3	25.8	0.0	13.4	9.1	16.1	9.2	14.0	27.0	16.2	3.2	9.9	18.4	31.2	5.2	9.2	18.5	6.8	21.6	25.9	9.7	11.2	17.5	15.2	5.0	7.2	0.0	9.5	1.2	0.7	9.7	7.7	20.0	19.1	12.2
ERAP2	"L-RAP, LRAP"	ENSG00000164308	"Endoplasmic reticulum aminopeptidase 2"	Q6P179	5	96875939-96919716	"Enzymes, Predicted intracellular proteins, Predicted secreted proteins"	"Adaptive immunity, Immunity"	"Aminopeptidase, Hydrolase, Metalloprotease, Protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"B-cells: 63.4;T-cells: 53.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"CAPAN-2: 49.1;GAMG: 30.0;hTEC/SVTERT24-B: 23.7;MOLT-4: 26.2;TIME: 51.5"					"Low region specificity"	"Detected in all"			"CAB025618, HPA034498, HPA064360"	Enhanced		Approved	"Golgi apparatus"	"Secreted to blood"	NA	NA		7400000	"Golgi apparatus"		"CAB025618: , HPA034498: AB_2674191, HPA064360: "	"unprognostic (4.62e-2)"	"unprognostic (1.60e-1)"	"unprognostic (4.98e-2)"	"unprognostic (1.56e-1)"	"unprognostic (3.14e-1)"	"unprognostic (8.71e-2)"	"unprognostic (2.60e-2)"	"unprognostic (1.17e-2)"	"unprognostic (5.03e-2)"	"unprognostic (1.40e-1)"	"prognostic unfavorable (1.20e-4)"	"unprognostic (1.01e-1)"	"unprognostic (9.54e-3)"	"unprognostic (6.59e-2)"	"unprognostic (8.48e-2)"	"unprognostic (4.65e-2)"	"unprognostic (3.05e-1)"	9.0	6.0	3.1	21.6	3.8	3.5	7.4	2.2	3.5	9.6	37.0	3.1	6.2	17.0	8.3	10.3	12.4	5.7	5.6	5.8	3.3	2.6	8.6	10.8	16.8	30.8	4.2	0.5	18.2	5.9	1.4	11.1	13.6	3.6	9.4	3.1	7.0	9.3	3.5	4.1	4.9	22.4	5.1	8.7	37.6	9.2	2.6	3.1	32.5	11.3	9.6	24.4	11.8	8.7	16.4	10.7	10.9	15.3	24.0	22.4	14.1	0.5	0.6	0.4	0.2	0.5	1.0	0.1	2.1	3.7	2.0	3.3	2.1	49.1	2.9	9.7	3.1	30.0	0.7	0.2	17.8	1.6	1.0	2.1	0.1	0.7	2.0	0.7	10.8	5.2	7.3	3.3	23.7	0.1	0.3	1.3	7.3	0.0	7.3	5.6	0.3	26.2	5.4	0.0	0.0	1.0	11.7	4.2	7.7	14.2	4.1	0.9	0.0	0.3	0.2	4.1	0.1	1.7	0.4	51.5	1.0	0.3	2.7	6.3	7.1	6.1	1.0	14.3	1.4	0.2	10.9	6.5	7.8	14.2	15.3	18.1	16.4	20.2	17.6	10.7	9.6	22.4	17.0	2.2	24.0	14.4	3.5	18.2	14.1	3.1	3.8	2.2	3.5	3.3	2.6	4.2	0.5	3.6	3.1	29.8	18.3	63.4	8.3	5.0	1.4	3.5	7.6	9.4	15.9	41.8	0.0	10.0	0.0	5.0	0.2	29.2	40.8	0.0	21.9	14.9	15.1	3.1	6.9	14.3	12.0	0.0	1.7	20.3	17.4	0.0	9.8	22.3	6.8	7.2	21.5	7.5	14.1	24.6	7.4	5.7	2.0	0.0	8.2	0.9	0.7	2.6	5.6	53.6	20.6	8.1
ERMP1	"FLJ23309, FXNA, KIAA1815"	ENSG00000099219	"Endoplasmic reticulum metallopeptidase 1"	Q7Z2K6	9	5765076-5833117	"Enzymes, Predicted membrane proteins"		"Hydrolase, Metalloprotease, Protease"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"parathyroid gland: 57.6"	"Cell type enhanced"	"Detected in many"	8	"Collecting duct cells: 69.8;Urothelial cells: 55.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"NK-cell: 4.7"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"RPTEC TERT1: 27.5;RT4: 53.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA055582	Approved					NA	NA					"HPA055582: "	"unprognostic (1.93e-2)"	"unprognostic (3.40e-1)"	"unprognostic (2.76e-2)"	"unprognostic (5.93e-2)"	"unprognostic (2.97e-1)"	"unprognostic (8.59e-2)"	"unprognostic (4.30e-3)"	"unprognostic (2.81e-1)"	"unprognostic (5.46e-2)"	"unprognostic (4.83e-3)"	"unprognostic (3.14e-2)"	"unprognostic (2.88e-2)"	"prognostic favorable (5.83e-10)"	"unprognostic (1.41e-1)"	"unprognostic (4.00e-1)"	"unprognostic (5.77e-2)"	"unprognostic (1.36e-1)"	4.0	12.0	5.3	3.6	13.8	1.6	4.8	7.3	12.3	8.5	8.2	20.5	1.5	3.4	4.9	2.9	12.7	4.9	8.8	7.1	6.8	5.8	18.8	3.5	4.7	2.7	18.3	7.0	5.6	4.4	57.6	3.3	5.7	17.0	4.8	8.4	6.9	12.8	3.4	5.2	6.8	4.8	3.2	15.9	2.5	9.1	5.9	11.5	4.6	19.1	4.6	7.2	18.7	8.1	0.2	0.3	0.9	0.5	4.7	2.0	0.3	15.3	15.0	0.6	1.8	7.8	7.5	8.0	1.7	3.9	0.8	0.7	3.6	9.4	3.6	6.8	2.9	9.2	11.0	3.2	10.2	1.2	18.9	2.6	19.1	7.9	7.0	1.7	5.4	7.5	3.8	4.5	0.7	4.5	10.3	10.6	1.6	2.3	3.4	0.9	7.0	0.2	2.1	2.3	9.6	2.9	0.5	1.9	4.8	27.5	53.7	3.5	1.1	2.5	18.1	2.8	9.0	12.0	6.9	6.3	0.5	1.8	1.1	5.5	3.2	4.5	1.8	2.3	4.5	1.4	0.6	0.3	0.9	1.3	0.5	2.0	0.2	0.6	0.3	0.0	0.0	0.5	0.5	0.0	4.7	0.2	0.3	0.5	0.3	5.3	13.8	7.3	12.3	6.8	5.8	18.3	7.0	17.0	11.5	6.0	0.6	0.0	11.5	2.6	3.5	12.6	20.4	5.3	4.5	69.8	9.8	5.8	0.0	3.6	19.1	5.0	9.1	0.0	2.6	5.6	2.6	6.9	9.2	5.1	5.4	3.2	10.9	3.1	1.3	31.7	2.8	3.3	1.7	1.0	10.0	3.5	3.4	27.9	4.6	2.8	2.1	6.5	1.9	7.2	4.1	4.0	3.4	4.4	10.3	55.0
FOLH1	"FOLH, GCP2, GCPII, NAALAD1, NAALAdase, PSM, PSMA"	ENSG00000086205	"Folate hydrolase 1"	Q04609	11	49146635-49208670	"Cancer-related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"		"Carboxypeptidase, Dipeptidase, Hydrolase, Metalloprotease, Multifunctional enzyme, Protease"	"Cancer-related genes, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 37.7;intestine: 111.2;prostate: 33.8"	"Cell type enhanced"	"Detected in some"	16	"Glandular cells: 41.1;Hepatocytes: 24.1;Muller glia cells: 17.3;Proximal tubular cells: 22.6"	"Cancer enriched"	"Detected in many"	27	"prostate cancer: 142.7"	"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"HAP1: 5.4;RPMI-8226: 3.8;SK-BR-3: 4.5;TIME: 2.9;U-2 OS: 2.7;WM-115: 5.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB001451, HPA010593"	Enhanced					NA	NA					"CAB001451: AB_563979, HPA010593: AB_1079685"	"unprognostic (1.33e-1)"	"unprognostic (1.19e-1)"	"unprognostic (1.24e-1)"	"prognostic favorable (5.24e-5)"	"unprognostic (2.55e-1)"	"unprognostic (8.31e-2)"	"prognostic favorable (4.25e-4)"	"unprognostic (1.32e-1)"	"unprognostic (2.09e-2)"	"unprognostic (2.67e-3)"	"unprognostic (2.13e-2)"	"unprognostic (2.72e-1)"	"prognostic unfavorable (1.30e-6)"	"unprognostic (4.81e-2)"	"unprognostic (7.27e-2)"	"unprognostic (4.74e-3)"	"unprognostic (4.04e-1)"	1.2	1.0	10.4	0.9	16.4	0.8	2.5	1.4	12.7	1.4	67.6	37.7	0.0	111.2	1.3	0.8	1.2	2.1	5.0	0.7	16.9	8.7	6.1	15.7	1.1	0.9	19.0	9.1	1.0	0.7	0.7	0.4	0.7	17.7	33.8	0.8	0.6	20.7	0.8	0.6	1.2	61.1	1.0	33.0	1.5	1.0	0.9	16.2	0.0	1.0	0.0	0.8	1.2	0.5	0.9	0.1	0.3	0.8	1.4	1.2	0.0	0.3	0.0	0.1	0.0	0.0	0.0	2.7	0.3	0.0	0.0	0.0	0.0	0.9	0.2	0.7	0.0	0.2	0.2	5.4	0.5	0.0	1.3	1.0	0.0	0.5	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.2	0.0	0.2	0.0	1.1	0.0	0.0	0.0	1.1	1.0	0.2	0.0	0.4	0.3	3.8	0.0	0.0	0.4	1.7	0.0	4.5	1.0	0.6	1.0	0.0	2.9	0.2	2.7	0.4	0.3	0.1	0.5	0.1	0.0	0.9	5.4	0.1	0.8	0.3	0.9	0.6	0.2	0.6	1.2	0.5	0.0	0.9	0.7	0.3	0.2	1.4	0.5	0.1	0.4	0.0	10.4	16.4	1.4	12.7	16.9	8.7	19.0	9.1	17.7	16.2	0.0	1.1	0.0	0.8	0.2	0.0	0.1	0.0	0.0	2.3	0.0	0.0	0.0	6.6	0.0	3.5	0.3	0.0	0.0	0.0	0.0	0.4	41.1	0.0	24.1	0.1	0.0	0.0	3.1	0.0	1.0	1.4	0.0	3.3	0.0	0.0	17.3	0.0	0.0	0.4	22.6	0.2	0.0	0.3	0.2	1.6	0.6	0.0	0.0	0.0	0.5
IDE		ENSG00000119912	"Insulin degrading enzyme"	P14735	10	92451684-92574076	"Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins"	"Host-virus interaction"	"Allosteric enzyme, Host cell receptor for virus entry, Hydrolase, Metalloprotease, Protease, Receptor"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	4	"Cone photoreceptor cells: 45.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA063478	Approved				"Intracellular and membrane"	NA	NA		140000			"HPA063478: AB_2685020"	"unprognostic (1.70e-1)"	"unprognostic (6.40e-2)"	"prognostic favorable (3.69e-4)"	"prognostic favorable (3.53e-4)"	"unprognostic (2.54e-1)"	"unprognostic (1.78e-1)"	"unprognostic (2.51e-1)"	"unprognostic (3.79e-1)"	"unprognostic (8.88e-2)"	"unprognostic (2.57e-1)"	"unprognostic (6.58e-2)"	"unprognostic (7.79e-2)"	"unprognostic (6.81e-2)"	"unprognostic (9.24e-3)"	"unprognostic (6.13e-2)"	"unprognostic (3.89e-2)"	"unprognostic (3.91e-1)"	9.8	13.1	6.9	11.7	8.8	6.0	19.8	8.6	9.4	10.5	9.9	6.5	17.5	7.4	10.2	15.9	13.0	8.4	9.6	13.6	5.8	5.3	13.3	21.3	7.9	9.2	8.9	5.1	7.7	15.7	19.4	11.1	9.4	7.6	11.6	10.0	10.5	11.0	17.2	31.1	45.2	10.7	14.3	8.8	9.9	10.3	18.1	7.5	13.5	12.0	13.9	10.7	11.5	9.8	7.4	11.3	3.8	13.7	7.7	10.6	5.5	12.3	18.4	14.4	29.4	14.0	11.8	7.9	11.0	26.1	11.6	9.9	18.7	14.8	17.5	16.3	16.0	10.9	16.0	18.9	12.1	7.6	21.0	11.6	8.7	15.4	16.4	12.3	26.6	13.8	8.3	11.8	13.6	19.7	16.4	19.5	7.4	16.2	12.5	13.1	8.3	8.8	10.5	11.4	13.8	7.3	12.3	13.4	11.2	17.1	23.3	6.7	9.3	14.8	10.6	9.7	15.6	15.2	7.5	18.1	7.5	8.5	7.8	14.2	11.4	14.3	18.8	10.9	21.3	5.2	2.3	8.2	3.8	6.7	11.4	5.9	7.4	7.9	6.5	11.3	5.3	6.0	6.4	0.5	7.7	13.7	4.4	10.6	5.5	6.9	8.8	8.6	9.4	5.8	5.3	8.9	5.1	7.6	7.5	8.9	10.2	2.2	5.3	4.6	14.0	39.2	7.6	24.1	6.8	7.0	45.2	9.9	1.7	11.7	31.2	8.0	10.7	0.0	17.4	4.7	5.5	10.9	1.1	22.4	10.4	6.4	10.4	14.7	18.1	7.7	6.1	8.6	8.5	1.8	11.4	7.5	14.5	5.8	9.6	8.8	26.3	6.5	7.5	18.0	10.8	14.3	3.2	4.3	8.3	7.8
KEL	"CD238, ECE3"	ENSG00000197993	"Kell blood group, metallo-endopeptidase"	P23276	7	142941114-142962681	"Blood group antigen proteins, Cancer-related genes, CD markers, Enzymes, Predicted intracellular proteins, Predicted membrane proteins"		"Blood group antigen, Hydrolase, Metalloprotease, Protease"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	6	"bone marrow: 21.1;testis: 36.4"	"Cell type enriched"	"Detected in some"	14	"Erythroid cells: 46.7"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in some"			"Cell type enriched"	"Detected in single"	7	"intermediate monocyte: 1.4"	"Lineage enriched"	"Detected in single"	14	"monocytes: 1.4"	"Group enriched"	"Detected in some"	12	"HEL: 15.3;K-562: 12.4"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA064442			Supported	"Nucleoplasm,Plasma membrane"		NA	NA			"Plasma membrane"	Nucleoplasm	"HPA064442: "	"unprognostic (5.78e-3)"	"unprognostic (1.08e-5)"	"unprognostic (5.29e-3)"	"unprognostic (4.85e-3)"	"unprognostic (9.68e-2)"	"unprognostic (1.96e-2)"	"unprognostic (1.03e-1)"	"unprognostic (1.54e-2)"	"unprognostic (5.18e-2)"	"unprognostic (1.08e-2)"	"unprognostic (3.71e-2)"	"unprognostic (3.57e-2)"	"unprognostic (2.29e-3)"	"unprognostic (9.24e-2)"	"unprognostic (7.05e-2)"	"unprognostic (3.32e-2)"	"unprognostic (3.25e-3)"	0.2	0.0	0.9	2.5	1.1	21.1	0.2	0.2	0.4	0.4	0.2	0.3	0.2	0.0	0.2	0.2	0.6	0.1	0.2	0.2	1.4	0.7	0.4	0.2	1.4	5.0	2.0	0.2	0.2	0.2	0.0	0.2	1.1	0.3	0.2	0.0	0.3	2.5	0.2	0.2	0.0	0.5	0.2	4.4	3.8	0.0	36.4	0.3	0.4	0.2	0.2	3.7	0.2	0.2	0.0	0.0	0.0	1.4	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	15.3	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	12.4	0.1	0.0	0.0	0.5	0.3	0.3	0.0	0.0	0.1	0.0	0.1	0.0	1.2	0.0	0.1	0.2	0.0	0.5	0.4	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.9	1.1	0.2	0.4	1.4	0.7	2.0	0.2	0.3	0.3	0.0	0.0	0.0	0.8	0.0	0.0	0.3	0.0	0.0	2.3	3.5	0.0	0.0	1.7	0.2	1.9	0.0	0.0	46.7	0.0	0.2	0.0	0.2	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.4	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.1	0.0	0.0	1.0
LAP3	"LAP, LAPEP, PEPS"	ENSG00000002549	"Leucine aminopeptidase 3"	P28838	4	17577192-17607972	"Enzymes, Plasma proteins, Predicted intracellular proteins"		"Aminopeptidase, Hydrolase, Protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Hofbauer cells: 227.4;monocytes: 251.5;Proximal tubular cells: 217.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA029606, HPA029607"	Enhanced		Supported	Nucleoplasm,Midbody,Cytosol		Yes	No		4100000	Cytosol	"Nucleoplasm, Midbody"	"HPA029606: AB_10599288, HPA029607: AB_10611381"	"unprognostic (2.10e-2)"	"unprognostic (1.01e-1)"	"unprognostic (6.95e-3)"	"unprognostic (1.46e-1)"	"unprognostic (1.26e-1)"	"unprognostic (2.87e-1)"	"unprognostic (2.16e-1)"	"unprognostic (1.55e-1)"	"unprognostic (5.33e-2)"	"unprognostic (1.44e-3)"	"unprognostic (2.61e-3)"	"unprognostic (1.17e-1)"	"unprognostic (4.29e-3)"	"unprognostic (1.73e-1)"	"unprognostic (3.28e-2)"	"unprognostic (3.06e-1)"	"unprognostic (8.79e-2)"	42.5	29.7	23.2	43.9	38.5	18.1	30.7	8.5	23.5	13.3	21.0	23.5	12.3	27.5	17.2	20.8	19.3	18.7	24.3	25.4	24.4	17.0	71.7	70.3	39.4	54.2	33.7	16.1	13.5	14.7	23.5	13.2	25.0	34.9	15.3	22.7	15.0	23.0	12.1	33.3	20.9	30.6	26.9	35.0	54.9	20.8	19.3	30.7	19.9	29.4	21.7	32.1	24.4	23.7	7.5	45.7	9.5	46.1	11.8	12.9	25.3	10.9	9.6	9.2	8.7	18.3	22.3	0.1	17.3	19.5	62.9	76.5	17.5	20.9	43.2	11.5	13.3	37.5	6.8	34.5	12.2	24.0	16.4	9.9	23.9	10.6	22.8	21.3	21.5	15.4	22.7	7.8	20.6	10.9	7.2	21.8	11.4	23.1	30.9	14.8	11.8	19.1	29.5	19.2	20.6	18.4	29.7	8.8	21.8	16.4	12.9	13.6	11.2	15.8	9.8	33.8	13.3	8.3	8.3	14.1	16.0	10.8	16.8	30.0	28.4	43.4	37.3	21.6	35.9	15.4	8.4	43.4	9.5	8.0	46.1	7.4	7.5	7.5	8.5	45.7	5.2	6.5	6.8	6.2	11.8	31.9	25.9	12.9	25.3	23.2	38.5	8.5	23.5	24.4	17.0	33.7	16.1	34.9	30.7	26.8	44.7	44.2	21.0	19.6	8.0	43.2	10.2	46.8	26.1	26.2	2.0	31.2	99.5	46.8	71.4	104.1	38.5	0.0	96.6	44.5	25.9	23.1	63.4	92.3	227.4	6.4	15.6	68.2	96.6	22.8	21.3	135.7	40.5	251.5	30.0	93.7	42.5	30.2	32.9	217.2	12.6	32.3	24.7	46.4	13.2	19.9	46.6	30.5	39.9	21.7
LMLN	"Gp63, LMNL1, Msp"	ENSG00000185621	"Leishmanolysin like peptidase"	Q96KR4	3	197960200-198043720	"Enzymes, Predicted intracellular proteins, Predicted membrane proteins"	"Cell cycle, Cell division, Mitosis"	"Hydrolase, Metalloprotease, Protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Ciliated cells: 32.1;Early spermatids: 29.2;Spermatocytes: 29.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA016481, HPA028844"	Uncertain		Supported	"Focal adhesion sites,Cytosol"		NA	NA			Cytosol	"Focal adhesion sites"	"HPA016481: AB_1852955, HPA028844: AB_10602347"	"unprognostic (2.54e-1)"	"unprognostic (3.15e-1)"	"unprognostic (7.63e-2)"	"prognostic favorable (6.77e-4)"	"unprognostic (1.14e-2)"	"unprognostic (1.19e-1)"	"unprognostic (1.30e-1)"	"unprognostic (4.07e-2)"	"unprognostic (1.94e-1)"	"unprognostic (2.31e-1)"	"unprognostic (6.36e-2)"	"unprognostic (2.98e-1)"	"unprognostic (4.82e-3)"	"unprognostic (8.78e-2)"	"unprognostic (7.65e-2)"	"unprognostic (1.01e-1)"	"unprognostic (1.63e-1)"	3.9	4.9	5.2	2.5	11.0	2.3	4.5	6.1	9.1	6.2	3.5	5.8	14.3	2.2	4.8	20.3	3.5	9.3	5.1	5.9	5.7	7.4	6.6	3.7	8.1	3.5	5.6	8.9	6.5	6.1	8.8	15.0	3.9	11.6	4.6	4.1	5.4	4.2	11.7	3.7	6.5	2.3	4.0	5.5	3.0	3.9	27.0	4.4	1.2	7.6	3.0	2.6	3.5	3.7	1.9	1.9	0.8	2.4	1.8	2.4	1.2	6.5	2.5	2.9	3.5	5.8	8.2	2.5	3.4	3.1	6.1	5.1	2.4	2.4	2.1	15.8	2.4	13.3	2.5	2.7	2.7	9.0	0.3	2.0	1.2	2.1	1.8	3.6	3.6	1.8	3.9	6.1	7.6	5.0	3.6	2.6	5.3	6.3	4.0	5.9	4.8	2.2	3.2	3.3	4.7	5.9	2.5	0.7	2.2	6.3	1.7	4.8	1.4	4.7	4.2	3.4	3.5	11.0	2.8	5.7	7.6	1.1	9.1	5.7	7.1	13.7	0.6	10.8	6.4	6.8	0.2	0.6	0.5	1.2	2.4	1.7	1.9	0.8	1.6	1.9	1.1	2.2	2.4	0.8	1.8	0.9	0.5	0.0	1.2	5.2	11.0	6.1	9.1	5.7	7.4	5.6	8.9	11.6	4.4	14.9	11.3	1.9	1.5	1.8	7.7	9.2	2.5	32.1	13.6	8.7	15.7	2.5	0.0	2.5	29.2	2.5	1.0	0.0	2.3	2.1	3.3	1.9	2.3	2.4	4.2	7.9	4.6	4.3	2.8	18.6	4.4	2.0	3.3	0.0	3.1	7.7	1.8	0.0	5.3	3.7	16.3	0.0	3.2	29.2	24.7	1.5	2.4	1.3	2.3	1.3
LNPEP	"CAP, IRAP, P-LAP, PLAP"	ENSG00000113441	"Leucyl and cystinyl aminopeptidase"	Q9UIQ6	5	96935394-97037515	"Enzymes, Predicted membrane proteins"		"Aminopeptidase, Hydrolase, Metalloprotease, Protease"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	4	"placenta: 104.4"	"Cell type enhanced"	"Detected in many"	4	"Cone photoreceptor cells: 117.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA043642	Approved				"Intracellular and membrane"	NA	NA		390000			"HPA043642: AB_10964137"	"unprognostic (1.52e-1)"	"unprognostic (5.39e-2)"	"unprognostic (7.78e-2)"	"unprognostic (1.53e-2)"	"unprognostic (6.38e-2)"	"unprognostic (6.59e-3)"	"unprognostic (6.83e-2)"	"unprognostic (2.11e-1)"	"unprognostic (1.11e-1)"	"unprognostic (3.54e-3)"	"unprognostic (6.24e-2)"	"unprognostic (2.08e-1)"	"unprognostic (3.28e-1)"	"unprognostic (4.13e-3)"	"unprognostic (1.46e-1)"	"unprognostic (1.69e-1)"	"unprognostic (1.17e-1)"	9.8	4.7	5.6	12.0	7.3	13.2	7.7	23.3	12.9	6.3	7.6	6.9	7.8	4.2	8.2	4.4	10.2	6.6	4.3	10.1	5.2	5.6	7.6	4.3	6.9	15.9	7.7	8.8	8.2	5.9	13.8	9.7	104.4	9.1	7.9	6.8	3.9	7.8	7.7	13.2	14.0	9.0	6.6	7.5	10.0	8.5	3.3	7.7	23.6	7.2	2.9	15.8	8.9	7.7	4.1	3.5	5.0	12.8	11.2	7.9	4.3	5.3	6.2	2.8	2.9	17.1	8.2	3.3	5.5	7.3	6.5	9.9	5.2	8.7	26.5	10.4	7.4	18.3	7.1	3.6	10.4	6.8	9.4	2.0	6.6	4.5	3.6	4.4	7.6	9.1	6.3	6.4	9.4	6.9	7.0	6.8	5.9	2.8	17.6	7.4	4.7	9.0	5.3	0.6	1.7	3.3	6.5	10.6	4.0	23.2	11.1	5.5	1.4	6.7	5.9	3.3	2.8	18.1	10.0	13.5	9.5	5.3	7.5	8.3	3.8	8.8	24.2	8.4	7.2	4.3	5.0	3.3	4.4	7.9	5.5	6.8	3.1	5.9	6.1	3.5	4.1	5.9	6.4	4.1	11.2	12.8	3.3	5.1	4.3	5.6	7.3	23.3	12.9	5.2	5.6	7.7	8.8	9.1	7.7	32.8	42.4	53.7	16.7	52.8	57.3	58.2	17.8	22.7	20.5	34.9	117.8	9.5	5.0	14.0	2.4	31.5	15.8	0.0	12.3	21.8	30.1	24.6	24.4	14.1	14.7	22.3	24.6	33.7	46.5	3.8	30.5	38.3	20.3	12.6	27.8	43.8	15.9	14.0	43.9	9.1	35.8	25.8	24.7	21.4	23.1	41.3	22.9	70.5	21.5	19.9
LTA4H		ENSG00000111144	"Leukotriene A4 hydrolase"	P09960	12	96000828-96043520	"Cancer-related genes, Enzymes, Plasma proteins, Predicted intracellular proteins"	"Leukotriene biosynthesis"	"Hydrolase, Metalloprotease, Protease"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	6	"Hofbauer cells: 215.6;Kupffer cells: 278.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA008399, CAB015221, HPA017017"	Supported		Approved	Nucleoplasm,Cytosol		NA	NA		85000000	"Nucleoplasm, Cytosol"		"CAB015221: , HPA008399: AB_1852816, HPA017017: AB_1852818"	"prognostic favorable (9.79e-4)"	"unprognostic (6.62e-2)"	"unprognostic (6.04e-2)"	"unprognostic (1.87e-1)"	"unprognostic (1.38e-2)"	"unprognostic (2.59e-2)"	"unprognostic (4.25e-3)"	"prognostic favorable (8.96e-4)"	"unprognostic (1.72e-1)"	"unprognostic (1.75e-2)"	"unprognostic (3.38e-2)"	"unprognostic (1.34e-1)"	"unprognostic (1.73e-1)"	"unprognostic (1.74e-1)"	"unprognostic (1.04e-1)"	"unprognostic (3.50e-2)"	"unprognostic (1.34e-1)"	27.9	33.2	11.2	21.5	16.7	55.7	19.0	24.1	15.6	27.2	29.1	13.1	16.7	27.6	27.6	14.1	53.4	22.7	14.5	19.2	10.6	12.2	27.2	19.4	68.0	33.4	12.3	11.3	49.9	28.2	21.2	31.8	11.3	13.3	29.6	17.8	20.7	21.1	16.1	20.6	23.6	41.2	21.5	13.3	44.3	22.1	13.7	11.5	29.2	38.8	22.3	43.1	30.1	25.2	20.6	35.3	6.1	84.2	14.2	9.0	54.6	21.0	22.6	31.8	18.9	27.6	30.9	13.9	8.8	26.1	17.4	20.3	16.5	18.2	47.1	11.1	13.1	13.7	27.7	26.0	35.9	23.8	16.1	25.2	17.3	14.5	20.0	16.3	9.1	10.5	29.4	30.3	24.0	29.5	79.5	34.5	27.6	10.5	8.3	25.1	14.4	23.9	28.0	37.0	25.1	30.7	22.4	23.7	27.1	32.0	26.8	16.5	19.5	17.8	20.8	19.1	25.5	25.9	11.2	12.3	7.4	12.5	10.5	9.5	11.2	19.4	21.8	5.2	16.5	5.8	0.4	76.0	2.2	4.5	84.2	8.4	15.1	6.3	5.8	35.3	20.6	9.0	6.7	6.1	14.2	73.2	8.7	6.3	54.6	11.2	16.7	24.1	15.6	10.6	12.2	12.3	11.3	13.3	11.5	35.7	107.1	87.8	57.2	46.0	19.4	23.4	17.8	48.2	91.0	36.6	31.4	27.0	63.0	34.2	44.9	33.1	22.4	0.0	24.3	24.3	27.5	27.6	7.0	18.1	215.6	11.1	20.7	47.3	278.8	8.1	33.9	139.0	20.3	38.7	40.9	32.1	23.4	24.6	38.5	53.1	58.0	6.5	18.5	45.1	12.5	65.5	17.4	34.8	53.6	42.1
LVRN	"APQ, AQPEP, FLJ90650, TAQPEP"	ENSG00000172901	Laeverin	Q6Q4G3	5	115962454-116027619	"Enzymes, Predicted intracellular proteins"		"Hydrolase, Metalloprotease, Protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	7	"placenta: 75.1"	"Cell type enhanced"	"Detected in some"	20	"Early spermatids: 25.5;Extravillous trophoblasts: 21.0;Late spermatids: 42.0;Syncytiotrophoblasts: 8.9"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"ASC diff: 2.4;ASC TERT1: 3.9;CAPAN-2: 1.8;SiHa: 1.5;U-266/70: 1.6"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA053254	Enhanced				"Intracellular and membrane"	NA	NA					"HPA053254: AB_2682092"	"unprognostic (1.47e-1)"	"unprognostic (3.38e-3)"	"unprognostic (5.81e-2)"	"unprognostic (2.97e-3)"	"unprognostic (5.38e-2)"	"unprognostic (1.32e-1)"	"unprognostic (2.59e-3)"	"unprognostic (1.88e-2)"	"unprognostic (2.23e-1)"	"unprognostic (2.23e-2)"	"unprognostic (3.83e-3)"	"unprognostic (1.22e-1)"	"unprognostic (1.67e-7)"	"unprognostic (1.05e-2)"	"unprognostic (5.94e-2)"	"unprognostic (6.53e-2)"	"unprognostic (3.31e-2)"	10.6	0.1	0.0	0.5	0.0	0.1	3.9	0.0	0.0	0.3	1.4	0.0	0.4	0.1	0.0	0.0	1.8	0.2	0.4	1.1	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.9	0.1	0.0	0.1	75.1	0.0	0.7	0.4	0.0	0.6	1.2	1.3	1.0	1.7	0.5	0.0	0.0	0.4	0.3	0.0	0.0	0.3	1.7	0.1	0.7	0.7	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.2	0.0	0.3	0.1	2.4	3.9	0.9	0.2	0.3	0.1	0.3	0.0	1.8	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.5	1.2	0.1	0.0	0.9	0.0	0.0	0.2	0.3	1.3	0.4	0.0	0.0	0.3	0.1	0.6	0.0	0.3	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.4	1.5	0.0	0.0	0.6	0.0	0.0	0.0	0.3	0.3	0.0	0.6	1.6	0.1	0.1	0.2	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.1	25.5	0.0	0.0	0.0	0.0	21.0	0.2	0.2	0.0	0.0	1.0	0.0	0.0	0.0	0.0	42.0	4.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.1	0.2	0.2	0.0	8.9	0.0	0.0	0.0
MBTPS2	"KFSD, S2P"	ENSG00000012174	"Membrane bound transcription factor peptidase, site 2"	O43462	X	21839636-21885424	"Disease related genes, Enzymes, Potential drug targets, Predicted membrane proteins"	"Cholesterol metabolism, Lipid metabolism, Steroid metabolism, Sterol metabolism"	"Hydrolase, Metalloprotease, Protease"	"Disease mutation, Ichthyosis, Osteogenesis imperfecta, Palmoplantar keratoderma"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	4	"Horizontal cells: 28.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA005494, CAB009486"	Approved		Approved	Nucleoplasm,Mitochondria,Cytosol		NA	NA			"Nucleoplasm, Mitochondria, Cytosol"		"CAB009486: AB_2140370, HPA005494: AB_1079329"	"unprognostic (7.97e-3)"	"unprognostic (9.12e-2)"	"unprognostic (5.38e-2)"	"unprognostic (1.18e-2)"	"unprognostic (2.65e-1)"	"unprognostic (1.50e-1)"	"unprognostic (1.85e-1)"	"unprognostic (7.22e-2)"	"unprognostic (3.32e-1)"	"unprognostic (9.30e-2)"	"unprognostic (1.99e-1)"	"unprognostic (1.77e-1)"	"unprognostic (8.38e-2)"	"unprognostic (7.76e-2)"	"unprognostic (1.07e-1)"	"unprognostic (3.61e-1)"	"unprognostic (3.05e-2)"	12.0	17.4	9.3	7.2	13.9	2.5	12.7	20.8	18.5	11.8	9.3	13.4	6.9	7.6	14.7	9.1	9.3	10.9	10.1	11.6	9.9	10.7	13.9	26.0	8.6	6.6	10.6	13.0	18.7	12.2	17.9	15.6	22.3	17.4	15.7	9.1	12.4	14.1	13.1	14.5	8.2	8.1	14.6	14.6	7.5	9.1	6.9	7.0	7.1	13.1	7.4	6.7	11.4	9.1	3.9	6.9	1.5	4.8	4.6	5.9	3.3	8.9	18.6	8.9	9.1	11.3	14.0	4.3	13.3	13.6	12.7	11.1	7.4	12.3	7.8	6.9	14.2	24.8	8.4	12.3	7.6	15.7	5.8	9.8	3.8	11.8	6.1	15.5	8.2	3.8	13.2	8.3	19.1	14.1	12.9	9.7	4.6	10.6	8.7	14.4	5.6	3.3	4.3	8.3	4.7	13.8	4.2	16.6	8.7	8.8	4.6	2.2	18.3	18.7	11.9	16.4	12.4	15.9	7.1	11.5	16.0	3.7	23.2	9.9	10.7	13.5	3.8	17.8	3.4	15.3	0.1	4.3	1.5	4.5	4.8	4.2	3.9	3.5	4.1	6.9	3.8	4.7	5.6	0.5	4.6	4.8	4.8	5.9	3.3	9.3	13.9	20.8	18.5	9.9	10.7	10.6	13.0	17.4	7.0	8.9	7.8	3.0	3.4	4.8	11.7	12.0	7.6	10.7	6.8	7.0	17.7	5.6	0.0	5.1	0.3	4.6	3.3	0.0	7.7	5.4	8.9	6.6	10.4	16.1	8.0	28.6	2.4	10.4	9.5	0.9	9.8	4.4	10.1	3.6	3.3	7.7	5.3	3.1	12.4	7.5	14.0	0.0	6.9	2.8	1.7	2.4	4.0	4.3	4.2	4.1
MEP1A	PPHA	ENSG00000112818	"Meprin A subunit alpha"	Q16819	6	46793390-46839782	"Enzymes, Plasma proteins, Predicted membrane proteins"		"Hydrolase, Metalloprotease, Protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	52	"intestine: 243.0"	"Group enriched"	"Detected in some"	4	"Enterocytes: 391.5;Paneth cells: 129.6"	"Cancer enriched"	"Detected in many"	5	"colorectal cancer: 38.6"	"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in single"		"myeloid DC: 1.6"	"Lineage enriched"	"Detected in single"	8	"dendritic cells: 1.6"	"Cell line enhanced"	"Detected in some"		"BEWO: 3.1;CACO-2: 7.1;Hep G2: 1.9;NB-4: 3.1;RPMI-8226: 3.5;SH-SY5Y: 2.2;U-2197: 2.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"CAB025163, HPA029416"	Enhanced					NA	NA		990000			"CAB025163: , HPA029416: AB_10600823"	"unprognostic (1.83e-1)"	"unprognostic (2.81e-4)"	"unprognostic (2.03e-1)"	"unprognostic (8.53e-2)"	"unprognostic (8.73e-2)"	"unprognostic (1.13e-1)"	"unprognostic (2.43e-2)"	"unprognostic (5.27e-4)"	"unprognostic (2.05e-1)"	"unprognostic (2.35e-2)"	"unprognostic (1.42e-1)"	"unprognostic (2.11e-1)"	"unprognostic (1.11e-3)"	"unprognostic (1.45e-1)"	"unprognostic (1.91e-2)"	"unprognostic (4.70e-3)"	"unprognostic (1.68e-1)"	0.1	0.1	0.1	4.7	0.1	0.0	0.1	0.1	0.1	0.1	100.5	0.1	0.1	51.7	0.1	0.1	0.1	0.2	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.2	0.1	0.1	0.5	0.0	0.1	0.1	0.1	0.1	19.8	0.1	0.2	0.1	0.1	0.1	243.0	0.2	0.2	0.2	0.1	0.3	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	1.6	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.1	0.0	0.0	0.0	0.0	7.1	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.2	0.0	0.0	0.0	0.0	0.0	1.9	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.1	0.0	0.2	0.0	0.0	0.0	3.5	0.0	0.0	0.5	2.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	2.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.2	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.8	0.0	391.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	14.9	0.0	0.0	4.7	0.0	0.0	0.0	0.0	61.3	0.0	0.0	129.6	0.4	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	28.3	0.0
MEP1B		ENSG00000141434	"Meprin A subunit beta"	Q16820	18	32185069-32220404	"Enzymes, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins, Transporters"	"Inflammatory response"	"Hydrolase, Metalloprotease, Protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	167	"intestine: 241.5"	"Group enriched"	"Detected in some"	6	"Early spermatids: 2.1;Enterocytes: 6.3"	"Group enriched"	"Detected in some"	5	"pancreatic cancer: 3.0;stomach cancer: 0.6"	"Not detected"	"Not detected"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"SCLC-21H: 10.6"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA029119	Enhanced				"Secreted to digestive system"	NA	NA		120000			"HPA029119: AB_2672913"	"unprognostic (1.33e-1)"	"unprognostic (6.72e-2)"	"unprognostic (2.79e-2)"	"unprognostic (1.00e-1)"	"unprognostic (3.50e-4)"	"unprognostic (1.27e-1)"	"unprognostic (1.74e-2)"	"unprognostic (4.30e-1)"	"unprognostic (1.73e-1)"	"unprognostic (1.24e-2)"	"unprognostic (1.55e-1)"	"unprognostic (8.31e-4)"	"unprognostic (4.74e-2)"	"unprognostic (3.39e-1)"	"unprognostic (2.71e-1)"	"unprognostic (3.39e-2)"	"unprognostic (3.75e-2)"	0.1	0.1	0.1	0.4	0.1	0.0	0.1	0.3	0.1	0.1	78.8	0.0	0.0	54.5	0.1	0.0	0.1	0.1	0.2	0.1	0.1	0.1	0.1	1.2	0.1	0.0	0.1	0.0	0.1	0.1	0.0	0.1	0.0	0.0	0.1	0.2	0.0	0.1	0.0	0.1	0.1	241.5	0.0	0.1	0.1	0.1	0.3	0.0	0.0	0.1	0.0	0.0	0.1	0.1	1.1	0.4	0.3	0.3	0.0	1.4	0.5	0.2	0.0	0.0	0.5	0.6	0.0	2.1	1.0	0.3	0.3	0.1	0.6	1.4	1.7	0.5	0.0	0.8	0.2	0.0	0.0	0.0	0.8	1.0	1.1	0.7	0.6	0.4	1.3	0.3	0.0	0.7	0.0	0.1	0.7	0.5	1.6	1.1	0.2	0.0	1.9	1.3	4.1	1.3	0.5	0.0	1.8	1.8	2.9	0.0	0.7	10.6	2.4	0.8	0.2	0.3	0.3	0.4	3.1	0.9	1.4	0.8	3.4	0.0	0.6	2.3	0.5	2.6	0.0	0.5	0.0	0.3	0.3	1.0	0.1	1.3	1.1	0.7	1.4	0.4	0.1	1.2	0.3	0.2	0.0	0.1	0.2	0.5	0.5	0.1	0.1	0.3	0.1	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.1	0.0	6.3	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.1	0.1	0.0	0.0	0.0
METAP1	"KIAA0094, MAP1A, MetAP1A"	ENSG00000164024	"Methionyl aminopeptidase 1"	P53582	4	98995620-99062813	"Enzymes, Plasma proteins, Predicted intracellular proteins"		"Aminopeptidase, Hydrolase, Protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in many"	14	"Early spermatids: 345.0;Late spermatids: 1171.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB025485, HPA037997, HPA037998"	Approved		Approved	"Nucleoplasm,Plasma membrane,Cytosol"		NA	NA		11000	Cytosol	"Nucleoplasm, Plasma membrane"	"CAB025485: , HPA037997: AB_2675777, HPA037998: AB_2675778"	"unprognostic (1.79e-1)"	"unprognostic (3.39e-1)"	"prognostic favorable (7.22e-4)"	"unprognostic (1.58e-2)"	"unprognostic (6.53e-2)"	"unprognostic (2.15e-1)"	"prognostic unfavorable (3.08e-5)"	"unprognostic (1.09e-1)"	"unprognostic (1.51e-3)"	"unprognostic (2.05e-1)"	"prognostic unfavorable (2.28e-5)"	"unprognostic (2.00e-1)"	"prognostic favorable (1.72e-4)"	"unprognostic (5.50e-2)"	"unprognostic (8.51e-2)"	"unprognostic (1.15e-3)"	"prognostic favorable (9.31e-4)"	12.1	8.3	10.0	16.0	10.1	11.8	18.6	9.2	13.8	16.0	17.9	7.0	22.9	13.4	24.1	25.9	37.2	14.0	12.3	27.9	9.5	7.1	14.3	13.7	10.7	12.6	7.9	9.8	11.3	13.0	7.8	14.4	9.2	9.9	19.1	19.3	7.5	19.0	21.5	27.2	16.4	15.2	27.8	10.1	13.9	11.6	46.8	8.1	27.0	10.8	21.8	19.1	36.6	22.6	12.7	11.7	10.4	11.1	12.5	19.2	10.8	21.7	21.5	18.9	20.3	15.0	24.1	21.0	31.2	20.1	26.7	25.5	24.1	32.5	32.3	12.5	25.2	16.0	21.9	33.1	31.2	37.1	22.5	15.8	28.8	15.7	25.9	16.3	38.9	24.2	17.3	22.8	22.7	24.1	20.8	21.9	18.3	22.5	19.5	28.5	16.6	34.1	18.6	23.2	37.1	17.5	22.4	29.5	17.2	42.9	28.2	25.9	15.3	10.4	32.4	12.3	22.1	12.4	14.9	17.8	21.6	27.5	19.8	27.2	14.2	19.9	25.5	18.6	20.0	21.4	10.4	9.4	4.2	14.9	11.1	19.2	12.7	15.4	14.5	11.7	10.1	15.1	13.5	2.3	12.5	10.7	5.8	13.4	10.8	10.0	10.1	9.2	13.8	9.5	7.1	7.9	9.8	9.9	8.1	38.7	10.5	13.7	44.1	37.7	4.6	49.8	20.4	18.7	17.0	14.0	2.0	22.0	11.6	26.9	345.0	13.5	29.0	0.0	25.4	55.9	12.3	21.8	3.5	16.4	15.6	3.2	7.5	16.5	19.6	1171.9	17.8	14.6	15.1	6.4	25.2	8.3	22.3	34.2	21.2	22.9	3.5	25.8	22.1	15.1	46.4	33.9	6.4	15.2	32.6	39.6
METAP1D	"MAP1D, Metap1l"	ENSG00000172878	"Methionyl aminopeptidase type 1D, mitochondrial"	Q6UB28	2	171999583-172082430	"Enzymes, Predicted intracellular proteins"		"Aminopeptidase, Hydrolase, Protease"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	6	"Leydig cells: 31.1;Peritubular cells: 24.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA030298, HPA030299"	Uncertain		Uncertain	Vesicles		NA	NA			Vesicles		"HPA030298: AB_2673419, HPA030299: AB_10602421"	"unprognostic (5.31e-2)"	"unprognostic (1.07e-1)"	"unprognostic (1.88e-1)"	"unprognostic (5.83e-2)"	"unprognostic (2.54e-2)"	"unprognostic (7.90e-3)"	"unprognostic (1.92e-3)"	"unprognostic (1.07e-2)"	"unprognostic (4.55e-1)"	"unprognostic (7.07e-2)"	"unprognostic (2.64e-2)"	"unprognostic (8.19e-2)"	"unprognostic (2.53e-3)"	"unprognostic (3.44e-3)"	"unprognostic (3.06e-2)"	"unprognostic (5.48e-3)"	"unprognostic (2.92e-2)"	7.1	7.5	7.2	8.0	8.4	6.3	8.2	6.7	9.2	6.5	6.1	9.6	6.5	5.0	9.0	6.4	5.2	10.3	4.5	6.4	6.0	4.9	5.4	8.3	3.6	8.1	9.3	7.1	18.9	23.8	5.5	13.8	4.1	8.6	8.3	7.1	7.3	9.7	10.3	13.8	7.1	5.9	10.0	7.2	8.6	6.3	5.9	9.5	2.1	5.6	6.3	6.7	5.4	5.7	2.5	0.5	0.2	1.2	1.2	3.6	0.7	3.3	2.7	3.9	13.2	5.8	7.6	8.1	3.9	3.9	6.2	4.0	6.1	4.5	1.7	7.1	4.1	6.4	6.2	8.6	6.8	6.4	6.0	10.3	9.5	7.0	8.1	6.2	5.6	2.5	5.8	10.7	6.2	10.0	5.4	3.5	6.6	13.7	4.9	4.7	4.1	3.2	7.6	7.2	9.6	3.3	7.2	3.4	3.0	4.4	4.7	8.2	3.2	2.7	5.6	9.6	3.6	6.5	7.6	4.1	8.0	6.3	4.8	3.7	6.1	5.5	3.8	5.7	11.2	7.6	0.0	0.2	0.0	1.3	1.2	0.6	1.2	1.9	0.7	0.5	2.5	1.9	3.6	0.2	1.2	0.2	0.0	1.4	0.7	7.2	8.4	6.7	9.2	6.0	4.9	9.3	7.1	8.6	9.5	0.0	5.8	5.8	8.8	4.9	4.9	3.4	5.1	1.4	1.2	3.5	2.0	3.9	6.6	2.1	0.6	3.8	0.4	0.0	2.9	3.9	8.0	4.7	4.6	6.0	3.4	4.8	0.0	6.2	2.8	0.9	31.1	1.3	5.0	0.0	2.6	3.2	1.8	0.0	24.8	3.8	4.9	12.9	5.6	6.9	10.6	5.0	1.6	6.9	5.2	4.1
METAP2	"MAP2, MNPEP, p67"	ENSG00000111142	"Methionyl aminopeptidase 2"	P50579	12	95473520-95515839	"Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins"		"Aminopeptidase, Hydrolase, Protease"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB013025, HPA019095"	Enhanced		Supported	"Plasma membrane,Cytosol"		NA	NA		22000	"Plasma membrane, Cytosol"		"CAB013025: AB_2533993, HPA019095: AB_1853823"	"unprognostic (1.91e-1)"	"unprognostic (1.02e-1)"	"unprognostic (5.92e-2)"	"unprognostic (2.44e-1)"	"unprognostic (3.27e-2)"	"unprognostic (2.57e-2)"	"prognostic unfavorable (4.51e-6)"	"unprognostic (1.25e-1)"	"unprognostic (2.28e-2)"	"unprognostic (1.40e-2)"	"unprognostic (8.53e-2)"	"unprognostic (1.66e-1)"	"unprognostic (1.49e-1)"	"unprognostic (2.51e-1)"	"unprognostic (1.07e-1)"	"unprognostic (2.95e-2)"	"unprognostic (1.03e-1)"	24.2	36.4	25.8	49.9	33.7	39.1	25.1	25.9	32.3	23.9	26.2	16.3	102.5	16.6	28.7	25.4	30.1	22.5	21.7	30.7	29.6	24.0	26.0	46.8	22.1	32.6	29.1	23.4	29.4	31.9	21.0	36.1	25.1	42.9	24.2	24.0	10.1	22.1	140.7	94.4	28.7	19.7	26.1	48.2	25.2	22.2	26.3	27.7	32.1	24.1	29.0	55.2	33.4	37.3	39.4	31.8	21.3	27.1	25.7	32.0	16.2	33.9	28.6	30.6	23.8	18.7	30.0	23.6	33.5	23.4	33.0	23.5	41.5	16.3	98.8	21.1	23.9	19.2	21.9	34.4	25.6	38.0	23.5	29.7	44.2	21.8	29.2	19.9	54.7	21.7	25.9	27.4	31.2	30.6	39.6	35.1	34.1	57.2	11.2	24.4	22.3	40.5	37.4	37.5	19.6	42.8	31.9	26.5	32.4	22.6	36.0	23.8	31.3	29.7	24.3	29.3	27.6	29.3	26.0	30.1	19.0	18.4	21.2	35.3	16.2	42.1	105.9	10.8	30.9	23.8	21.3	27.1	11.1	23.8	19.1	29.2	39.4	26.7	26.6	24.4	37.6	32.0	29.7	1.2	25.7	22.3	31.8	25.3	16.2	25.8	33.7	25.9	32.3	29.6	24.0	29.1	23.4	42.9	27.7	262.0	228.6	96.8	102.9	207.2	62.7	117.4	91.7	104.4	160.3	275.7	62.8	125.5	139.3	94.7	135.8	104.6	80.2	256.9	126.2	136.4	102.7	68.6	119.0	278.9	86.9	71.5	88.0	102.5	122.4	83.3	92.9	93.2	87.7	80.2	109.6	67.6	105.7	83.4	100.4	81.6	68.7	97.0	97.6	340.7	217.0	187.9	143.8	93.5	118.5	90.7
MIPEP	MIP	ENSG00000027001	"Mitochondrial intermediate peptidase"	Q99797	13	23730189-23889419	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"		"Hydrolase, Metalloprotease, Protease"	"Disease mutation, Primary mitochondrial disease"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	8	"Cardiomyocytes: 80.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"OE19: 35.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA030676, HPA031669, HPA031670"	Approved		Enhanced	Mitochondria		NA	NA			Mitochondria		"HPA030676: AB_10598907, HPA031669: AB_10600986, HPA031670: AB_10602198"	"unprognostic (2.05e-1)"	"unprognostic (3.17e-2)"	"unprognostic (3.75e-3)"	"unprognostic (3.72e-2)"	"unprognostic (1.24e-1)"	"unprognostic (1.23e-1)"	"unprognostic (2.41e-1)"	"unprognostic (2.21e-1)"	"unprognostic (4.69e-2)"	"unprognostic (1.12e-1)"	"unprognostic (7.54e-2)"	"unprognostic (4.76e-1)"	"prognostic favorable (7.66e-12)"	"unprognostic (1.62e-2)"	"unprognostic (4.95e-2)"	"unprognostic (2.79e-1)"	"unprognostic (6.90e-3)"	7.3	14.9	6.2	7.1	12.2	4.4	11.0	4.7	10.3	8.1	12.2	12.9	12.1	8.4	9.6	20.4	14.4	17.1	11.7	16.9	8.8	5.3	24.7	12.0	8.2	8.4	5.1	8.0	8.5	14.7	8.1	15.4	5.3	9.1	10.9	13.1	9.1	12.9	10.1	16.2	22.0	8.9	11.5	4.4	6.5	9.8	13.9	4.9	8.9	10.9	15.7	11.1	11.2	8.6	9.2	6.5	1.2	10.6	9.7	10.0	3.9	7.8	8.9	4.4	10.3	10.1	13.7	9.4	5.7	8.9	8.6	7.3	11.8	15.7	9.3	5.8	4.6	7.6	19.9	10.1	12.0	10.7	5.4	6.4	4.0	4.2	10.1	8.3	9.4	2.2	6.7	15.0	8.9	7.9	7.3	10.7	7.1	7.7	1.5	13.4	5.8	6.7	5.3	6.1	35.4	9.0	7.5	11.9	8.0	19.2	5.2	10.3	3.4	6.1	10.0	12.0	5.8	10.3	5.3	5.9	5.2	4.4	8.6	6.1	1.5	2.1	5.0	9.1	4.8	6.5	0.0	3.0	1.2	7.9	3.7	10.0	9.2	7.7	7.1	6.5	7.7	7.4	7.3	0.0	9.7	10.6	5.6	5.1	3.9	6.2	12.2	4.7	10.3	8.8	5.3	5.1	8.0	9.1	4.9	14.9	7.5	0.8	5.9	35.4	3.2	80.7	15.3	36.1	10.3	8.7	5.9	8.4	24.9	20.8	6.6	3.7	5.5	0.0	9.4	7.7	4.5	5.6	2.3	5.6	8.7	14.3	5.8	2.5	2.7	5.9	6.4	4.1	5.0	3.6	6.4	5.2	8.0	8.6	8.1	18.1	10.7	0.0	5.2	9.5	19.0	36.9	4.2	2.9	12.4	3.8
MME	"CALLA, CD10, NEP"	ENSG00000196549	"Membrane metalloendopeptidase"	P08473	3	155024124-155183729	"Cancer-related genes, Candidate cardiovascular disease genes, CD markers, Disease related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"		"Hydrolase, Metalloprotease, Protease"	"Cancer-related genes, Charcot-Marie-Tooth disease, Disease mutation, FDA approved drug targets, Neurodegeneration, Neuropathy, Spinocerebellar ataxia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 61.1;intestine: 136.0;kidney: 64.9"	"Cell type enhanced"	"Detected in many"	8	"Basal glandular cells: 62.4;Cytotrophoblasts: 71.6;Proximal tubular cells: 101.6;Syncytiotrophoblasts: 105.4"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Cell type enriched"	"Detected in single"	129	"neutrophil: 61.1"	"Lineage enriched"	"Detected in single"	129	"granulocytes: 61.1"	"Cell line enhanced"	"Detected in many"		"ASC TERT1: 97.1;BJ hTERT+: 146.1;HSkMC: 94.2"	"Low region specificity"	"Detected in many"			"Region enhanced"	"Detected in many"		"basal ganglia: 26.8"	"CAB000013, HPA052583, HPA056072"	Enhanced					NA	NA		99000			"CAB000013: AB_563478, HPA052583: AB_2681872, HPA056072: AB_2683027"	"unprognostic (1.36e-1)"	"unprognostic (1.02e-3)"	"unprognostic (8.52e-2)"	"unprognostic (2.95e-1)"	"unprognostic (2.78e-2)"	"unprognostic (6.52e-3)"	"unprognostic (1.20e-1)"	"unprognostic (1.67e-2)"	"unprognostic (8.67e-2)"	"unprognostic (1.96e-1)"	"unprognostic (7.30e-3)"	"unprognostic (1.31e-1)"	"unprognostic (2.71e-3)"	"unprognostic (1.50e-1)"	"unprognostic (7.29e-2)"	"unprognostic (1.06e-2)"	"unprognostic (1.37e-2)"	26.5	0.4	0.4	3.4	7.4	1.9	14.7	0.4	0.7	4.8	65.6	0.1	18.4	74.0	2.8	8.1	0.7	0.9	8.5	1.8	0.3	0.4	64.9	11.5	13.7	3.0	2.1	0.2	0.9	0.6	0.0	0.6	35.0	8.6	18.3	0.4	1.3	3.7	11.3	11.7	1.4	136.0	0.6	0.9	2.7	0.7	1.0	1.2	13.2	1.0	5.3	2.3	3.4	4.9	0.1	0.4	61.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	39.4	97.1	0.2	21.7	146.1	11.1	28.7	0.0	0.0	23.9	0.0	19.2	15.1	0.0	0.7	0.8	26.7	0.0	0.1	0.0	0.0	0.0	31.6	0.0	0.0	94.2	0.1	5.9	42.5	12.3	8.4	0.0	0.0	0.0	17.7	0.1	0.0	0.1	0.9	0.0	0.1	39.7	18.7	0.1	0.6	0.2	0.0	0.2	0.0	0.0	4.2	8.9	0.0	0.0	23.8	47.7	0.1	16.3	3.7	0.0	0.0	31.5	5.7	0.0	1.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	61.1	0.0	0.0	0.4	0.0	0.0	0.4	7.4	0.4	0.7	0.3	0.4	2.1	0.2	8.6	1.2	8.9	18.3	0.9	62.4	0.7	0.0	1.1	17.8	2.7	19.4	21.0	0.0	71.6	8.3	0.1	0.3	0.6	0.0	0.0	0.0	48.9	19.2	29.2	2.3	48.9	8.1	0.0	0.0	3.1	1.8	0.2	3.7	2.7	0.0	0.0	0.2	0.0	0.3	0.0	1.1	101.6	0.0	0.0	3.1	0.2	0.4	0.3	105.4	0.0	0.0	29.2
MMEL1	"MMEL2, NEPII, NL1, NL2, SEP"	ENSG00000142606	"Membrane metalloendopeptidase like 1"	Q495T6	1	2590639-2632990	"Enzymes, Predicted intracellular proteins"		"Hydrolase, Metalloprotease, Protease"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"testis: 30.2"	"Cell type enhanced"	"Detected in many"	14	"Cholangiocytes: 28.1;Early spermatids: 82.5;Late spermatids: 27.3;Paneth cells: 37.7"	"Low cancer specificity"	"Detected in many"			"Region enhanced"	"Detected in many"		"basal ganglia: 8.5"	"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enriched"	"Detected in some"	5	"SK-BR-3: 17.8"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"HPA007876, HPA008205, CAB020786"	Uncertain				"Intracellular and membrane"	NA	NA					"CAB020786: , HPA007876: AB_1854012, HPA008205: AB_1854011"	"unprognostic (5.80e-2)"	"unprognostic (4.61e-2)"	"unprognostic (1.87e-1)"	"unprognostic (4.27e-2)"	"unprognostic (1.33e-1)"	"unprognostic (2.71e-2)"	"unprognostic (1.45e-1)"	"unprognostic (7.96e-2)"	"unprognostic (1.36e-2)"	"unprognostic (2.37e-1)"	"unprognostic (4.54e-3)"	"unprognostic (2.44e-2)"	"unprognostic (4.79e-2)"	"unprognostic (3.18e-1)"	"unprognostic (2.82e-1)"	"unprognostic (2.18e-3)"	"unprognostic (7.01e-4)"	1.5	0.5	0.8	1.8	8.5	0.6	1.8	0.4	0.6	4.3	4.2	0.4	1.9	3.2	0.8	10.3	3.0	3.0	9.6	1.3	1.0	2.6	1.4	0.4	1.4	1.4	1.7	0.4	1.1	7.3	0.3	0.4	0.7	0.5	4.2	1.4	0.4	2.0	2.0	0.4	0.3	2.6	0.9	0.7	1.4	7.9	30.2	0.9	0.8	1.1	0.8	0.8	3.7	1.6	0.6	1.1	6.6	5.1	2.3	6.1	2.2	0.0	0.0	0.0	0.0	0.0	0.1	0.3	0.0	0.0	0.0	0.0	0.0	3.0	0.0	3.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.2	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	2.9	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.5	0.0	0.6	0.0	0.5	0.0	17.8	0.0	0.1	1.7	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.4	1.5	6.6	0.5	3.9	0.3	0.6	1.7	0.7	1.1	0.0	4.5	2.2	1.0	2.3	5.1	0.2	6.1	2.2	0.8	8.5	0.4	0.6	1.0	2.6	1.7	0.4	0.5	0.9	0.0	0.0	0.0	4.6	0.0	0.0	0.8	28.1	10.7	2.3	17.4	0.0	0.0	0.0	7.1	82.5	0.6	15.7	0.0	3.1	0.0	0.3	12.4	0.0	0.0	1.3	0.0	1.2	0.6	1.5	27.3	1.7	0.5	0.0	0.0	14.9	0.5	2.7	37.7	1.1	0.0	0.0	0.0	0.4	0.5	0.9	0.0	0.0	0.0	9.7	10.9
MMP1	CLG	ENSG00000196611	"Matrix metallopeptidase 1"	P03956	11	102789920-102798160	"Cancer-related genes, Candidate cardiovascular disease genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted secreted proteins"	"Collagen degradation, Host-virus interaction"	"Hydrolase, Metalloprotease, Protease"	"Cancer-related genes, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"gallbladder: 62.4;stomach 1: 27.2"	"Cell type enriched"	"Detected in some"	7	"Pancreatic endocrine cells: 1303.6"	"Cancer enhanced"	"Detected in many"		"head and neck cancer: 344.2"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"BJ hTERT+: 90.2;HBF TERT88: 89.3;HUVEC TERT2: 234.8;WM-115: 115.7"									HPA004920			Approved	Vesicles	"Secreted to extracellular matrix"	NA	NA	7730000	430000	Vesicles		"HPA004920: AB_2667293"	"unprognostic (4.11e-3)"	"prognostic unfavorable (4.66e-4)"	"unprognostic (4.20e-3)"	"unprognostic (1.19e-3)"	"unprognostic (6.46e-2)"	"unprognostic (6.50e-2)"	"prognostic unfavorable (4.22e-6)"	"unprognostic (7.83e-3)"	"unprognostic (2.94e-2)"	"unprognostic (5.44e-2)"	"unprognostic (1.11e-3)"	"unprognostic (1.75e-1)"	"prognostic unfavorable (9.86e-10)"	"unprognostic (1.67e-2)"	"unprognostic (1.49e-1)"	"unprognostic (1.26e-2)"	"unprognostic (5.11e-2)"	0.2	0.1	0.3	12.3	0.3	0.0	0.9	0.3	0.3	0.3	2.7	0.3	0.2	3.2	4.8	0.2	3.3	0.1	62.4	0.4	0.2	0.1	0.7	1.3	4.7	0.2	0.2	0.2	0.2	1.6	0.0	0.2	8.6	0.5	0.7	3.0	0.3	2.0	0.2	0.2	0.3	8.8	0.2	0.4	1.8	27.2	2.2	0.2	0.4	0.3	1.3	0.9	11.0	0.2	0.0	0.0	0.6	0.0	0.0	0.0	1.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	40.8	90.2	36.9	9.6	0.7	0.0	0.0	0.4	21.6	14.2	0.3	0.0	12.6	89.3	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	37.9	3.2	0.0	234.8	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	14.7	1.6	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.3	0.0	0.1	0.0	0.0	0.0	12.1	30.6	0.0	1.3	0.1	0.0	0.0	0.0	0.7	0.0	115.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	1.9	0.3	0.3	0.3	0.3	0.2	0.1	0.2	0.2	0.5	0.2	3.0	1.6	0.0	14.4	2.1	0.0	0.0	35.7	0.0	23.9	3.5	0.0	0.0	0.0	3.5	0.0	0.1	0.0	0.0	184.0	0.0	0.2	5.4	0.0	0.0	0.3	0.0	0.0	0.0	1.9	0.0	0.0	0.2	0.0	7.2	0.0	0.0	1303.6	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.3	0.1	0.0	0.0	25.0
MMP10	STMY2	ENSG00000166670	"Matrix metallopeptidase 10"	P09238	11	102770503-102780628	"Cancer-related genes, Enzymes, FDA approved drug targets, Predicted secreted proteins"	"Collagen degradation"	"Hydrolase, Metalloprotease, Protease"	"Cancer-related genes, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	4	"endometrium 1: 89.4"	"Cell type enhanced"	"Detected in some"	14	"Basal glandular cells: 38.9;Club cells: 70.5;Collecting duct cells: 27.9;Pancreatic endocrine cells: 62.0"	"Cancer enhanced"	"Detected in many"		"head and neck cancer: 102.2"	"Region enriched"	"Detected in single"	9	"pons and medulla: 2.8"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"BJ: 12.6;HUVEC TERT2: 16.2;SCLC-21H: 5.2"	"Not detected"	"Not detected"							CAB002159	Uncertain		Approved	"Plasma membrane,Cytosol"	"Secreted to extracellular matrix"	NA	NA	765000		Cytosol	"Plasma membrane"	"CAB002159: AB_564103"	"unprognostic (8.76e-2)"	"unprognostic (3.38e-1)"	"unprognostic (1.98e-3)"	"unprognostic (2.72e-3)"	"unprognostic (7.17e-3)"	"unprognostic (1.52e-2)"	"unprognostic (5.67e-8)"	"unprognostic (2.08e-3)"	"unprognostic (2.20e-1)"	"unprognostic (1.75e-1)"	"unprognostic (1.67e-2)"	"unprognostic (2.67e-1)"	"unprognostic (6.99e-5)"	"unprognostic (2.66e-2)"	"unprognostic (7.98e-2)"	"unprognostic (5.46e-2)"	"prognostic favorable (7.12e-4)"	0.1	0.1	0.0	2.6	0.2	0.1	0.1	0.0	0.3	1.7	0.5	0.0	0.0	0.4	89.4	0.1	0.2	0.1	0.5	0.1	0.0	0.1	0.1	3.6	11.0	0.1	0.0	0.0	0.5	0.3	0.1	0.9	19.8	2.8	3.2	0.2	0.0	2.9	0.1	0.1	0.1	0.7	0.1	0.0	0.2	3.3	0.5	0.0	1.2	0.1	0.0	1.9	0.6	5.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.8	0.2	0.0	0.0	0.2	12.6	0.7	0.1	0.1	0.3	0.0	0.0	3.7	1.9	0.2	2.9	0.0	1.4	0.0	0.0	0.2	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.4	0.6	0.0	16.2	0.0	0.7	0.0	0.0	0.0	0.0	0.3	3.0	0.5	1.7	0.0	0.0	0.0	0.0	0.7	5.2	0.0	2.5	0.0	0.0	0.9	0.0	0.0	2.0	3.9	1.3	0.4	0.5	0.0	0.0	0.0	0.6	0.0	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.3	0.0	0.1	0.0	0.0	2.8	0.0	0.0	0.0	0.0	38.9	0.7	0.0	0.0	0.0	5.3	70.5	27.9	0.0	0.0	0.0	9.8	5.0	0.0	0.0	0.0	12.9	0.0	0.2	5.0	2.3	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	1.2	0.0	2.8	0.0	0.0	62.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.1	0.1	0.0	0.0	0.0	7.4
MMP11	STMY3	ENSG00000099953	"Matrix metallopeptidase 11"	P24347	22	23768226-23784316	"Cancer-related genes, Enzymes, FDA approved drug targets, Predicted secreted proteins"	"Collagen degradation"	"Hydrolase, Metalloprotease, Protease"	"Cancer-related genes, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	6	"endometrium 1: 44.1;placenta: 119.6"	"Cell type enhanced"	"Detected in many"	15	"Extravillous trophoblasts: 34.6;Syncytiotrophoblasts: 15.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in single"			"Cell type enhanced"	"Detected in some"		"plasmacytoid DC: 7.8"	"Group enriched"	"Detected in many"	5	"B-cells: 2.4;dendritic cells: 7.8"	"Cell line enhanced"	"Detected in some"		"AN3-CA: 18.7;hTERT-RPE1: 9.7;REH: 7.8"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"CAB002593, HPA068864"	Approved				"Secreted to extracellular matrix"	NA	NA					"CAB002593: , HPA068864: AB_2686051"	"unprognostic (1.06e-1)"	"unprognostic (3.08e-1)"	"unprognostic (1.83e-1)"	"unprognostic (1.84e-3)"	"unprognostic (2.77e-2)"	"unprognostic (6.73e-2)"	"unprognostic (2.14e-2)"	"unprognostic (5.15e-1)"	"unprognostic (2.73e-2)"	"unprognostic (2.20e-1)"	"unprognostic (1.89e-3)"	"unprognostic (7.04e-2)"	"prognostic unfavorable (2.62e-4)"	"unprognostic (8.05e-2)"	"unprognostic (6.78e-2)"	"unprognostic (1.10e-1)"	"unprognostic (1.68e-2)"	1.7	0.6	0.2	1.0	0.6	0.1	1.6	1.0	0.5	13.4	1.8	0.4	0.4	1.9	44.1	1.1	0.8	2.2	2.0	3.1	0.5	0.0	1.7	0.5	0.7	1.8	0.4	0.2	7.7	1.1	0.2	0.3	119.6	0.5	1.4	1.0	0.8	2.5	0.4	0.5	2.0	4.0	2.7	0.3	0.9	0.7	3.4	0.2	2.6	0.5	0.6	0.9	1.6	2.1	2.4	7.8	0.0	0.0	0.0	1.0	0.1	0.1	0.0	2.3	18.7	2.8	4.2	0.0	0.2	5.0	0.6	0.4	0.0	0.6	0.6	3.5	1.3	0.9	0.1	1.0	0.0	0.2	0.0	0.3	0.0	0.0	1.0	2.1	0.0	0.0	2.7	0.4	0.5	0.0	9.7	2.9	0.2	0.3	0.0	0.6	0.1	0.0	0.0	0.6	0.5	0.1	7.8	0.0	0.2	0.3	0.0	2.9	5.0	1.9	0.3	0.0	3.0	1.7	0.0	1.3	0.3	0.0	0.7	0.0	0.1	0.0	2.5	0.1	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	2.4	1.0	0.3	0.0	0.0	0.0	7.8	0.0	0.1	0.2	0.6	1.0	0.5	0.5	0.0	0.4	0.2	0.5	0.2	0.0	4.5	0.8	0.8	0.9	0.4	4.3	2.5	1.4	0.0	0.0	0.0	0.3	1.7	5.9	6.6	0.2	0.0	0.0	0.6	34.6	5.7	0.4	1.1	0.0	0.7	0.0	1.7	1.3	0.0	8.0	0.6	0.0	1.7	0.0	0.8	0.5	1.6	0.0	0.4	2.2	0.6	0.0	2.0	1.1	2.7	0.5	15.6	0.0	0.8	0.3
MMP12	HME	ENSG00000262406	"Matrix metallopeptidase 12"	P39900	11	102862736-102875034	"Cancer-related genes, Enzymes, FDA approved drug targets, Predicted secreted proteins"		"Hydrolase, Metalloprotease, Protease"	"Cancer-related genes, FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"lymphoid tissue: 42.4;urinary bladder: 13.2"	"Cell type enriched"	"Detected in some"	5	"Extravillous trophoblasts: 80.4"	"Low cancer specificity"	"Detected in all"							"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	12	"BJ: 4.2;fHDF/TERT166: 14.6;hTEC/SVTERT24-B: 8.4"	"Not detected"	"Not detected"			"Not detected"	"Not detected"								"Secreted to extracellular matrix"	NA	NA						"unprognostic (7.33e-2)"	"unprognostic (3.20e-2)"	"unprognostic (1.00e-2)"	"unprognostic (1.03e-1)"	"unprognostic (2.74e-1)"	"unprognostic (1.67e-1)"	"prognostic unfavorable (1.42e-4)"	"unprognostic (1.69e-2)"	"unprognostic (7.31e-2)"	"unprognostic (1.52e-2)"	"unprognostic (1.52e-3)"	"unprognostic (5.45e-2)"	"unprognostic (3.05e-6)"	"unprognostic (1.08e-2)"	"unprognostic (4.66e-2)"	"unprognostic (1.73e-1)"	"unprognostic (6.92e-2)"	2.7	0.0	0.0	21.2	0.0	0.0	0.0	0.0	0.0	0.3	6.9	0.0	0.0	3.3	0.0	5.9	0.0	0.0	1.0	0.0	0.0		0.0	0.4	0.6	18.9	0.0	0.0	0.1	0.0	0.0	0.0	9.7	0.0	0.3	8.4	0.0	0.9	0.0	0.0	0.0	3.8	4.6	0.0	42.4	1.3	0.1	0.0	5.5	0.0	1.5	9.9	13.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.2	0.4	0.2	0.0	0.1	0.0	0.0	0.0	14.6	0.1	0.5	0.0	0.0	0.4	0.4	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.4	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.4	0.0	0.0	0.0	0.5	0.0	0.1	0.0	0.0	0.0	0.5	0.6	0.2	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0											0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	1.0	0.0	0.0	0.0	0.0	17.0	80.4	0.0	0.0	0.0	0.0	15.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.8	0.0	0.0	1.4
MMP13	CLG3	ENSG00000137745	"Matrix metallopeptidase 13"	P45452	11	102942995-102955734	"Cancer-related genes, Disease related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted secreted proteins"	"Collagen degradation"	"Hydrolase, Metalloprotease, Protease"	"Cancer-related genes, Disease mutation, Dwarfism, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"lung: 12.6;vagina: 10.8"	"Group enriched"	"Detected in some"	8	"Club cells: 30.7;Urothelial cells: 14.0"	"Cancer enhanced"	"Detected in many"		"head and neck cancer: 70.9"	"Not detected"	"Not detected"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Group enriched"	"Detected in some"	5	"HaCaT: 19.5;PC-3: 7.4"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			CAB002742	Supported				"Secreted to extracellular matrix"	NA	NA					"CAB002742: "	"unprognostic (8.98e-3)"	"unprognostic (1.54e-1)"	"unprognostic (4.75e-2)"	"unprognostic (4.57e-2)"	"unprognostic (3.05e-2)"	"unprognostic (1.59e-3)"		"unprognostic (1.32e-1)"	"unprognostic (6.35e-3)"	"unprognostic (1.69e-1)"	"unprognostic (7.55e-3)"	"unprognostic (2.24e-1)"	"unprognostic (1.73e-8)"	"unprognostic (2.12e-2)"	"unprognostic (3.14e-1)"	"unprognostic (4.14e-2)"	"unprognostic (4.33e-2)"	0.5	0.1	0.0	0.8	0.0	1.3	0.4	0.0	0.2	1.3	0.1	0.0	0.0	0.6	0.1	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.2	0.1	12.6	0.1	0.0	0.0	0.1	0.0	0.0	3.1	0.1	0.1	1.2	0.0	0.0	0.6	0.0	0.0	1.0	0.5	0.0	0.0	0.1	0.1	1.9	0.0	1.4	0.0	0.0	0.1	4.6	10.8	1.0	0.7	2.7	0.5	1.9	1.3	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.4	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.1	19.5	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.6	0.1	0.0	0.0	0.0	7.4	0.0	0.0	0.1	0.0	1.9	0.0	0.1	0.1	2.3	0.0	0.0	0.0	0.0	0.0	2.8	1.5	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	2.7	0.5	0.6	1.3	0.4	1.0	0.5	0.7	0.8	0.3	1.0	0.6	1.1	1.9	1.9	0.3	0.7	0.4	0.5	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	2.8	0.0	0.0	0.1	0.0	2.7	30.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	14.0
MMP14	MT1-MMP	ENSG00000157227	"Matrix metallopeptidase 14"	P50281	14	22836557-22849027	"Cancer-related genes, Disease related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"		"Hydrolase, Metalloprotease, Protease"	"Cancer-related genes, Disease mutation, FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"	8	"Extravillous trophoblasts: 216.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"ASC diff: 96.4;HHSteC: 91.2;HSkMC: 92.7;hTERT-RPE1: 91.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB009918, HPA051432"	Approved		Approved	"Intermediate filaments,Cytosol"		No	No		570000	Cytosol	"Intermediate filaments"	"CAB009918: AB_2250767, HPA051432: AB_2681484"	"unprognostic (1.34e-1)"	"unprognostic (1.37e-1)"	"unprognostic (1.11e-2)"	"unprognostic (2.81e-1)"	"unprognostic (4.28e-2)"	"unprognostic (1.12e-2)"	"unprognostic (3.05e-3)"	"unprognostic (5.91e-3)"	"unprognostic (1.95e-1)"	"prognostic unfavorable (9.48e-4)"	"unprognostic (3.82e-3)"	"unprognostic (7.31e-2)"	"prognostic unfavorable (1.34e-4)"	"unprognostic (5.02e-2)"	"unprognostic (6.69e-2)"	"unprognostic (1.00e-2)"	"unprognostic (3.41e-3)"	60.9	10.5	2.4	16.6	4.7	0.2	64.2	2.2	3.2	56.3	35.0	8.2	12.7	12.0	53.1	24.1	47.0	21.9	39.6	17.5	3.4	1.8	16.8	9.0	29.8	16.9	5.8	2.9	39.3	11.2	34.4	4.7	73.5	16.4	39.1	11.3	27.1	24.4	16.7	20.4	37.0	22.9	28.5	20.7	22.5	18.2	26.3	4.6	5.4	22.3	14.6	16.7	52.5	53.9	0.1	0.7	0.0	0.7	0.0	0.0	0.1	7.8	0.1	2.4	0.1	96.4	61.3	44.3	24.7	49.8	7.5	13.4	2.3	29.4	0.1	13.8	26.0	2.3	20.0	0.0	25.7	9.6	0.1	0.1	3.6	0.1	0.5	91.2	0.0	0.1	92.7	15.5	31.2	26.8	91.6	45.3	0.1	0.0	0.2	17.6	0.1	0.0	8.8	1.4	1.7	4.3	0.3	8.5	0.0	6.8	13.5	0.0	0.0	16.1	0.0	53.5	10.8	0.1	7.9	40.0	60.9	5.2	17.7	28.1	0.1	0.1	0.1	37.1	0.0	35.3	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	2.4	4.7	2.2	3.2	3.4	1.8	5.8	2.9	16.4	4.6	11.9	4.8	3.7	19.4	30.2	0.0	3.6	53.5	2.7	3.4	7.0	0.0	83.6	10.0	61.2	0.4	13.5	16.8	0.0	24.9	216.8	65.7	13.9	3.5	2.9	79.3	0.0	7.5	41.1	18.3	0.7	66.7	26.5	35.4	34.3	32.5	17.1	102.2	28.5	51.6	13.0	0.8	38.8	34.8	0.9	0.7	29.9	102.6	1.0	17.1	28.7
MMP15	"MT2-MMP, MTMMP2, SMCP-2"	ENSG00000102996	"Matrix metallopeptidase 15"	P51511	16	58025566-58046901	"Cancer-related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"		"Hydrolase, Metalloprotease, Protease"	"Cancer-related genes, FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 43.2"	"Cell type enhanced"	"Detected in many"	7	"Cholangiocytes: 56.0;Enterocytes: 81.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in single"	30	"plasmacytoid DC: 2.9"	"Lineage enriched"	"Detected in single"	30	"dendritic cells: 2.9"	"Cell line enhanced"	"Detected in many"		"BEWO: 37.1;Hep G2: 19.3;SK-BR-3: 18.6;WM-115: 30.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB002611, HPA040390"	Uncertain		Approved	"Nucleoplasm,Plasma membrane,Cytosol"		NA	NA			"Plasma membrane, Cytosol"	Nucleoplasm	"CAB002611: , HPA040390: AB_2676956"	"unprognostic (1.76e-2)"	"unprognostic (7.32e-2)"	"unprognostic (2.69e-1)"	"unprognostic (6.85e-2)"	"unprognostic (3.09e-1)"	"unprognostic (1.68e-1)"	"unprognostic (6.88e-3)"	"unprognostic (1.40e-1)"	"unprognostic (3.02e-2)"	"unprognostic (1.24e-2)"	"unprognostic (4.81e-2)"	"unprognostic (1.81e-1)"	"prognostic favorable (8.54e-8)"	"unprognostic (3.63e-2)"	"unprognostic (1.36e-1)"	"unprognostic (1.28e-1)"	"prognostic favorable (3.08e-4)"	5.9	2.3	2.0	5.5	3.0	0.1	7.7	3.7	7.2	3.3	19.5	4.2	16.3	22.6	2.9	1.7	2.5	3.6	15.9	17.6	2.3	3.7	8.4	26.4	6.1	2.0	2.5	2.2	2.1	10.3	7.3	5.2	28.5	10.4	3.6	8.2	9.5	4.7	14.7	3.4	2.3	43.2	3.4	3.4	5.2	14.7	28.0	2.1	1.1	26.8	2.5	2.2	3.3	4.2	0.0	2.9	0.0	0.0	0.0	0.0	0.0	5.7	4.4	2.3	11.9	2.4	0.1	37.1	0.5	0.3	2.1	0.5	3.5	14.9	0.0	7.0	0.6	1.6	8.1	2.0	1.7	0.6	0.0	3.9	0.0	1.9	19.3	3.1	0.1	7.7	1.2	3.1	0.3	0.9	3.3	1.4	3.3	4.8	0.0	0.7	2.9	0.2	0.9	6.8	17.0	1.2	2.9	0.3	3.1	6.5	2.1	0.6	4.1	7.7	18.6	3.5	5.5	2.0	3.1	1.3	0.1	3.7	1.4	0.5	0.0	0.0	0.1	0.7	0.9	30.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.9	0.0	0.0	2.0	3.0	3.7	7.2	2.3	3.7	2.5	2.2	10.4	2.1	17.9	11.8	0.9	1.0	2.3	1.9	19.3	56.0	5.3	9.1	17.4	15.7	33.4	1.7	33.5	2.2	6.0	81.1	0.0	10.5	19.6	2.8	1.6	0.0	29.0	10.2	1.6	10.9	19.6	3.5	4.8	0.9	0.1	1.7	0.0	31.8	1.7	13.5	40.7	3.2	5.4	1.4	0.0	0.8	0.9	4.9	1.9	40.5	1.5	28.3	1.4
MMP16	"C8orf57, DKFZp761D112, MT3-MMP"	ENSG00000156103	"Matrix metallopeptidase 16"	P51512	8	88032009-88328025	"Cancer-related genes, Enzymes, FDA approved drug targets, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins"	"Collagen degradation"	"Hydrolase, Metalloprotease, Protease"	"Cancer-related genes, FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 15.9"	"Cell type enhanced"	"Detected in some"	11	"Bipolar cells: 3.9;Early spermatids: 4.9;Fibroblasts: 9.9;Late spermatids: 4.7"	"Cancer enhanced"	"Detected in many"		"glioma: 4.8"	"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"AN3-CA: 20.4;HUVEC TERT2: 8.8;SH-SY5Y: 11.4;U-138 MG: 9.7;WM-115: 20.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA023693	Uncertain		Approved	Vesicles,Cytosol	"Secreted to extracellular matrix"	NA	NA			Cytosol	Vesicles	"HPA023693: AB_1854025"	"unprognostic (2.58e-1)"	"unprognostic (2.42e-2)"	"unprognostic (1.38e-1)"	"unprognostic (1.87e-1)"	"unprognostic (7.09e-2)"	"unprognostic (3.31e-2)"	"unprognostic (2.39e-3)"	"unprognostic (1.45e-3)"	"unprognostic (2.46e-1)"	"unprognostic (2.61e-1)"	"unprognostic (9.42e-2)"	"unprognostic (2.92e-1)"	"unprognostic (2.09e-8)"	"unprognostic (6.90e-3)"	"unprognostic (1.16e-1)"	"unprognostic (3.62e-1)"	"unprognostic (2.19e-3)"	2.4	1.3	11.0	1.4	6.8	0.5	4.9	8.3	15.9	5.3	2.2	2.9	0.7	0.8	4.9	2.1	1.7	2.1	7.3	2.7	8.7	6.9	0.8	0.9	1.0	1.0	5.5	9.1	3.3	2.1	1.5	1.7	3.0	6.3	3.2	1.7	0.6	1.2	2.4	0.7	1.1	1.3	4.0	4.6	1.5	1.4	1.5	5.5	0.0	3.2	0.7	1.0	2.6	3.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	5.5	20.4	0.7	1.4	0.0	7.5	1.1	2.1	1.3	0.0	0.0	0.0	0.0	3.3	1.2	0.0	4.0	0.0	2.6	0.0	2.4	0.0	0.0	0.0	1.7	0.0	0.3	1.0	0.0	3.1	0.9	3.8	8.8	0.0	0.0	0.7	1.1	0.0	0.0	0.0	1.2	0.0	2.0	0.2	0.4	0.0	0.4	0.0	0.1	11.4	0.0	0.0	0.1	1.6	0.8	0.0	4.9	9.7	5.5	0.1	2.8	0.0	0.0	0.0	3.9	0.0	20.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	11.0	6.8	8.3	14.1	8.7	6.9	5.5	9.1	6.3	5.5	0.0	0.0	0.0	0.0	1.0	3.9	0.6	0.0	0.0	0.0	0.0	2.0	0.0	1.7	0.0	4.9	2.9	0.0	0.0	0.0	0.0	9.9	0.0	0.0	0.0	0.3	1.6	0.0	0.6	0.0	4.7	0.9	0.6	1.7	0.0	0.0	3.2	0.2	0.0	1.1	0.0	0.3	0.0	1.3	0.0	0.9	0.1	0.0	0.0	0.0	0.0
MMP17	MT4-MMP	ENSG00000198598	"Matrix metallopeptidase 17"	Q9ULZ9	12	131828393-131851783	"Enzymes, FDA approved drug targets, Predicted intracellular proteins, Predicted secreted proteins"		"Hydrolase, Metalloprotease, Protease"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 23.3"	"Cell type enriched"	"Detected in some"	7	"Melanocytes: 27.0"	"Cancer enriched"	"Detected in many"	10	"melanoma: 29.9"	"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	9	"classical monocyte: 2.2;intermediate monocyte: 2.1;memory B-cell: 1.4;myeloid DC: 1.2;naive B-cell: 1.7;non-classical monocyte: 2.7"	"Group enriched"	"Detected in many"	9	"B-cells: 1.7;dendritic cells: 1.2;monocytes: 2.7"	"Group enriched"	"Detected in many"	4	"REH: 17.3;SK-MEL-30: 42.1;WM-115: 62.3"	"Group enriched"	"Detected in many"	5	"amygdala: 51.6;basal ganglia: 52.2;cerebral cortex: 70.8;hippocampal formation: 73.1;hypothalamus: 21.6"	"Low region specificity"	"Detected in all"								"Secreted to extracellular matrix"	NA	NA						"unprognostic (9.11e-2)"	"unprognostic (1.27e-2)"	"unprognostic (1.69e-2)"	"unprognostic (3.71e-3)"	"unprognostic (5.62e-2)"	"unprognostic (1.85e-2)"	"unprognostic (8.90e-3)"	"unprognostic (2.14e-2)"	"unprognostic (2.60e-1)"	"unprognostic (2.66e-4)"	"unprognostic (7.68e-2)"	"unprognostic (5.88e-2)"	"unprognostic (9.26e-10)"	"unprognostic (1.15e-2)"	"unprognostic (2.65e-1)"	"unprognostic (1.21e-3)"	"unprognostic (2.81e-2)"	4.6	2.0	12.6	3.0	23.3	6.2	2.5	1.4	21.5	5.6	3.0	3.1	0.0	1.4	4.2	0.9	2.1	2.1	7.0	1.1	22.5	10.1	0.5	0.5	1.8	5.5	3.7	7.6	9.0	5.0	3.1	0.7	1.1	2.2	1.6	0.8	1.6	8.5	2.5	1.6	9.7	1.9	1.7	1.6	4.8	1.4	2.9	3.5	0.0	0.8	1.5	1.6	2.8	2.8	1.7	1.2	0.2	2.7	0.1	0.0	1.1	0.1	5.3	0.2	0.5	4.3	1.7	0.1	2.7	6.7	2.6	2.7	0.0	1.5	0.0	2.2	4.2	1.6	2.3	2.2	2.5	0.5	0.0	0.3	0.9	1.9	0.0	5.3	0.0	3.8	2.6	0.7	3.7	0.9	1.0	3.5	0.0	1.0	0.1	3.3	4.7	0.1	4.0	2.4	1.6	3.2	17.3	0.0	2.0	0.0	0.0	2.3	0.7	0.3	0.9	42.1	0.7	4.9	10.0	2.7	0.7	0.7	3.8	0.3	0.0	0.0	0.0	1.4	0.5	62.3	0.1	2.2	0.0	0.0	2.1	0.0	1.4	0.0	0.0	1.2	1.7	0.0	0.0	0.2	0.1	2.7	0.0	0.0	1.1	12.6	23.3	1.4	17.9	22.5	10.1	3.7	7.6	2.2	3.5	0.0	0.0	0.0	0.1	2.3	0.5	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.2	0.1	1.0	0.2	0.0	0.0	0.6	3.2	0.0	1.3	4.0	0.0	0.9	0.4	27.0	0.0	0.0	0.2	0.0	0.0	1.8	0.3	0.0	0.0	1.0	0.5	0.4	1.0	0.0	0.0	0.0	0.1
MMP19	"MMP18, RASI-1"	ENSG00000123342	"Matrix metallopeptidase 19"	Q99542	12	55835433-55842966	"Disease related genes, Enzymes, FDA approved drug targets, Predicted secreted proteins"	"Angiogenesis, Collagen degradation, Differentiation"	"Developmental protein, Hydrolase, Metalloprotease, Protease"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adipose tissue: 60.7"	"Cell type enhanced"	"Detected in many"	8	"Extravillous trophoblasts: 42.0;Hofbauer cells: 31.2;Kupffer cells: 30.5;Macrophages: 48.2;monocytes: 38.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in single"			"Group enriched"	"Detected in some"	16	"classical monocyte: 3.2;myeloid DC: 1.0"	"Group enriched"	"Detected in many"	16	"dendritic cells: 1.0;monocytes: 3.2"	"Cell line enriched"	"Detected in many"	6	"BEWO: 57.2"	"Region enriched"	"Detected in single"	6	"olfactory region: 8.8"	"Low region specificity"	"Detected in all"			HPA070804			Approved	"Endoplasmic reticulum,Vesicles"	"Secreted to extracellular matrix"	NA	NA		800000	"Endoplasmic reticulum, Vesicles"		"HPA070804: AB_2686315"	"unprognostic (2.61e-1)"	"unprognostic (6.56e-2)"	"unprognostic (2.28e-2)"	"unprognostic (2.42e-1)"	"unprognostic (4.77e-3)"	"unprognostic (4.77e-3)"	"unprognostic (2.01e-2)"	"unprognostic (4.03e-2)"	"unprognostic (2.85e-2)"	"unprognostic (4.30e-2)"	"unprognostic (2.37e-1)"	"unprognostic (2.09e-1)"	"prognostic unfavorable (8.56e-9)"	"unprognostic (5.06e-3)"	"unprognostic (1.28e-3)"	"unprognostic (2.73e-2)"	"unprognostic (4.00e-2)"	60.7	1.9	0.2	10.9	0.7	0.0	9.9	0.2	0.5	7.6	3.9	0.4	1.4	0.8	12.7	6.0	3.6	11.8	30.3	4.7	0.6	0.1	4.1	3.0	14.0	15.5	0.5	0.2	7.4	8.1	0.0	0.5	24.5	1.0	2.9	2.8	3.1	2.0	3.5	2.1	2.7	4.1	7.7	0.8	27.4	5.0	2.9	0.2	2.7	3.3	1.8	7.1	5.9	3.5	0.0	1.0	0.1	3.2	0.0	0.0	0.6	0.8	0.0	0.0	0.0	6.3	8.1	57.2	6.0	7.1	2.5	2.9	0.3	0.2	0.0	0.0	8.4	0.1	0.0	0.0	1.8	3.4	0.3	0.0	0.0	0.0	0.1	5.2	0.0	0.2	8.4	0.2	1.5	1.6	3.0	0.4	0.0	0.1	0.0	8.2	0.0	0.0	0.0	0.2	0.0	0.0	0.0	1.4	0.0	1.1	2.9	0.0	0.0	0.1	0.0	0.0	0.6	0.0	0.1	9.7	1.5	3.3	0.0	0.2	0.0	0.0	0.0	4.5	0.0	0.0	0.0	3.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.6	0.2	0.7	0.2	0.5	0.6	0.1	0.5	0.2	1.0	0.2	0.0	5.8	0.9	0.2	6.4	0.5	0.6	5.1	2.7	5.7	0.0	3.9	14.4	0.0	0.3	0.4	2.1	0.0	0.0	0.4	42.0	24.0	0.4	2.3	0.5	31.2	0.0	0.0	4.9	30.5	0.4	5.5	48.2	11.8	38.7	0.0	0.3	0.1	0.0	4.9	0.0	1.7	0.0	9.6	0.0	0.2	3.8	15.7	0.0	0.0	0.1
MMP2	"CLG4, CLG4A, TBE-1"	ENSG00000087245	"Matrix metallopeptidase 2"	P08253	16	55389700-55506691	"Cancer-related genes, Candidate cardiovascular disease genes, Disease related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"	"Angiogenesis, Collagen degradation"	"Hydrolase, Metalloprotease, Protease"	"Cancer-related genes, Disease mutation, FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"	11	"Extravillous trophoblasts: 217.4;Fibroblasts: 249.9;Leydig cells: 315.0;Peritubular cells: 393.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"ASC diff: 292.5;ASC TERT1: 85.2;hTERT-RPE1: 329.2;U-87 MG: 93.1"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA001939, CAB002788"	Approved		Approved	Vesicles	"Secreted to extracellular matrix"	NA	NA	1600000000	160000000	Vesicles		"CAB002788: , HPA001939: AB_1079395"	"unprognostic (7.26e-2)"	"unprognostic (1.36e-3)"	"unprognostic (1.66e-1)"	"unprognostic (2.14e-3)"	"unprognostic (5.03e-2)"	"unprognostic (1.20e-1)"	"unprognostic (1.74e-1)"	"unprognostic (9.36e-3)"	"unprognostic (4.81e-3)"	"unprognostic (3.79e-2)"	"unprognostic (4.59e-3)"	"unprognostic (6.12e-2)"	"unprognostic (1.28e-3)"	"unprognostic (1.59e-2)"	"unprognostic (8.00e-2)"	"unprognostic (8.98e-2)"	"unprognostic (4.63e-2)"	197.5	9.0	1.2	13.2	1.6	0.0	136.4	0.8	1.4	74.3	74.4	2.4	36.9	5.6	85.0	123.0	52.3	25.7	115.4	54.0	0.9	0.5	9.4	3.5	38.9	3.9	1.5	1.1	71.0	6.5	0.7	2.2	58.9	2.2	66.8	18.7	36.4	18.6	20.4	68.6	68.2	22.6	57.1	1.8	12.4	20.5	57.0	1.1	1.3	20.6	31.8	9.1	84.1	105.3	0.0	0.0	0.9	0.7	0.0	0.0	0.0	0.3	0.1	9.7	0.1	292.5	85.2	15.9	25.0	57.5	5.0	4.0	0.0	0.1	0.0	20.1	44.1	1.9	2.7	0.0	0.2	2.9	0.0	0.0	0.0	0.6	0.1	27.7	0.0	0.7	72.6	0.0	26.0	0.2	329.2	32.7	0.0	0.0	0.1	16.8	0.0	0.0	0.3	7.7	0.0	0.0	0.0	2.3	0.0	0.8	0.3	0.1	17.6	4.6	0.0	0.1	45.4	0.0	1.7	45.9	79.6	7.6	15.2	3.2	0.0	0.0	0.0	93.1	1.3	14.5	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.2	0.0	0.0	0.0	1.2	1.6	0.8	1.4	0.9	0.5	1.5	1.1	2.2	1.1	0.0	0.3	0.0	13.0	108.4	5.2	3.1	0.0	0.0	3.4	10.4	0.0	5.4	0.0	1.7	11.5	11.9	0.0	0.0	0.3	217.4	249.9	2.7	0.0	0.0	25.6	1.6	27.1	15.4	0.0	26.9	315.0	5.3	121.4	0.0	0.0	5.0	6.9	0.0	393.8	0.0	1.8	12.9	70.0	1.2	2.1	89.5	14.4	0.0	0.0	3.8
MMP20		ENSG00000137674	"Matrix metallopeptidase 20"	O60882	11	102576835-102625332	"Disease related genes, Enzymes, FDA approved drug targets, Predicted secreted proteins"		"Hydrolase, Metalloprotease, Protease"	"Amelogenesis imperfecta, FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in some"		"lymphoid tissue: 1.0;testis: 3.5"	"Cell type enriched"	"Detected in some"	10	"Early spermatids: 66.1"	"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	7	"OE19: 7.4"	"Not detected"	"Not detected"			"Not detected"	"Not detected"								"Secreted to extracellular matrix"	NA	NA						"unprognostic (4.62e-3)"		"unprognostic (2.61e-2)"	"unprognostic (1.68e-3)"		"unprognostic (1.75e-1)"		"unprognostic (2.13e-1)"		"unprognostic (3.06e-1)"	"unprognostic (2.97e-2)"	"unprognostic (6.75e-2)"	"unprognostic (9.58e-5)"	"unprognostic (6.10e-2)"		"unprognostic (2.35e-1)"		0.0	0.0	0.0	0.3	0.0	0.0	0.8	0.0	0.0	0.0	0.0			0.2	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.5	0.0	0.0	0.2	0.0		0.0	0.0	0.0	0.0	0.0		0.0	0.0		0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.5			0.0		1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	1.1	0.0	0.2	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0											0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	66.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.6	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	6.5	0.0	0.0	0.3	0.0	0.5	0.0	0.0	0.5
MMP21		ENSG00000154485	"Matrix metallopeptidase 21"	Q8N119	10	125766453-125775821	"Disease related genes, Enzymes, FDA approved drug targets, Predicted secreted proteins"		"Hydrolase, Metalloprotease, Protease"	"FDA approved drug targets, Heterotaxy"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enriched"	"Detected in some"	13	"epididymis: 37.6"	"Cell type enhanced"	"Detected in single"	32	"Distal tubular cells: 1.7"	"Not detected"	"Not detected"							"Cell type enhanced"	"Detected in single"		"naive B-cell: 1.1"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in some"		"BEWO: 1.1;NB-4: 1.2;U-266/70: 2.1;U-266/84: 1.8"	"Not detected"	"Not detected"												"Secreted to extracellular matrix"	NA	NA						"unprognostic (1.32e-2)"	"unprognostic (1.28e-1)"	"unprognostic (8.51e-2)"	"unprognostic (2.19e-2)"	"unprognostic (4.02e-2)"	"unprognostic (2.21e-2)"	"unprognostic (4.22e-3)"	"unprognostic (1.01e-1)"	"unprognostic (2.12e-1)"	"unprognostic (1.48e-1)"	"unprognostic (2.89e-2)"	"unprognostic (3.62e-2)"	"unprognostic (9.70e-8)"	"unprognostic (1.30e-2)"	"unprognostic (7.69e-2)"	"unprognostic (7.00e-2)"	"unprognostic (2.18e-1)"	0.2	0.1	0.1	0.1	0.4	0.1	0.3	0.7	0.0	0.1	0.2			0.1	0.1	37.6	0.1	0.4	0.2	0.9	0.0	0.4	0.1	1.0	0.1	0.1	0.0		2.8	0.8	0.0	0.3	0.0		0.6	0.1		0.5	0.1	0.0	0.1	0.5	0.1	0.0	0.7	0.2	0.1			0.6		0.1	0.2	0.0	1.1	0.0	0.0	0.1	0.5	0.6	0.0	0.1	0.0	0.0	0.8	0.3	0.0	1.1	0.2	0.1	0.0	0.0	0.0	0.1	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.7	0.7	0.5	0.0	0.0	0.2	0.2	0.1	0.0	0.3	0.0	0.0	0.2	0.0	0.1	0.0	0.1	0.0	0.0	0.0	1.2	0.1	0.0	0.0	0.1	0.0	0.5	0.0	0.0	0.1	0.1	0.2	0.3	0.0	0.1	0.0	0.1	0.0	0.0	0.3	0.7	0.0	2.1	1.8	0.0	0.2	0.1	0.0	0.0	0.1	0.0	0.0	0.1	0.1	0.0	0.6	0.0	0.0	1.1	0.0	0.4	0.0	0.5	0.0	0.0	0.0	0.0											0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0
MMP23B	"MIFR, MIFR-1, MMP22"	ENSG00000189409	"Matrix metallopeptidase 23B"	O75900	1	1632095-1635263	"Enzymes, FDA approved drug targets, Predicted intracellular proteins"		"Hydrolase, Metalloprotease, Protease"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"ovary: 51.8"	"Group enriched"	"Detected in many"	6	"Fibroblasts: 124.0;Leydig cells: 90.9;Peritubular cells: 167.3"	"Cancer enhanced"	"Detected in single"		"ovarian cancer: 0.8"	"Not detected"	"Not detected"			"Cell type enriched"	"Detected in some"	5	"plasmacytoid DC: 12.3"	"Lineage enriched"	"Detected in many"	5	"dendritic cells: 12.3"	"Cell line enhanced"	"Detected in some"		"AN3-CA: 3.4;HHSteC: 8.3;NTERA-2: 3.6;PC-3: 3.6;U-266/70: 6.5"	"Region enriched"	"Detected in some"	5	"cerebellum: 8.7"	"Not detected"	"Not detected"									NA	NA						"unprognostic (2.19e-2)"	"unprognostic (6.31e-2)"	"unprognostic (6.70e-3)"	"unprognostic (1.29e-1)"	"unprognostic (3.99e-2)"	"unprognostic (9.31e-2)"	"unprognostic (6.94e-2)"	"unprognostic (1.20e-1)"	"unprognostic (8.06e-2)"	"unprognostic (8.37e-2)"	"unprognostic (2.22e-1)"	"unprognostic (2.33e-1)"	"unprognostic (2.26e-11)"	"unprognostic (1.60e-3)"	"unprognostic (1.36e-1)"	"unprognostic (2.44e-2)"	"unprognostic (6.66e-2)"	4.7	2.4	0.3	3.9	0.3	2.1	2.3	0.5	0.4	19.6	3.2	0.1	4.2	3.9	17.3	20.1	4.7	6.4	28.5	14.4	0.2	0.3	3.6	2.3	11.0	3.3	0.1	0.0	51.8	0.7	0.0	3.1	10.5	0.1	32.1	0.2	1.2	1.4	6.3	0.9	2.5	2.7	11.7	0.2	4.1	4.3	13.5	0.0	0.4	1.2	0.9	2.8	13.9	7.0	0.2	12.3	0.1	0.2	2.2	1.8	1.3	1.0	0.0	0.3	3.4	0.0	0.0	1.7	0.0	0.0	0.2	0.0	0.7	1.0	0.2	0.8	0.0	0.0	0.1	0.0	0.0	0.0	0.7	2.6	1.0	0.3	2.2	8.3	0.4	0.5	0.2	0.0	0.0	0.0	0.1	0.0	0.4	0.3	0.3	0.0	0.9	0.0	0.6	3.6	0.0	3.6	1.3	0.1	1.6	0.0	0.1	0.6	0.2	0.5	0.0	0.2	0.1	1.0	0.0	0.7	0.5	0.3	0.7	0.0	6.5	0.3	1.1	0.1	0.4	0.3	0.0	0.2	0.0	1.8	0.0	1.1	0.0	0.4	1.1	0.0	0.2	0.1	0.9	0.1	2.2	0.1	12.3	0.2	1.3	0.3	0.3	0.5	0.4	0.2	0.3	0.1	0.0	0.1	0.0	0.0	0.3	0.0	0.9	11.8	1.1	9.0	2.5	0.0	0.0	1.8	0.0	2.7	0.0	0.8	0.8	1.5	1.7	0.0	0.5	1.6	124.0	0.4	0.0	1.0	5.1	3.2	2.9	20.9	1.5	3.2	90.9	1.0	18.6	1.0	1.7	0.8	3.4	0.0	167.3	0.6	5.7	0.0	8.2	1.6	10.7	13.8	8.6	9.2	1.2	0.7
MMP24	MT5-MMP	ENSG00000125966	"Matrix metallopeptidase 24"	Q9Y5R2	20	35226654-35277000	"Enzymes, FDA approved drug targets, Predicted membrane proteins, Predicted secreted proteins"	"Cell adhesion"	"Hydrolase, Metalloprotease, Protease"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	4	"brain: 38.5"	"Cell type enhanced"	"Detected in some"	10	"Alveolar cells type 1: 14.9;Cholangiocytes: 12.7;Ductal cells: 7.5;Horizontal cells: 14.3;Proximal tubular cells: 7.3"	"Low cancer specificity"	"Detected in many"			"Region enriched"	"Detected in all"	5	"cerebellum: 38.5"	"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"A549: 20.1;CACO-2: 30.6;EFO-21: 9.0;RPTEC TERT1: 13.8;U-2 OS: 10.4"	"Low region specificity"	"Detected in all"			"Region enriched"	"Detected in all"	4	"cerebellum: 91.3"	"HPA049280, HPA078816"	Approved		Approved	"Nucleoli,Plasma membrane"	"Secreted to extracellular matrix"	Yes	No			"Nucleoli, Plasma membrane"		"HPA049280: , HPA078816: "	"unprognostic (1.52e-3)"	"unprognostic (1.36e-1)"	"unprognostic (1.18e-1)"	"unprognostic (4.51e-4)"	"unprognostic (2.47e-2)"	"unprognostic (7.61e-3)"	"unprognostic (1.22e-1)"	"unprognostic (4.59e-2)"	"unprognostic (2.32e-2)"	"unprognostic (8.82e-2)"	"unprognostic (9.20e-3)"	"unprognostic (7.12e-2)"	"prognostic favorable (8.17e-11)"	"unprognostic (3.32e-2)"	"unprognostic (5.63e-2)"	"unprognostic (1.69e-2)"	"unprognostic (9.90e-4)"	1.6	1.3	4.0	0.4	7.8	0.6	0.4	38.5	8.9	0.7	0.3	1.3	0.2	2.8	1.6	0.9	0.2	2.8	0.6	1.0	2.7	3.2	8.6	0.9	6.1	0.3	1.8	1.5	0.9	8.0	0.0	3.8	0.6	1.7	2.2	0.1	0.5	0.4	6.0	0.2	1.5	1.7	2.5	0.9	0.6	0.7	0.4	1.4	0.2	0.8	0.2	0.2	0.5	0.2	0.8	0.4	2.2	0.8	0.6	1.2	0.3	0.3	20.1	0.0	0.1	0.1	0.0	0.6	1.1	1.3	2.1	1.1	30.6	5.4	0.0	9.0	1.4	0.7	0.3	4.7	0.0	0.9	0.1	0.2	1.1	0.6	0.3	0.0	0.0	0.2	0.1	0.1	0.1	0.0	0.6	0.0	0.1	0.0	0.3	0.2	0.2	0.1	0.1	7.7	0.0	1.4	0.0	0.1	0.0	13.8	0.1	8.0	5.5	1.4	0.5	0.2	1.8	0.3	0.1	0.3	4.3	10.4	1.0	0.4	0.1	0.1	0.0	0.9	0.1	0.6	1.0	0.6	0.1	1.0	0.7	1.2	0.6	0.7	0.8	0.4	0.8	0.6	0.6	2.2	0.6	0.8	0.2	0.0	0.3	4.0	7.8	38.5	5.3	2.7	3.2	1.8	1.5	1.7	1.4	14.9	1.0	0.0	0.1	0.1	3.6	0.6	12.7	0.0	2.3	1.8	0.0	0.0	5.0	7.5	0.6	0.7	0.3	0.0	0.8	0.1	0.2	0.4	0.0	0.2	0.0	14.3	0.0	0.0	0.3	0.0	0.3	0.0	1.7	0.0	0.0	0.2	2.1	0.0	0.0	7.3	0.3	0.0	0.2	0.0	0.0	0.3	0.0	0.0	0.0	0.0
MMP25	"MMP20, MMPL1, MT6-MMP"	ENSG00000008516	"Matrix metallopeptidase 25"	Q9NPA2	16	3046681-3060726	"Enzymes, FDA approved drug targets, Predicted intracellular proteins, Predicted secreted proteins"		"Hydrolase, Metalloprotease, Protease"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 17.6;bone marrow: 25.6;lymphoid tissue: 54.1"	"Group enriched"	"Detected in some"	4	"Alveolar cells type 2: 10.7;Kupffer cells: 5.9;monocytes: 23.4"	"Cancer enhanced"	"Detected in many"		"testis cancer: 7.1"	"Low region specificity"	"Detected in some"			"Group enriched"	"Detected in some"	6	"basophil: 10.2;eosinophil: 6.0;neutrophil: 17.6"	"Lineage enriched"	"Detected in many"	10	"granulocytes: 17.6"	"Cell line enriched"	"Detected in some"	12	"HMC-1: 50.5"	"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in many"			"CAB025177, HPA055640"	Uncertain		Supported	"Plasma membrane"	"Secreted to blood"	NA	NA			"Plasma membrane"		"CAB025177: , HPA055640: "	"unprognostic (4.51e-3)"	"unprognostic (9.28e-3)"	"unprognostic (7.57e-2)"	"unprognostic (2.95e-3)"	"unprognostic (2.26e-1)"	"prognostic favorable (1.09e-5)"	"unprognostic (1.36e-1)"	"unprognostic (7.39e-3)"	"unprognostic (7.63e-3)"	"unprognostic (2.29e-2)"	"unprognostic (1.51e-1)"	"unprognostic (2.53e-2)"	"unprognostic (2.37e-3)"	"unprognostic (1.17e-2)"	"unprognostic (8.30e-2)"	"unprognostic (4.01e-1)"	"unprognostic (2.02e-1)"	4.0	0.3	0.6	12.3	0.4	25.6	0.8	0.5	0.6	0.8	1.1	0.2	0.0	1.0	0.4	0.5	0.8	3.8	1.1	2.8	0.5	0.4	0.7	2.5	10.7	54.1	1.8	0.0	0.6	0.8	0.0	0.5	2.0	1.1	0.6	1.0	1.0	0.9	0.0	2.4	0.6	1.8	0.5	0.4	43.9	1.1	0.7	0.5	4.1	0.7	0.9	4.2	1.5	2.5	0.0	0.3	17.6	0.2	1.7	0.5	0.1	0.2	0.1	0.7	1.5	0.0	0.0	0.2	0.2	0.0	0.0	0.0	0.0	0.3	0.3	0.2	0.0	0.3	0.6	0.3	0.0	0.0	4.0	0.8	0.1	0.1	0.0	0.0	0.1	50.5	0.0	0.0	0.0	0.0	0.2	0.0	0.2	0.1	0.3	0.0	0.5	0.2	3.0	1.4	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.3	0.0	0.0	0.1	0.3	3.6	0.1	0.1	0.4	0.1	0.0	1.2	0.1	0.1	0.0	1.0	0.1	10.2	0.2	6.0	0.3	0.0	0.5	0.0	0.2	0.2	0.0	0.0	0.3	0.2	17.6	1.7	0.0	0.3	0.3	0.1	0.6	0.4	0.5	0.6	0.5	0.4	1.8	0.0	1.1	0.5	3.0	10.7	0.0	0.2	0.3	0.6	0.4	0.0	0.0	1.2	1.8	0.0	0.0	0.0	0.4	0.0	0.0	0.3	0.0	0.5	0.1	0.2	0.5	1.1	0.0	0.1	0.0	0.0	0.0	5.9	0.0	0.0	2.0	0.0	23.4	0.0	0.1	1.1	0.0	0.7	0.0	0.0	0.0	0.4	0.0	0.1	0.3	0.0	3.1	0.1	0.1
MMP26	"endometase, MGC126590, MGC126592"	ENSG00000167346	"Matrix metallopeptidase 26"	Q9NRE1	11	4704927-4992429	"Enzymes, FDA approved drug targets, Predicted secreted proteins"	"Collagen degradation"	"Hydrolase, Metalloprotease, Protease"	"FDA approved drug targets"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enriched"	"Detected in some"	13	"endometrium 1: 19.1"	"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	20	"endometrial cancer: 8.8;prostate cancer: 2.0"					"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"																"Secreted to extracellular matrix"	NA	NA									"unprognostic (4.21e-3)"								"unprognostic (2.63e-1)"						0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0			0.0	19.1	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0		0.0	0.0	0.0	0.0	0.0		1.4	0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3			0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0											0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
MMP27		ENSG00000137675	"Matrix metallopeptidase 27"	Q9H306	11	102691487-102705806	"Enzymes, FDA approved drug targets, Predicted intracellular proteins"	"Collagen degradation"	"Hydrolase, Metalloprotease, Protease"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in many"		"breast: 10.4;tongue: 10.0"	"Cell type enriched"	"Detected in single"	5	"Suprabasal keratinocytes: 1.1"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell type enriched"	"Detected in single"	7	"neutrophil: 1.0"	"Lineage enriched"	"Detected in single"	7	"granulocytes: 1.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA069097	Approved				"Intracellular and membrane"	NA	NA					"HPA069097: AB_2686085"	"unprognostic (3.99e-2)"	"unprognostic (2.37e-4)"				"unprognostic (1.25e-3)"			"unprognostic (1.63e-1)"					"unprognostic (4.60e-1)"				3.2	0.0	0.0	0.0	0.5	2.4	10.4	0.0	0.0	1.5	0.8	0.0	0.0	0.3	0.9	4.7	0.8	0.1	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.6	0.0	5.1	0.0	0.8	5.4	2.6	2.0	0.0	0.1	0.4	0.4	0.0	0.9	0.1	10.0	2.2	0.4	0.3	0.0	0.0	1.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	1.1	0.0	0.0	0.0	0.0
MMP28	"EPILYSIN, MM28, MMP-25, MMP-28"	ENSG00000271447	"Matrix metallopeptidase 28"	Q9H239	17	35756249-35795707	"Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"		"Hydrolase, Metalloprotease, Protease"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"	6	"Basal keratinocytes: 34.2;Enterocytes: 39.1;Mucus-secreting cells: 31.9;Paneth cells: 47.6;Urothelial cells: 34.5"	"Low cancer specificity"	"Detected in many"							"Cell type enhanced"	"Detected in many"		"naive CD4 T-cell: 7.2;naive CD8 T-cell: 5.9"	"Lineage enriched"	"Detected in many"	5	"T-cells: 7.2"	"Cell line enriched"	"Detected in some"	7	"HaCaT: 28.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA057288, HPA057890"			Approved	"Nucleoplasm,Focal adhesion sites"	"Secreted to extracellular matrix"	NA	NA			Nucleoplasm	"Focal adhesion sites"	"HPA057288: , HPA057890: "	"unprognostic (7.99e-3)"	"unprognostic (3.27e-1)"	"unprognostic (2.20e-1)"	"unprognostic (1.01e-1)"	"unprognostic (7.52e-2)"	"unprognostic (1.63e-1)"	"unprognostic (6.90e-2)"	"unprognostic (1.09e-2)"	"unprognostic (1.51e-1)"	"unprognostic (1.99e-1)"	"prognostic unfavorable (6.28e-6)"	"unprognostic (9.37e-2)"	"unprognostic (1.31e-1)"	"unprognostic (8.87e-2)"	"unprognostic (1.74e-1)"	"unprognostic (1.76e-2)"	"unprognostic (3.27e-3)"	8.0	1.6	1.8	2.7	3.7	0.5	4.3	0.0	5.1	1.7	7.3	1.6	1.4	3.0	3.2	4.8	4.3	1.5	12.3	0.5	2.8		0.8	0.2	10.3	0.4	0.0	2.9	0.1	1.3	0.5	0.0	0.7	1.3	2.9	4.1	2.7	0.1	2.1	0.6	4.5	9.3	4.3	0.2	0.6	7.2	13.4	0.2	0.0	4.2	4.4	2.5	5.5	2.2	1.1	1.5	0.1	0.2	1.3	7.2	0.9	0.1	0.5	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	3.0	0.1	0.7	0.0	0.1	28.7	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	1.1	0.0	0.0	0.0	2.6	0.0	0.1	0.0	0.2	0.2	0.0	0.1	0.0	0.2	0.1	0.2	0.0	3.9	0.2	0.6	0.0	0.0	0.0	1.6	0.2	0.5	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.1	2.0	1.1	0.4	1.7	0.1	0.9	7.2	5.9	0.1	1.3	0.2	1.5	0.0	0.9											26.8	20.8	0.0	5.1	34.2	0.4	1.0	2.5	5.3	5.7	7.0	0.0	0.0	0.0	0.1	5.0	8.1	39.1	0.0	0.3	0.0	1.6	1.8	0.0	0.0	0.1	1.6	3.5	6.2	0.0	7.1	1.1	0.9	3.3	0.0	31.9	9.1	9.7	47.6	2.8	0.7	0.5	6.5	2.0	0.5	2.5	29.0	0.0	0.7	18.5	34.5
MMP3	"STMY, STMY1"	ENSG00000149968	"Matrix metallopeptidase 3"	P08254	11	102835801-102843803	"Cancer-related genes, Candidate cardiovascular disease genes, Disease related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"	"Collagen degradation"	"Hydrolase, Metalloprotease, Protease"	"Cancer-related genes, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"epididymis: 177.5;salivary gland: 73.4"	"Cell type enhanced"	"Detected in some"	10	"Basal glandular cells: 11.5;Basal keratinocytes: 7.4;Club cells: 11.4;Early spermatids: 14.6"	"Cancer enhanced"	"Detected in many"		"head and neck cancer: 59.9"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	17	"BJ: 101.3;BJ hTERT+: 275.6;fHDF/TERT166: 119.3"					"Low region specificity"	"Detected in many"			HPA007875	Uncertain		Supported	Vesicles	"Secreted to extracellular matrix"	NA	NA	2540000	170000	Vesicles		"HPA007875: AB_1079396"	"unprognostic (2.27e-1)"	"prognostic unfavorable (9.73e-4)"	"unprognostic (1.63e-3)"	"unprognostic (5.11e-3)"	"unprognostic (3.78e-1)"	"unprognostic (5.11e-2)"	"unprognostic (5.26e-6)"	"unprognostic (3.46e-2)"	"unprognostic (7.14e-2)"	"unprognostic (2.87e-1)"	"prognostic unfavorable (4.09e-4)"	"unprognostic (3.26e-2)"	"unprognostic (1.22e-15)"	"unprognostic (3.17e-1)"	"unprognostic (1.55e-1)"	"unprognostic (3.43e-2)"	"unprognostic (2.34e-1)"	19.1	0.0	0.2	14.4	0.3	0.0	6.9	0.2	0.5	0.2	1.5	0.3	0.2	1.8	28.3	177.5	0.2	0.0	1.4	0.2	0.2	0.0	0.3	0.5	0.4	0.2	0.2	0.2	0.3	0.2	0.0	0.2	0.2	0.2	1.2	1.7	0.2	73.4	1.5	7.3	12.6	0.7	5.9	0.2	0.2	2.8	1.4	0.2	0.2	0.6	1.5	0.9	7.5	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	101.3	275.6	1.8	0.5	0.0	0.0	0.0	0.0	119.3	6.8	0.0	0.0	0.0	3.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	8.1	0.4	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	9.4	0.8	0.1	0.0	0.0	0.0	0.0	3.9	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.3	0.2	0.5	0.2	0.0	0.2	0.2	0.2	0.2	3.0	0.0	0.0	11.5	7.4	0.0	0.2	5.1	0.0	11.4	0.0	0.0	0.1	0.0	0.7	14.6	0.0	0.0	0.0	1.2	2.2	1.3	0.6	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	2.3	0.6	0.0	0.0	0.0	0.0	1.0	0.0	0.9	3.0	0.2	0.0	0.1	5.2
MMP7	"MPSL1, PUMP-1"	ENSG00000137673	"Matrix metallopeptidase 7"	P09237	11	102520508-102530753	"Cancer-related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted secreted proteins"	"Collagen degradation"	"Hydrolase, Metalloprotease, Protease"	"Cancer-related genes, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"gallbladder: 93.0;kidney: 129.5;salivary gland: 79.3"	"Cell type enriched"	"Detected in many"	6	"Ductal cells: 5335.6"	"Cancer enhanced"	"Detected in all"		"pancreatic cancer: 352.1"	"Region enriched"	"Detected in single"	5	"pons and medulla: 1.3"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"A549: 23.2;CAPAN-2: 129.5;EFO-21: 30.7;RPTEC TERT1: 56.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"CAB025869, HPA051358"	Supported		Approved	Nucleoplasm,Vesicles	"Secreted to extracellular matrix"	NA	NA	2810000		"Nucleoplasm, Vesicles"		"CAB025869: , HPA051358: AB_2681452"	"unprognostic (1.06e-3)"	"unprognostic (9.51e-2)"	"unprognostic (4.15e-2)"	"unprognostic (1.38e-1)"	"unprognostic (7.70e-3)"	"unprognostic (7.28e-2)"	"prognostic unfavorable (2.53e-4)"	"prognostic unfavorable (3.38e-4)"	"unprognostic (3.96e-2)"	"unprognostic (5.63e-2)"	"unprognostic (6.59e-3)"	"unprognostic (1.51e-1)"	"unprognostic (6.36e-3)"	"unprognostic (1.42e-2)"	"unprognostic (5.54e-2)"	"unprognostic (1.48e-1)"	"unprognostic (1.46e-1)"	6.8	0.2	0.2	1.2	0.2	0.0	28.8	0.2	0.2	5.2	0.2	0.2	2.1	0.0	17.2	12.3	3.3	16.4	93.0	0.2	0.2	0.2	129.5	1.4	5.0	0.9	0.2	0.2	3.9	23.5	0.0	0.7	2.7	1.3	42.0	0.0	0.2	79.3	6.7	0.2	7.8	0.3	0.5	0.2	0.2	0.9	9.4	0.2	1.2	0.3	1.4	4.5	19.9	0.8	0.8	0.0	0.0	0.0	0.0	0.0	0.1	0.0	23.2	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.3	129.5	0.0	30.7	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.8	0.0	0.0	0.0	0.0	56.0	0.1	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.1	0.4	0.0	0.2	0.0	0.0	0.0	0.1	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.2	0.2	0.2	0.2	0.2	0.2	0.2	1.3	0.2	80.4	30.5	0.0	310.5	0.9	0.0	0.6	119.8	113.8	646.0	964.8	0.0	0.3	0.0	5335.6	3.9	0.3	0.0	0.0	184.1	0.2	0.4	323.2	2.3	0.0	103.8	0.0	0.0	0.0	0.0	6.5	10.9	7.3	0.0	113.6	0.0	0.0	723.2	0.0	0.0	6.0	0.0	0.0	0.4	0.0	0.1	2.0	0.7	0.0	0.0	640.3
MMP8	CLG1	ENSG00000118113	"Matrix metallopeptidase 8"	P22894	11	102711795-102727050	"Cancer-related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"	"Collagen degradation"	"Hydrolase, Metalloprotease, Protease"	"Cancer-related genes, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	6	"bone marrow: 119.3"	"Cell type enriched"	"Detected in single"	32	"Hofbauer cells: 4.3"	"Cancer enriched"	"Detected in single"	17	"melanoma: 5.7"	"Region enhanced"	"Detected in single"		"cerebral cortex: 1.7"	"Group enriched"	"Detected in some"	32	"neutrophil: 1.4;non-classical monocyte: 4.9"	"Group enriched"	"Detected in many"	32	"granulocytes: 1.4;monocytes: 4.9"	"Cell line enriched"	"Detected in some"	8	"WM-115: 40.1"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA021221, HPA022935"	Enhanced				"Secreted to extracellular matrix"	NA	NA		83000			"HPA021221: AB_1854043, HPA022935: AB_1854044"	"unprognostic (3.03e-1)"	"unprognostic (8.49e-5)"	"unprognostic (1.08e-2)"	"unprognostic (3.95e-3)"	"unprognostic (1.80e-1)"	"unprognostic (1.01e-2)"		"unprognostic (7.68e-3)"	"unprognostic (1.27e-1)"	"unprognostic (4.92e-2)"	"unprognostic (6.64e-3)"		"unprognostic (2.45e-6)"	"unprognostic (2.33e-4)"	"unprognostic (1.33e-1)"	"unprognostic (4.97e-1)"	"unprognostic (2.30e-2)"	1.9	0.1	0.2	0.2	0.4	119.3	0.3	0.1	1.7	0.1	0.2	0.0	0.0	0.1	0.6	0.1	0.1	0.1	0.1	9.0	0.2	0.3	0.4	0.8	12.6	2.6	0.3	0.0	0.9	0.9	0.1	0.6	1.4	0.2	0.1	0.1	0.1	0.3	0.1	0.6	0.3	0.1	0.2	0.3	18.7	0.2	0.1	0.1	5.2	1.9	0.0	0.1	0.2	7.6	0.0	0.0	1.4	4.9	0.0	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.1	0.0	0.0	0.0	0.0	2.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	40.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.0	4.9	0.0	0.0	1.7	0.2	0.4	0.1	1.7	0.2	0.3	0.3	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
MMP9	CLG4B	ENSG00000100985	"Matrix metallopeptidase 9"	P14780	20	46008908-46016561	"Cancer-related genes, Candidate cardiovascular disease genes, Disease related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted secreted proteins"	"Collagen degradation"	"Hydrolase, Metalloprotease, Protease"	"Cancer-related genes, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	6	"adipose tissue: 64.0;blood: 63.2;bone marrow: 89.4;lymphoid tissue: 80.1"	"Cell type enhanced"	"Detected in many"	25	"Hofbauer cells: 273.8;Macrophages: 115.1;Melanocytes: 54.0"	"Low cancer specificity"	"Detected in all"			"Not detected"	"Not detected"			"Cell type enriched"	"Detected in single"	141	"neutrophil: 63.2"	"Lineage enriched"	"Detected in single"	339	"granulocytes: 63.2"	"Cell line enriched"	"Detected in some"	12	"NB-4: 89.4"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"CAB000348, HPA001238, HPA063909, CAB068199, CAB068200, CAB068201"	Enhanced		Approved	Cytosol	"Secreted to blood"	NA	NA	43300000	57000000	Cytosol		"CAB000348: , CAB068199: AB_2665675, CAB068200: AB_2665676, CAB068201: AB_2665677, HPA001238: AB_1079398, HPA063909: AB_2685150"	"unprognostic (4.62e-2)"	"unprognostic (1.64e-1)"	"unprognostic (2.85e-2)"	"prognostic favorable (2.55e-4)"	"unprognostic (6.65e-3)"	"unprognostic (2.82e-1)"	"prognostic unfavorable (7.19e-4)"	"unprognostic (1.54e-1)"	"unprognostic (8.57e-2)"	"unprognostic (3.21e-2)"	"unprognostic (4.15e-2)"	"unprognostic (1.96e-1)"	"prognostic unfavorable (4.05e-5)"	"unprognostic (4.65e-1)"	"unprognostic (9.85e-3)"	"unprognostic (2.48e-2)"	"unprognostic (2.17e-3)"	64.0	0.5	0.6	38.6	0.7	89.4	4.3	0.4	0.6	0.8	1.2	0.1	0.0	2.8	0.6	0.2	0.9	1.5	0.6	4.0	0.5	0.6	1.4	2.0	13.3	80.1	0.6	0.0	2.7	1.4	0.0	0.8	2.6	0.5	0.6	0.8	0.5	12.5	0.0	1.3	1.3	4.2	0.3	0.5	53.7	2.5	2.7	0.0	23.6	1.3	2.3	44.5	4.5	2.9	0.0	0.0	63.2	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.8	0.0	7.5	0.0	0.0	0.1	0.0	0.3	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.9	0.0	89.4	0.2	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.1	0.1	0.0	0.1	0.0	1.0	0.0	0.3	0.0	2.7	2.8	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	63.2	0.0	0.0	0.0	0.0	0.0	0.6	0.7	0.4	0.6	0.5	0.6	0.6	0.0	0.5	0.0	0.0	8.5	0.0	0.0	30.5	1.6	0.4	0.0	0.0	0.0	0.0	7.9	0.9	0.0	0.8	0.6	0.5	0.0	0.0	1.5	2.0	1.7	0.1	1.1	0.0	273.8	3.2	0.0	0.0	1.9	0.0	0.0	115.1	54.0	3.6	0.0	0.5	1.6	0.0	0.0	0.3	4.3	0.0	12.3	5.4	5.5	24.6	1.6	0.0	0.0	0.0
MPND	FLJ14981	ENSG00000008382	"MPN domain containing"	Q8N594	19	4343527-4360086	"Enzymes, Predicted intracellular proteins"		"Hydrolase, Metalloprotease, Protease"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	7	"Enterocytes: 65.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA043274, HPA045475"	Approved		Approved	"Nucleoplasm,Nucleoli rim"		No	No			"Nucleoli rim"	Nucleoplasm	"HPA043274: AB_2678403, HPA045475: AB_2679339"	"unprognostic (3.16e-2)"	"prognostic favorable (2.99e-4)"	"unprognostic (4.85e-2)"	"prognostic favorable (6.12e-4)"	"unprognostic (8.60e-2)"	"unprognostic (5.37e-3)"	"unprognostic (3.16e-2)"	"prognostic favorable (1.55e-4)"	"unprognostic (1.23e-1)"	"unprognostic (2.87e-2)"	"unprognostic (3.94e-3)"	"unprognostic (5.18e-2)"	"prognostic favorable (7.04e-4)"	"unprognostic (2.22e-3)"	"unprognostic (3.22e-1)"	"unprognostic (5.44e-2)"	"unprognostic (9.04e-2)"	7.7	13.7	18.9	14.1	12.3	11.5	8.0	12.1	21.6	6.5	19.9	6.6	15.7	25.9	8.5	7.8	13.8	8.2	11.8	12.1	14.2	11.3	12.8	25.1	14.3	8.5	12.7	20.0	8.7	20.7	14.5	7.2	7.0	11.9	12.1	13.9	11.5	14.3	9.0	17.4	12.5	20.7	9.3	8.9	10.1	12.5	4.2	6.7	13.5	8.6	8.3	10.1	9.3	11.0	3.1	4.5	10.3	6.0	2.4	5.6	1.9	7.9	6.7	11.1	12.7	7.0	3.3	11.3	3.9	3.8	3.2	4.0	12.9	4.1	7.2	12.2	5.0	9.5	8.2	5.0	6.7	1.8	8.1	11.3	5.5	9.5	20.9	5.6	7.4	10.0	5.0	4.9	3.5	3.7	5.0	9.9	19.2	2.9	18.8	4.0	23.0	17.4	6.3	5.1	13.5	9.7	14.3	3.4	10.4	8.2	14.1	12.4	12.7	7.1	10.0	5.3	6.6	6.7	9.1	3.7	5.2	5.6	31.4	7.7	15.7	9.6	4.8	5.7	4.1	5.9	10.3	5.1	2.4	2.2	6.0	3.4	1.8	2.6	3.1	4.5	3.1	1.7	1.9	1.2	2.4	2.7	4.5	5.6	1.9	18.9	12.3	12.1	21.6	14.2	11.3	12.7	20.0	11.9	6.7	0.0	3.0	4.5	6.6	4.7	7.2	11.5	10.2	1.4	3.4	10.4	2.0	11.3	0.0	4.3	0.5	4.9	65.9	0.0	4.4	9.3	3.9	9.1	4.6	21.2	13.6	6.4	16.0	6.7	23.8	2.2	5.8	10.2	3.3	6.4	27.9	3.9	4.9	32.5	3.5	11.4	3.4	6.5	5.1	0.0	5.3	7.3	8.7	5.3	28.8	7.1
MYSM1	KIAA1915	ENSG00000162601	"Myb like, SWIRM and MPN domains 1"	Q5VVJ2	1	58654739-58700092	"Enzymes, Predicted intracellular proteins"	"Transcription, Transcription regulation, Ubl conjugation pathway"	"Activator, Chromatin regulator, DNA-binding, Hydrolase, Metalloprotease, Protease"	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA054291, HPA057306"	Approved		Supported	Nucleoplasm,Nucleoli		NA	NA			Nucleoplasm	Nucleoli	"HPA054291: AB_2682438, HPA057306: "	"unprognostic (2.95e-3)"	"unprognostic (3.64e-2)"	"unprognostic (3.20e-2)"	"unprognostic (8.68e-2)"	"unprognostic (2.08e-2)"	"prognostic favorable (5.09e-5)"	"unprognostic (8.12e-3)"	"unprognostic (9.63e-3)"	"unprognostic (5.72e-3)"	"unprognostic (3.74e-1)"	"unprognostic (2.25e-1)"	"unprognostic (4.56e-2)"	"unprognostic (2.38e-3)"	"unprognostic (4.22e-2)"	"unprognostic (1.83e-1)"	"unprognostic (8.45e-2)"	"unprognostic (1.44e-2)"	13.2	12.3	14.1	14.4	15.7	24.4	17.3	16.9	24.3	14.3	13.7	11.4	11.9	12.5	17.5	14.3	13.5	13.0	9.9	14.1	11.7	8.1	11.0	11.0	12.9	14.3	14.0	13.3	18.1	14.0	16.5	19.2	11.3	18.0	14.4	11.6	9.3	15.5	15.2	23.2	20.4	14.6	13.7	15.2	14.2	11.5	8.3	14.7	11.9	15.5	10.6	12.9	13.3	14.7	1.1	0.7	2.2	2.1	0.2	2.3	0.5	8.3	2.4	6.2	6.6	5.7	7.3	8.9	5.0	5.6	5.0	4.3	4.2	3.7	8.7	1.5	3.8	5.9	6.4	6.8	2.9	9.6	5.8	4.6	10.5	1.1	4.6	6.9	15.8	8.0	5.2	5.0	6.4	3.3	6.6	1.2	5.6	11.1	5.6	5.7	2.8	7.7	13.2	9.8	3.4	4.5	6.6	14.9	5.3	4.1	3.2	5.1	5.0	4.2	8.3	11.7	11.7	2.5	9.0	4.0	8.9	4.0	6.8	9.5	10.2	4.8	11.6	5.2	11.5	9.7	0.8	0.7	0.5	2.0	1.0	1.4	0.9	1.4	1.6	0.6	1.1	2.3	1.1	2.2	0.2	2.1	0.7	1.4	0.5	14.1	15.7	16.9	24.3	11.7	8.1	14.0	13.3	18.0	14.7	20.8	28.9	12.6	19.3	16.9	20.3	24.6	10.2	22.7	48.9	10.4	23.6	7.0	13.3	7.0	3.2	17.3	18.0	0.0	8.1	4.8	11.6	20.1	54.4	12.4	9.7	17.5	15.5	31.3	13.2	4.0	11.8	14.6	8.5	15.4	16.2	12.0	10.3	14.4	16.3	6.3	26.3	25.8	14.1	13.0	20.4	16.2	9.5	25.5	13.6	22.6
NAALAD2	"GCPIII, NAALADASE2"	ENSG00000077616	"N-acetylated alpha-linked acidic dipeptidase 2"	Q9Y3Q0	11	90131515-90192894	"Enzymes, Predicted intracellular proteins, Predicted membrane proteins"		"Carboxypeptidase, Dipeptidase, Hydrolase, Metalloprotease, Multifunctional enzyme, Protease"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"pituitary gland: 44.1"	"Cell type enhanced"	"Detected in some"	17	"Bipolar cells: 15.8;Early spermatids: 37.5;Horizontal cells: 66.7"	"Cancer enhanced"	"Detected in some"		"testis cancer: 1.5"	"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in single"	6	"non-classical monocyte: 2.4"	"Lineage enriched"	"Detected in single"	12	"monocytes: 2.4"	"Cell line enhanced"	"Detected in some"		"CACO-2: 20.0;SH-SY5Y: 6.7;SuSa: 4.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA060820, HPA065419"	Approved		Approved	Nucleoplasm		NA	NA			Nucleoplasm		"HPA060820: AB_2684373, HPA065419: AB_2685487"	"unprognostic (1.68e-1)"	"unprognostic (2.66e-3)"	"unprognostic (1.49e-1)"	"unprognostic (4.52e-3)"	"unprognostic (4.73e-3)"	"unprognostic (2.97e-1)"	"unprognostic (3.82e-3)"	"unprognostic (1.77e-2)"	"unprognostic (2.44e-1)"	"unprognostic (2.30e-1)"	"unprognostic (3.30e-2)"	"unprognostic (8.00e-2)"	"unprognostic (9.97e-4)"	"unprognostic (1.52e-2)"	"unprognostic (2.54e-1)"	"unprognostic (1.63e-2)"	"unprognostic (2.93e-1)"	7.7	13.0	5.3	1.8	9.9	1.1	3.1	2.1	9.8	7.8	2.1	3.7	2.8	1.3	10.3	5.4	1.8	4.7	3.7	2.5	5.5	7.4	2.7	1.7	2.8	1.6	6.5	5.0	12.9	2.5	0.9	44.1	8.8	11.9	5.2	2.2	5.8	1.9	3.7	2.1	1.5	2.1	3.5	6.2	4.4	1.8	16.6	7.4	0.0	1.7	1.7	1.2	1.8	3.8	0.0	0.1	0.0	2.4	0.0	0.1	0.1	0.1	0.2	1.9	0.1	0.6	0.1	2.4	0.1	0.1	0.1	0.0	20.0	0.7	0.3	0.2	0.0	0.3	0.3	1.4	0.0	0.0	0.0	0.4	1.9	0.4	1.8	0.2	0.1	0.1	2.3	0.0	0.0	0.0	0.6	0.4	0.2	0.1	0.0	0.0	0.0	0.3	0.3	1.9	0.5	0.2	0.3	0.0	0.2	0.0	0.0	0.2	6.7	0.0	0.2	0.0	4.9	0.2	0.4	2.6	0.1	1.6	0.4	0.3	1.1	0.3	0.3	0.7	0.3	1.1	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	2.4	0.1	0.1	0.1	5.3	9.9	2.1	9.8	5.5	7.4	6.5	5.0	11.9	7.4	0.0	0.0	0.0	0.1	0.2	15.8	0.8	2.5	0.0	1.2	0.0	0.0	0.8	0.0	0.0	37.5	0.7	0.0	0.0	0.0	0.5	3.4	0.2	0.0	0.0	0.3	66.7	0.0	1.3	5.4	13.2	10.3	0.2	0.0	0.0	0.0	10.1	0.0	0.0	13.8	0.0	2.3	0.0	4.7	0.3	4.4	0.0	0.7	0.0	0.0	0.0
NAALADL1		ENSG00000168060	"N-acetylated alpha-linked acidic dipeptidase like 1"	Q9UQQ1	11	65044818-65058549	"Enzymes, Plasma proteins, Predicted intracellular proteins"		"Aminopeptidase, Hydrolase, Metalloprotease, Protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	12	"blood: 49.5;intestine: 123.4"	"Cell type enhanced"	"Detected in many"	7	"Enterocytes: 39.3;monocytes: 22.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"basophil: 49.5"	"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in some"		"ASC TERT1: 5.4;fHDF/TERT166: 6.8;HHSteC: 19.0;HSkMC: 12.5;SCLC-21H: 9.8"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA047123	Enhanced		Uncertain	Cytosol		NA	NA			Cytosol		"HPA047123: AB_2679942"	"unprognostic (2.98e-2)"	"unprognostic (2.06e-1)"	"unprognostic (1.58e-1)"	"unprognostic (8.76e-2)"	"unprognostic (1.70e-1)"	"unprognostic (1.28e-3)"	"unprognostic (1.36e-1)"	"unprognostic (1.40e-1)"	"unprognostic (1.89e-2)"	"unprognostic (1.38e-1)"	"unprognostic (3.03e-1)"	"unprognostic (2.18e-1)"	"unprognostic (1.75e-4)"	"unprognostic (2.10e-3)"	"unprognostic (3.22e-2)"	"unprognostic (1.45e-1)"	"unprognostic (4.80e-2)"	4.1	0.9	1.4	3.3	1.6	7.0	4.1	1.9	1.4	6.0	54.3	1.2	2.6	7.8	7.2	1.8	2.7	4.4	3.4	3.5	1.3	0.6	2.3	1.2	3.4	5.2	1.5	1.5	6.2	1.0	0.9	2.0	1.5	1.6	4.6	2.6	3.1	2.3	4.8	2.0	1.6	123.4	4.3	1.4	5.0	2.8	1.8	1.2	1.8	1.8	2.3	2.9	3.1	5.4	8.8	4.9	49.5	6.3	22.2	12.9	7.0	0.0	0.0	0.1	0.2	0.5	5.4	0.9	2.0	0.0	2.5	1.1	0.0	0.0	0.1	0.0	6.8	0.0	0.0	0.0	0.1	0.0	0.8	0.3	0.0	0.1	3.1	19.0	0.0	0.0	12.5	0.0	2.5	0.0	0.0	3.2	0.1	0.0	0.2	0.0	0.2	0.2	0.6	0.0	0.0	0.1	0.1	0.0	0.8	0.2	0.0	9.8	0.4	0.1	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.3	0.1	0.7	0.0	0.1	0.1	49.5	6.3	10.3	9.5	4.3	4.9	8.0	7.6	4.8	4.9	8.8	8.8	4.9	1.1	22.2	2.5	0.2	12.9	7.0	1.4	1.6	1.9	1.4	1.3	0.6	1.5	1.5	1.6	1.2	0.0	0.0	8.2	3.2	3.2	1.1	1.1	2.5	0.0	0.0	0.0	0.0	0.1	3.3	0.0	0.6	9.0	39.3	0.0	0.7	0.2	5.7	0.5	19.6	0.0	2.8	9.5	1.2	16.5	7.6	1.7	10.9	6.4	15.1	22.6	0.7	10.8	0.3	14.4	17.0	0.0	0.9	0.0	13.7	1.6	2.6	2.9	0.3	11.7	0.4	0.3
NAALADL2		ENSG00000177694	"N-acetylated alpha-linked acidic dipeptidase like 2"	Q58DX5	3	174438573-175810552	"Enzymes, Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"seminal vesicle: 29.3"	"Cell type enhanced"	"Detected in many"	8	"Early spermatids: 60.1"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in single"		"plasmacytoid DC: 1.7"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in some"		"ASC TERT1: 11.7;BJ hTERT+: 4.2;fHDF/TERT166: 4.9;WM-115: 4.5"	"Low region specificity"	"Detected in many"							"HPA012413, HPA017425, CAB025586"	Approved		Enhanced	Nucleoplasm		NA	NA			Nucleoplasm		"CAB025586: , HPA012413: AB_1854274, HPA017425: AB_1854275"	"unprognostic (7.28e-3)"	"unprognostic (1.10e-1)"	"unprognostic (6.28e-2)"	"unprognostic (1.60e-1)"	"unprognostic (2.56e-1)"	"unprognostic (2.56e-1)"	"unprognostic (2.29e-4)"	"unprognostic (3.44e-3)"	"unprognostic (5.70e-2)"	"unprognostic (7.42e-2)"	"unprognostic (7.85e-3)"	"unprognostic (9.49e-2)"	"unprognostic (3.66e-6)"	"unprognostic (7.11e-2)"	"unprognostic (1.48e-1)"	"unprognostic (9.05e-2)"	"unprognostic (2.22e-2)"	4.9	2.3	2.2	4.6	3.7	0.8	7.0	1.9	2.7	8.3	8.3	5.4	23.8	2.4	9.7	10.5	2.3	5.0	8.9	5.4	2.5	1.8	7.0	3.7	3.3	1.3	2.3	2.0	5.4	3.9	20.6	3.0	6.4	4.0	9.6	3.3	4.4	17.0	29.3	1.8	3.2	6.6	6.0	3.6	2.6	4.5	1.9	2.9	4.9	3.5	2.6	1.7	8.7	5.0	0.1	1.7	0.2	0.1	0.1	0.8	0.0	0.0	0.0	0.2	0.0	3.5	11.7	0.1	2.3	4.2	0.6	0.7	0.2	1.3	0.0	0.5	4.9	0.1	0.0	0.0	0.0	1.8	0.0	0.0	0.2	0.0	0.0	0.6	0.0	0.0	3.2	0.6	0.1	0.0	3.0	0.4	0.0	0.0	0.1	2.3	0.4	0.2	0.0	0.0	1.6	0.0	0.0	0.2	0.1	1.7	0.2	0.0	0.0	0.2	0.2	0.9	0.3	3.1	0.1	0.5	2.3	0.1	0.1	0.5	0.0	0.0	0.0	1.5	0.0	4.5	0.2	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.8	0.1	0.0	0.1	0.0	1.7	0.0	0.0	2.2	3.7	1.9	2.7	2.5	1.8	2.3	2.0	4.0	2.9	0.0	11.5	0.0	7.2	2.1	7.6	2.8	10.2	18.7	6.8	12.2	11.8	16.3	6.6	6.8	60.1	2.1	11.1	0.0	2.3	1.5	7.8	18.3	4.6	2.4	1.6	0.0	8.6	3.1	0.3	28.0	14.1	0.7	3.3	0.0	1.1	7.7	2.5	3.5	11.3	1.7	6.6	0.0	2.3	3.2	1.9	1.6	10.3	0.0	14.9	13.7
NLN	"AGTBP, KIAA1226"	ENSG00000123213	Neurolysin	Q9BYT8	5	65722196-65871725	"Enzymes, Plasma proteins, Predicted intracellular proteins"		"Hydrolase, Metalloprotease, Protease"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	5	"classical monocyte: 4.7;intermediate monocyte: 5.9;myeloid DC: 4.1;non-classical monocyte: 4.1"	"Group enriched"	"Detected in many"	5	"dendritic cells: 4.1;monocytes: 5.9"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA031862	Approved		Approved	Mitochondria		Yes	No		53000	Mitochondria		"HPA031862: AB_10600827"	"unprognostic (5.91e-3)"	"unprognostic (4.52e-2)"	"unprognostic (1.34e-3)"	"unprognostic (4.37e-2)"	"unprognostic (3.85e-1)"	"unprognostic (1.45e-2)"	"unprognostic (7.29e-3)"	"unprognostic (3.24e-2)"	"unprognostic (3.19e-1)"	"unprognostic (3.58e-1)"	"prognostic unfavorable (7.51e-4)"	"unprognostic (1.27e-1)"	"prognostic favorable (5.58e-7)"	"unprognostic (1.52e-2)"	"unprognostic (1.98e-1)"	"unprognostic (1.29e-1)"	"unprognostic (6.18e-3)"	4.5	2.4	7.6	4.7	10.5	2.9	7.3	2.8	11.9	4.1	6.8	5.8	1.0	2.4	5.8	5.0	5.2	3.3	2.7	5.1	7.2	7.6	7.5	18.9	3.4	5.1	8.7	8.5	4.0	11.0	3.6	2.4	4.9	9.8	5.4	6.5	2.0	4.3	2.6	15.0	5.7	5.3	5.5	10.9	5.8	7.5	2.4	6.2	1.8	5.5	7.9	4.0	4.3	3.3	0.9	4.1	0.6	5.9	0.9	0.7	1.8	9.2	8.9	5.3	8.7	6.7	11.5	10.6	9.4	4.0	5.5	6.0	5.1	5.5	13.2	11.9	11.2	11.1	7.4	6.8	14.4	9.7	3.9	4.6	3.6	6.7	12.8	5.8	8.3	2.2	8.7	7.9	7.6	9.1	4.7	15.5	5.9	7.8	2.8	11.9	7.1	5.7	7.5	16.1	4.7	2.6	6.7	11.2	20.9	9.1	4.1	16.4	8.5	7.6	7.8	7.7	14.9	9.3	9.9	8.9	3.7	4.4	5.4	7.0	2.4	4.8	5.8	5.7	16.4	5.5	0.2	4.7	0.2	0.2	5.9	0.3	0.9	0.4	0.3	4.1	0.9	0.7	0.5	0.6	0.9	4.1	0.2	0.1	1.8	7.6	10.5	2.8	11.9	7.2	7.6	8.7	8.5	9.8	6.2	6.0	3.2	1.5	5.1	5.0	0.6	13.2	10.2	2.7	11.4	12.2	3.9	5.2	5.0	15.3	0.2	5.0	20.6	0.0	12.3	12.1	5.2	8.8	15.0	26.4	24.7	4.8	1.7	5.5	23.4	0.0	4.0	8.4	1.7	2.8	7.1	13.2	23.5	10.7	2.1	17.4	3.5	0.0	3.1	1.4	4.3	4.5	2.4	0.9	7.1	5.5
NPEPL1	"bA261P9.2, FLJ11583"	ENSG00000215440	"Aminopeptidase like 1"	Q8NDH3	20	58689131-58719238	"Enzymes, Predicted intracellular proteins"		"Aminopeptidase, Hydrolase, Protease"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	4	"basophil: 12.2;classical monocyte: 13.4;eosinophil: 4.9;intermediate monocyte: 8.9;myeloid DC: 8.2;neutrophil: 9.6;non-classical monocyte: 11.9"	"Group enriched"	"Detected in all"	5	"dendritic cells: 8.2;granulocytes: 12.2;monocytes: 13.4"	"Cell line enhanced"	"Detected in many"		"MCF7: 43.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"CAB004986, CAB017025, HPA036356"	Approved		Approved	Nucleoplasm		NA	NA		16000	Nucleoplasm		"CAB004986: AB_426073, CAB017025: , HPA036356: AB_2675082"	"unprognostic (1.68e-1)"	"unprognostic (5.87e-3)"	"unprognostic (8.28e-2)"	"unprognostic (2.78e-1)"	"unprognostic (5.42e-2)"	"unprognostic (1.47e-3)"	"unprognostic (2.86e-3)"	"unprognostic (3.11e-2)"	"unprognostic (4.14e-1)"	"unprognostic (1.08e-2)"	"unprognostic (1.62e-3)"	"unprognostic (3.78e-2)"	"prognostic unfavorable (1.87e-9)"	"unprognostic (7.97e-2)"	"unprognostic (1.64e-1)"	"unprognostic (2.21e-1)"	"prognostic favorable (5.73e-4)"	17.2	10.3	9.9	9.7	15.3	15.8	25.0	24.2	10.1	9.6	14.9	10.2	17.2	14.4	11.9	23.5	17.9	12.5	24.5	19.4	10.1	8.6	16.7	11.9	14.5	12.6	12.9	7.2	12.5	15.6	13.6	11.4	11.2	13.1	15.0	4.5	15.7	19.1	17.2	51.8	15.2	13.7	25.8	10.0	16.5	12.8	13.0	9.0	5.6	16.5	20.4	11.8	15.3	20.4	1.0	8.2	12.2	13.4	2.0	2.3	4.1	9.3	13.1	2.4	1.9	5.3	9.8	0.7	3.4	0.3	11.8	6.6	7.5	7.1	0.4	19.6	6.7	0.1	10.1	3.2	4.4	1.1	8.2	2.9	3.1	10.0	3.3	13.4	3.3	5.6	9.6	14.0	4.1	0.0	4.3	9.9	2.6	0.4	1.5	4.6	43.7	1.3	8.8	3.5	5.5	13.7	2.7	1.1	5.1	4.8	6.0	4.4	1.4	9.5	2.6	17.6	1.4	10.2	6.5	10.4	3.0	2.4	5.9	1.8	4.5	1.6	0.3	4.3	6.4	1.2	12.2	13.4	4.9	1.9	8.9	2.3	1.0	1.1	1.3	8.2	0.7	0.7	1.3	9.6	2.0	11.9	0.4	2.3	4.1	9.9	15.3	24.2	10.1	10.1	8.6	12.9	7.2	13.1	9.0	8.9	14.1	0.8	7.2	8.1	14.8	13.3	7.6	14.7	12.5	26.2	23.6	11.6	11.6	13.1	1.3	12.2	10.9	0.0	8.0	6.9	9.0	5.9	2.3	7.3	10.0	7.9	11.5	14.7	15.1	6.4	20.4	9.9	6.8	8.2	9.9	20.9	8.6	15.3	13.8	17.3	8.6	19.4	11.8	2.1	3.3	9.8	7.4	10.1	12.0	4.7
NPEPPS	"MP100, PSA"	ENSG00000141279	"Aminopeptidase puromycin sensitive"	P55786	17	47522942-47623276	"Enzymes, Plasma proteins, Predicted intracellular proteins"		"Aminopeptidase, Hydrolase, Metalloprotease, Protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	4	"Cone photoreceptor cells: 253.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"T-47d: 81.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA021453, HPA045649"	Uncertain		Supported	Cytosol		No	No		2100000	Cytosol		"HPA021453: AB_2670709, HPA045649: AB_2679406"	"unprognostic (1.63e-1)"	"unprognostic (3.15e-2)"	"prognostic favorable (3.39e-5)"	"unprognostic (2.66e-2)"	"unprognostic (1.53e-1)"	"unprognostic (5.92e-2)"	"prognostic unfavorable (3.67e-5)"	"unprognostic (3.84e-2)"	"unprognostic (1.22e-1)"	"unprognostic (1.77e-1)"	"unprognostic (3.85e-2)"	"unprognostic (3.63e-2)"	"unprognostic (1.93e-1)"	"unprognostic (8.55e-2)"	"unprognostic (1.52e-1)"	"unprognostic (1.23e-2)"	"unprognostic (1.07e-1)"	16.0	26.0	27.2	15.9	27.7	11.1	56.1	36.5	33.8	17.1	17.7	9.8	14.6	14.6	16.9	17.1	47.7	17.2	16.3	22.2	24.0	15.6	18.8	11.1	30.3	24.1	16.0	29.7	20.8	16.8	21.2	15.3	17.6	27.2	18.6	20.0	13.3	21.8	16.5	52.3	29.6	17.3	20.4	22.8	15.7	16.2	15.3	16.1	7.0	14.5	14.8	18.1	19.0	30.5	6.9	9.0	23.2	8.6	9.3	9.2	5.4	32.7	21.6	21.8	15.3	25.1	25.4	45.9	14.5	18.8	21.9	21.4	13.9	37.7	19.6	22.4	21.1	19.9	20.0	23.9	13.3	34.2	8.7	20.6	23.5	22.3	16.1	14.5	13.3	15.3	19.4	13.2	15.9	8.4	32.0	22.5	6.8	19.8	11.4	31.1	8.8	17.6	11.9	13.3	18.5	19.6	14.3	30.6	17.3	27.4	24.0	17.4	15.0	18.6	10.9	12.9	38.4	81.1	9.3	28.8	14.7	10.6	21.8	10.1	23.4	22.5	11.9	20.7	7.0	9.6	10.2	8.6	10.7	9.1	6.6	9.2	6.8	7.3	8.5	8.7	6.9	6.5	7.6	23.2	9.3	6.8	9.0	8.4	5.4	27.2	27.7	36.5	33.8	24.0	15.6	16.0	29.7	27.2	16.1	77.4	58.6	28.2	59.7	69.1	136.0	50.0	50.9	29.4	39.8	40.1	253.3	68.9	23.2	54.3	25.4	43.7	53.1	0.0	47.2	63.0	58.6	89.0	39.4	26.9	35.7	106.5	42.6	39.3	44.0	43.4	48.9	38.9	55.6	26.2	41.6	39.6	80.1	54.0	47.0	38.3	167.1	77.6	44.8	47.1	27.9	89.6	87.5	32.0	44.8	147.8
NRDC	"hNRD1, hNRD2, NRD1"	ENSG00000078618	"Nardilysin convertase"	O43847	1	51789191-51878937	"Enzymes, Plasma proteins, Predicted intracellular proteins"		"Hydrolase, Metalloprotease, Protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 96.4"	"Group enriched"	"Detected in many"	8	"Early spermatids: 492.5;Late spermatids: 1318.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA053661			Approved	Nucleoplasm		NA	NA			Nucleoplasm		"HPA053661: AB_2682221"	"unprognostic (1.22e-1)"	"unprognostic (6.52e-2)"	"unprognostic (2.14e-2)"	"unprognostic (5.62e-2)"	"unprognostic (2.61e-1)"	"unprognostic (3.25e-2)"	"prognostic unfavorable (5.49e-6)"	"unprognostic (1.42e-1)"	"unprognostic (4.17e-2)"	"unprognostic (1.67e-1)"	"unprognostic (5.86e-2)"	"unprognostic (1.00e-1)"	"prognostic unfavorable (2.12e-9)"	"unprognostic (2.75e-1)"	"unprognostic (2.35e-2)"	"unprognostic (9.54e-2)"	"unprognostic (5.53e-3)"	16.4	15.9	13.4	15.8	17.5	14.5	11.7	14.7	16.9	12.2	13.7	11.0	9.9	11.2	11.8	12.1	14.4	10.9	10.9	25.7	13.1	13.3	12.4	28.5	12.0	13.6	16.2	10.6	11.7	15.9	19.3	21.4	14.2	15.7	13.8	12.1	9.8	11.9	11.3	96.4	19.1	10.3	13.3	14.0	13.6	11.9	32.3	14.5	19.4	11.7	21.5	15.1	13.0	16.0	13.8	18.5	36.3	19.1	15.8	15.1	16.2	46.9	26.5	26.6	38.1	28.0	43.3	30.9	47.5	41.1	34.6	36.7	18.5	18.6	31.0	25.4	35.7	46.4	27.4	39.0	36.8	43.8	36.7	19.2	37.0	36.0	16.1	28.7	32.3	28.2	34.4	28.2	50.4	46.8	29.8	35.9	33.0	48.7	20.8	43.2	17.2	29.2	11.2	47.2	19.4	28.5	28.6	31.8	34.2	25.5	27.3	25.5	19.2	43.3	34.9	25.7	53.9	23.3	39.3	29.8	30.4	28.2	33.1	40.3	31.1	46.9	29.0	35.9	40.7	34.8	19.3	18.1	26.0	13.7	19.1	13.7	13.8	12.7	15.1	18.5	9.3	12.5	13.4	36.3	15.8	14.5	15.0	14.4	16.2	13.4	17.5	14.7	16.9	13.1	13.3	16.2	10.6	15.7	14.5	32.8	55.9	17.8	35.3	0.0	67.0	0.0	17.8	108.4	63.7	26.2	76.6	47.3	26.6	38.1	492.5	33.3	18.8	70.0	55.1	37.0	33.6	42.0	32.5	52.9	39.9	58.8	17.5	28.3	38.2	1318.0	61.2	53.3	0.0	60.5	26.4	53.0	45.7	14.0	55.5	15.1	68.3	58.2	0.0	37.6	20.9	0.0	69.0	40.6	27.9	33.4
OMA1	"FLJ33782, MPRP-1, YKR087C, ZMPOMA1"	ENSG00000162600	"OMA1 zinc metallopeptidase"	Q96E52	1	58415384-58546802	"Cancer-related genes, Enzymes, Predicted intracellular proteins, Predicted membrane proteins"		"Hydrolase, Metalloprotease, Protease"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Ciliated cells: 54.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA055120	Approved		Approved	Nucleoplasm,Mitochondria		NA	NA			"Nucleoplasm, Mitochondria"		"HPA055120: AB_2682702"	"prognostic favorable (1.63e-4)"	"unprognostic (2.67e-2)"	"prognostic favorable (7.70e-4)"	"unprognostic (1.60e-3)"	"unprognostic (1.61e-1)"	"unprognostic (9.57e-2)"	"unprognostic (3.94e-3)"	"prognostic favorable (8.52e-4)"	"unprognostic (8.22e-3)"	"unprognostic (6.91e-2)"	"unprognostic (4.10e-2)"	"unprognostic (1.40e-1)"	"unprognostic (9.54e-3)"	"unprognostic (2.52e-2)"	"unprognostic (3.93e-2)"	"unprognostic (1.74e-2)"	"unprognostic (5.24e-3)"	10.2	22.4	13.8	21.5	18.1	9.2	15.8	10.6	14.6	14.5	16.4	14.1	20.1	12.1	15.4	15.1	17.1	15.9	12.1	15.8	12.6	10.0	23.0	23.8	19.1	17.9	16.7	9.6	15.0	18.2	15.7	20.9	8.9	13.0	17.8	16.1	11.3	20.6	22.7	20.9	10.2	16.1	24.2	18.2	17.2	13.9	6.9	19.4	18.4	18.3	14.5	16.4	17.0	20.6	22.5	9.5	18.6	19.5	18.6	22.8	10.2	13.5	5.7	3.8	3.5	19.2	18.0	10.9	5.6	6.1	4.9	6.2	1.6	8.2	30.6	11.9	5.8	17.2	13.9	13.4	13.6	5.8	23.4	7.5	9.5	4.4	6.6	9.5	23.3	6.7	16.9	15.3	4.8	10.0	11.1	4.3	15.3	18.0	9.2	13.4	8.3	7.9	8.3	5.6	20.5	12.4	9.9	12.5	12.8	10.7	9.1	4.0	1.9	11.4	18.8	15.8	18.3	8.5	9.0	2.5	2.5	5.1	12.6	5.8	7.5	9.8	20.1	7.8	18.3	6.2	10.8	9.2	18.6	12.8	14.5	16.5	22.5	15.7	15.0	9.5	21.4	22.8	20.8	10.6	18.6	19.5	5.0	13.9	10.2	13.8	18.1	10.6	14.6	12.6	10.0	16.7	9.6	13.0	19.4	17.9	11.5	14.7	15.7	5.4	7.2	25.0	10.2	54.9	11.4	24.4	11.8	19.1	21.6	7.7	5.0	4.9	6.9	0.0	4.8	7.8	8.6	15.0	5.8	15.5	13.6	1.6	5.8	8.6	10.7	9.7	9.2	10.4	6.8	7.2	15.0	10.0	5.2	10.4	8.1	20.7	19.6	6.5	4.4	11.7	12.1	5.9	15.3	13.8	13.0	17.5
PA2G4		ENSG00000170515	"Proliferation-associated 2G4"	Q9UQ80	12	56104319-56113907	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"rRNA processing, Transcription, Transcription regulation, Translation regulation"	"Repressor, Ribonucleoprotein, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"											"CAB011711, CAB012428, HPA016484"	Supported		Approved	Cytosol		NA	NA		1200000	Cytosol		"CAB011711: AB_732060, CAB012428: , HPA016484: AB_1854912"	"unprognostic (5.53e-2)"	"unprognostic (1.06e-1)"	"unprognostic (2.35e-2)"	"unprognostic (2.34e-2)"	"unprognostic (3.87e-1)"	"unprognostic (6.03e-3)"	"prognostic unfavorable (6.31e-7)"	"unprognostic (4.25e-3)"	"unprognostic (2.77e-1)"	"unprognostic (3.79e-3)"	"unprognostic (2.29e-2)"	"unprognostic (1.30e-2)"	"prognostic unfavorable (4.59e-7)"	"unprognostic (1.17e-1)"	"unprognostic (2.01e-1)"	"unprognostic (1.32e-1)"	"unprognostic (4.67e-2)"	41.1	32.1	26.6	41.4	29.8	52.5	38.5	35.1	38.8	33.7	39.2	31.0	27.1	34.4	36.1	22.4	69.4	31.2	31.9	55.6	26.6	25.5	36.1	51.6	32.6	43.3	26.7	28.0	43.3	44.3	42.8	20.5	39.0	28.2	40.3	44.2	23.6	34.6	33.4	77.3	53.0	31.7	39.4	32.3	46.7	34.4	27.9	23.9	70.8	39.7	57.2	54.0	45.5	39.6	25.5	27.1	13.5	25.1	37.4	48.9	36.0	53.5	47.6	32.7	36.0	15.1	23.0	65.7	56.8	27.2	69.9	39.0	58.2	39.9	107.3	38.2	26.8	20.6	44.2	74.5	63.3	68.3	30.4	63.9	82.4	32.5	49.6	29.6	111.8	30.5	23.2	32.4	60.5	54.7	28.9	42.4	36.7	100.0	49.9	38.2	47.5	86.9	58.4	53.6	33.4	58.5	71.6	59.1	72.7	35.3	40.2	49.1	29.7	37.4	59.1	34.7	25.3	63.8	43.5	33.9	34.1	48.2	39.2	62.6	30.7	42.0	105.1	30.9	67.3	44.2	7.8	23.0	13.5	36.6	25.1	48.9	25.5	38.9	39.4	27.1	22.2	37.6	37.3	3.7	37.4	20.0	26.3	43.3	36.0	26.6	29.8	35.1	38.8	26.6	25.5	26.7	28.0	28.2	23.9	50.6	76.2	104.2	176.7	327.3	53.9	31.3	112.1	121.8	170.6	123.9	17.7	192.6	164.2	166.6	352.5	140.6	87.8	373.8	214.0	240.3	114.2	91.6	164.3	167.1	182.5	31.8	89.5	96.3	99.0	161.4	122.3	128.8	123.2	116.4	123.0	92.6	216.5	94.7	119.2	155.9	42.6	142.3	166.0	162.3	110.4	317.1	161.8	164.1	218.3	201.6
PAPPA	"ASBABP2, DIPLA1, IGFBP-4ase, PAPA, PAPP-A, PAPPA1"	ENSG00000182752	"Pappalysin 1"	Q13219	9	116153804-116402322	"Cancer-related genes, Candidate cardiovascular disease genes, Enzymes, Plasma proteins, Predicted secreted proteins"		"Hydrolase, Metalloprotease, Protease"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	86	"placenta: 484.6"	"Group enriched"	"Detected in many"	6	"Collecting duct cells: 157.1;Proximal tubular cells: 39.6"	"Low cancer specificity"	"Detected in some"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"ASC diff: 19.3;ASC TERT1: 14.8;HSkMC: 53.2;U-138 MG: 13.9"	"Low region specificity"	"Detected in some"			"Group enriched"	"Detected in many"	5	"midbrain: 10.4;olfactory region: 4.1;pons and medulla: 8.3;thalamus: 4.8"	"HPA001667, CAB016724"	Enhanced				"Secreted in female reproductive system"	NA	NA		41000			"CAB016724: , HPA001667: AB_1854960"	"unprognostic (3.25e-1)"	"unprognostic (6.18e-6)"	"unprognostic (2.47e-1)"	"unprognostic (6.49e-2)"	"unprognostic (2.01e-2)"	"unprognostic (1.14e-1)"	"unprognostic (1.13e-1)"	"unprognostic (5.42e-3)"	"unprognostic (5.44e-2)"	"unprognostic (3.87e-2)"	"unprognostic (6.87e-3)"	"unprognostic (8.25e-2)"	"unprognostic (8.00e-3)"	"unprognostic (2.37e-3)"	"unprognostic (2.48e-1)"	"unprognostic (4.01e-1)"	"unprognostic (1.02e-3)"	4.8	2.3	0.5	1.0	0.5	0.0	0.8	0.4	0.6	3.6	2.4	0.6	1.0	0.1	3.5	1.0	3.6	2.0	1.1	3.7	0.4	0.0	4.3	0.5	2.4	0.7	0.4	0.4	1.4	0.7	5.6	0.7	484.6	0.7	1.4	0.9	0.9	0.5	1.2	0.5	1.1	0.9	2.4	0.6	0.6	1.0	0.8	0.5	0.4	1.3	1.0	1.0	2.3	3.4	0.2	0.0	0.2	0.0	0.0	0.1	0.0	0.0	5.5	8.4	0.0	19.3	14.8	0.0	4.5	8.0	1.2	2.1	0.0	0.0	0.0	0.0	3.1	0.4	0.6	0.0	0.0	6.0	0.0	0.0	0.9	4.6	0.0	9.4	0.0	0.0	53.2	0.0	6.2	0.7	10.3	0.0	0.0	0.2	0.0	1.4	0.0	0.0	0.0	2.4	0.0	0.0	0.0	0.2	0.0	0.2	0.0	0.0	0.4	0.6	0.0	0.0	2.7	0.0	0.0	10.7	13.9	0.7	0.4	0.5	0.0	0.0	0.0	9.9	0.0	4.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.5	0.5	0.4	0.6	0.4	0.0	0.4	0.4	0.7	0.5	0.0	1.0	0.0	0.2	2.6	5.0	2.2	0.0	0.0	2.3	157.1	11.8	0.3	8.3	5.8	14.3	0.7	0.0	0.0	0.8	7.4	16.4	0.6	1.1	0.0	0.4	0.0	0.0	5.5	0.0	12.7	13.3	0.3	1.7	0.0	0.0	2.3	0.5	0.0	8.1	39.6	2.7	0.0	8.2	1.7	0.4	1.0	11.7	0.0	0.0	0.1
PAPPA2	"PAPP-A2, PAPPE, PLAC3"	ENSG00000116183	"Pappalysin 2"	Q9BXP8	1	176463171-176845605	"Enzymes, Predicted membrane proteins, Predicted secreted proteins"		"Hydrolase, Metalloprotease, Protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	35	"placenta: 406.4"	"Group enriched"	"Detected in many"	7	"Intestinal endocrine cells: 135.4;Muller glia cells: 47.6;Syncytiotrophoblasts: 61.9"	"Low cancer specificity"	"Detected in some"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	5	"U-87 MG: 21.2"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"HPA018412, HPA018430"	Enhanced		Approved	"Endoplasmic reticulum,Vesicles"	"Secreted in female reproductive system"	NA	NA			"Endoplasmic reticulum, Vesicles"		"HPA018412: AB_1854962, HPA018430: AB_1854961"	"unprognostic (2.90e-1)"	"unprognostic (1.58e-1)"	"unprognostic (1.07e-1)"	"unprognostic (3.61e-2)"	"unprognostic (9.04e-2)"	"unprognostic (1.60e-3)"	"unprognostic (1.36e-1)"	"unprognostic (2.45e-1)"	"unprognostic (1.00e-2)"	"unprognostic (3.54e-2)"	"unprognostic (1.29e-2)"	"unprognostic (4.39e-2)"	"unprognostic (2.85e-2)"	"unprognostic (1.52e-4)"	"unprognostic (1.85e-1)"	"unprognostic (8.18e-4)"	"unprognostic (4.35e-2)"	0.6	0.0	0.6	0.2	0.2	0.0	3.0	0.8	0.3	5.0	0.6	0.2	0.2	0.0	0.3	0.2	0.2	0.2	1.1	0.2	0.2	0.1	11.6	0.7	0.2	0.2	0.2	0.2	0.2	1.5	0.0	1.2	406.4	0.3	0.2	0.2	0.2	0.2	0.3	0.2	0.0	0.2	0.3	0.5	0.2	1.0	0.3	0.2	0.2	0.5	0.2	0.2	0.2	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.7	0.0	0.1	0.3	0.0	0.5	0.0	0.0	0.0	0.1	0.8	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	1.3	4.6	2.2	3.8	0.9	0.0	0.0	0.0	0.2	0.2	0.0	0.0	0.0	0.2	0.0	0.4	0.0	0.0	0.0	0.8	0.5	0.5	0.2	0.0	0.0	0.1	0.8	0.0	0.0	0.3	1.7	1.4	0.1	0.6	0.3	0.4	0.0	21.2	0.0	2.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.2	0.8	0.3	0.2	0.1	0.2	0.2	0.3	0.2	0.0	0.0	0.0	0.0	0.0	2.7	0.6	0.0	0.0	0.0	5.2	0.0	0.8	10.0	0.0	1.9	0.0	0.0	0.0	0.2	11.6	0.6	0.0	0.0	0.2	1.2	0.0	135.4	0.0	0.0	1.3	10.6	0.0	0.0	0.0	0.2	47.6	1.2	0.0	10.3	0.3	1.1	6.5	0.5	1.2	1.9	0.0	61.9	0.0	0.0	0.0
PEPD		ENSG00000124299	"Peptidase D"	P12955	19	33386950-33521794	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Collagen degradation"	"Dipeptidase, Hydrolase, Metalloprotease, Protease"	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"intestine: 92.9;kidney: 106.0"	"Cell type enriched"	"Detected in many"	5	"Proximal tubular cells: 1020.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA015599, HPA072045"	Enhanced		Approved	Nucleoplasm		NA	NA		1000000000	Nucleoplasm		"HPA015599: AB_1855192, HPA072045: AB_2732194"	"unprognostic (1.39e-1)"	"unprognostic (2.62e-2)"	"unprognostic (2.27e-1)"	"unprognostic (4.01e-2)"	"unprognostic (2.98e-1)"	"unprognostic (6.77e-2)"	"unprognostic (2.82e-1)"	"unprognostic (3.64e-2)"	"unprognostic (3.96e-1)"	"unprognostic (5.10e-2)"	"unprognostic (1.11e-2)"	"unprognostic (1.99e-1)"	"prognostic favorable (6.50e-9)"	"unprognostic (4.38e-2)"	"unprognostic (1.99e-1)"	"unprognostic (1.65e-1)"	"unprognostic (1.29e-1)"	23.5	17.2	9.8	8.9	10.4	4.1	21.8	7.6	14.9	9.8	60.1	18.7	6.9	58.1	14.3	11.5	14.9	9.6	13.6	8.0	10.8	9.1	106.0	48.6	11.1	10.6	16.0	7.7	12.6	9.0	9.6	12.5	10.4	13.0	9.2	6.6	13.3	9.6	9.0	9.7	11.4	92.9	10.4	17.4	13.4	9.3	8.4	11.5	8.4	15.0	9.7	10.6	11.9	11.9	17.1	32.3	27.5	39.1	16.8	25.8	32.6	13.3	36.3	10.7	17.3	45.7	17.6	24.8	11.9	24.4	15.2	17.3	31.6	11.8	5.4	17.8	29.8	11.7	3.5	15.4	9.7	12.5	15.4	15.2	34.7	7.4	32.1	31.3	10.1	42.1	21.7	9.2	13.8	8.6	11.2	20.3	10.7	6.6	15.8	16.5	16.3	7.7	3.4	14.7	26.6	14.8	15.2	14.6	15.0	13.1	35.3	13.2	33.8	22.2	11.0	17.9	9.4	7.6	11.0	16.9	14.7	15.9	19.0	13.7	14.5	21.5	4.8	15.7	14.6	20.9	27.5	36.1	2.5	25.8	39.1	22.6	17.1	25.7	23.8	32.3	16.3	16.9	19.6	1.9	16.8	27.2	9.9	23.6	32.6	9.8	10.4	7.6	14.9	10.8	9.1	16.0	7.7	13.0	11.5	20.8	24.3	20.2	26.1	17.2	33.9	11.7	43.3	26.8	11.4	69.8	3.9	19.3	167.5	63.4	7.6	44.9	37.6	0.0	38.3	59.7	34.6	21.4	55.5	161.7	189.6	58.8	16.6	35.0	46.9	8.9	45.8	63.2	64.1	131.7	14.5	69.3	37.3	28.5	57.0	1020.8	23.8	38.8	38.8	11.4	48.3	17.8	25.4	31.0	16.7	18.0
PHEX	"HPDR, HPDR1, HYP, HYP1, PEX, XLH"	ENSG00000102174	"Phosphate regulating endopeptidase homolog X-linked"	P78562	X	22032441-22251310	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted membrane proteins"	Biomineralization	"Hydrolase, Metalloprotease, Protease"	"Disease mutation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 8.3;lung: 6.7"	"Cell type enhanced"	"Detected in some"	21	"Basal glandular cells: 5.2;Horizontal cells: 15.9"	"Cancer enhanced"	"Detected in some"		"thyroid cancer: 5.9"	"Low region specificity"	"Detected in many"			"Cell type enriched"	"Detected in single"	37	"plasmacytoid DC: 8.3"	"Lineage enriched"	"Detected in single"	37	"dendritic cells: 8.3"	"Cell line enhanced"	"Detected in some"		"HBEC3-KT: 5.8;HUVEC TERT2: 4.4;PC-3: 4.8;TIME: 4.9;U-87 MG: 10.6;WM-115: 4.4"	"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in many"									NA	NA						"unprognostic (2.01e-2)"	"unprognostic (2.69e-1)"	"unprognostic (2.43e-1)"	"unprognostic (1.05e-3)"	"unprognostic (1.22e-1)"	"unprognostic (3.04e-2)"	"unprognostic (2.25e-3)"	"unprognostic (1.23e-1)"	"unprognostic (1.87e-1)"	"unprognostic (1.21e-2)"	"unprognostic (7.53e-2)"	"unprognostic (7.45e-2)"	"unprognostic (9.84e-8)"	"unprognostic (1.18e-1)"	"unprognostic (1.58e-1)"	"prognostic favorable (2.51e-4)"	"unprognostic (7.68e-2)"	0.3	0.0	1.8	1.9	1.1	0.0	1.7	0.9	1.1	0.8	0.9	0.8	0.3	1.2	5.0	0.3	0.4	0.1	2.0	0.3	1.5	1.8	0.3	0.3	6.7	3.4	2.0	0.3	3.9	0.3	0.0	0.3	0.3	5.0	1.3	0.0	0.3	2.8	0.9	0.3	0.1	1.4	3.9	3.8	3.4	0.0	0.3	0.3	1.3	4.8	0.3	4.3	0.5	0.6	0.1	8.3	0.0	0.0	0.0	0.2	0.0	0.3	0.8	0.2	0.1	0.1	0.4	0.0	0.0	0.1	0.1	0.3	1.3	0.1	0.1	1.3	0.1	0.2	0.1	0.0	5.8	0.3	0.0	0.1	0.1	0.5	0.0	0.1	0.1	0.2	2.2	1.1	1.1	3.4	0.2	4.4	0.4	0.0	0.5	0.5	0.0	0.0	0.2	0.0	0.0	4.8	0.0	1.0	0.0	0.6	0.2	0.1	0.2	0.4	2.5	0.8	0.6	2.9	0.0	4.9	1.0	0.2	0.6	0.8	0.0	0.1	0.0	10.6	0.0	4.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	8.3	0.0	0.0	1.8	1.1	0.9	1.1	1.5	1.8	2.0	0.3	5.0	0.3	0.0	0.0	0.0	5.2	0.0	0.4	0.4	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.8	0.4	0.2	1.7	0.0	1.0	0.1	0.5	1.6	0.0	0.0	0.0	15.9	0.0	0.0	0.0	0.0	1.7	0.0	1.7	0.0	0.0	0.8	0.7	0.0	0.0	0.5	0.5	0.0	0.4	0.0	0.0	0.1	0.7	0.0	0.0	2.7
PITRM1	"hMP1, KIAA1104, MP1, PreP"	ENSG00000107959	"Pitrilysin metallopeptidase 1"	Q5JRX3	10	3137728-3172841	"Enzymes, Plasma proteins, Predicted intracellular proteins"		"Hydrolase, Metalloprotease, Protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	8	"Early spermatids: 149.7;Late spermatids: 75.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA006753, HPA006754"	Enhanced		Supported	Mitochondria		NA	NA			Mitochondria		"HPA006753: AB_1079624, HPA006754: AB_1079623"	"unprognostic (1.83e-3)"	"unprognostic (7.01e-3)"	"unprognostic (2.19e-1)"	"unprognostic (1.69e-1)"	"unprognostic (3.20e-2)"	"unprognostic (6.67e-2)"	"unprognostic (1.55e-1)"	"unprognostic (1.78e-1)"	"unprognostic (6.31e-2)"	"unprognostic (3.41e-1)"	"unprognostic (1.00e-2)"	"unprognostic (3.32e-1)"	"unprognostic (7.10e-2)"	"unprognostic (3.99e-1)"	"unprognostic (5.80e-2)"	"unprognostic (4.76e-3)"	"unprognostic (2.08e-2)"	26.7	39.4	22.7	20.4	34.4	31.0	21.5	29.7	47.8	21.6	23.4	29.8	19.1	19.1	27.6	27.2	25.0	21.3	23.7	41.0	22.1	19.3	28.8	47.1	23.6	21.2	22.9	25.6	35.3	25.7	31.2	26.0	17.8	38.8	27.2	22.4	29.2	25.1	23.8	62.0	28.0	25.3	26.3	19.1	18.9	21.6	41.6	20.4	48.6	28.7	33.0	26.8	26.0	22.4	11.5	13.7	6.0	13.9	12.4	13.9	9.1	25.7	20.9	8.3	11.2	23.6	25.6	9.5	38.2	17.9	30.6	16.7	18.8	15.8	13.0	13.3	23.9	11.8	19.9	13.3	29.5	23.1	22.4	18.9	18.3	17.1	14.1	13.4	7.1	21.9	21.1	22.0	33.4	19.1	20.9	31.7	20.2	18.5	17.1	40.3	22.3	17.8	7.3	5.7	33.1	25.4	8.8	11.5	18.4	24.3	19.8	10.6	6.5	29.0	21.2	16.1	12.2	24.7	8.5	39.0	24.2	6.8	59.1	18.3	13.7	14.4	13.4	36.9	13.0	11.8	6.0	9.4	4.9	13.1	12.0	12.9	11.5	11.3	12.2	13.7	6.8	12.1	13.9	1.4	12.4	13.9	7.6	13.8	9.1	22.7	34.4	29.7	47.8	22.1	19.3	22.9	25.6	38.8	20.4	26.8	22.3	6.5	17.3	6.1	13.1	36.4	10.2	22.7	29.6	3.5	19.6	10.5	6.6	14.9	149.7	11.3	11.1	0.0	25.0	16.4	10.8	18.9	13.9	13.0	12.9	6.4	17.3	7.4	9.4	75.9	15.8	9.4	18.6	13.6	10.9	5.8	26.9	8.6	13.8	7.5	19.1	6.5	14.2	25.1	19.3	5.0	11.3	8.7	12.4	15.7
PM20D1	"Cps1, FLJ32569"	ENSG00000162877	"Peptidase M20 domain containing 1"	Q6GTS8	1	205828022-205850132	"Enzymes, Predicted secreted proteins"		"Hydrolase, Lyase, Protease"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	7	"pancreas: 103.5"	"Group enriched"	"Detected in some"	6	"Exocrine glandular cells: 18.7;Proximal tubular cells: 5.8"	"Cancer enriched"	"Detected in some"	32	"urothelial cancer: 30.2"	"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in some"		"T-reg: 4.5"	"Lineage enriched"	"Detected in single"	5	"T-cells: 4.5"	"Cell line enriched"	"Detected in single"	9	"Karpas-707: 6.6"	"Low region specificity"	"Detected in all"												"Secreted to digestive system"	NA	NA		3000000				"unprognostic (1.16e-1)"	"unprognostic (1.95e-1)"	"unprognostic (1.30e-1)"	"unprognostic (4.07e-2)"	"unprognostic (4.83e-1)"	"unprognostic (4.08e-3)"	"unprognostic (1.17e-3)"	"unprognostic (3.11e-1)"	"unprognostic (1.20e-1)"	"unprognostic (5.50e-2)"	"unprognostic (5.81e-2)"	"unprognostic (4.57e-2)"	"unprognostic (7.79e-3)"	"unprognostic (9.77e-2)"	"unprognostic (1.45e-1)"	"unprognostic (2.48e-1)"	"unprognostic (1.68e-2)"	0.5	0.0	0.0	0.5	0.2	0.0	0.6	0.1	0.4	0.0	0.2	0.6	0.4	0.0	0.2	0.3	0.0	0.1	0.0	0.3	0.3	0.0	3.2	0.1	0.2	0.5	0.2	0.0	0.3	103.5	0.0	0.0	0.1	0.4	0.8	0.0	0.3	0.2	0.4	0.0	14.3	0.1	0.1	0.1	0.4	1.2	0.2	0.1	0.1	0.1	0.1	0.4	1.5	0.3	0.3	0.0	0.8	0.2	0.0	4.5	1.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.6	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.2	0.0	0.8	0.7	0.0	1.3	0.3	0.9	2.4	0.0	0.2	0.3	0.9	0.0	0.0	0.2	0.0	4.5	1.0	0.0	0.2	0.1	0.4	0.3	0.0	0.2	0.0	0.4	0.1	0.0	0.0	0.0	0.0	0.0	0.2	1.2	0.0	0.0	0.0	0.0	2.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	18.7	0.2	0.0	0.1	0.0	0.0	0.1	0.0	0.0	1.3	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	5.8	0.6	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0
PM20D2	"ACY1L2, bA63L7.3"	ENSG00000146281	"Peptidase M20 domain containing 2"	Q8IYS1	6	89146050-89165565	"Enzymes, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"Daudi: 34.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA030325, HPA030326, HPA030327"	Approved		Enhanced	Nucleoplasm		NA	NA			Nucleoplasm		"HPA030325: , HPA030326: AB_2673429, HPA030327: AB_10603129"	"unprognostic (3.60e-2)"	"unprognostic (1.40e-1)"	"unprognostic (6.36e-2)"	"unprognostic (3.18e-3)"	"unprognostic (3.22e-2)"	"unprognostic (2.73e-1)"	"unprognostic (1.13e-3)"	"unprognostic (8.60e-2)"	"unprognostic (1.04e-1)"	"unprognostic (5.86e-2)"	"unprognostic (2.27e-2)"	"unprognostic (1.04e-1)"	"unprognostic (9.99e-2)"	"unprognostic (6.84e-2)"	"unprognostic (1.28e-1)"	"unprognostic (1.32e-1)"	"unprognostic (1.31e-1)"	6.8	5.0	4.8	11.4	6.9	6.5	7.6	11.2	4.9	11.9	13.4	4.4	9.3	7.0	11.3	7.1	14.2	11.0	9.1	16.9	5.1	5.5	9.6	9.7	6.2	8.3	3.7	3.1	21.0	11.3	12.5	23.8	6.9	8.6	23.5	8.5	17.6	8.6	8.7	38.5	10.2	8.0	27.7	4.8	5.2	7.6	4.0	2.9	16.6	23.0	10.6	12.1	19.5	8.5	4.1	2.4	3.0	1.0	4.8	4.0	1.5	11.9	5.3	4.8	7.4	1.6	1.0	0.3	6.0	6.0	9.0	11.6	6.2	5.9	34.9	7.4	1.3	7.7	4.6	9.8	4.8	20.6	10.8	12.5	7.0	3.2	5.8	1.8	20.2	5.7	1.6	3.6	3.4	7.3	7.4	2.1	10.5	2.7	18.7	2.8	1.8	12.7	16.0	1.9	10.4	5.3	21.2	23.8	25.3	10.1	2.3	13.5	9.4	3.6	5.8	5.9	6.5	0.0	17.9	3.5	0.2	5.5	1.9	12.6	10.0	14.6	7.4	2.5	17.5	0.8	1.9	1.0	2.9	2.2	0.6	3.5	4.1	2.7	3.7	1.6	3.1	4.0	3.5	3.0	4.8	0.6	2.4	0.5	1.5	4.8	6.9	11.2	3.9	5.1	5.5	3.7	3.1	8.6	2.9	8.9	9.3	11.5	19.6	26.9	19.1	18.2	28.1	10.7	14.8	15.7	29.5	2.0	5.0	11.3	4.3	10.5	4.9	0.0	9.0	1.9	14.7	40.0	5.8	7.3	3.0	7.9	10.4	7.4	8.2	7.0	22.7	3.2	16.9	19.8	16.1	10.3	16.0	3.5	18.0	13.2	21.1	6.5	17.6	4.5	6.1	27.7	1.0	10.0	24.9	14.4
PMPCA	"Alpha-MPP, INPP5E, KIAA0123"	ENSG00000165688	"Peptidase, mitochondrial processing alpha subunit"	Q10713	9	136410570-136423761	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"			"Disease mutation, Mental retardation, Neurodegeneration"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA021648, HPA063735"	Supported		Enhanced	Mitochondria		NA	NA		6500	Mitochondria		"HPA021648: AB_1855491, HPA063735: AB_2685108"	"unprognostic (9.80e-2)"	"unprognostic (1.96e-2)"	"unprognostic (4.03e-1)"	"unprognostic (1.69e-2)"	"unprognostic (4.01e-2)"	"unprognostic (8.19e-2)"	"unprognostic (6.09e-2)"	"unprognostic (1.19e-2)"	"unprognostic (1.97e-1)"	"unprognostic (3.32e-2)"	"prognostic favorable (8.00e-5)"	"unprognostic (9.47e-3)"	"prognostic favorable (2.14e-6)"	"unprognostic (4.27e-3)"	"unprognostic (1.57e-2)"	"unprognostic (2.40e-1)"	"unprognostic (3.54e-2)"	15.2	27.3	19.8	14.6	23.8	20.1	13.2	20.3	24.3	12.3	15.1	13.0	10.4	18.6	14.2	14.1	16.5	13.6	14.9	37.0	15.6	14.8	17.0	48.3	12.3	18.4	15.2	21.9	15.5	18.2	14.7	19.5	15.6	16.8	15.2	11.9	12.8	20.3	17.1	56.7	17.5	17.0	13.8	14.1	18.9	16.3	23.2	12.5	14.0	15.0	19.8	15.3	13.1	13.4	25.5	30.1	17.0	25.1	32.1	30.8	28.2	14.4	27.2	13.0	26.2	9.9	14.5	20.0	15.1	12.2	21.2	15.4	31.0	17.3	20.3	15.9	15.3	11.3	33.9	24.0	22.1	9.4	29.1	29.0	16.3	35.0	37.4	17.4	21.2	14.2	21.2	15.3	16.5	8.5	12.0	17.9	18.9	41.3	13.4	13.1	40.1	20.0	27.3	26.5	25.9	25.7	24.9	18.4	44.9	14.5	10.4	26.7	17.6	20.3	29.0	17.6	9.3	39.5	28.9	14.7	15.1	16.2	12.4	19.2	8.3	10.9	21.8	19.9	18.5	13.5	15.4	25.1	17.0	27.2	24.4	26.4	25.5	25.7	29.3	30.1	23.7	30.8	26.9	5.9	32.1	23.2	15.3	24.3	28.2	19.8	23.8	20.3	24.3	15.6	14.8	15.2	21.9	16.8	12.5	14.9	25.3	23.9	29.5	24.5	22.5	31.3	10.2	13.4	18.2	21.0	21.6	90.0	41.4	28.9	19.7	20.2	19.7	0.0	26.4	41.5	17.6	17.8	24.3	54.0	33.8	17.5	20.0	20.3	17.4	12.4	17.5	14.1	15.1	21.6	22.3	19.3	25.1	17.3	21.2	37.9	25.3	38.8	16.9	32.8	39.5	23.5	86.8	23.0	30.4	23.5
PMPCB	"MPPB, MPPP52"	ENSG00000105819	"Peptidase, mitochondrial processing beta subunit"	O75439	7	103297422-103329511	"Enzymes, Predicted intracellular proteins"		"Hydrolase, Metalloprotease, Protease"	"Disease mutation, Neurodegeneration"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA040674, HPA074168"	Approved		Enhanced	Mitochondria		No	No		57000	Mitochondria		"HPA040674: AB_10961998, HPA074168: AB_2686671"	"prognostic favorable (2.79e-4)"	"unprognostic (3.11e-1)"	"unprognostic (7.18e-3)"	"unprognostic (3.03e-1)"	"unprognostic (3.65e-2)"	"unprognostic (1.72e-1)"	"unprognostic (1.06e-1)"	"unprognostic (7.67e-2)"	"unprognostic (7.74e-2)"	"unprognostic (1.21e-1)"	"unprognostic (1.38e-1)"	"unprognostic (1.42e-3)"	"prognostic favorable (2.95e-8)"	"unprognostic (2.59e-2)"	"unprognostic (9.79e-2)"	"unprognostic (2.40e-1)"	"unprognostic (4.39e-2)"	29.1	41.8	31.8	23.0	34.3	41.5	31.6	41.1	38.4	29.0	26.9	21.6	28.2	35.1	32.0	25.9	27.9	26.9	23.5	41.4	27.7	20.1	45.9	47.2	21.9	31.3	32.6	35.0	36.8	40.6	41.1	33.9	24.8	34.2	31.6	31.5	20.8	30.6	31.0	31.5	31.6	31.0	25.7	27.8	27.9	33.6	31.3	35.9	37.2	33.2	24.2	30.0	30.7	27.9	19.5	18.4	9.7	16.1	12.9	21.9	15.7	12.4	18.0	21.2	28.6	12.9	26.2	16.0	11.6	20.0	23.5	28.0	19.2	14.3	32.0	18.6	19.7	25.1	16.2	25.5	18.7	22.4	11.2	30.4	11.1	30.9	25.6	15.7	15.2	13.1	23.9	17.4	18.3	17.7	22.5	12.4	24.1	21.4	32.6	21.4	28.9	25.1	35.8	26.0	24.8	22.6	17.6	14.9	32.5	22.0	22.3	26.7	32.6	15.6	46.2	22.8	22.4	18.9	20.4	10.2	20.7	24.9	36.9	21.5	25.0	31.9	24.6	15.4	24.5	16.3	9.7	14.1	9.3	14.7	16.1	16.1	19.5	17.1	14.7	18.4	14.3	21.5	17.4	4.4	12.9	13.6	9.4	21.9	15.7	31.8	34.3	41.1	38.4	27.7	20.1	32.6	35.0	34.2	35.9	29.8	31.7	53.2	52.9	32.5	29.3	64.2	28.1	49.5	40.9	26.2	21.6	104.2	61.3	64.5	72.7	34.3	36.7	0.0	64.0	49.3	41.1	31.6	58.9	46.5	48.7	22.3	26.0	24.5	42.2	18.6	48.1	38.4	25.3	93.8	43.0	33.6	54.8	42.1	46.7	96.5	33.4	64.7	42.9	84.6	53.0	32.9	104.5	57.5	55.1	47.7
PSMD14	"pad1, POH1, Rpn11"	ENSG00000115233	"Proteasome 26S subunit, non-ATPase 14"	O00487	2	161308038-161411717	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"DNA damage, DNA repair, Ubl conjugation pathway"	"Hydrolase, Metalloprotease, Protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA002114, HPA003828"	Approved		Supported	Nucleoplasm		NA	NA		9400	Nucleoplasm		"HPA002114: AB_1855850, HPA003828: AB_2667057"	"unprognostic (3.50e-3)"	"unprognostic (1.48e-1)"	"unprognostic (9.61e-2)"	"unprognostic (6.63e-2)"	"unprognostic (2.57e-1)"	"unprognostic (7.61e-3)"	"prognostic unfavorable (2.66e-8)"	"unprognostic (3.11e-2)"	"unprognostic (4.04e-2)"	"unprognostic (3.90e-3)"	"unprognostic (9.84e-3)"	"unprognostic (3.02e-1)"	"prognostic unfavorable (3.10e-6)"	"unprognostic (2.86e-2)"	"unprognostic (4.70e-2)"	"unprognostic (3.54e-1)"	"unprognostic (1.66e-1)"	18.2	26.3	24.8	19.9	25.0	16.8	19.8	21.0	36.9	14.7	17.9	13.5	11.0	15.0	15.6	16.3	23.7	14.4	12.2	22.3	24.8	26.1	23.5	33.7	16.2	24.9	26.2	16.1	11.8	15.0	18.6	24.3	21.5	27.9	16.8	21.9	13.0	15.1	16.7	60.8	16.7	14.3	20.6	26.0	20.2	13.6	19.0	15.3	22.1	18.2	21.6	25.6	15.2	13.1	22.9	27.2	13.1	24.6	23.6	29.6	24.7	35.5	30.9	34.8	30.5	25.4	21.7	42.6	37.4	36.0	53.6	43.7	45.4	30.3	42.2	57.1	27.2	31.8	27.4	37.9	39.6	53.6	43.9	28.5	42.1	25.0	50.9	31.2	40.8	25.1	16.5	30.0	60.5	56.6	20.8	39.8	25.3	45.6	30.4	44.5	33.9	30.1	30.8	48.3	26.2	46.9	26.0	33.8	41.2	47.2	30.5	30.3	22.3	25.4	28.7	34.6	30.2	19.5	26.2	31.4	36.0	33.8	24.4	40.8	18.2	49.2	39.6	38.6	27.2	39.4	13.1	17.9	8.8	25.3	24.6	26.5	22.9	27.4	27.0	27.2	19.1	22.2	26.5	1.9	23.6	19.1	26.7	29.6	24.7	24.8	25.0	21.0	36.9	24.8	26.1	26.2	16.1	27.9	15.3	47.6	33.9	44.7	39.4	44.0	40.0	76.7	63.7	42.8	47.8	22.7	17.7	140.9	76.3	104.7	52.8	33.7	43.3	116.8	102.6	127.3	45.3	47.7	48.7	107.7	92.8	44.5	50.4	38.6	35.5	24.8	25.6	45.0	45.5	84.8	42.0	72.5	114.5	46.3	32.2	81.6	54.2	32.3	39.1	93.8	67.0	48.9	184.2	43.6	58.4	43.1
PSMD7	"MOV34, P40, Rpn8, S12"	ENSG00000103035	"Proteasome 26S subunit, non-ATPase 7"	P51665	16	74296775-74306288	"Enzymes, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"	5	"Syncytiotrophoblasts: 498.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB019379, HPA049824, HPA056069"	Enhanced		Enhanced	Nucleoplasm		NA	NA		340000	Nucleoplasm		"CAB019379: , HPA049824: AB_2680899, HPA056069: AB_2683025"	"unprognostic (4.75e-3)"	"unprognostic (1.30e-1)"	"unprognostic (2.84e-2)"	"unprognostic (6.95e-2)"	"unprognostic (7.62e-2)"	"prognostic unfavorable (6.64e-5)"	"prognostic unfavorable (7.71e-6)"	"unprognostic (1.97e-2)"	"unprognostic (6.51e-2)"	"unprognostic (1.91e-2)"	"unprognostic (9.34e-3)"	"unprognostic (1.34e-2)"	"unprognostic (2.52e-2)"	"unprognostic (5.06e-3)"	"unprognostic (7.04e-2)"	"unprognostic (2.12e-1)"	"unprognostic (1.86e-2)"	26.5	30.3	23.6	20.8	32.8	45.7	21.7	21.7	34.4	17.7	26.6	22.4	17.0	19.8	24.3	26.1	31.5	16.9	17.6	59.0	22.0	21.7	25.0	47.8	20.3	23.5	24.9	22.9	17.1	18.8	23.2	17.4	44.1	36.1	30.3	28.3	16.7	22.8	27.1	88.8	30.6	22.3	26.4	25.1	27.1	21.8	20.3	22.4	30.7	18.2	34.4	28.4	34.6	22.3	50.3	71.0	64.7	60.8	44.6	56.5	58.1	27.2	45.4	33.7	17.2	24.4	25.3	42.6	38.4	32.4	47.3	43.9	60.1	38.0	37.4	42.7	31.1	20.9	35.4	26.9	34.8	42.3	22.1	29.6	28.9	35.3	45.8	32.2	46.7	49.3	23.2	35.1	42.6	42.8	21.1	41.4	23.7	42.7	16.6	30.1	67.6	26.8	44.2	36.6	27.9	22.8	38.8	21.8	49.7	25.0	41.2	21.5	24.3	37.3	14.0	22.0	26.9	29.7	32.2	37.5	28.4	23.8	30.9	28.7	35.6	45.7	109.0	38.7	34.2	29.3	45.6	58.4	64.7	49.8	60.8	48.5	50.3	49.7	52.0	71.0	36.1	48.7	49.9	34.8	44.6	60.2	59.6	56.5	58.1	23.6	32.8	21.7	34.4	22.0	21.7	24.9	22.9	36.1	22.4	62.5	54.4	81.1	136.0	92.7	50.9	45.6	63.7	85.6	83.0	43.6	7.9	286.0	68.0	118.6	92.9	69.2	93.5	70.0	165.2	180.6	80.2	157.1	101.6	127.1	167.8	54.0	82.1	71.8	72.2	15.2	52.3	110.5	94.5	141.5	71.9	64.7	136.6	87.7	61.5	80.1	48.3	90.5	77.3	113.4	94.9	113.0	498.5	82.8	82.9	180.5
RNPEP	APB	ENSG00000176393	"Arginyl aminopeptidase"	Q9H4A4	1	201982372-202006147	"Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"		"Aminopeptidase, Hydrolase, Metalloprotease, Protease"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	4	"Enterocytes: 152.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Group enriched"	"Detected in all"	4	"dendritic cells: 12.1;granulocytes: 12.3;monocytes: 17.0"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA036074, HPA036075, HPA061487"	Approved		Approved	"Golgi apparatus"	"Secreted - unknown location"	NA	NA		6600000	"Golgi apparatus"		"HPA036074: AB_2674926, HPA036075: AB_10672999, HPA061487: AB_2684537"	"unprognostic (8.57e-2)"	"unprognostic (3.43e-2)"	"unprognostic (2.81e-1)"	"unprognostic (5.45e-2)"	"unprognostic (2.68e-1)"	"unprognostic (1.74e-2)"	"unprognostic (1.95e-2)"	"unprognostic (2.87e-2)"	"unprognostic (1.93e-3)"	"unprognostic (1.80e-1)"	"unprognostic (1.07e-1)"	"unprognostic (1.28e-1)"	"unprognostic (3.50e-3)"	"unprognostic (1.91e-1)"	"unprognostic (6.00e-2)"	"unprognostic (1.97e-2)"	"unprognostic (1.68e-1)"	18.5	22.0	6.4	14.9	8.2	9.5	16.7	9.2	11.0	17.8	34.2	13.5	21.2	31.1	17.4	18.7	33.2	19.2	21.8	11.5	6.1	4.6	22.5	18.3	21.5	14.1	7.0	5.4	18.0	19.5	11.6	10.4	26.3	9.0	18.4	26.8	16.4	25.1	13.6	10.0	18.3	66.6	12.8	8.1	22.7	15.7	21.2	6.0	13.9	28.4	19.1	24.7	17.6	17.5	2.3	12.1	12.3	17.0	1.6	3.1	2.2	19.1	20.9	12.5	18.7	20.4	19.2	31.4	14.8	28.8	18.6	21.0	15.0	24.6	4.2	19.1	26.1	11.5	34.9	15.9	29.0	13.0	11.4	20.5	10.5	10.0	14.0	17.4	26.7	37.1	17.5	30.0	16.6	19.1	23.1	33.4	10.4	23.8	6.2	18.8	17.5	3.6	11.4	17.6	30.6	10.4	14.0	17.6	29.6	38.6	17.5	14.4	12.2	36.7	45.8	14.8	25.3	34.8	15.2	23.8	8.7	11.8	8.5	18.0	13.9	11.2	3.8	8.7	22.7	17.4	10.8	9.2	12.3	1.9	15.7	2.6	1.6	2.0	2.2	12.1	2.3	1.8	2.1	6.7	1.6	17.0	4.5	3.1	2.2	6.4	8.2	9.2	11.0	6.1	4.6	7.0	5.4	9.0	6.0	8.9	19.2	23.6	35.3	25.5	11.5	9.0	43.3	13.4	15.9	24.4	9.8	99.1	16.6	59.5	4.4	20.4	152.6	0.0	44.9	74.5	19.0	29.0	15.0	46.6	92.1	11.1	43.1	27.0	67.5	3.8	23.6	48.7	23.6	85.6	66.6	10.8	41.4	81.6	21.5	50.1	7.7	25.8	18.6	15.7	8.2	18.9	73.2	17.5	73.0	31.8
RNPEPL1		ENSG00000142327	"Arginyl aminopeptidase like 1"	Q9HAU8	2	240565804-240581372	"Enzymes, Predicted intracellular proteins"		"Aminopeptidase, Hydrolase, Metalloprotease, Protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	4	"Enterocytes: 92.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA036772, HPA036773"	Uncertain		Supported	"Nucleoplasm,Nuclear bodies"		NA	NA			Nucleoplasm	"Nuclear bodies"	"HPA036772: AB_10670848, HPA036773: "	"unprognostic (3.92e-2)"	"unprognostic (7.28e-2)"	"unprognostic (1.20e-2)"	"unprognostic (2.39e-1)"	"unprognostic (5.24e-3)"	"prognostic favorable (7.43e-4)"	"prognostic unfavorable (5.06e-4)"	"unprognostic (3.72e-3)"	"unprognostic (9.10e-2)"	"unprognostic (1.66e-3)"	"unprognostic (3.10e-1)"	"unprognostic (1.71e-1)"	"unprognostic (1.98e-2)"	"unprognostic (5.33e-2)"	"unprognostic (1.57e-1)"	"unprognostic (5.31e-2)"	"unprognostic (9.86e-2)"	17.2	13.7	10.1	13.7	8.8	17.2	48.4	7.2	10.5	11.0	21.0	9.5	11.8	18.6	8.0	8.9	22.1	8.0	22.3	28.3	9.2	6.0	18.2	26.7	32.2	54.1	12.9	8.2	7.1	40.0	7.7	4.3	10.1	8.1	14.9	9.1	7.0	21.5	13.5	26.5	22.5	31.0	11.4	9.7	25.7	20.0	5.9	7.6	23.1	8.8	16.7	12.1	14.4	18.8	7.0	7.6	22.4	9.1	7.6	12.4	5.4	6.9	11.7	2.6	6.9	9.6	10.0	8.9	4.5	11.2	5.0	6.3	3.2	20.6	2.0	2.3	11.3	7.1	7.6	2.9	8.4	0.5	12.2	4.0	4.6	3.8	18.9	24.1	3.0	8.4	11.8	13.6	2.6	5.2	8.1	17.3	8.0	3.4	13.6	3.4	9.8	3.7	11.3	3.4	13.6	4.7	7.9	3.9	16.9	20.5	9.6	2.4	5.2	3.0	10.4	20.3	3.1	7.3	13.8	11.8	5.5	5.7	7.6	5.1	12.9	1.9	2.3	11.3	8.4	8.2	5.8	9.1	22.4	12.4	7.8	10.6	7.0	9.6	11.1	6.4	6.8	5.4	8.1	16.0	7.6	7.6	7.6	11.1	5.4	10.1	8.8	7.2	10.5	9.2	6.0	12.9	8.2	8.1	7.6	20.8	28.4	28.0	12.0	6.9	6.3	30.7	15.3	2.7	10.3	12.2	0.0	6.1	14.9	22.4	2.6	17.8	92.4	0.0	42.5	5.7	9.9	19.0	33.5	37.6	38.2	3.2	25.3	28.3	58.8	3.7	8.1	30.5	21.9	22.6	46.2	12.2	47.4	37.7	12.7	26.5	6.2	12.9	16.5	0.9	8.3	8.2	4.2	40.6	33.1	19.2
SPG7	"CAR, CMAR, SPG5C"	ENSG00000197912	"SPG7, paraplegin matrix AAA peptidase subunit"	Q9UQ90	16	89490719-89557768	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"		"Hydrolase, Metalloprotease, Protease"	"Disease mutation, Hereditary spastic paraplegia, Neurodegeneration, Osteogenesis imperfecta"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"									NA	NA						"unprognostic (1.42e-1)"	"unprognostic (1.72e-1)"	"unprognostic (4.12e-2)"	"prognostic favorable (2.22e-4)"	"unprognostic (4.10e-1)"	"unprognostic (1.11e-2)"	"unprognostic (1.14e-1)"	"unprognostic (1.50e-1)"	"unprognostic (1.54e-1)"	"unprognostic (2.33e-1)"	"prognostic favorable (4.91e-4)"	"unprognostic (3.56e-2)"	"unprognostic (7.01e-2)"	"unprognostic (1.44e-2)"	"unprognostic (2.58e-1)"	"unprognostic (1.71e-1)"	"prognostic favorable (4.25e-4)"	14.6	23.6	15.6	11.7	19.9	14.5	17.5	25.2	33.2	14.2	14.9	19.1	19.5	18.0	18.3	16.1	14.2	13.9	15.9	34.3	15.6	15.6	22.3	24.5	14.1	16.2	13.9	23.7	21.6	22.1	17.9	21.0	10.2	19.3	15.9	14.0	16.5	17.4	18.1	75.6	27.9	17.7	17.8	16.9	17.8	16.5	24.1	12.9	13.3	28.4	18.4	16.1	16.6	13.4	6.6	5.0	7.9	4.9	7.2	6.4	2.0	5.5	15.2	7.9	14.1	15.1	9.3	6.2	14.9	10.4	8.7	5.2	12.0	11.6	8.7	16.0	9.2	8.4	14.9	10.7	11.1	9.5	5.0	13.4	4.2	7.6	21.8	6.6	3.5	5.7	5.2	7.7	5.4	6.3	12.5	12.1	10.3	9.5	3.7	8.2	10.9	7.6	12.8	14.0	13.1	11.0	14.1	13.9	5.3	8.4	8.5	8.5	5.6	21.8	3.8	4.5	9.0	12.4	9.1	18.9	6.9	9.6	4.8	6.9	6.2	9.8	7.6	8.9	10.1	8.2	7.9	4.9	7.4	5.6	4.7	5.4	3.3	3.5	2.8	5.0	6.6	6.4	4.3	7.2	7.2	3.3	4.9	3.6	2.0	15.6	19.9	25.2	33.2	15.6	15.6	13.9	23.7	19.3	12.9	44.7	49.6	31.3	24.6	14.2	52.0	39.7	25.5	26.8	43.3	33.2	90.3	32.7	16.6	35.1	57.2	38.6	49.1	23.3	22.6	24.1	28.8	23.0	19.8	33.4	28.0	38.1	35.7	52.2	37.1	16.2	39.7	32.7	20.3	39.7	41.2	36.4	31.8	45.6	31.5	18.3	70.5	6.5	29.3	44.2	37.0	15.7	21.6	38.3	44.4	23.8
STAMBP	AMSH	ENSG00000124356	"STAM binding protein"	O95630	2	73828916-73873659	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Ubl conjugation pathway"	"Hydrolase, Metalloprotease, Protease"	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enriched"	"Detected in all"	12	"LHCN-M2: 162.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA035800, HPA035801"	Uncertain		Supported	"Nucleoplasm,Plasma membrane,Cytosol"		NA	NA		11000	Nucleoplasm	"Plasma membrane, Cytosol"	"HPA035800: AB_10670591, HPA035801: AB_2732470"	"unprognostic (1.86e-2)"	"unprognostic (1.14e-1)"	"unprognostic (2.16e-1)"	"prognostic unfavorable (4.70e-5)"	"unprognostic (6.13e-2)"	"unprognostic (2.08e-3)"	"unprognostic (3.73e-2)"	"unprognostic (1.71e-1)"	"unprognostic (6.58e-2)"	"unprognostic (2.96e-2)"	"prognostic unfavorable (5.79e-4)"	"unprognostic (1.01e-1)"	"unprognostic (2.29e-1)"	"unprognostic (7.72e-2)"	"unprognostic (2.63e-1)"	"unprognostic (1.43e-1)"	"unprognostic (2.89e-1)"	12.9	12.8	22.1	13.9	23.0	10.5	17.8	20.1	21.8	18.1	18.4	35.0	13.6	17.8	23.1	15.4	22.7	16.5	14.7	19.0	23.3	21.2	19.6	16.9	13.4	15.3	33.0	14.3	16.3	15.1	20.9	17.8	20.6	26.3	20.2	20.7	14.6	18.3	15.7	30.1	14.4	25.2	19.0	54.7	13.8	15.6	13.3	22.3	18.4	20.1	15.9	19.0	16.8	16.4	17.6	16.9	27.8	17.8	16.7	20.7	12.3	5.4	6.3	5.0	4.6	4.7	5.7	5.8	3.3	4.6	6.2	6.0	10.5	5.2	4.6	5.3	2.8	8.3	4.3	5.3	11.8	7.1	8.0	6.0	6.1	4.4	8.2	6.5	5.0	7.4	4.5	8.5	7.3	10.6	7.9	3.6	6.3	6.6	7.0	162.7	6.6	7.7	4.5	8.0	7.8	3.4	5.4	13.2	6.5	6.6	6.2	9.2	6.8	4.1	5.0	7.1	5.6	4.7	3.0	3.1	5.6	6.7	3.3	5.9	6.6	6.4	3.5	6.9	5.4	6.5	22.6	16.2	27.8	14.4	17.8	15.4	17.6	16.7	14.0	16.9	16.2	17.5	13.2	24.1	16.7	15.7	16.4	20.7	12.3	22.1	23.0	20.1	21.2	23.3	21.2	33.0	14.3	26.3	22.3	17.9	15.3	14.1	25.1	14.4	19.9	35.5	35.7	25.4	27.3	24.4	11.8	35.2	41.4	32.4	59.2	21.7	40.9	46.7	31.9	28.3	22.6	34.8	51.9	34.7	29.0	25.4	9.9	20.3	24.7	104.7	30.2	29.2	6.8	36.9	31.9	21.5	36.9	38.6	32.5	47.1	19.2	38.8	20.6	32.3	49.5	18.9	37.2	19.5	31.2	23.0
STAMBPL1	"ALMalpha, AMSH-FP, AMSH-LP, bA399O19.2, FLJ31524, KIAA1373"	ENSG00000138134	"STAM binding protein like 1"	Q96FJ0	10	88879734-88975153	"Enzymes, Predicted intracellular proteins"	"Ubl conjugation pathway"	"Hydrolase, Metalloprotease, Protease"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"testis: 18.6"	"Cell type enhanced"	"Detected in many"	8	"Early spermatids: 37.8;Spermatocytes: 27.6"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA040202	Uncertain		Approved	"Plasma membrane"		NA	NA			"Plasma membrane"		"HPA040202: AB_10805708"	"unprognostic (2.73e-1)"	"unprognostic (1.95e-1)"	"unprognostic (7.56e-2)"	"unprognostic (4.25e-2)"	"unprognostic (6.46e-2)"	"unprognostic (6.27e-2)"	"unprognostic (1.68e-2)"	"unprognostic (1.05e-2)"	"unprognostic (4.67e-2)"	"unprognostic (8.20e-2)"	"unprognostic (2.78e-1)"	"unprognostic (6.57e-2)"	"prognostic unfavorable (1.08e-5)"	"unprognostic (4.41e-2)"	"unprognostic (4.06e-2)"	"unprognostic (1.50e-1)"	"unprognostic (4.40e-3)"	3.9	15.9	3.7	6.8	5.1	2.8	2.1	12.4	8.9	2.0	5.8	3.4	1.5	4.5	2.7	1.5	2.7	1.2	2.9	4.8	3.3	3.4	1.5	1.7	2.9	11.3	2.6	14.8	8.5	1.8	2.2	6.6	1.5	4.1	1.9	8.0	1.5	1.5	1.5	1.5	3.4	6.1	1.8	3.1	6.0	3.1	18.6	3.2	1.5	1.5	1.5	9.5	3.9	2.7	10.5	15.2	4.3	0.6	13.1	14.7	4.5	6.8	8.1	0.5	0.3	8.1	15.6	0.0	14.4	14.2	9.3	8.3	0.3	13.1	8.4	1.0	7.8	6.2	3.4	2.0	2.9	9.4	7.4	5.1	2.1	5.8	0.4	5.5	9.2	3.0	5.5	0.7	15.5	4.9	10.6	0.2	10.1	0.0	3.8	24.9	1.4	15.3	10.9	3.0	6.5	6.3	1.5	6.1	1.8	3.5	2.6	4.7	5.6	1.8	0.6	16.4	2.0	1.0	1.9	2.1	8.3	6.0	9.9	9.0	8.9	8.4	7.8	9.1	9.4	7.8	4.3	0.6	4.2	6.3	0.6	8.2	10.5	9.2	7.9	0.9	7.0	9.9	5.9	0.9	13.1	0.3	15.2	14.7	4.5	3.7	5.1	12.4	8.9	3.3	3.4	2.6	14.8	4.1	3.2	0.0	5.0	9.3	4.1	8.5	3.7	5.0	0.0	8.1	0.0	5.2	0.0	0.1	0.0	0.8	37.8	2.2	7.4	0.0	1.6	0.1	5.1	1.5	4.7	1.9	3.0	6.4	8.7	1.8	1.0	13.9	6.6	3.5	0.0	1.0	8.1	10.6	1.2	0.0	1.4	0.5	0.2	0.0	6.7	27.6	2.4	9.9	0.1	14.9	13.3	1.6
SUPT16H	"CDC68, FACT, FACTP140, FLJ10857, FLJ14010, SPT16/CDC68"	ENSG00000092201	"SPT16 homolog, facilitates chromatin remodeling subunit"	Q9Y5B9	14	21351472-21384266	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"DNA damage, DNA repair, DNA replication, Host-virus interaction, Transcription, Transcription regulation"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB022551, HPA049787"	Enhanced		Supported	"Nucleoplasm,Nucleoli fibrillar center"		NA	NA			Nucleoplasm	"Nucleoli fibrillar center"	"CAB022551: , HPA049787: AB_2680881"	"unprognostic (1.65e-1)"	"unprognostic (2.22e-1)"	"unprognostic (3.52e-2)"	"unprognostic (7.12e-2)"	"unprognostic (7.32e-2)"	"unprognostic (1.22e-2)"	"unprognostic (1.38e-3)"	"unprognostic (1.86e-1)"	"unprognostic (7.65e-2)"	"unprognostic (4.91e-2)"	"unprognostic (1.09e-1)"	"unprognostic (1.26e-1)"	"unprognostic (6.48e-3)"	"unprognostic (1.02e-1)"	"unprognostic (7.58e-3)"	"unprognostic (9.05e-2)"	"unprognostic (5.87e-3)"	21.6	18.3	16.3	21.6	26.2	21.5	21.3	39.1	27.9	22.8	21.3	14.4	20.7	13.5	31.5	18.5	20.9	23.7	14.5	15.9	17.9	16.2	17.7	14.1	17.1	28.0	18.8	22.8	29.0	15.7	40.3	24.0	18.9	28.6	18.8	21.5	11.3	19.3	20.5	21.4	22.1	19.9	27.4	18.9	22.6	19.1	24.9	19.0	32.7	20.3	17.0	29.5	24.6	20.7	23.3	17.1	21.1	20.4	23.2	26.8	16.7	30.4	28.8	39.9	29.2	18.1	18.1	28.4	27.6	22.0	33.7	31.8	27.8	27.5	64.7	10.6	20.0	21.7	32.6	50.5	24.9	51.1	20.6	21.5	39.2	26.3	39.0	18.5	55.4	29.2	15.9	15.3	28.1	31.8	16.3	22.8	36.9	32.2	27.9	27.8	19.7	51.7	16.9	44.6	28.0	28.6	56.0	45.6	35.0	13.5	33.7	40.0	34.1	44.6	26.8	16.7	26.9	14.8	26.3	19.2	29.6	24.7	18.3	29.8	27.8	46.5	65.2	10.9	32.7	22.4	21.1	13.1	19.6	22.8	17.3	26.8	23.3	21.8	25.3	17.1	21.3	25.0	25.1	11.0	23.2	20.4	16.1	20.3	16.7	16.3	26.2	39.1	27.9	17.9	16.2	18.8	22.8	28.6	19.0	59.6	49.3	32.0	29.5	31.6	44.4	58.8	33.1	42.8	59.1	50.6	45.2	48.1	21.6	50.6	100.7	39.8	13.9	23.3	52.8	51.4	33.7	25.7	81.0	29.7	36.5	52.4	22.4	28.3	36.2	67.9	55.3	36.3	16.9	116.4	31.1	49.8	52.6	10.5	56.3	25.0	40.5	19.4	44.2	130.3	136.3	36.3	38.1	45.9	38.2	26.4
TFR2	"HFE3, TFRC2"	ENSG00000106327	"Transferrin receptor 2"	Q9UP52	7	100620416-100642779	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted membrane proteins, Transporters"		Receptor	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	20	"liver: 112.6"	"Cell type enriched"	"Detected in many"	4	"Hepatocytes: 379.7"	"Cancer enriched"	"Detected in many"	70	"liver cancer: 136.2"	"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	46	"basophil: 5.5;eosinophil: 3.9"	"Lineage enriched"	"Detected in single"	54	"granulocytes: 5.5"	"Group enriched"	"Detected in some"	11	"HEL: 28.5;HMC-1: 39.6;K-562: 26.3"	"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"CAB016255, HPA017171, HPA073125"	Enhanced		Approved	"Golgi apparatus"		NA	NA			"Golgi apparatus"		"CAB016255: AB_628395, HPA017171: , HPA073125: "	"unprognostic (4.18e-2)"	"unprognostic (1.97e-2)"	"unprognostic (2.74e-1)"	"unprognostic (1.04e-1)"	"unprognostic (1.26e-2)"	"unprognostic (4.13e-2)"	"prognostic favorable (2.48e-4)"	"unprognostic (2.29e-2)"	"unprognostic (4.49e-2)"	"unprognostic (9.26e-2)"	"unprognostic (1.93e-1)"	"unprognostic (2.90e-1)"	"unprognostic (1.18e-9)"	"unprognostic (6.51e-2)"	"unprognostic (1.68e-1)"	"unprognostic (3.28e-1)"	"unprognostic (8.18e-2)"	0.1	0.0	0.1	0.1	0.1	5.3	0.1	0.8	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.0	0.3	0.3	0.1	0.0	0.1	112.6	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.2	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.2	1.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	5.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	28.5	0.0	2.9	0.0	0.6	39.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	26.3	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.5	0.0	3.9	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.8	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.0	0.0	7.8	0.9	0.2	5.3	0.9	12.7	0.0	1.2	0.0	7.9	0.1	0.0	0.4	4.0	0.0	0.0	93.5	0.2	1.1	0.4	0.5	0.0	379.7	0.3	20.6	0.0	7.4	6.9	5.7	0.0	0.5	0.0	0.0	0.2	0.3	0.1	0.0	0.0	0.0	1.8	0.0	0.7	0.7	2.0	0.5	0.1	2.5	0.5	0.6
TFRC	"CD71, p90, TFR1"	ENSG00000072274	"Transferrin receptor"	P02786	3	196027183-196082189	"Cancer-related genes, CD markers, Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins, Transporters"	"Endocytosis, Host-virus interaction"	"Host cell receptor for virus entry, Receptor, Transducer"	"Cancer-related genes, Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"placenta: 110.0"	"Cell type enhanced"	"Detected in many"	10	"Erythroid cells: 560.6;Syncytiotrophoblasts: 420.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB000153, HPA028598"	Enhanced		Supported	Endosomes,Lysosomes	"Secreted to blood"	NA	NA	1310000000	14000000	"Endosomes, Lysosomes"		"CAB000153: AB_2533029, HPA028598: AB_10601599"	"unprognostic (2.95e-2)"	"prognostic unfavorable (3.67e-4)"	"unprognostic (2.55e-1)"	"unprognostic (1.48e-2)"	"unprognostic (6.75e-2)"	"unprognostic (7.88e-3)"	"prognostic unfavorable (1.15e-4)"	"unprognostic (6.92e-2)"	"unprognostic (3.30e-3)"	"unprognostic (4.35e-2)"	"unprognostic (1.34e-2)"	"unprognostic (1.14e-2)"	"unprognostic (3.63e-3)"	"unprognostic (3.65e-2)"	"unprognostic (1.19e-2)"	"prognostic unfavorable (2.96e-4)"	"unprognostic (2.62e-2)"	24.3	11.9	11.9	20.6	11.3	73.8	7.6	9.6	17.8	11.8	25.0	9.5	3.8	11.9	12.1	7.5	18.5	11.7	11.4	18.7	9.5	8.3	15.3	13.6	28.1	8.1	7.4	9.5	50.0	7.8	18.0	6.9	110.0	26.5	7.2	19.4	8.5	8.3	5.0	25.6	9.9	37.4	10.9	13.2	7.9	10.0	8.3	6.1	14.3	7.0	10.5	12.9	11.2	8.0	5.7	7.5	2.2	12.4	1.8	6.5	2.1	22.2	20.2	9.3	18.9	20.6	12.0	58.3	31.8	24.2	22.4	37.2	49.3	20.5	22.8	60.4	11.8	49.0	34.3	31.9	10.5	27.5	109.0	10.8	86.4	17.3	22.9	16.3	70.8	17.5	13.5	10.4	19.3	17.4	6.4	7.4	12.6	36.0	21.9	17.5	20.6	23.2	15.0	28.4	29.3	41.5	12.3	13.8	27.3	20.1	56.3	21.3	8.8	30.7	80.8	7.2	16.1	78.4	14.8	9.5	26.7	21.7	23.3	47.6	6.2	48.1	35.6	31.2	19.2	16.1	0.0	1.6	2.2	2.5	7.9	1.7	5.7	2.7	1.7	3.7	3.2	2.5	1.9	0.3	1.8	12.4	7.5	6.5	2.1	11.9	11.3	9.6	17.8	9.5	8.3	7.4	9.5	26.5	6.1	41.7	27.2	29.6	33.6	53.5	48.1	81.5	45.9	28.1	26.1	19.2	139.4	104.0	0.0	43.1	2.6	17.8	72.1	560.6	36.6	18.5	33.8	15.8	22.0	94.1	70.3	12.7	53.9	6.7	33.3	3.9	10.6	89.7	16.9	72.1	50.0	17.3	38.9	52.6	8.1	9.1	42.4	25.8	34.8	22.3	19.3	31.2	420.4	21.8	70.2	22.9
THOP1		ENSG00000172009	"Thimet oligopeptidase 1"	P52888	19	2785460-2815807	"Enzymes, Plasma proteins, Predicted intracellular proteins"		"Hydrolase, Metalloprotease, Protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	8	"Enterocytes: 167.6;Paneth cells: 149.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB025497, HPA035262"	Uncertain		Supported	Cytosol		NA	NA		1400000	Cytosol		"CAB025497: , HPA035262: AB_2674541"	"unprognostic (1.52e-2)"	"unprognostic (1.73e-3)"	"unprognostic (7.94e-2)"	"prognostic favorable (2.35e-4)"	"unprognostic (1.82e-1)"	"unprognostic (2.16e-2)"	"unprognostic (9.35e-2)"	"unprognostic (1.19e-1)"	"unprognostic (4.05e-2)"	"unprognostic (1.43e-1)"	"unprognostic (1.20e-3)"	"unprognostic (3.00e-2)"	"unprognostic (1.39e-1)"	"prognostic favorable (5.90e-4)"	"unprognostic (1.27e-1)"	"unprognostic (2.64e-1)"	"unprognostic (5.37e-2)"	8.2	9.4	19.1	12.3	19.8	18.4	6.2	21.7	26.1	5.2	11.8	14.1	5.8	24.6	7.5	8.4	11.0	8.4	6.7	11.6	18.5	15.4	7.1	30.4	6.2	11.9	14.1	15.2	11.1	7.8	7.0	12.7	22.3	13.1	18.1	8.2	11.9	13.7	6.8	29.1	11.9	20.0	7.1	10.7	9.8	7.8	27.3	10.9	17.0	7.5	11.5	11.3	5.8	6.8	7.5	9.8	8.0	7.5	3.9	9.5	3.2	29.4	21.9	8.6	18.3	4.4	4.3	30.5	18.4	6.8	18.3	14.8	25.7	9.4	26.6	9.0	7.1	12.8	24.0	12.7	15.1	7.7	0.1	26.6	9.4	24.1	30.4	4.7	18.1	14.7	4.8	5.4	15.2	6.8	5.2	10.4	18.0	21.8	13.0	7.7	22.8	20.1	34.0	25.2	8.8	30.2	16.7	11.4	25.1	7.6	17.1	23.3	18.5	16.1	14.5	8.9	4.6	14.0	17.6	11.7	14.1	12.1	30.0	31.1	22.8	19.1	17.9	15.7	30.4	16.7	8.0	3.5	1.6	5.5	3.9	4.5	5.6	4.0	7.4	4.9	7.5	5.1	4.3	1.7	3.9	7.5	9.8	9.5	3.2	19.1	19.8	21.7	26.1	18.5	15.4	14.1	15.2	13.1	10.9	3.0	11.7	12.3	8.7	6.1	20.3	7.3	10.2	5.3	7.9	10.4	33.4	20.9	8.3	17.0	11.4	5.7	167.6	0.0	12.9	46.8	8.4	12.6	5.7	79.1	19.9	6.4	39.2	6.2	9.5	18.4	10.6	7.0	3.3	11.8	46.9	12.9	15.9	149.7	5.6	9.1	29.7	12.9	9.2	47.9	19.4	5.1	28.3	6.5	38.5	6.4
TLL1		ENSG00000038295	"Tolloid like 1"	O43897	4	165873258-166103895	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted secreted proteins"	Differentiation	"Developmental protein, Hydrolase, Metalloprotease, Protease"	"Atrial septal defect, Disease mutation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 40.6"	"Cell type enhanced"	"Detected in many"	11	"Bipolar cells: 15.1;Endothelial cells: 11.3;Horizontal cells: 7.9"	"Low cancer specificity"	"Detected in some"			"Region enriched"	"Detected in many"	5	"cerebellum: 40.6"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	4	"HeLa: 8.7;Karpas-707: 13.6;PC-3: 4.9"	"Low region specificity"	"Detected in many"			"Region enriched"	"Detected in all"	10	"cerebellum: 132.6"	HPA060767			Approved	Vesicles	"Secreted to extracellular matrix"	NA	NA			Vesicles		"HPA060767: AB_2684357"	"unprognostic (2.17e-1)"	"unprognostic (6.45e-4)"	"unprognostic (8.60e-2)"	"unprognostic (2.65e-5)"	"unprognostic (9.85e-2)"	"unprognostic (2.51e-4)"	"unprognostic (3.37e-2)"	"unprognostic (3.61e-2)"	"unprognostic (1.56e-1)"	"unprognostic (5.07e-4)"	"unprognostic (2.86e-2)"	"unprognostic (2.34e-1)"	"unprognostic (2.23e-2)"	"unprognostic (2.13e-3)"	"unprognostic (7.76e-2)"	"unprognostic (6.91e-3)"	"unprognostic (1.21e-5)"	10.1	1.3	1.2	2.6	2.8	0.0	7.9	40.6	2.9	5.0	5.4	0.2	4.2	1.4	3.0	2.7	2.5	2.4	5.4	2.4	2.2	1.7	3.3	0.5	3.1	3.0	1.1	0.6	1.6	4.6	1.1	2.2	13.8	8.5	3.1	2.2	3.3	1.9	1.9	1.6	2.7	4.4	3.3	0.9	0.4	1.7	1.5	0.1	0.0	3.2	1.4	1.6	3.6	7.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	2.0	0.5	1.7	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	2.2	0.0	0.1	0.0	8.7	0.0	0.0	0.0	0.0	0.6	1.5	0.0	1.8	0.0	1.4	0.0	0.0	13.6	0.0	0.0	0.0	0.2	1.2	0.0	4.9	0.0	0.0	0.0	0.2	0.0	1.1	0.0	0.7	0.2	0.0	0.0	0.0	0.0	0.0	0.1	1.5	0.0	0.3	0.2	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	2.8	40.6	2.9	2.2	1.7	1.1	0.6	8.5	0.1	0.0	1.1	0.0	0.2	1.5	15.1	4.1	0.0	1.4	1.2	0.0	0.0	3.9	0.0	1.5	0.0	11.3	0.0	0.0	1.9	0.9	1.6	0.8	0.0	0.0	0.2	7.9	0.0	1.8	0.0	0.0	2.8	0.0	1.7	0.0	0.0	0.0	0.1	0.0	4.2	0.8	0.5	0.0	0.3	0.1	0.0	1.5	1.6	0.0	0.0	0.1
TLL2		ENSG00000095587	"Tolloid like 2"	Q9Y6L7	10	96364606-96513918	"Enzymes, Predicted secreted proteins"	Differentiation	"Developmental protein, Hydrolase, Metalloprotease, Protease"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"heart muscle: 7.4"	"Cell type enhanced"	"Detected in some"	8	"Cardiomyocytes: 4.8;Early spermatids: 5.2;Late spermatids: 3.4;Syncytiotrophoblasts: 2.9"	"Low cancer specificity"	"Detected in single"			"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	11	"RPTEC TERT1: 21.7"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"								"Secreted - unknown location"	NA	NA						"unprognostic (1.28e-2)"	"unprognostic (7.54e-4)"	"unprognostic (1.50e-1)"	"unprognostic (3.31e-3)"	"unprognostic (2.67e-1)"	"unprognostic (2.14e-3)"	"unprognostic (1.31e-2)"	"unprognostic (3.52e-4)"	"unprognostic (7.08e-2)"	"unprognostic (2.50e-1)"	"unprognostic (6.71e-2)"	"unprognostic (3.37e-2)"	"unprognostic (4.98e-4)"	"unprognostic (2.90e-1)"	"unprognostic (8.41e-2)"	"unprognostic (1.95e-4)"	"unprognostic (2.30e-1)"	0.7	1.1	3.2	1.4	4.9	1.6	0.7	0.7	5.8	0.8	1.1	5.7	2.5	1.7	1.2	1.1	0.9	0.7	2.6	7.4	3.3	3.8	0.7	0.6	0.5	1.8	3.4	2.1	1.4	1.5	0.4	2.8	1.1	4.6	1.1	1.1	0.0	3.9	2.7	4.1	1.0	2.1	0.9	6.1	0.9	2.1	1.1	5.7	0.0	1.5	4.0	0.7	0.8	0.5	0.9	0.3	0.6	0.2	0.3	0.2	0.0	0.2	0.1	0.4	0.2	0.1	0.0	0.1	0.2	0.0	0.1	0.1	0.0	0.1	0.3	1.1	0.1	0.2	0.1	0.2	0.1	0.0	2.0	0.4	0.0	0.2	0.0	0.0	0.0	0.1	0.2	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.1	0.1	0.0	1.3	0.7	0.1	0.1	0.4	0.0	21.7	0.1	0.8	0.1	0.1	0.0	0.1	0.7	0.0	0.0	0.0	0.1	0.4	0.1	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.1	0.2	0.0	0.2	0.9	0.2	0.1	0.0	0.9	0.2	0.2	0.6	0.3	0.2	0.3	0.1	0.0	3.2	4.9	0.7	4.0	3.3	3.8	3.4	2.1	4.6	5.7	0.0	0.6	0.0	0.4	0.1	0.0	4.8	2.5	0.0	1.2	0.0	0.0	2.2	0.0	0.3	5.2	0.5	0.0	0.0	0.5	0.0	0.6	0.9	0.0	0.0	0.3	0.0	0.0	0.0	0.3	3.4	0.3	1.0	0.0	0.0	1.3	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.5	0.1	2.0	0.4	2.9	0.0	0.0	0.4
TRHDE	"PAP-II, PGPEP2, TRH-DE"	ENSG00000072657	"Thyrotropin releasing hormone degrading enzyme"	Q9UKU6	12	72087266-72670757	"Enzymes, Predicted intracellular proteins, Predicted membrane proteins"		"Aminopeptidase, Hydrolase, Metalloprotease, Protease"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 30.3;pancreas: 19.4"	"Group enriched"	"Detected in some"	4	"Early spermatids: 30.7;Late spermatids: 47.8;Leydig cells: 27.3;Peritubular cells: 12.7"	"Cancer enhanced"	"Detected in some"		"renal cancer: 1.9"	"Region enhanced"	"Detected in many"		"cerebellum: 30.3"	"Cell type enhanced"	"Detected in single"		"basophil: 1.0"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in some"		"BJ: 20.8;BJ hTERT+: 20.2;EFO-21: 10.9;HBF TERT88: 7.4;hTERT-RPE1: 7.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"									NA	NA		6200000				"unprognostic (3.56e-2)"	"unprognostic (4.06e-3)"	"unprognostic (6.01e-2)"	"unprognostic (1.44e-6)"	"unprognostic (1.77e-1)"	"unprognostic (6.37e-2)"	"unprognostic (7.79e-2)"	"unprognostic (6.96e-2)"	"unprognostic (3.99e-2)"	"unprognostic (1.48e-1)"	"unprognostic (5.14e-4)"	"unprognostic (2.40e-1)"	"prognostic favorable (1.53e-7)"	"unprognostic (2.55e-2)"	"unprognostic (2.48e-1)"	"unprognostic (8.91e-3)"	"unprognostic (2.94e-2)"	6.2	2.2	2.9	1.0	4.7	1.0	7.6	30.3	12.3	10.2	2.4	0.1	2.5	4.8	2.7	1.7	0.9	2.5	2.5	2.2	7.3	2.8	9.9	1.5	3.0	0.6	1.2	5.5	6.5	19.4	0.4	1.6	0.7	1.5	5.5	1.5	1.0	2.4	5.8	0.7	0.8	4.2	1.2	0.9	4.8	1.1	1.7	0.5	0.0	0.5	0.4	1.0	2.8	7.6	0.2	0.0	1.0	0.3	0.3	0.0	0.0	2.4	0.0	0.4	0.0	1.1	0.0	6.7	20.8	20.2	2.0	1.4	0.0	0.0	0.0	10.9	3.0	2.1	0.2	3.8	0.0	7.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.0	1.6	7.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	6.0	0.0	0.0	0.0	6.9	4.6	2.0	0.0	0.0	0.0	0.0	0.4	0.0	4.0	0.0	0.0	2.2	0.0	0.3	0.0	0.0	0.0	0.0	0.4	0.0	1.0	0.1	0.2	0.0	0.3	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.8	0.3	0.0	0.0	0.0	0.0	2.9	4.7	30.3	12.3	7.3	2.8	1.2	5.5	1.5	0.5	0.0	0.3	0.0	0.0	0.0	0.2	0.8	0.0	1.4	0.0	1.8	0.0	0.0	3.3	0.0	30.7	0.0	6.9	0.0	2.2	0.3	0.5	0.2	0.0	1.3	0.2	0.0	0.0	0.0	0.0	47.8	27.3	0.3	0.0	0.0	1.5	0.3	2.1	2.9	12.7	7.4	0.6	0.0	0.4	0.1	0.7	0.0	0.1	0.0	0.7	0.1
UQCRC1	"D3S3191, QCR1, UQCR1"	ENSG00000010256	"Ubiquinol-cytochrome c reductase core protein 1"	P31930	3	48599002-48610976	"Enzymes, Predicted intracellular proteins"	"Electron transport, Respiratory chain, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 172.7"	"Cell type enhanced"	"Detected in all"	4	"Cardiomyocytes: 576.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"PC-3: 65.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA002815, HPA003525, CAB033782"	Enhanced		Supported	Mitochondria		NA	NA		1300000	Mitochondria		"CAB033782: AB_2213631, HPA002815: AB_1080486, HPA003525: AB_1080484"	"unprognostic (1.29e-1)"	"unprognostic (3.15e-3)"	"unprognostic (6.91e-3)"	"unprognostic (1.06e-1)"	"unprognostic (1.66e-1)"	"unprognostic (9.91e-2)"	"unprognostic (8.53e-2)"	"unprognostic (1.99e-1)"	"unprognostic (3.11e-2)"	"unprognostic (9.14e-2)"	"unprognostic (3.37e-1)"	"unprognostic (7.20e-2)"	"prognostic favorable (2.35e-10)"	"unprognostic (5.37e-2)"	"unprognostic (2.35e-1)"	"unprognostic (1.02e-1)"	"unprognostic (6.72e-2)"	18.1	13.7	11.1	9.8	12.5	9.4	11.8	12.5	20.5	11.0	33.7	6.9	10.4	20.0	9.1	9.7	15.8	12.4	10.8	66.7	10.8	11.2	23.0	30.5	7.7	9.3	13.3	13.5	6.3	14.4	20.4	7.8	11.5	13.3	12.5	12.3	7.8	19.5	21.9	172.7	14.0	20.9	12.0	8.7	8.4	23.0	18.4	7.4	9.4	9.1	39.9	9.8	10.3	9.1	23.3	52.7	28.1	57.8	15.1	22.0	74.3	10.1	16.5	6.0	3.6	8.8	8.1	27.1	18.8	15.2	15.6	14.2	25.6	3.0	26.3	11.9	8.4	18.3	9.8	7.5	21.8	2.9	15.6	35.9	27.0	14.3	27.7	17.5	16.9	11.7	11.1	24.8	10.6	17.5	7.4	15.5	17.4	14.5	1.8	9.4	17.7	12.2	19.3	15.0	15.0	65.5	8.3	16.0	21.5	16.1	11.1	6.4	11.4	25.4	3.1	15.0	1.7	6.5	2.7	15.5	4.3	16.5	13.6	19.3	16.0	14.1	15.2	9.6	19.5	13.9	17.6	57.8	28.1	18.9	56.9	17.9	23.3	18.9	19.0	52.7	18.6	17.1	16.4	14.1	15.1	48.5	21.0	22.0	74.3	11.1	12.5	12.5	20.5	10.8	11.2	13.3	13.5	13.3	7.4	53.6	50.3	63.6	133.4	104.5	38.0	576.9	142.7	78.9	46.6	115.1	27.5	292.1	310.0	150.4	116.4	44.8	496.0	46.7	145.4	266.4	68.1	72.4	80.8	173.2	214.8	38.1	138.8	44.2	110.4	218.8	54.1	87.6	113.1	113.6	228.6	55.4	138.8	252.6	66.4	309.3	39.8	58.2	92.9	102.7	76.4	92.1	281.6	56.5	307.7	117.4
UQCRC2	"QCR2, UQCR2"	ENSG00000140740	"Ubiquinol-cytochrome c reductase core protein 2"	P22695	16	21952660-21983660	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Electron transport, Respiratory chain, Transport"		"Disease mutation, Primary mitochondrial disease"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA007998, HPA019146"	Enhanced		Enhanced	Mitochondria		NA	NA		4000000	Mitochondria		"HPA007998: AB_1858648, HPA019146: AB_1858649"	"unprognostic (1.33e-1)"	"unprognostic (1.32e-1)"	"unprognostic (1.49e-3)"	"unprognostic (3.35e-1)"	"unprognostic (1.26e-2)"	"unprognostic (6.91e-2)"	"unprognostic (2.71e-2)"	"unprognostic (1.32e-1)"	"unprognostic (1.72e-1)"	"unprognostic (8.87e-2)"	"unprognostic (1.67e-2)"	"unprognostic (2.43e-2)"	"prognostic favorable (6.58e-9)"	"unprognostic (2.33e-1)"	"unprognostic (9.78e-3)"	"unprognostic (4.67e-3)"	"unprognostic (7.36e-2)"	22.7	26.8	20.6	17.1	32.7	20.5	21.3	29.2	33.7	17.7	38.4	17.4	19.5	45.0	20.8	18.6	28.7	20.0	19.1	94.9	19.8	19.3	35.1	35.8	15.9	23.6	20.9	28.5	21.9	20.8	36.6	20.2	17.8	29.6	17.7	40.5	18.5	22.1	20.2	103.9	22.2	42.0	30.4	16.5	16.5	29.3	10.3	19.2	25.2	21.4	70.0	22.9	27.9	20.0	20.0	30.6	14.3	29.3	18.7	25.7	27.4	19.3	21.2	13.1	8.7	14.7	20.6	18.6	18.8	15.3	17.2	17.5	34.3	19.1	38.3	16.9	16.1	12.8	35.3	21.3	18.8	19.9	17.5	19.7	21.7	18.7	48.4	15.5	27.5	54.9	24.0	23.6	13.4	18.5	17.6	22.5	21.3	23.4	20.1	18.6	25.6	28.6	17.9	14.4	24.5	16.4	33.5	30.5	41.9	25.8	22.8	18.2	13.3	26.6	33.6	20.2	16.6	38.4	29.3	19.9	12.2	11.5	11.9	16.7	14.5	10.5	34.0	20.0	29.3	13.9	14.3	24.7	12.8	16.9	29.3	21.9	20.0	20.5	18.6	30.6	15.8	22.8	20.8	9.1	18.7	27.6	13.2	25.7	27.4	20.6	32.7	29.2	33.7	19.8	19.3	20.9	28.5	29.6	19.2	59.6	42.0	98.3	164.9	80.5	95.9	481.5	84.1	72.3	54.6	68.0	82.5	196.5	386.3	104.6	67.7	84.2	282.6	23.3	96.2	128.0	82.0	92.1	91.1	104.1	172.2	65.2	109.2	63.3	130.3	64.8	63.3	104.5	124.9	144.3	181.4	81.7	88.0	175.6	91.2	254.0	122.1	77.6	118.3	52.3	51.5	77.2	232.7	106.2	298.0	149.1
XPNPEP1	"XPNPEP, XPNPEPL, XPNPEPL1"	ENSG00000108039	"X-prolyl aminopeptidase 1"	Q9NQW7	10	109864766-109923553	"Enzymes, Predicted intracellular proteins"		"Aminopeptidase, Hydrolase, Metalloprotease, Protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB025196, HPA030419, HPA030420, HPA030422"	Supported		Enhanced	Cytosol		NA	NA		760000	Cytosol		"CAB025196: , HPA030419: AB_10598917, HPA030420: AB_10611523, HPA030422: AB_10601783"	"unprognostic (3.17e-2)"	"unprognostic (2.36e-2)"	"unprognostic (1.11e-1)"	"unprognostic (2.31e-2)"	"unprognostic (2.46e-1)"	"unprognostic (2.01e-3)"	"prognostic unfavorable (2.12e-5)"	"unprognostic (8.03e-2)"	"unprognostic (2.10e-2)"	"unprognostic (1.88e-1)"	"unprognostic (4.89e-2)"	"unprognostic (7.61e-2)"	"unprognostic (2.43e-2)"	"unprognostic (1.34e-2)"	"unprognostic (1.74e-1)"	"unprognostic (2.40e-1)"	"unprognostic (5.18e-2)"	16.6	14.7	13.4	16.1	18.9	12.8	13.6	14.8	22.2	15.7	20.6	19.5	14.1	33.2	17.5	16.1	17.8	15.8	20.3	17.8	13.7	11.4	18.3	21.0	14.8	14.9	13.8	14.0	17.8	46.0	14.9	15.9	19.0	17.2	16.0	26.9	15.6	19.6	11.3	18.5	20.4	38.6	18.6	11.9	18.0	16.8	15.1	12.0	9.9	15.7	15.2	24.2	14.1	13.8	5.5	24.0	10.0	21.0	14.7	10.6	13.4	25.5	11.2	18.0	24.5	29.4	27.6	13.8	14.2	29.1	21.4	23.2	21.8	22.0	36.5	12.3	21.9	10.9	13.6	14.2	17.6	21.0	10.8	13.7	24.3	7.3	9.0	20.5	18.9	20.3	27.2	10.9	23.5	20.9	32.9	35.1	23.7	7.9	11.7	27.1	8.6	13.5	11.8	7.0	19.4	12.2	15.1	36.3	6.5	27.2	8.0	5.5	20.9	12.4	7.9	23.8	20.5	9.6	17.7	18.0	8.7	11.4	13.8	12.5	19.9	9.7	31.2	20.6	26.5	6.9	10.0	13.7	5.6	10.6	21.0	7.3	5.5	7.0	9.5	24.0	4.8	5.0	6.6	1.1	14.7	17.5	18.8	7.5	13.4	13.4	18.9	14.8	22.2	13.7	11.4	13.8	14.0	17.2	12.0	6.0	15.6	11.9	11.4	7.9	19.1	15.7	20.4	12.0	10.3	3.5	5.9	33.7	14.9	29.4	4.5	12.1	36.7	0.0	63.7	24.7	19.7	19.6	10.5	9.6	27.2	25.4	16.1	16.5	16.1	4.1	17.0	17.4	8.5	39.7	34.2	24.9	47.2	35.3	28.0	18.8	18.4	12.9	8.8	8.4	37.1	7.5	21.1	20.8	34.1	19.3
XPNPEP2		ENSG00000122121	"X-prolyl aminopeptidase 2"	O43895	X	129738974-129769538	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"		"Aminopeptidase, Hydrolase, Metalloprotease, Protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	9	"intestine: 145.6;kidney: 49.7"	"Cell type enhanced"	"Detected in some"	23	"Enterocytes: 21.3;Hepatocytes: 11.6;Proximal tubular cells: 49.7"	"Group enriched"	"Detected in many"	6	"colorectal cancer: 5.3;liver cancer: 18.3;stomach cancer: 3.9"	"Not detected"	"Not detected"			"Group enriched"	"Detected in many"	4	"gdT-cell: 7.3;intermediate monocyte: 2.1;MAIT T-cell: 2.2;memory CD4 T-cell: 2.4;memory CD8 T-cell: 4.8;naive CD8 T-cell: 3.6;non-classical monocyte: 4.4;T-reg: 2.2"	"Group enriched"	"Detected in many"	7	"monocytes: 4.4;T-cells: 7.3"	"Cell line enhanced"	"Detected in some"		"ASC diff: 6.3;ASC TERT1: 33.4;HSkMC: 16.9"	"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"HPA000339, CAB025136, CAB025269, HPA064568"	Enhanced		Approved	"Plasma membrane,Cytosol"	"Intracellular and membrane"	NA	NA		8900000	"Plasma membrane, Cytosol"		"CAB025136: , CAB025269: , HPA000339: AB_1858894, HPA064568: "	"unprognostic (7.95e-2)"	"unprognostic (5.73e-2)"	"unprognostic (2.56e-1)"	"unprognostic (6.21e-3)"	"unprognostic (3.54e-2)"	"unprognostic (1.54e-1)"	"unprognostic (4.04e-1)"	"unprognostic (3.26e-1)"	"unprognostic (3.01e-1)"	"unprognostic (2.41e-2)"	"unprognostic (3.07e-1)"	"unprognostic (9.28e-3)"	"unprognostic (2.77e-2)"	"unprognostic (6.53e-2)"	"unprognostic (3.18e-2)"	"unprognostic (1.39e-2)"	"unprognostic (3.26e-3)"	4.7	0.5	0.0	1.1	0.1	0.0	3.2	0.0	0.1	1.7	57.4	0.1	0.8	37.0	1.2	1.7	4.2	3.4	1.3	2.6	0.0	0.0	49.7	8.0	1.0	1.2	0.0	0.0	3.5	0.9	0.0	0.0	0.6	0.1	3.6	2.0	0.7	0.7	0.3	1.6	2.1	145.6	2.5	0.1	0.2	1.7	1.2	0.0	0.1	0.9	1.4	0.3	4.0	10.7	0.4	0.8	0.2	4.4	0.0	7.3	1.3	0.0	0.0	0.5	0.0	6.3	33.4	0.4	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.8	0.0	0.0	16.9	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.2	0.2	0.0	0.0	0.0	0.4	0.0	0.6	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	1.6	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	7.3	2.1	2.2	0.0	2.4	4.8	0.3	0.4	0.7	3.6	0.2	0.0	4.4	0.8	2.2	1.3	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.5	0.0	1.6	0.0	0.4	0.0	0.0	0.0	1.8	0.0	0.1	5.0	0.0	0.0	0.0	21.3	0.0	0.0	0.0	4.4	0.0	0.0	11.6	0.7	0.0	1.2	0.6	0.3	0.0	0.0	0.0	1.7	0.0	0.9	0.0	0.0	5.8	0.0	49.7	0.0	0.0	0.2	0.0	0.0	0.9	1.0	0.0	0.2	0.0
XPNPEP3	"APP3, ICP55, NPHPL1"	ENSG00000196236	"X-prolyl aminopeptidase 3"	Q9NQH7	22	40857077-40932815	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"		"Aminopeptidase, Hydrolase, Metalloprotease, Protease"	"Disease mutation, Nephronophthisis"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in many"	4	"Early spermatids: 196.2;Late spermatids: 233.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"							HPA000527	Approved		Supported	Mitochondria,Cytosol		NA	NA			Mitochondria	Cytosol	"HPA000527: AB_1079266"	"prognostic unfavorable (8.19e-4)"	"unprognostic (6.77e-2)"	"unprognostic (3.22e-3)"	"unprognostic (5.03e-3)"	"unprognostic (6.18e-2)"	"unprognostic (1.29e-1)"	"unprognostic (1.65e-1)"	"unprognostic (1.13e-1)"	"unprognostic (1.64e-1)"	"unprognostic (2.53e-1)"	"unprognostic (1.73e-2)"	"unprognostic (1.51e-1)"	"unprognostic (6.69e-2)"	"unprognostic (8.00e-3)"	"unprognostic (2.49e-1)"	"prognostic unfavorable (6.10e-4)"	"unprognostic (1.24e-1)"	8.2	13.6	7.5	5.8	9.2	4.7	9.7	5.2	7.8	7.3	6.1	10.8	11.6	32.3	10.7	12.3	7.2	9.4	10.5	11.2	7.6	7.1	9.8	19.0	6.6	10.6	7.9	6.1	10.7	10.5	8.0	15.0	6.1	10.7	7.3	6.2	9.3	8.5	13.6	12.0	11.5	20.9	7.1	9.3	7.7	6.8	18.9	8.2	11.5	9.1	7.3	8.8	12.6	8.2	5.9	6.0	6.4	10.0	1.2	4.4	4.0	3.3	4.7	3.2	7.1	9.0	6.0	2.2	4.1	3.1	2.3	2.3	3.9	2.1	6.5	2.3	7.9	9.7	7.6	6.0	3.2	3.4	3.9	12.4	4.2	9.3	7.3	4.1	7.4	0.7	5.3	5.0	7.2	4.3	3.5	4.0	4.6	3.5	5.9	4.9	5.0	3.5	3.9	1.9	6.0	9.6	4.9	4.3	3.7	6.5	4.4	2.8	2.5	4.1	6.1	3.8	3.5	7.1	3.4	4.0	4.7	4.1	4.3	2.4	5.6	4.2	7.9	7.2	9.6	3.2	4.0	4.4	4.4	3.4	3.9	1.8	5.9	2.1	2.2	3.1	3.7	4.4	3.3	6.4	1.2	10.0	6.0	3.0	4.0	7.5	9.2	5.2	7.8	7.6	7.1	7.9	6.1	10.7	8.2	6.0	21.2	6.5	6.9	11.7	14.9	17.6	20.4	29.4	13.6	8.7	17.7	17.8	13.3	11.7	196.2	11.7	4.2	0.0	14.7	16.0	11.3	6.7	13.9	32.1	12.4	15.9	13.3	11.1	13.5	233.7	18.4	13.0	16.9	2.8	9.5	12.1	10.8	9.7	14.5	18.6	19.3	32.3	13.2	50.5	32.5	14.3	16.7	5.0	10.6	6.2
YME1L1		ENSG00000136758	"YME1 like 1 ATPase"	Q96TA2	10	27110112-27155266	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"		"Hydrolase, Metalloprotease, Protease"	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA066953	Approved		Supported	"Nuclear bodies,Mitochondria"		NA	NA			Mitochondria	"Nuclear bodies"	"HPA066953: AB_2685753"	"unprognostic (2.28e-3)"	"unprognostic (3.00e-2)"	"unprognostic (1.34e-1)"	"unprognostic (7.19e-2)"	"unprognostic (8.12e-2)"	"unprognostic (2.47e-1)"	"prognostic unfavorable (8.25e-6)"	"unprognostic (7.08e-2)"	"unprognostic (2.91e-1)"	"unprognostic (9.24e-2)"	"unprognostic (9.43e-3)"	"unprognostic (1.64e-1)"	"unprognostic (1.21e-1)"	"unprognostic (1.03e-1)"	"unprognostic (5.53e-2)"	"unprognostic (1.44e-2)"	"unprognostic (7.09e-2)"	27.8	37.3	22.7	25.0	26.2	41.4	39.2	27.8	27.5	27.6	24.3	15.7	29.8	22.3	29.9	35.9	34.5	25.3	24.4	34.1	23.4	21.5	26.8	45.4	26.9	38.7	19.3	25.5	32.5	33.8	27.8	28.6	33.4	22.0	25.9	26.3	23.3	28.1	31.3	79.0	26.8	25.3	34.6	20.2	26.5	24.7	24.7	20.9	41.7	30.9	32.0	28.9	36.4	28.9	55.6	79.2	73.9	53.0	45.5	56.0	45.9	40.9	30.8	36.8	18.2	36.2	38.9	30.1	40.5	23.7	41.5	47.7	41.5	50.4	43.6	26.9	44.6	29.8	39.6	44.2	35.7	45.9	39.6	26.5	41.5	27.4	29.1	39.7	28.3	34.1	31.9	42.3	36.2	36.7	36.7	43.4	39.9	48.1	44.5	45.8	27.7	52.3	16.4	29.2	34.2	14.4	45.3	59.1	40.4	33.9	19.5	28.4	36.4	40.4	31.4	40.5	31.8	30.1	35.5	42.5	25.2	35.2	42.2	36.2	22.4	32.8	55.8	35.8	52.6	19.2	53.0	53.0	55.2	55.3	44.8	56.0	51.4	53.8	51.2	42.6	55.6	49.7	51.9	73.9	45.5	47.3	79.2	52.6	45.9	22.7	26.2	27.8	27.5	23.4	21.5	19.3	25.5	22.0	20.9	62.5	66.8	93.1	70.6	62.3	52.1	93.2	25.5	80.3	70.5	27.9	78.5	53.8	13.3	45.6	37.7	61.8	166.4	0.0	41.6	60.0	62.5	67.3	107.5	64.8	64.5	47.7	48.2	55.3	92.4	21.3	53.5	112.2	54.0	43.3	68.3	59.1	53.7	84.2	40.7	38.2	67.9	71.1	75.6	83.7	30.3	56.8	79.3	84.7	70.3	58.6
ZMPSTE24	"FACE-1, HGPS, PRO1, STE24, Ste24p"	ENSG00000084073	"Zinc metallopeptidase STE24"	O75844	1	40258107-40294184	"Disease related genes, Enzymes, Potential drug targets, Predicted membrane proteins, Transporters"		"Hydrolase, Metalloprotease, Protease"	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA006988	Approved					NA	NA		13000			"HPA006988: AB_1080659"	"unprognostic (6.32e-2)"	"unprognostic (1.63e-2)"	"unprognostic (3.75e-3)"	"unprognostic (4.63e-2)"	"unprognostic (4.16e-3)"	"unprognostic (1.37e-1)"	"prognostic unfavorable (5.73e-6)"	"unprognostic (1.86e-1)"	"unprognostic (1.17e-1)"	"unprognostic (1.84e-3)"	"unprognostic (4.78e-2)"	"unprognostic (7.96e-2)"	"unprognostic (5.06e-2)"	"unprognostic (3.65e-2)"	"unprognostic (2.65e-1)"	"prognostic unfavorable (6.34e-4)"	"unprognostic (2.71e-2)"	21.6	24.2	17.6	15.4	19.6	6.5	18.6	10.7	21.3	20.9	20.6	14.9	27.0	17.9	29.7	19.7	21.4	19.9	20.7	20.8	17.1	16.9	34.2	48.7	16.2	23.1	21.9	17.0	16.0	20.4	39.8	17.0	23.0	23.5	21.7	23.3	15.6	18.9	19.0	19.1	14.7	20.9	25.2	19.2	17.7	19.0	10.7	17.9	20.9	20.6	14.7	18.4	19.1	16.7	15.1	25.8	15.1	23.9	24.2	22.5	20.3	20.9	14.0	10.9	8.1	29.0	23.3	21.2	22.0	18.4	24.9	22.8	15.3	36.4	18.1	15.3	26.9	9.7	21.8	22.3	20.3	28.7	17.0	14.3	17.4	15.0	14.0	16.6	28.1	21.9	16.8	20.8	21.2	9.2	14.0	17.4	9.0	18.5	18.2	23.5	9.8	17.0	8.4	21.0	13.9	14.6	14.8	19.4	22.4	22.0	20.3	11.4	13.5	20.3	45.3	27.3	17.6	16.7	77.7	17.3	22.5	16.5	20.9	26.7	11.2	30.0	15.8	24.7	19.8	23.8	15.1	20.0	13.6	17.9	23.9	21.5	15.1	19.1	18.9	25.8	11.6	17.0	22.5	11.8	24.2	22.7	16.9	22.3	20.3	17.6	19.6	10.7	21.3	17.1	16.9	21.9	17.0	23.5	17.9	35.7	23.7	17.1	19.8	28.4	5.7	18.7	50.9	49.5	28.4	69.8	0.0	33.1	26.6	47.9	2.1	31.5	34.1	0.0	31.7	32.0	28.1	33.2	20.7	56.7	30.7	9.5	26.5	20.3	28.9	0.5	26.4	29.6	23.6	31.5	26.3	29.0	37.5	25.9	30.8	33.7	6.3	0.0	21.5	7.0	5.5	23.7	32.6	17.5	28.0	19.9
